1	I	PRP	O	I	_	0	SENT_1	[p1l1641t142r1677b159],
2	/	:	O	/	punct	1	SENT_1	[p1l1641t142r1677b159],
3	ﬁe	NN	O	ﬁe	dep	1	SENT_1	[p1l1641t142r1677b159],
4	»	CD	NUMBER	»	num	5	SENT_1	[p1l1641t142r1677b159],
5	_	NN	O	_	dep	3	SENT_1	[p1l1699t138r1725b162],
6	/	:	O	/	punct	1	SENT_1	[p1l1699t138r1725b162],
7	'	''	O	'	_	0	SENT_1	[p1l1713t164r1717b166],

1	A	DT	O	a	det	3	SENT_2	[p1l1759t172r1770b184],
2	LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL	NN	O	llllllllllllllllllllllllllllllll	nn	3	SENT_2	[p1l1771t172r2051b184],
3	ev	NN	O	ev	_	0	SENT_2	[p1l2052t175r2068b184],
4	Advancing	VBG	O	advance	dep	3	SENT_2	[p1l1759t197r1813b208],
5	C/imcal	NNP	O	C/imcal	nn	9	SENT_2	[p1l1816t197r1853b206],
6	Cale	NNP	O	Cale	nn	9	SENT_2	[p1l1856t197r1880b206],
7	MNVQH	NNP	O	MNVQH	nn	9	SENT_2	[p1l1884t197r1922b208],
8	Fharmacaioslf	NNP	O	Fharmacaioslf	nn	9	SENT_2	[p1l1925t197r2003b208],
9	‘	NN	O	‘	pobj	4	SENT_2	[p1l1925t197r2003b208],

1	Drug	NN	O	drug	nn	2	SENT_3	[p1l94t178r171b216],
2	Interactions	NNS	O	interaction	_	0	SENT_3	[p1l185t178r362b207],

1	The	DT	O	the	det	2	SENT_4	[p1l1631t269r1676b290],
2	journal	NN	O	journal	_	0	SENT_4	[p1l1684t269r1766b297],
3	of	IN	O	of	_	0	SENT_4	[p1l1778t269r1802b290],
4	Clinical	JJ	O	clinical	amod	5	SENT_4	[p1l1811t269r1894b290],
5	Pharmacology	NN	O	pharmacology	prep_of	2	SENT_4	[p1l1906t269r2068b297],

1	Different	JJ	O	different	amod	2	SENT_5	[p1l97t286r369b333],
2	Effects	NNS	O	effect	_	0	SENT_5	[p1l394t286r592b333],
3	of	IN	O	of	_	0	SENT_5	[p1l615t285r677b333],
4	Clopidogrel	NNP	O	Clopidogrel	prep_of	2	SENT_5	[p1l694t286r1050b348],
5	and	CC	O	and	cc	2	SENT_5	[p1l1076t286r1182b333],
6	;	:	O	;	_	0	SENT_5	[p1l1630t305r1910b368],
7	3	CD	NUMBER	3	num	8	SENT_5	[p1l1630t305r1910b368],
8	(	NN	O	(	dep	2	SENT_5	[p1l1630t305r1910b368],
9	?	.	O	?	_	0	SENT_5	[p1l1630t305r1910b368],

1	hss2	NN	O	hss2	nn	3	SENT_6	[p1l1630t305r1910b368],
2	—	CD	NUMBER	—	num	3	SENT_6	[p1l1630t305r1910b368],
3	shs8	NN	O	shs8	_	0	SENT_6	[p1l1630t305r1910b368],
4	(	CD	NUMBER	(	number	5	SENT_6	[p1l1630t305r1910b368],
5	)	CD	NUMBER	)	dep	3	SENT_6	[p1l1630t305r1910b368],
6	20	CD	NUMBER	20	num	7	SENT_6	[p1l1630t305r1910b368],
7	|	NN	O	|	dep	5	SENT_6	[p1l1630t305r1910b368],
8	3	CD	NUMBER	3	dep	3	SENT_6	[p1l1630t305r1910b368],

1	. . . .	NN	O	. . . .	_	0	SENT_7	[p1l1220t361r1231b372],[p1l230t361r241b372],
2	e	SYM	O	e	dep	3	SENT_7	[p1l1706t347r1718b361],
3	Ut	NNP	O	Ut	rcmod	1	SENT_7	[p1l1749t345r1772b361],
4	or	CC	O	or	prep	1	SENT_7	[p1l1787t347r1813b361],
5	S	NN	O	s	dep	4	SENT_7	[p1l1824t347r1833b361],

1	Clarlthromycln	NN	PERSON	clarlthromycln	_	0	SENT_8	[p1l95t361r561b422],
2	on	IN	O	on	dep	1	SENT_8	[p1l587t376r659b408],
3	the	DT	O	the	det	7	SENT_8	[p1l682t362r781b408],
4	Enantloselectlve	JJ	MISC	enantloselectlve	amod	7	SENT_8	[p1l808t361r1303b408],
5	Dot	NN	MISC	dot	nn	7	SENT_8	[p1l1633t376r1689b397],
6	I0	NN	MISC	i0	nn	7	SENT_8	[p1l1706t376r1885b403],
7	~	NN	O	~	pobj	2	SENT_8	[p1l1706t376r1885b403],
8	I	PRP	O	I	nsubj	9	SENT_8	[p1l1706t376r1885b403],
9	°	VBP	O	°	rcmod	7	SENT_8	[p1l1706t376r1885b403],
10	02/icr	JJ	O	02/icr	acomp	9	SENT_8	[p1l1706t376r1885b403],
11	>	JJR	O	>	amod	12	SENT_8	[p1l1706t376r1885b403],
12	h.	NN	O	h.	ccomp	9	SENT_8	[p1l1706t376r1885b403],
13	69	CD	NUMBER	69	num	14	SENT_8	[p1l1706t376r1885b403],
14	Pharmacokinetics	NNS	O	pharmacokinetic	dobj	12	SENT_8	[p1l98t436r642b484],
15	of	IN	O	of	_	0	SENT_8	[p1l665t436r727b484],
16	Sibutramine	NN	O	sibutramine	prep_of	14	SENT_8	[p1l744t436r1120b484],
17	and	CC	O	and	_	0	SENT_8	[p1l1144t437r1250b484],
18	its	PRP$	O	its	poss	20	SENT_8	[p1l1276t436r1344b484],
19	Active	JJ	O	active	amod	20	SENT_8	[p1l1365t436r1562b484],
20	Metabolites	NNS	O	metabolite	prep_of	14	SENT_8	[p1l97t506r451b553],
21	in	IN	O	in	_	0	SENT_8	[p1l475t506r525b553],
22	Healthy	JJ	O	healthy	amod	23	SENT_8	[p1l553t507r790b567],
23	Subjects	NNS	O	subject	prep_in	12	SENT_8	[p1l812t506r1066b568],

1	Dhananjay	NNP	PERSON	Dhananjay	nn	3	SENT_9	[p1l96t654r335b700],
2	D.	NNP	PERSON	D.	nn	3	SENT_9	[p1l350t654r397b689],
3	Shinde	NNP	PERSON	Shinde	_	0	SENT_9	[p1l414t653r579b697],
4	,	,	O	,	_	0	SENT_9	[p1l414t653r579b697],
5	PhD	NN	O	phd	appos	3	SENT_9	[p1l597t643r726b697],
6	'	''	O	'	_	0	SENT_9	[p1l597t643r726b697],
7	,	,	O	,	_	0	SENT_9	[p1l597t643r726b697],
8	Ho-Sook	NNP	PERSON	Ho-Sook	nn	9	SENT_9	[p1l743t653r944b689],
9	Kim	NNP	PERSON	Kim	appos	3	SENT_9	[p1l958t654r1063b697],
10	,	,	O	,	_	0	SENT_9	[p1l958t654r1063b697],
11	PhD	NN	O	phd	appos	3	SENT_9	[p1l1081t643r1210b697],
12	'	''	O	'	_	0	SENT_9	[p1l1081t643r1210b697],
13	,	,	O	,	_	0	SENT_9	[p1l1081t643r1210b697],
14	Jae-Seok	NNP	PERSON	Jae-Seok	nn	15	SENT_9	[p1l1222t653r1423b698],
15	Choi	NNP	PERSON	Choi	appos	3	SENT_9	[p1l1436t653r1556b697],
16	,	,	O	,	_	0	SENT_9	[p1l1436t653r1556b697],
17	MS	NN	O	m	appos	3	SENT_9	[p1l1574t643r1676b697],
18	'	''	O	'	_	0	SENT_9	[p1l1574t643r1676b697],
19	,	,	O	,	_	0	SENT_9	[p1l1574t643r1676b697],
20	Wei	NNP	PERSON	Wei	nn	21	SENT_9	[p1l93t712r189b748],
21	Pan	NNP	PERSON	Pan	appos	3	SENT_9	[p1l207t712r302b755],
22	,	,	O	,	_	0	SENT_9	[p1l207t712r302b755],
23	MD	NNP	O	MD	poss	25	SENT_9	[p1l319t701r449b755],
24	'	POS	O	'	_	0	SENT_9	[p1l319t701r449b755],
25	*	NN	O	*	appos	3	SENT_9	[p1l319t701r449b755],
26	,	,	O	,	_	0	SENT_9	[p1l319t701r449b755],
27	Soo	NNP	PERSON	Soo	nn	29	SENT_9	[p1l465t712r550b748],
28	Kyung	NNP	PERSON	Kyung	nn	29	SENT_9	[p1l567t712r708b759],
29	Bae	NNP	PERSON	Bae	appos	25	SENT_9	[p1l724t712r820b756],
30	,	,	O	,	_	0	SENT_9	[p1l724t712r820b756],
31	PhD	NN	O	phd	appos	29	SENT_9	[p1l838t701r967b755],
32	'	''	O	'	_	0	SENT_9	[p1l838t701r967b755],
33	,	,	O	,	_	0	SENT_9	[p1l838t701r967b755],
34	Chang-Woo	NNP	PERSON	Chang-Woo	nn	35	SENT_9	[p1l983t712r1262b759],
35	Yeo	NNP	PERSON	Yeo	appos	29	SENT_9	[p1l1275t712r1378b755],
36	,	,	O	,	_	0	SENT_9	[p1l1275t712r1378b755],
37	MD	NNP	O	MD	appos	29	SENT_9	[p1l1396t712r1487b756],
38	,	,	O	,	_	0	SENT_9	[p1l1396t712r1487b756],
39	PhD	NNP	O	PhD	appos	29	SENT_9	[p1l1505t701r1664b755],
40	"	``	O	"	punct	39	SENT_9	[p1l1505t701r1664b755],
41	2	CD	NUMBER	2	dep	39	SENT_9	[p1l1505t701r1664b755],
42	,	,	O	,	_	0	SENT_9	[p1l1505t701r1664b755],
43	ji-Hong	NNP	O	ji-Hong	nn	44	SENT_9	[p1l91t771r265b817],
44	Shon	NNP	PERSON	Shon	appos	29	SENT_9	[p1l279t770r405b814],
45	,	,	O	,	_	0	SENT_9	[p1l279t770r405b814],
46	MD	NNP	O	MD	nn	48	SENT_9	[p1l423t771r514b814],
47	,	,	O	,	_	0	SENT_9	[p1l423t771r514b814],
48	PhD	NNP	O	PhD	appos	3	SENT_9	[p1l532t760r691b814],
49	"	``	O	"	punct	50	SENT_9	[p1l532t760r691b814],
50	2	CD	NUMBER	2	dep	3	SENT_9	[p1l532t760r691b814],
51	,	,	O	,	_	0	SENT_9	[p1l532t760r691b814],
52	Dong-Hyun	NNP	PERSON	Dong-Hyun	nn	53	SENT_9	[p1l708t771r967b817],
53	Kim	NNP	PERSON	Kim	appos	50	SENT_9	[p1l985t771r1089b814],
54	,	,	O	,	_	0	SENT_9	[p1l985t771r1089b814],
55	PhD	NN	O	phd	appos	50	SENT_9	[p1l1107t760r1236b814],
56	'	''	O	'	_	0	SENT_9	[p1l1107t760r1236b814],
57	,	,	O	,	_	0	SENT_9	[p1l1107t760r1236b814],
58	and	CC	O	and	_	0	SENT_9	[p1l1263t771r1343b806],
59	Jae	NNP	PERSON	Jae	nn	61	SENT_9	[p1l1355t771r1425b815],
60	Gook	NNP	PERSON	Gook	nn	61	SENT_9	[p1l1440t770r1566b806],
61	Shin	NNP	PERSON	Shin	conj_and	50	SENT_9	[p1l1579t770r1689b814],
62	,	,	O	,	_	0	SENT_9	[p1l1579t770r1689b814],
63	MD	NNP	O	MD	nn	65	SENT_9	[p1l1707t771r1798b814],
64	,	,	O	,	_	0	SENT_9	[p1l1707t771r1798b814],
65	PhD	NNP	O	PhD	appos	61	SENT_9	[p1l1816t760r1962b806],
66	"	``	O	"	punct	65	SENT_9	[p1l1816t760r1962b806],
67	2	CD	NUMBER	2	dep	65	SENT_9	[p1l1816t760r1962b806],

1	Abstract	JJ	O	abstract	ccomp	7	SENT_10	[p1l93t892r260b922],
2	In	IN	O	in	dep	1	SENT_10	[p1l95t952r116b976],
3	this	DT	O	this	det	4	SENT_10	[p1l127t952r174b976],
4	study	NN	O	study	pobj	2	SENT_10	[p1l186t952r262b984],
5	,	,	O	,	_	0	SENT_10	[p1l186t952r262b984],
6	we	PRP	O	we	nsubj	7	SENT_10	[p1l273t960r312b976],
7	assessed	VBD	O	assess	_	0	SENT_10	[p1l323t952r432b976],
8	the	DT	O	the	det	9	SENT_10	[p1l443t952r486b976],
9	effects	NNS	O	effect	dobj	7	SENT_10	[p1l497t952r581b976],
10	of	IN	O	of	_	0	SENT_10	[p1l593t952r620b976],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_10	[p1l629t952r774b984],
12	and	CC	O	and	_	0	SENT_10	[p1l786t952r832b976],
13	clarithromycin	NN	O	clarithromycin	prep_of	9	SENT_10	[p1l844t952r1042b984],
14	,	,	O	,	_	0	SENT_10	[p1l844t952r1042b984],
15	known	VBN	O	know	partmod	9	SENT_10	[p1l1055t952r1142b976],
16	CYPZB6	NN	O	cypzb6	nn	19	SENT_10	[p1l1155t952r1265b976],
17	and	CC	O	and	_	0	SENT_10	[p1l1276t952r1321b976],
18	CYP3A	NN	O	cyp3a	nn	19	SENT_10	[p1l1334t952r1431b976],
19	inhibitors	NNS	O	inhibitor	dobj	15	SENT_10	[p1l1442t952r1572b980],
20	,	,	O	,	_	0	SENT_10	[p1l1442t952r1572b980],
21	respectively	RB	O	respectively	advmod	15	SENT_10	[p1l1586t952r1748b984],
22	,	,	O	,	_	0	SENT_10	[p1l1586t952r1748b984],
23	on	IN	O	on	_	0	SENT_10	[p1l1760t960r1792b976],
24	the	DT	O	the	det	26	SENT_10	[p1l1803t952r1846b976],
25	enantioselective	JJ	O	enantioselective	amod	26	SENT_10	[p1l1857t952r2068b976],
26	disposition	NN	O	disposition	prep_on	15	SENT_10	[p1l94t993r234b1025],
27	of	IN	O	of	_	0	SENT_10	[p1l246t993r273b1017],
28	racemic	JJ	O	racemic	amod	29	SENT_10	[p1l283t995r385b1017],
29	sibutramine	NN	O	sibutramine	prep_of	26	SENT_10	[p1l396t993r550b1017],
30	in	IN	O	in	_	0	SENT_10	[p1l561t995r582b1017],
31	conjunction	NN	O	conjunction	prep_in	7	SENT_10	[p1l594t995r748b1024],
32	with	IN	O	with	_	0	SENT_10	[p1l759t993r816b1017],
33	CYPZB6	NN	O	cypzb6	nn	34	SENT_10	[p1l828t993r926b1017],
34	polymorphisms	NNS	O	polymorphism	prep_with	7	SENT_10	[p1l938t993r1140b1025],
35	in	IN	O	in	_	0	SENT_10	[p1l1152t995r1172b1017],
36	humans	NNS	O	human	prep_in	34	SENT_10	[p1l1185t993r1291b1017],
37	.	.	O	.	_	0	SENT_10	[p1l1185t993r1291b1017],

1	Sibutramine	NN	O	sibutramine	nsubj	2	SENT_11	[p1l1302t993r1459b1017],
2	showed	VBD	O	show	_	0	SENT_11	[p1l1470t993r1571b1017],
3	enantioselective	JJ	O	enantioselective	amod	5	SENT_11	[p1l1582t993r1793b1017],
4	plasma	NN	O	plasma	nn	5	SENT_11	[p1l1805t993r1893b1025],
5	proﬁles	NNS	O	proﬁles	dobj	2	SENT_11	[p1l1904t993r2000b1025],
6	with	IN	O	with	_	0	SENT_11	[p1l2010t993r2066b1017],
7	consistently	RB	O	consistently	advmod	8	SENT_11	[p1l94t1034r249b1066],
8	higher	JJR	O	higher	amod	9	SENT_11	[p1l259t1034r340b1066],
9	concentrations	NNS	O	concentration	prep_with	2	SENT_11	[p1l349t1036r546b1058],
10	of	IN	O	of	_	0	SENT_11	[p1l556t1034r583b1058],
11	R-enantiomers	NNS	O	r-enantiomer	prep_of	9	SENT_11	[p1l590t1034r789b1058],
12	.	.	O	.	_	0	SENT_11	[p1l590t1034r789b1058],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	5	SENT_12	[p1l799t1034r953b1066],
2	and	CC	O	and	_	0	SENT_12	[p1l963t1034r1008b1058],
3	clarithromycin	NN	O	clarithromycin	conj_and	1	SENT_12	[p1l1019t1034r1209b1066],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_12	[p1l1220t1034r1369b1066],
5	increased	VBD	O	increase	_	0	SENT_12	[p1l1379t1034r1502b1058],
6	the	DT	O	the	det	9	SENT_12	[p1l1511t1034r1553b1058],
7	sibutramine	NN	O	sibutramine	nn	9	SENT_12	[p1l1563t1034r1717b1058],
8	plasma	NN	O	plasma	nn	9	SENT_12	[p1l1727t1034r1815b1066],
9	concentration	NN	O	concentration	dobj	5	SENT_12	[p1l1824t1036r2015b1062],
10	,	,	O	,	_	0	SENT_12	[p1l1824t1036r2015b1062],
11	but	CC	O	but	_	0	SENT_12	[p1l2026t1034r2069b1058],
12	their	PRP$	O	they	poss	13	SENT_12	[p1l92t1075r156b1099],
13	effects	NNS	O	effect	nsubj	14	SENT_12	[p1l169t1075r252b1099],
14	differed	VBD	O	differ	conj_but	5	SENT_12	[p1l266t1075r365b1099],
15	between	IN	O	between	_	0	SENT_12	[p1l380t1075r491b1099],
16	enantiomers	NNS	O	enantiomer	prep_between	14	SENT_12	[p1l505t1077r676b1102],
17	;	:	O	;	_	0	SENT_12	[p1l505t1077r676b1102],
18	a	DT	O	a	det	19	SENT_12	[p1l689t1083r703b1099],
19	2.2-fold	JJ	O	2.2-fold	dep	16	SENT_12	[p1l715t1075r814b1099],
20	versus	CC	O	versus	prep	19	SENT_12	[p1l827t1083r911b1099],
21	4.l-fold	JJ	O	4.l-fold	amod	22	SENT_12	[p1l924t1075r1024b1099],
22	increase	NN	O	increase	dep	20	SENT_12	[p1l1038t1077r1145b1099],
23	in	IN	O	in	_	0	SENT_12	[p1l1159t1077r1179b1099],
24	the	DT	O	the	det	25	SENT_12	[p1l1193t1075r1235b1099],
25	AUC	NN	ORGANIZATION	auc	prep_in	22	SENT_12	[p1l1247t1075r1315b1099],
26	in	IN	O	in	_	0	SENT_12	[p1l1329t1077r1350b1099],
27	S-enantiomer	NN	O	s-enantiomer	prep_in	25	SENT_12	[p1l1364t1075r1542b1099],
28	and	CC	O	and	_	0	SENT_12	[p1l1554t1075r1599b1099],
29	|	NN	O	|	prep_in	25	SENT_12	[p1l1618t1075r1712b1099],
30	.8	CD	NUMBER	.8	num	29	SENT_12	[p1l1618t1075r1712b1099],
31	-	:	O	-	_	0	SENT_12	[p1l1618t1075r1712b1099],
32	fold	JJ	O	fold	dep	19	SENT_12	[p1l1618t1075r1712b1099],
33	versus	CC	O	versus	prep	32	SENT_12	[p1l1725t1083r1809b1099],
34	2.0-fold	JJ	O	2.0-fold	dep	33	SENT_12	[p1l1823t1075r1921b1099],
35	for	IN	O	for	_	0	SENT_12	[p1l1934t1075r1974b1099],
36	the	DT	O	the	det	37	SENT_12	[p1l1985t1075r2028b1099],
37	Renantiomer	NNP	MISC	Renantiomer	prep_for	34	SENT_12	[p1l2041t1075r2067b1099, p1l94t1118r252b1143],
38	,	,	O	,	_	0	SENT_12	[p1l2041t1075r2067b1099, p1l94t1118r252b1143],
39	respectively	RB	O	respectively	advmod	14	SENT_12	[p1l266t1116r428b1148],
40	.	.	O	.	_	0	SENT_12	[p1l266t1116r428b1148],

1	The	DT	O	the	det	2	SENT_13	[p1l440t1116r492b1140],
2	AUCs	NNS	O	auc	nsubj	9	SENT_13	[p1l503t1116r584b1140],
3	of	IN	O	of	_	0	SENT_13	[p1l596t1116r623b1140],
4	S	NN	O	s	prep_of	2	SENT_13	[p1l634t1116r657b1140],
5	-	:	O	-	_	0	SENT_13	[p1l634t1116r657b1140],
6	and	CC	O	and	_	0	SENT_13	[p1l670t1116r715b1140],
7	R-desmethyl	NN	O	r-desmethyl	nn	8	SENT_13	[p1l729t1116r889b1148],
8	metabolites	NNS	O	metabolite	prep_of	2	SENT_13	[p1l903t1116r1054b1140],
9	changed	VBD	O	change	_	0	SENT_13	[p1l1068t1116r1173b1147],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_13	[p1l1186t1116r1336b1148],
11	during	IN	O	during	_	0	SENT_13	[p1l1348t1116r1431b1147],
12	the	DT	O	the	det	14	SENT_13	[p1l1442t1116r1485b1140],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_13	[p1l1497t1116r1642b1148],
14	phase	NN	O	phase	prep_during	9	SENT_13	[p1l1657t1116r1730b1148],
15	(	CD	NUMBER	(	num	16	SENT_13	[p1l1743t1116r1768b1148],
16	P	NN	O	p	npadvmod	17	SENT_13	[p1l1743t1116r1768b1148],
17	<	JJR	O	<	amod	14	SENT_13	[p1l1781t1121r1801b1141],
18	.	.	O	.	_	0	SENT_13	[p1l1816t1116r1866b1140],

1	ool	NN	O	ool	dep	4	SENT_14	[p1l1816t1116r1866b1140],
2	and	CC	O	and	_	0	SENT_14	[p1l1884t1116r1929b1140],
3	P	NN	O	p	dep	4	SENT_14	[p1l1942t1116r1957b1140],
4	<	JJR	O	<	_	0	SENT_14	[p1l1970t1121r1990b1141],
5	.	.	O	.	_	0	SENT_14	[p1l2005t1116r2067b1143],

1	ool	NN	O	ool	_	0	SENT_15	[p1l2005t1116r2067b1143],
2	,	,	O	,	_	0	SENT_15	[p1l2005t1116r2067b1143],
3	respectively	RB	O	respectively	advmod	4	SENT_15	[p1l95t1157r259b1189],
4	)	CD	NUMBER	)	appos	1	SENT_15	[p1l95t1157r259b1189],
5	but	CC	O	but	prep	4	SENT_15	[p1l272t1157r315b1181],
6	not	RB	O	not	advmod	21	SENT_15	[p1l325t1162r369b1181],
7	during	IN	O	during	_	0	SENT_15	[p1l378t1157r462b1189],
8	the	DT	O	the	det	12	SENT_15	[p1l470t1157r512b1181],
9	clarithromycin	NN	O	clarithromycin	nn	12	SENT_15	[p1l523t1157r713b1189],
10	phase	NN	O	phase	nn	12	SENT_15	[p1l725t1157r798b1189],
11	(	CD	NUMBER	(	num	12	SENT_15	[p1l809t1157r833b1189],
12	P	NN	O	p	prep_during	6	SENT_15	[p1l809t1157r833b1189],
13	=	JJ	O	=	amod	12	SENT_15	[p1l846t1168r868b1176],
14	.099	CD	NUMBER	.099	tmod	13	SENT_15	[p1l882t1157r937b1181],
15	and	CC	O	and	_	0	SENT_15	[p1l947t1157r992b1181],
16	P	NN	O	p	prep_during	6	SENT_15	[p1l1003t1157r1018b1181],
17	=	JJ	O	=	amod	16	SENT_15	[p1l1030t1168r1053b1176],
18	.090	CD	NUMBER	.090	tmod	17	SENT_15	[p1l1067t1157r1129b1185],
19	,	,	O	,	_	0	SENT_15	[p1l1067t1157r1129b1185],
20	respectively	RB	O	respectively	advmod	6	SENT_15	[p1l1140t1157r1313b1189],
21	)	CD	NUMBER	)	dep	5	SENT_15	[p1l1140t1157r1313b1189],
22	.	.	O	.	_	0	SENT_15	[p1l1140t1157r1313b1189],

1	Exposure	NN	O	exposure	nsubj	5	SENT_16	[p1l1325t1157r1448b1189],
2	to	TO	O	to	_	0	SENT_16	[p1l1457t1162r1486b1181],
3	sibutramine	NN	O	sibutramine	prep_to	1	SENT_16	[p1l1496t1157r1650b1181],
4	was	VBD	O	be	cop	5	SENT_16	[p1l1659t1165r1709b1181],
5	higher	JJR	O	higher	_	0	SENT_16	[p1l1720t1157r1802b1189],
6	in	IN	O	in	_	0	SENT_16	[p1l1812t1159r1832b1181],
7	subjects	NNS	O	subject	prep_in	5	SENT_16	[p1l1844t1157r1949b1188],
8	with	IN	O	with	prep	5	SENT_16	[p1l1958t1157r2015b1181],
9	the	DT	O	the	det	11	SENT_16	[p1l2025t1157r2068b1181],
10	CYP2B6	NN	O	cyp2b6	nn	11	SENT_16	[p1l94t1197r265b1222],
11	*	NN	O	*	dep	8	SENT_16	[p1l94t1197r265b1222],
12	6	CD	NUMBER	6	dep	11	SENT_16	[p1l94t1197r265b1222],
13	/	:	O	/	punct	11	SENT_16	[p1l94t1197r265b1222],
14	*	CD	NUMBER	*	num	15	SENT_16	[p1l94t1197r265b1222],
15	6	CD	NUMBER	6	dep	11	SENT_16	[p1l94t1197r265b1222],
16	genotype	NN	O	genotype	dep	15	SENT_16	[p1l280t1204r408b1230],
17	,	,	O	,	_	0	SENT_16	[p1l280t1204r408b1230],
18	but	CC	O	but	_	0	SENT_16	[p1l423t1198r466b1222],
19	no	DT	O	no	det	21	SENT_16	[p1l481t1206r513b1222],
20	statistical	JJ	O	statistical	amod	21	SENT_16	[p1l528t1198r646b1222],
21	difference	NN	O	difference	nsubjpass	23	SENT_16	[p1l663t1198r793b1222],
22	was	VBD	O	be	auxpass	23	SENT_16	[p1l806t1206r856b1222],
23	observed	VBN	O	observe	conj_but	5	SENT_16	[p1l871t1198r991b1222],
24	among	IN	O	among	_	0	SENT_16	[p1l1006t1206r1094b1230],
25	the	DT	O	the	det	27	SENT_16	[p1l1107t1198r1149b1222],
26	CYPZB6	NN	O	cypzb6	nn	27	SENT_16	[p1l1164t1198r1262b1222],
27	genotypes	NNS	O	genotype	prep_among	23	SENT_16	[p1l1276t1204r1416b1230],
28	.	.	O	.	_	0	SENT_16	[p1l1276t1204r1416b1230],

1	These	DT	O	these	det	2	SENT_17	[p1l1431t1198r1511b1222],
2	results	NNS	O	result	nsubj	3	SENT_17	[p1l1526t1198r1612b1222],
3	suggest	VBP	O	suggest	_	0	SENT_17	[p1l1627t1204r1722b1230],
4	that	IN	O	that	complm	15	SENT_17	[p1l1735t1198r1787b1222],
5	the	DT	O	the	det	7	SENT_17	[p1l1800t1198r1842b1222],
6	enantioselective	JJ	O	enantioselective	amod	7	SENT_17	[p1l1857t1198r2068b1222],
7	disposition	NN	O	disposition	nsubjpass	15	SENT_17	[p1l94t1240r234b1272],
8	of	IN	O	of	_	0	SENT_17	[p1l247t1240r274b1264],
9	sibutramine	NN	O	sibutramine	prep_of	7	SENT_17	[p1l283t1240r437b1264],
10	and	CC	O	and	_	0	SENT_17	[p1l448t1240r494b1264],
11	its	PRP$	O	its	poss	13	SENT_17	[p1l506t1242r534b1264],
12	active	JJ	O	active	amod	13	SENT_17	[p1l546t1242r621b1264],
13	metabolites	NNS	O	metabolite	conj_and	9	SENT_17	[p1l633t1240r784b1264],
14	are	VBP	O	be	auxpass	15	SENT_17	[p1l795t1248r837b1264],
15	inﬂuenced	VBN	O	inﬂuenced	ccomp	3	SENT_17	[p1l849t1240r981b1264],
16	by	IN	O	by	_	0	SENT_17	[p1l994t1240r1024b1272],
17	the	DT	O	the	dep	19	SENT_17	[p1l1033t1240r1076b1264],
18	altered	JJ	O	altered	amod	19	SENT_17	[p1l1087t1240r1178b1264],
19	genetic	JJ	O	genetic	agent	15	SENT_17	[p1l1189t1242r1282b1271],
20	and	CC	O	and	_	0	SENT_17	[p1l1293t1240r1338b1264],
21	environmental	JJ	O	environmental	amod	22	SENT_17	[p1l1351t1240r1539b1264],
22	factors	NNS	O	factor	conj_and	19	SENT_17	[p1l1551t1240r1642b1264],
23	of	IN	O	of	_	0	SENT_17	[p1l1653t1240r1680b1264],
24	CYPZB6	NN	O	cypzb6	nn	27	SENT_17	[p1l1690t1240r1799b1264],
25	and	CC	O	and	_	0	SENT_17	[p1l1810t1240r1855b1264],
26	CYP3A	NN	O	cyp3a	nn	27	SENT_17	[p1l1868t1240r1965b1264],
27	activity	NN	O	activity	prep_of	15	SENT_17	[p1l1975t1242r2068b1272],
28	in	FW	O	in	prep	27	SENT_17	[p1l94t1282r115b1304],
29	vivo	FW	O	vivo	pobj	28	SENT_17	[p1l127t1282r187b1304],
30	.	.	O	.	_	0	SENT_17	[p1l127t1282r187b1304],

1	Keywords	NNS	O	keyword	_	0	SENT_18	[p1l95t1379r282b1417],
2	sibutramine	NN	O	sibutramine	dep	1	SENT_18	[p1l94t1439r254b1466],
3	,	,	O	,	_	0	SENT_18	[p1l94t1439r254b1466],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_18	[p1l267t1439r420b1470],
5	,	,	O	,	_	0	SENT_18	[p1l267t1439r420b1470],
6	clarithromycin	NN	O	clarithromycin	appos	2	SENT_18	[p1l432t1439r631b1470],
7	,	,	O	,	_	0	SENT_18	[p1l432t1439r631b1470],
8	CYPZB6	NN	O	cypzb6	nn	9	SENT_18	[p1l643t1439r753b1463],
9	genotype	NN	O	genotype	appos	2	SENT_18	[p1l763t1444r891b1470],
10	,	,	O	,	_	0	SENT_18	[p1l763t1444r891b1470],
11	enantioselective	JJ	O	enantioselective	amod	12	SENT_18	[p1l903t1439r1114b1463],
12	disposition	NN	O	disposition	appos	2	SENT_18	[p1l1125t1439r1266b1470],

1	Sibutramine	NN	O	sibutramine	nn	3	SENT_19	[p1l13t1639r457b1705],
2	(	CD	NUMBER	(	num	3	SENT_19	[p1l549t1639r705b1724],
3	N	NN	O	n	_	0	SENT_19	[p1l549t1639r705b1724],
4	-	:	O	-	_	0	SENT_19	[p1l549t1639r705b1724],
5	{	NN	O	{	dep	3	SENT_19	[p1l549t1639r705b1724],
6	l	NN	O	l	tmod	5	SENT_19	[p1l725t1639r1524b1724],
7	-	:	O	-	_	0	SENT_19	[p1l725t1639r1524b1724],
8	[	NN	O	[	dep	3	SENT_19	[p1l725t1639r1524b1724],
9	1	CD	NUMBER	1	dep	8	SENT_19	[p1l725t1639r1524b1724],
10	-	:	O	-	_	0	SENT_19	[p1l725t1639r1524b1724],
11	(	CD	NUMBER	(	num	13	SENT_19	[p1l725t1639r1524b1724],
12	4-chlorophenyl	NN	O	4-chlorophenyl	nn	13	SENT_19	[p1l725t1639r1524b1724],
13	)	NN	O	)	dep	3	SENT_19	[p1l725t1639r1524b1724],
14	cyclobutyl	NN	O	cyclobutyl	nn	17	SENT_19	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
15	]	CD	NUMBER	]	num	17	SENT_19	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
16	3methylbutyl	NN	O	3methylbutyl	nn	17	SENT_19	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
17	}	NN	O	}	dep	13	SENT_19	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
18	.	.	O	.	_	0	SENT_19	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],

1	—	NN	O	—	_	0	SENT_20	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
2	.	.	O	.	_	0	SENT_20	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],

1	N,N-dimethylamine	NN	O	n,n-dimethylamine	nn	2	SENT_21	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
2	)	NN	O	)	nsubjpass	6	SENT_21	[p1l1615t1639r2140b1724, p1l8t1750r1294b1835],
3	has	VBZ	O	have	aux	6	SENT_21	[p1l1328t1750r1449b1816],
4	been	VBN	O	be	auxpass	6	SENT_21	[p1l1482t1750r1657b1816],
5	widely	RB	O	widely	advmod	6	SENT_21	[p1l1689t1750r1940b1835],
6	used	VBN	O	use	_	0	SENT_21	[p1l1971t1750r2142b1816],
7	as	IN	O	as	_	0	SENT_21	[p1l10t1882r82b1928],
8	a	DT	O	a	det	10	SENT_21	[p1l114t1882r152b1928],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_21	[p1l178t1860r586b1946],
10	agent	NN	O	agent	prep_as	6	SENT_21	[p1l617t1870r816b1947],
11	for	IN	O	for	_	0	SENT_21	[p1l845t1860r951b1928],
12	treating	VBG	O	treat	prepc_for	6	SENT_21	[p1l976t1860r1255b1947],
13	obesity	NN	O	obesity	dobj	12	SENT_21	[p1l1286t1860r1569b1947],
14	.	.	O	.	_	0	SENT_21	[p1l1286t1860r1569b1947],

1	Its	PRP$	O	its	dep	125	SENT_22	[p1l1603t1863r1690b1928],
2	mechanism	NN	O	mechanism	dep	125	SENT_22	[p1l1720t1860r2143b1928],
3	of	IN	O	of	dep	125	SENT_22	[p1l10t1973r95b2039],
4	action	NN	O	action	dep	125	SENT_22	[p1l156t1973r380b2039],
5	involves	VBZ	O	involve	dep	125	SENT_22	[p1l452t1973r762b2039],
6	the	DT	O	the	dep	125	SENT_22	[p1l834t1973r944b2039],
7	inhibition	NN	O	inhibition	dep	125	SENT_22	[p1l1018t1973r1377b2039],
8	of	IN	O	of	dep	125	SENT_22	[p1l1449t1973r1534b2039],
9	serotonin	NN	O	serotonin	dep	125	SENT_22	[p1l1597t1973r1938b2039],
10	and	CC	O	and	dep	125	SENT_22	[p1l2010t1973r2143b2039],
11	noradrenalin	NN	O	noradrenalin	dep	125	SENT_22	[p1l8t2084r476b2150],
12	reuptake	NN	O	reuptake	dep	125	SENT_22	[p1l513t2084r850b2169],
13	,	,	O	,	_	0	SENT_22	[p1l513t2084r850b2169],
14	leading	VBG	O	lead	dep	125	SENT_22	[p1l894t2084r1164b2169],
15	to	TO	O	to	dep	125	SENT_22	[p1l1202t2093r1271b2150],
16	the	DT	O	the	dep	125	SENT_22	[p1l1311t2084r1422b2150],
17	activation	NN	O	activation	dep	125	SENT_22	[p1l1463t2084r1825b2150],
18	of	IN	O	of	dep	125	SENT_22	[p1l1865t2084r1950b2150],
19	both	CC	O	both	dep	125	SENT_22	[p1l1976t2084r2142b2150],
20	serotonin	NN	O	serotonin	dep	125	SENT_22	[p1l11t2194r380b2262],
21	-	:	O	-	_	0	SENT_22	[p1l11t2194r380b2262],
22	and	CC	O	and	dep	125	SENT_22	[p1l416t2194r548b2262],
23	noradrenalin-mediated	JJ	O	noradrenalin-mediated	dep	125	SENT_22	[p1l578t2194r1416b2262],
24	pathways	NNS	O	pathway	dep	125	SENT_22	[p1l1445t2194r1816b2281],
25	,	,	O	,	_	0	SENT_22	[p1l1445t2194r1816b2281],
26	increasing	VBG	O	increase	dep	125	SENT_22	[p1l1853t2194r2139b2262, p1l10t2307r125b2392],
27	satiety	NN	O	satiety	dep	125	SENT_22	[p1l161t2307r396b2392],
28	and	CC	O	and	dep	125	SENT_22	[p1l429t2307r562b2373],
29	energy	NN	O	energy	dep	125	SENT_22	[p1l593t2328r843b2392],
30	expenditure	NN	O	expenditure	dep	125	SENT_22	[p1l876t2307r1330b2392],
31	,	,	O	,	_	0	SENT_22	[p1l876t2307r1330b2392],
32	and	CC	O	and	dep	125	SENT_22	[p1l1367t2307r1499b2373],
33	decreasing	VBG	O	decrease	dep	125	SENT_22	[p1l1531t2307r1924b2392],
34	body	NN	O	body	dep	125	SENT_22	[p1l1954t2307r2142b2392],
35	weight	NN	O	weight	dep	125	SENT_22	[p1l8t2399r384b2503],
36	.1	CD	NUMBER	.1	dep	125	SENT_22	[p1l8t2399r384b2503],
37	‘	NN	O	‘	dep	125	SENT_22	[p1l8t2399r384b2503],
38	3	CD	NUMBER	3	dep	125	SENT_22	[p1l8t2399r384b2503],
39	In	IN	O	in	dep	125	SENT_22	[p1l435t2421r510b2483],
40	humans	NNS	O	human	dep	125	SENT_22	[p1l555t2418r863b2498],
41	,	,	O	,	_	0	SENT_22	[p1l555t2418r863b2498],
42	sibutramine	NN	O	sibutramine	dep	125	SENT_22	[p1l917t2418r1347b2484],
43	is	VBZ	O	be	dep	125	SENT_22	[p1l1396t2418r1453b2484],
44	rapidly	RB	O	rapidly	dep	125	SENT_22	[p1l1500t2418r1761b2503],
45	absorbed	VBN	O	absorb	dep	125	SENT_22	[p1l1809t2418r2142b2484],
46	from	IN	O	from	dep	125	SENT_22	[p1l10t2529r187b2596],
47	the	DT	O	the	dep	125	SENT_22	[p1l213t2529r324b2596],
48	gastrointestinal	JJ	O	gastrointestinal	dep	125	SENT_22	[p1l355t2529r916b2615],
49	tract	NN	O	tract	dep	125	SENT_22	[p1l944t2539r1107b2596],
50	after	IN	O	after	dep	125	SENT_22	[p1l1135t2529r1302b2596],
51	oral	JJ	O	oral	dep	125	SENT_22	[p1l1329t2529r1468b2596],
52	administration	NN	O	administration	dep	125	SENT_22	[p1l1499t2511r2136b2610],
53	,	,	O	,	_	0	SENT_22	[p1l1499t2511r2136b2610],
54	”	NN	O	”	dep	125	SENT_22	[p1l1499t2511r2136b2610],
55	and	CC	O	and	dep	125	SENT_22	[p1l10t2641r142b2707],
56	undergoes	VBZ	O	undergo	dep	125	SENT_22	[p1l171t2641r551b2726],
57	extensive	JJ	O	extensive	dep	125	SENT_22	[p1l585t2641r930b2707],
58	hepatic	JJ	O	hepatic	dep	125	SENT_22	[p1l962t2641r1226b2726],
59	metabolism	NN	O	metabolism	dep	125	SENT_22	[p1l1258t2641r1691b2707],
60	to	TO	O	to	dep	125	SENT_22	[p1l1720t2650r1788b2707],
61	form	VB	O	form	dep	125	SENT_22	[p1l1824t2641r2000b2707],
62	the	DT	O	the	dep	125	SENT_22	[p1l2029t2641r2140b2707],
63	pharmacologically	RB	O	pharmacologically	dep	125	SENT_22	[p1l7t2752r697b2837],
64	active	JJ	O	active	dep	125	SENT_22	[p1l761t2752r977b2818],
65	metabolite	NN	O	metabolite	dep	125	SENT_22	[p1l1040t2752r1451b2832],
66	;	:	O	;	_	0	SENT_22	[p1l1040t2752r1451b2832],
67	mono-desmethyl	NN	O	mono-desmethyl	dep	125	SENT_22	[p1l1518t2752r2140b2837],
68	sibutramine	NN	O	sibutramine	dep	125	SENT_22	[p1l11t2862r443b2930],
69	(	CD	NUMBER	(	dep	125	SENT_22	[p1l493t2863r677b2948],
70	M1	NN	O	m1	dep	125	SENT_22	[p1l493t2863r677b2948],
71	)	NN	O	)	dep	125	SENT_22	[p1l493t2863r677b2948],
72	and	CC	O	and	dep	125	SENT_22	[p1l727t2862r860b2930],
73	is	VBZ	O	be	dep	125	SENT_22	[p1l906t2862r963b2930],
74	further	JJ	O	further	dep	125	SENT_22	[p1l1013t2862r1262b2930],
75	demethylated	VBN	O	demethylate	dep	125	SENT_22	[p1l1308t2862r1806b2949],
76	into	IN	O	into	dep	125	SENT_22	[p1l1853t2862r1991b2930],
77	didesmethyl	NN	O	didesmethyl	dep	125	SENT_22	[p1l2043t2862r2140b2930, p1l10t2975r387b3060],
78	sibutramine	NN	O	sibutramine	dep	125	SENT_22	[p1l435t2975r865b3041],
79	(	CD	NUMBER	(	dep	125	SENT_22	[p1l913t2956r1226b3060],
80	M2	NN	O	m2	dep	125	SENT_22	[p1l913t2956r1226b3060],
81	)	CD	NUMBER	)	dep	125	SENT_22	[p1l913t2956r1226b3060],
82	.4	CD	NUMBER	.4	dep	125	SENT_22	[p1l913t2956r1226b3060],
83	’	NN	O	’	dep	125	SENT_22	[p1l913t2956r1226b3060],
84	7	CD	NUMBER	7	dep	125	SENT_22	[p1l913t2956r1226b3060],
85	The	DT	O	the	dep	125	SENT_22	[p1l1273t2975r1413b3041],
86	in	FW	O	in	dep	125	SENT_22	[p1l1460t2975r1529b3040],
87	vivo	FW	O	vivo	dep	125	SENT_22	[p1l1571t2975r1733b3041],
88	effects	NNS	O	effect	dep	125	SENT_22	[p1l1781t2975r2020b3041],
89	of	IN	O	of	dep	125	SENT_22	[p1l2067t2975r2152b3041],
90	sibutramine	NN	O	sibutramine	dep	125	SENT_22	[p1l12t3086r443b3152],
91	are	VBP	O	be	dep	125	SENT_22	[p1l465t3107r572b3152],
92	primarily	RB	O	primarily	dep	125	SENT_22	[p1l592t3086r935b3171],
93	attributable	JJ	O	attributable	dep	125	SENT_22	[p1l956t3086r1371b3152],
94	to	TO	O	to	dep	125	SENT_22	[p1l1392t3095r1461b3152],
95	the	DT	O	the	dep	125	SENT_22	[p1l1482t3086r1593b3152],
96	action	NN	O	action	dep	125	SENT_22	[p1l1616t3086r1839b3152],
97	of	IN	O	of	dep	125	SENT_22	[p1l1860t3086r1945b3152],
98	these	DT	O	these	dep	125	SENT_22	[p1l1952t3086r2140b3152],
99	two	CD	NUMBER	two	dep	125	SENT_22	[p1l8t3206r144b3263],
100	metabolites	NNS	O	metabolite	dep	125	SENT_22	[p1l164t3178r698b3263],
101	.8	CD	NUMBER	.8	dep	125	SENT_22	[p1l164t3178r698b3263],
102	’	CD	NUMBER	’	dep	125	SENT_22	[p1l164t3178r698b3263],
103	9	CD	NUMBER	9	dep	125	SENT_22	[p1l164t3178r698b3263],
104	However	RB	O	however	dep	125	SENT_22	[p1l719t3199r1077b3277],
105	,	,	O	,	_	0	SENT_22	[p1l719t3199r1077b3277],
106	recent	JJ	O	recent	dep	125	SENT_22	[p1l1099t3206r1324b3263],
107	reports	NNS	O	report	dep	125	SENT_22	[p1l1341t3206r1594b3281],
108	of	IN	O	of	dep	125	SENT_22	[p1l1616t3196r1701b3263],
109	the	DT	O	the	dep	125	SENT_22	[p1l1707t3196r1818b3263],
110	SCOUT	NNP	O	SCOUT	dep	125	SENT_22	[p1l1843t3198r2140b3263],
111	(	CD	NUMBER	(	dep	125	SENT_22	[p1l11t3308r487b3392],
112	Sibutramine	NNP	O	Sibutramine	dep	125	SENT_22	[p1l11t3308r487b3392],
113	Cardiovascular	NNP	O	Cardiovascular	dep	125	SENT_22	[p1l529t3308r1089b3374],
114	OUTcome	NN	O	outcome	dep	125	SENT_22	[p1l1127t3308r1544b3392],
115	)	NN	O	)	dep	125	SENT_22	[p1l1127t3308r1544b3392],
116	trials	NNS	O	trial	dep	125	SENT_22	[p1l1583t3308r1763b3374],
117	indicated	VBD	O	indicate	dep	125	SENT_22	[p1l1805t3308r2142b3374],
118	that	IN	O	that	dep	125	SENT_22	[p1l8t3419r146b3485],
119	sibutramine	NN	O	sibutramine	dep	125	SENT_22	[p1l190t3419r621b3485],
120	is	VBZ	O	be	dep	125	SENT_22	[p1l665t3419r722b3485],
121	associated	VBN	O	associate	dep	125	SENT_22	[p1l767t3419r1144b3485],
122	with	IN	O	with	dep	125	SENT_22	[p1l1184t3419r1349b3485],
123	an	DT	O	a	dep	125	SENT_22	[p1l1392t3440r1477b3485],
124	increased	VBN	O	increase	dep	125	SENT_22	[p1l1519t3419r1866b3485],
125	occurrence	NN	O	occurrence	_	0	SENT_22	[p1l1909t3440r2140b3485, p1l8t3552r205b3597],

1	of	IN	O	of	dep	3	SENT_23	[p1l239t3530r324b3597],
2	cardiovascular	JJ	O	cardiovascular	amod	3	SENT_23	[p1l344t3530r883b3598],
3	events	NNS	O	event	_	0	SENT_23	[p1l912t3540r1166b3611],
4	,	,	O	,	_	0	SENT_23	[p1l912t3540r1166b3611],
5	such	JJ	O	such	_	0	SENT_23	[p1l1203t3530r1370b3598],
6	as	IN	O	as	_	0	SENT_23	[p1l1401t3552r1473b3597],
7	strokes	NNS	O	stroke	prep_such_as	3	SENT_23	[p1l1508t3530r1763b3597],
8	and	CC	O	and	_	0	SENT_23	[p1l1798t3530r1930b3598],
9	heart	NN	O	heart	nn	10	SENT_23	[p1l1958t3530r2142b3597],
10	attacks	NNS	O	attack	prep_such_as	3	SENT_23	[p1l10t3643r282b3723],
11	,	,	O	,	_	0	SENT_23	[p1l10t3643r282b3723],
12	which	WDT	O	which	nsubj	13	SENT_23	[p1l317t3643r543b3710],
13	led	VBD	O	lead	rcmod	7	SENT_23	[p1l575t3643r686b3710],
14	to	TO	O	to	_	0	SENT_23	[p1l715t3652r784b3710],
15	a	DT	O	a	det	16	SENT_23	[p1l818t3664r857b3710],
16	recommendation	NN	O	recommendation	prep_to	13	SENT_23	[p1l885t3643r1508b3710],
17	that	WDT	O	that	dobj	20	SENT_23	[p1l1538t3643r1677b3710],
18	sibutramine	NN	O	sibutramine	nsubjpass	20	SENT_23	[p1l1709t3643r2139b3710],
19	was	VBD	O	be	auxpass	20	SENT_23	[p2l8t43r149b88],
20	withdrawn	VBN	O	withdraw	ccomp	13	SENT_23	[p2l180t22r577b88],
21	from	IN	O	from	_	0	SENT_23	[p2l609t22r785b88],
22	the	DT	O	the	det	24	SENT_23	[p2l814t22r924b88],
23	global	JJ	O	global	amod	24	SENT_23	[p2l957t22r1185b107],
24	market	NN	O	market	prep_from	20	SENT_23	[p2l1215t22r1488b88],
25	.	.	O	.	_	0	SENT_23	[p2l1215t22r1488b88],

1	Sibutramine	NN	O	sibutramine	nsubj	12	SENT_24	[p2l126t133r570b201],
2	and	CC	O	and	_	0	SENT_24	[p2l628t133r760b200],
3	its	PRP$	O	its	poss	4	SENT_24	[p2l815t133r897b200],
4	metabolites	NNS	O	metabolite	conj_and	1	SENT_24	[p2l952t133r1397b214],
5	,	,	O	,	_	0	SENT_24	[p2l952t133r1397b214],
6	M1	NN	O	m1	appos	1	SENT_24	[p2l1456t135r1573b199],
7	and	CC	O	and	_	0	SENT_24	[p2l1640t133r1772b201],
8	M2	NN	O	m2	appos	1	SENT_24	[p2l1826t135r1973b214],
9	,	,	O	,	_	0	SENT_24	[p2l1826t135r1973b214],
10	are	VBP	O	be	cop	12	SENT_24	[p2l2033t155r2140b201],
11	optically	RB	O	optically	advmod	12	SENT_24	[p2l10t245r331b330],
12	active	JJ	O	active	_	0	SENT_24	[p2l363t245r599b325],
13	,	,	O	,	_	0	SENT_24	[p2l363t245r599b325],
14	but	CC	O	but	_	0	SENT_24	[p2l632t245r752b311],
15	the	DT	O	the	det	16	SENT_24	[p2l780t245r890b311],
16	drug	NN	O	drug	nsubjpass	19	SENT_24	[p2l924t245r1090b330],
17	has	VBZ	O	have	aux	19	SENT_24	[p2l1120t245r1241b311],
18	been	VBN	O	be	auxpass	19	SENT_24	[p2l1272t245r1448b311],
19	used	VBN	O	use	conj_but	12	SENT_24	[p2l1477t245r1648b311],
20	as	IN	O	as	_	0	SENT_24	[p2l1679t266r1750b311],
21	a	DT	O	a	det	23	SENT_24	[p2l1784t266r1823b311],
22	racemic	JJ	O	racemic	amod	23	SENT_24	[p2l1851t245r2139b311],
23	mixture	NN	O	mixture	prep_as	19	SENT_24	[p2l8t356r312b422],
24	.	.	O	.	_	0	SENT_24	[p2l8t356r312b422],

1	Despite	IN	O	despite	_	0	SENT_25	[p2l344t356r623b441],
2	its	PRP$	O	its	poss	4	SENT_25	[p2l652t356r733b422],
3	long	JJ	O	long	amod	4	SENT_25	[p2l762t356r924b441],
4	history	NN	O	history	prep_despite	12	SENT_25	[p2l949t356r1206b441],
5	of	IN	O	of	_	0	SENT_25	[p2l1233t356r1317b422],
6	clinical	JJ	O	clinical	amod	7	SENT_25	[p2l1334t356r1600b422],
7	use	NN	O	use	prep_of	4	SENT_25	[p2l1626t377r1769b436],
8	,	,	O	,	_	0	SENT_25	[p2l1626t377r1769b436],
9	little	JJ	O	little	amod	10	SENT_25	[p2l1799t356r1962b422],
10	data	NNS	O	datum	nsubj	12	SENT_25	[p2l1991t356r2143b422],
11	are	VBP	O	be	cop	12	SENT_25	[p2l10t488r117b534],
12	available	JJ	O	available	_	0	SENT_25	[p2l157t466r485b534],
13	on	IN	O	on	_	0	SENT_25	[p2l526t488r617b534],
14	the	DT	O	the	det	17	SENT_25	[p2l653t466r763b534],
15	differential	JJ	O	differential	amod	17	SENT_25	[p2l803t466r1207b534],
16	pharmacological	JJ	O	pharmacological	amod	17	SENT_25	[p2l1243t466r1861b553],
17	effects	NNS	O	effect	prep_on	12	SENT_25	[p2l1900t466r2139b534],
18	between	IN	O	between	_	0	SENT_25	[p2l7t580r316b647],
19	sibutramine	NN	O	sibutramine	nn	20	SENT_25	[p2l370t580r800b647],
20	R	NN	O	r	prep_between	17	SENT_25	[p2l848t582r935b646],
21	-	:	O	-	_	0	SENT_25	[p2l848t582r935b646],
22	and	CC	O	and	_	0	SENT_25	[p2l989t580r1122b647],
23	S-enantiomers	NNS	O	s-enantiomer	prep_on	12	SENT_25	[p2l1169t580r1715b647],
24	.	.	O	.	_	0	SENT_25	[p2l1169t580r1715b647],

1	Thus	RB	O	thus	advmod	14	SENT_26	[p2l1773t580r1976b658],
2	,	,	O	,	_	0	SENT_26	[p2l1773t580r1976b658],
3	the	DT	O	the	det	6	SENT_26	[p2l2029t580r2140b647],
4	enantioselective	JJ	O	enantioselective	amod	6	SENT_26	[p2l14t691r607b758],
5	pharmacological	JJ	O	pharmacological	amod	6	SENT_26	[p2l626t691r1245b777],
6	activities	NNS	O	activity	nsubjpass	14	SENT_26	[p2l1268t691r1596b758],
7	of	IN	O	of	_	0	SENT_26	[p2l1620t691r1705b758],
8	sibutramine	NN	O	sibutramine	prep_of	6	SENT_26	[p2l1717t691r2149b758],
9	and	CC	O	and	_	0	SENT_26	[p2l14t803r146b869],
10	its	PRP$	O	its	poss	11	SENT_26	[p2l185t803r266b869],
11	metabolites	NNS	O	metabolite	prep_of	6	SENT_26	[p2l306t803r731b869],
12	should	MD	O	should	aux	14	SENT_26	[p2l774t803r1020b869],
13	be	VB	O	be	auxpass	14	SENT_26	[p2l1055t803r1141b869],
14	examined	VBN	O	examine	_	0	SENT_26	[p2l1183t803r1542b869],
15	to	TO	O	to	aux	16	SENT_26	[p2l1579t812r1648b869],
16	increase	VB	O	increase	xcomp	14	SENT_26	[p2l1690t803r1988b869],
17	our	PRP$	O	we	poss	18	SENT_26	[p2l2029t824r2153b869],
18	understanding	NN	O	understanding	dobj	16	SENT_26	[p2l10t913r538b1000],
19	of	IN	O	of	_	0	SENT_26	[p2l567t913r652b981],
20	the	DT	O	the	det	21	SENT_26	[p2l666t913r777b981],
21	potency	NN	O	potency	prep_of	18	SENT_26	[p2l802t923r1098b1000],
22	and	CC	O	and	_	0	SENT_26	[p2l1125t913r1258b981],
23	safety	NN	O	safety	prep_of	18	SENT_26	[p2l1287t913r1503b1000],
24	of	IN	O	of	_	0	SENT_26	[p2l1530t913r1616b981],
25	this	DT	O	this	det	26	SENT_26	[p2l1629t913r1760b981],
26	drug	NN	O	drug	prep_of	21	SENT_26	[p2l1790t913r1975b1000],
27	.	.	O	.	_	0	SENT_26	[p2l1790t913r1975b1000],

1	The	DT	O	the	det	2	SENT_27	[p2l2009t913r2149b981],
2	R-sibutramine	NN	MISC	r-sibutramine	nsubjpass	4	SENT_27	[p2l8t1026r534b1093],
3	was	VBD	O	be	auxpass	4	SENT_27	[p2l560t1047r702b1093],
4	shown	VBN	O	show	_	0	SENT_27	[p2l732t1026r973b1093],
5	to	TO	O	to	_	0	SENT_27	[p2l997t1035r1066b1093],
6	more	JJR	O	more	prep_to	4	SENT_27	[p2l1093t1047r1280b1093],
7	potently	RB	O	potently	advmod	8	SENT_27	[p2l1306t1026r1611b1112],
8	suppress	VBP	O	suppress	dep	6	SENT_27	[p2l1640t1047r1954b1112],
9	food	NN	O	food	nn	10	SENT_27	[p2l1983t1026r2151b1093],
10	intake	NN	O	intake	dobj	8	SENT_27	[p2l13t1138r235b1205],
11	and	CC	O	and	_	0	SENT_27	[p2l266t1138r398b1205],
12	body	NN	O	body	nn	13	SENT_27	[p2l423t1138r611b1224],
13	weight	NN	O	weight	conj_and	10	SENT_27	[p2l637t1138r890b1224],
14	compared	VBN	O	compare	_	0	SENT_27	[p2l917t1138r1281b1224],
15	with	IN	O	with	prepc_compared_with	10	SENT_27	[p2l1307t1138r1472b1205],
16	the	DT	O	the	det	17	SENT_27	[p2l1497t1138r1608b1205],
17	S-sibutramine	NN	O	s-sibutramine	pobj	10	SENT_27	[p2l1636t1138r2149b1205],
18	in	IN	O	in	_	0	SENT_27	[p2l13t1250r83b1316],
19	rats	NNS	O	rat	prep_in	17	SENT_27	[p2l114t1232r339b1317],
20	.10	CD	NUMBER	.10	nsubj	33	SENT_27	[p2l114t1232r339b1317],
21	In	IN	O	in	_	0	SENT_27	[p2l373t1253r449b1316],
22	addition	NN	O	addition	prep_in	20	SENT_27	[p2l482t1250r804b1331],
23	,	,	O	,	_	0	SENT_27	[p2l482t1250r804b1331],
24	The	DT	O	the	det	25	SENT_27	[p2l842t1250r982b1317],
25	R-enantiomers	NNS	O	r-enantiomer	appos	22	SENT_27	[p2l1012t1250r1553b1317],
26	of	IN	O	of	_	0	SENT_27	[p2l1590t1250r1674b1317],
27	M1	NN	O	m1	prep_of	25	SENT_27	[p2l1696t1252r1814b1316],
28	and	CC	O	and	_	0	SENT_27	[p2l1858t1250r1991b1318],
29	M2	NN	O	m2	prep_of	25	SENT_27	[p2l2022t1252r2147b1316],
30	were	VBD	O	be	cop	33	SENT_27	[p2l11t1383r188b1429],
31	more	JJR	O	more	amod	33	SENT_27	[p2l225t1383r413b1429],
32	potent	JJ	O	potent	amod	33	SENT_27	[p2l448t1371r682b1448],
33	(	NN	O	(	rcmod	19	SENT_27	[p2l719t1362r883b1448],
34	200	CD	NUMBER	200	num	37	SENT_27	[p2l719t1362r883b1448],
35	and	CC	O	and	_	0	SENT_27	[p2l923t1362r1056b1429],
36	40	CD	NUMBER	40	num	37	SENT_27	[p2l1090t1363r1179b1429],
37	times	NNS	O	time	tmod	33	SENT_27	[p2l1217t1362r1435b1443],
38	,	,	O	,	_	0	SENT_27	[p2l1217t1362r1435b1443],
39	respectively	RB	O	respectively	advmod	19	SENT_27	[p2l1474t1362r1949b1448],
40	)	CD	NUMBER	)	dep	19	SENT_27	[p2l1474t1362r1949b1448],
41	with	IN	O	with	prep	8	SENT_27	[p2l1986t1362r2151b1429],

1	Supplementary	JJ	O	supplementary	amod	2	SENT_28	[p2l14t1747r456b1818],
2	material	NN	O	material	nsubj	7	SENT_28	[p2l482t1748r716b1801],
3	for	IN	O	for	_	0	SENT_28	[p2l743t1747r832b1801],
4	this	DT	O	this	det	5	SENT_28	[p2l854t1748r959b1801],
5	article	NN	O	article	prep_for	2	SENT_28	[p2l985t1748r1167b1801],
6	is	VBZ	O	be	cop	7	SENT_28	[p2l1195t1751r1234b1801],
7	available	JJ	O	available	_	0	SENT_28	[p2l1260t1748r1505b1801],
8	on	IN	O	on	_	0	SENT_28	[p2l1531t1765r1602b1801],
9	the	DT	O	the	det	10	SENT_28	[p2l1629t1748r1724b1801],
10	journal	NN	O	journal	poss	12	SENT_28	[p2l1748t1748r2000b1817],
11	’s	POS	O	’s	_	0	SENT_28	[p2l1748t1748r2000b1817],
12	website	NN	O	website	prep_on	7	SENT_28	[p2l11t1842r240b1894],
13	at	IN	O	at	_	0	SENT_28	[p2l265t1853r320b1894],
14	wvvw	NN	O	wvvw	prep_at	12	SENT_28	[p2l341t1842r1210b1912],
15	.	.	O	.	_	0	SENT_28	[p2l341t1842r1210b1912],

1	wi	NN	O	wus	_	0	SENT_29	[p2l341t1842r1210b1912],
2	|	SYM	O	|	dep	1	SENT_29	[p2l341t1842r1210b1912],
3	eyon	FW	O	eyon	nn	7	SENT_29	[p2l341t1842r1210b1912],
4	|	FW	O	|	nn	7	SENT_29	[p2l341t1842r1210b1912],
5	ine	FW	O	ine	nn	7	SENT_29	[p2l341t1842r1210b1912],
6	|	FW	O	|	nn	7	SENT_29	[p2l341t1842r1210b1912],
7	ibrary.com	FW	O	ibrary.com	dep	1	SENT_29	[p2l341t1842r1210b1912],
8	.	.	O	.	_	0	SENT_29	[p2l341t1842r1210b1912],
9	'	''	O	'	_	0	SENT_29	[p2l22t1918r408b2004],

1	Department	NNP	O	Department	dep	28	SENT_30	[p2l22t1918r408b2004],
2	of	IN	O	of	_	0	SENT_30	[p2l432t1934r493b1987],
3	Pharmacology	NNP	O	Pharmacology	prep_of	1	SENT_30	[p2l516t1935r930b2005],
4	and	CC	O	and	_	0	SENT_30	[p2l954t1935r1056b1987],
5	PharmacoGenomics	NNP	ORGANIZATION	PharmacoGenomics	nn	7	SENT_30	[p2l1086t1934r1681b1987],
6	Research	NNP	ORGANIZATION	Research	nn	7	SENT_30	[p2l1710t1935r1975b1987],
7	Center	NNP	ORGANIZATION	Center	conj_and	1	SENT_30	[p2l14t2027r238b2089],
8	,	,	O	,	_	0	SENT_30	[p2l14t2027r238b2089],
9	lnje	NNP	O	lnje	nn	11	SENT_30	[p2l269t2028r370b2097],
10	University	NNP	ORGANIZATION	University	nn	11	SENT_30	[p2l398t2028r699b2098],
11	College	NNP	ORGANIZATION	College	appos	7	SENT_30	[p2l725t2027r947b2097],
12	of	IN	ORGANIZATION	of	_	0	SENT_30	[p2l972t2027r1033b2081],
13	Medicine	NNP	ORGANIZATION	Medicine	nn	15	SENT_30	[p2l1057t2028r1334b2089],
14	,	,	O	,	_	0	SENT_30	[p2l1057t2028r1334b2089],
15	Busan	NNP	ORGANIZATION	Busan	prep_of	11	SENT_30	[p2l1364t2028r1549b2089],
16	,	,	O	,	_	0	SENT_30	[p2l1364t2028r1549b2089],
17	South	NNP	LOCATION	South	nn	19	SENT_30	[p2l1577t2027r1743b2081],
18	Korea	NNP	LOCATION	Korea	nn	19	SENT_30	[p2l1775t2028r1955b2081],
19	2Department	NN	O	2department	appos	15	SENT_30	[p2l13t2105r408b2191],
20	of	IN	O	of	_	0	SENT_30	[p2l432t2121r493b2174],
21	Clinical	JJ	O	clinical	amod	22	SENT_30	[p2l515t2121r726b2174],
22	Pharmacology	NN	O	pharmacology	prep_of	19	SENT_30	[p2l758t2121r1186b2191],
23	,	,	O	,	_	0	SENT_30	[p2l758t2121r1186b2191],
24	lnje	NN	O	lnje	dep	28	SENT_30	[p2l1216t2121r1317b2190],
25	University	NNP	ORGANIZATION	University	nn	28	SENT_30	[p2l1345t2121r1646b2191],
26	Busan	NNP	ORGANIZATION	Busan	nn	28	SENT_30	[p2l1674t2121r1841b2174],
27	Paik	NNP	ORGANIZATION	Paik	nn	28	SENT_30	[p2l1871t2121r1990b2174],
28	Hospital	NNP	ORGANIZATION	Hospital	_	0	SENT_30	[p2l16t2215r273b2284],
29	,	,	O	,	_	0	SENT_30	[p2l16t2215r273b2284],
30	Busan	NNP	ORGANIZATION	Busan	appos	28	SENT_30	[p2l303t2215r488b2275],
31	,	,	O	,	_	0	SENT_30	[p2l303t2215r488b2275],
32	South	NNP	LOCATION	South	nn	36	SENT_30	[p2l516t2214r682b2267],
33	Korea	NNP	LOCATION	Korea	nn	36	SENT_30	[p2l714t2215r894b2267],
34	*	NNP	O	*	nn	36	SENT_30	[p2l11t2304r289b2360],
35	Current	NNP	DATE	Current	nn	36	SENT_30	[p2l11t2304r289b2360],
36	affiliation	NN	O	affiliation	appos	28	SENT_30	[p2l312t2307r591b2360],
37	:	:	O	:	_	0	SENT_30	[p2l312t2307r591b2360],
38	China	NNP	LOCATION	China	nn	40	SENT_30	[p2l620t2307r791b2360],
39	Novartis	NNP	ORGANIZATION	Novartis	nn	40	SENT_30	[p2l819t2307r1073b2360],
40	Institutes	NNPS	ORGANIZATION	Institutes	dep	36	SENT_30	[p2l1102t2307r1368b2360],
41	for	IN	ORGANIZATION	for	_	0	SENT_30	[p2l1393t2307r1482b2360],
42	BioMedica	NNP	ORGANIZATION	BioMedica	nn	45	SENT_30	[p2l1510t2307r1826b2360],
43	|	NNP	ORGANIZATION	|	nn	45	SENT_30	[p2l1510t2307r1826b2360],
44	Research	NNP	ORGANIZATION	Research	nn	45	SENT_30	[p2l1859t2307r2123b2360],
45	Co.	NNP	ORGANIZATION	Co.	prep_for	40	SENT_30	[p2l14t2400r133b2461],
46	,	,	O	,	_	0	SENT_30	[p2l14t2400r133b2461],
47	Ltd	NNP	ORGANIZATION	Ltd	nn	51	SENT_30	[p2l164t2401r271b2461],
48	,	,	O	,	_	0	SENT_30	[p2l164t2401r271b2461],
49	Shanghai	NNP	LOCATION	Shanghai	appos	51	SENT_30	[p2l299t2400r566b2470],
50	,	,	O	,	_	0	SENT_30	[p2l299t2400r566b2470],
51	China	NNP	LOCATION	China	appos	28	SENT_30	[p2l594t2400r766b2453],

1	Submitted	VBN	O	submit	_	0	SENT_31	[p2l14t2587r311b2640],
2	for	IN	O	for	_	0	SENT_31	[p2l337t2587r426b2640],
3	publication	NN	O	publication	prep_for	1	SENT_31	[p2l452t2588r772b2657],
4	7	CD	DATE	7	num	3	SENT_31	[p2l801t2588r835b2640],
5	March	NNP	DATE	March	tmod	3	SENT_31	[p2l863t2588r1043b2640],
6	20	CD	DATE	20	num	5	SENT_31	[p2l1072t2587r1233b2648],
7	|	NN	O	|	dobj	1	SENT_31	[p2l1072t2587r1233b2648],
8	2	CD	NUMBER	2	num	7	SENT_31	[p2l1072t2587r1233b2648],
9	;	:	O	;	_	0	SENT_31	[p2l1072t2587r1233b2648],
10	accepted	VBN	O	accept	partmod	7	SENT_31	[p2l1260t2588r1521b2657],
11	9	CD	DATE	9	num	14	SENT_31	[p2l1549t2587r1581b2640],
12	May	NNP	DATE	May	nn	14	SENT_31	[p2l1611t2588r1728b2658],
13	20	CD	DATE	20	num	14	SENT_31	[p2l1753t2587r1913b2640],
14	|	NN	O	|	nsubj	15	SENT_31	[p2l1753t2587r1913b2640],
15	2	CD	NUMBER	2	xcomp	10	SENT_31	[p2l1753t2587r1913b2640],
16	.	.	O	.	_	0	SENT_31	[p2l1753t2587r1913b2640],

1	Corresponding	VBG	O	correspond	partmod	60	SENT_32	[p2l14t2745r528b2815],
2	Authors	NNS	O	author	dobj	1	SENT_32	[p2l551t2746r850b2799],
3	:	:	O	:	_	0	SENT_32	[p2l551t2746r850b2799],
4	Jae-Gook	NNP	PERSON	Jae-Gook	nn	6	SENT_32	[p2l6t2839r290b2910],
5	Shin	NNP	PERSON	Shin	nn	6	SENT_32	[p2l309t2839r424b2892],
6	MD	NNP	O	MD	dep	2	SENT_32	[p2l452t2840r574b2900],
7	,	,	O	,	_	0	SENT_32	[p2l452t2840r574b2900],
8	PhD	NNP	O	PhD	nn	11	SENT_32	[p2l599t2840r721b2892],
9	and	CC	O	and	_	0	SENT_32	[p2l744t2840r844b2892],
10	Dong-Hyun	NNP	PERSON	Dong-Hyun	nn	11	SENT_32	[p2l871t2840r1209b2910],
11	Kim	NNP	PERSON	Kim	dep	2	SENT_32	[p2l1236t2840r1364b2900],
12	,	,	O	,	_	0	SENT_32	[p2l1236t2840r1364b2900],
13	PhD	NNP	O	PhD	dep	2	SENT_32	[p2l1390t2840r1529b2900],
14	,	,	O	,	_	0	SENT_32	[p2l1390t2840r1529b2900],
15	Department	NNP	ORGANIZATION	Department	conj_and	6	SENT_32	[p2l1555t2840r1913b2909],
16	of	IN	ORGANIZATION	of	_	0	SENT_32	[p2l1933t2839r1994b2892],
17	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	15	SENT_32	[p2l16t2934r424b3004],
18	and	CC	ORGANIZATION	and	_	0	SENT_32	[p2l443t2934r543b2986],
19	PharmacoGenomics	NNP	ORGANIZATION	PharmacoGenomics	nn	21	SENT_32	[p2l569t2933r1155b2986],
20	Research	NNP	ORGANIZATION	Research	nn	21	SENT_32	[p2l1181t2934r1442b2986],
21	Center	NNP	ORGANIZATION	Center	conj_and	6	SENT_32	[p2l1467t2933r1687b2994],
22	,	,	O	,	_	0	SENT_32	[p2l1467t2933r1687b2994],
23	lnje	NNP	O	lnje	nn	25	SENT_32	[p2l1714t2934r1813b3003],
24	University	NNP	ORGANIZATION	University	nn	25	SENT_32	[p2l1837t2934r2133b3004],
25	College	NNP	ORGANIZATION	College	nsubj	60	SENT_32	[p2l14t3028r234b3098],
26	of	IN	ORGANIZATION	of	_	0	SENT_32	[p2l255t3028r316b3081],
27	Medicine	NNP	ORGANIZATION	Medicine	prep_of	25	SENT_32	[p2l335t3028r608b3089],
28	,	,	O	,	_	0	SENT_32	[p2l335t3028r608b3089],
29	#	#	MONEY	#	dep	30	SENT_32	[p2l628t3028r803b3081],
30	633	CD	MONEY	633	appos	27	SENT_32	[p2l628t3028r803b3081],
31	-	:	O	-	_	0	SENT_32	[p2l628t3028r803b3081],
32	I	PRP	O	I	dep	27	SENT_32	[p2l820t3028r828b3080],
33	65	CD	NUMBER	65	num	36	SENT_32	[p2l846t3028r912b3081],
34	Gaegum-Dong	NNP	O	Gaegum-Dong	nn	36	SENT_32	[p2l938t3028r1379b3098],
35	,	,	O	,	_	0	SENT_32	[p2l938t3028r1379b3098],
36	Jin-Gu	NNP	O	Jin-Gu	dep	32	SENT_32	[p2l1396t3028r1600b3099],
37	,	,	O	,	_	0	SENT_32	[p2l1396t3028r1600b3099],
38	Busan	NNP	ORGANIZATION	Busan	nn	40	SENT_32	[p2l1627t3028r1790b3081],
39	6	CD	NUMBER	6	num	40	SENT_32	[p2l1816t3028r1848b3081],
40	I4-735	NN	O	i4-735	appos	36	SENT_32	[p2l1866t3028r2072b3089],
41	,	,	O	,	_	0	SENT_32	[p2l1866t3028r2072b3089],
42	Korea	NNP	LOCATION	Korea	nn	43	SENT_32	[p2l16t3122r193b3174],
43	Email	NNP	O	Email	appos	36	SENT_32	[p2l16t3216r181b3268],
44	:	:	O	:	_	0	SENT_32	[p2l16t3216r181b3268],
45	phshinjg@inje.ac.kr	NN	O	phshinjg@inje.ac.kr	dep	27	SENT_32	[p2l205t3207r775b3285],
46	(	CD	NUMBER	(	num	48	SENT_32	[p2l798t3215r976b3285],
47	Shin	NNP	O	Shin	nn	48	SENT_32	[p2l798t3215r976b3285],
48	)	NN	O	)	dep	45	SENT_32	[p2l798t3215r976b3285],
49	;	:	O	;	_	0	SENT_32	[p2l798t3215r976b3285],
50	dhkim@inje.ac.kr	NN	O	dhkim@inje.ac.kr	dep	27	SENT_32	[p2l1000t3207r1515b3285],
51	(	CD	NUMBER	(	num	50	SENT_32	[p2l1537t3215r1697b3285],
52	Kim	NNP	PERSON	Kim	nn	56	SENT_32	[p2l1537t3215r1697b3285],
53	)	CD	NUMBER	)	num	56	SENT_32	[p2l1537t3215r1697b3285],
54	Dhananjay	NNP	PERSON	Dhananjay	nn	56	SENT_32	[p2l16t3310r323b3381],
55	D.	NNP	PERSON	D.	nn	56	SENT_32	[p2l343t3311r407b3363],
56	Shinde	NNP	PERSON	Shinde	dep	50	SENT_32	[p2l428t3310r622b3363],
57	and	CC	O	and	_	0	SENT_32	[p2l641t3311r742b3363],
58	Ho-Sook	NNP	PERSON	Ho-Sook	nn	59	SENT_32	[p2l766t3310r1031b3363],
59	Kim	NNP	PERSON	Kim	prep_of	25	SENT_32	[p2l1050t3311r1163b3362],
60	contributed	VBD	O	contribute	_	0	SENT_32	[p2l1186t3310r1532b3363],
61	equally	RB	O	equally	advmod	60	SENT_32	[p2l1554t3311r1758b3381],
62	to	TO	O	to	_	0	SENT_32	[p2l1773t3322r1837b3363],
63	this	DT	O	this	det	64	SENT_32	[p2l1853t3310r1958b3363],
64	work	NN	O	work	prep_to	60	SENT_32	[p2l1975t3310r2148b3363],
65	.	.	O	.	_	0	SENT_32	[p2l1975t3310r2148b3363],

1	Shinde	NNP	O	Shinde	_	0	SENT_33	[p2l97t3459r187b3486],
2	et	FW	O	et	nn	3	SENT_33	[p2l202t3465r228b3486],
3	al	FW	O	al	dep	1	SENT_33	[p2l241t3459r265b3486],
4	55	CD	NUMBER	55	dep	3	SENT_33	[p2l2003t3456r2040b3486],
5	I	PRP	O	I	dep	1	SENT_33	[p2l2051t3456r2055b3486],

1	regard	NN	O	regard	_	0	SENT_34	[p2l15t3632r250b3717],
2	to	TO	O	to	_	0	SENT_34	[p2l323t3641r391b3698],
3	serotonin	NN	O	serotonin	nn	4	SENT_34	[p2l471t3632r810b3698],
4	uptake	NN	O	uptake	prep_to	1	SENT_34	[p2l883t3632r1128b3717],
5	than	IN	O	than	_	0	SENT_34	[p2l1202t3632r1362b3698],
6	the	DT	O	the	det	8	SENT_34	[p2l1435t3632r1545b3698],
7	respective	JJ	O	respective	amod	8	SENT_34	[p2l1620t3632r1991b3717],
8	Senantiomers	NNS	O	senantiomer	prep_than	1	SENT_34	[p2l2065t3633r2140b3698, p2l17t3743r482b3810],
9	.	.	O	.	_	0	SENT_34	[p2l2065t3633r2140b3698, p2l17t3743r482b3810],

1	11	CD	NUMBER	11	_	0	SENT_35	[p2l497t3725r551b3767],
2	The	DT	O	the	det	4	SENT_35	[p2l580t3743r720b3810],
3	enantioselective	JJ	O	enantioselective	amod	4	SENT_35	[p2l745t3743r1333b3810],
4	metabolism	NN	O	metabolism	dep	1	SENT_35	[p2l1356t3743r1787b3810],
5	of	IN	O	of	_	0	SENT_35	[p2l1809t3743r1893b3810],
6	sibutramine	NN	O	sibutramine	prep_of	4	SENT_35	[p2l1906t3743r2140b3810, p3l17t38r238b105],

1	has	VBZ	O	have	aux	3	SENT_36	[p3l300t38r420b105],
2	been	VBN	O	be	auxpass	3	SENT_36	[p3l482t38r658b105],
3	reported	VBN	O	report	ccomp	26	SENT_36	[p3l717t38r1024b123],
4	from	IN	O	from	_	0	SENT_36	[p3l1087t38r1264b105],
5	rat	NN	O	rat	nn	8	SENT_36	[p3l1323t48r1420b105],
6	liver	NN	O	liver	nn	8	SENT_36	[p3l1481t38r1648b105],
7	microsomal	JJ	O	microsomal	amod	8	SENT_36	[p3l1707t38r2140b105],
8	studies	NNS	O	study	prep_from	3	SENT_36	[p3l19t132r327b216],
9	.7	CD	NUMBER	.7	dep	17	SENT_36	[p3l19t132r327b216],
10	Because	IN	O	because	dep	17	SENT_36	[p3l374t153r679b216],
11	the	DT	O	the	det	12	SENT_36	[p3l725t150r835b216],
12	biotransformation	NN	O	biotransformation	nsubjpass	17	SENT_36	[p3l881t150r1542b216],
13	of	IN	O	of	_	0	SENT_36	[p3l1589t150r1674b216],
14	sibutramine	NN	O	sibutramine	prep_of	12	SENT_36	[p3l1711t150r2140b216],
15	is	VBZ	O	be	auxpass	17	SENT_36	[p3l17t261r73b328],
16	also	RB	O	also	advmod	17	SENT_36	[p3l116t261r259b328],
17	expected	VBN	O	expect	ccomp	3	SENT_36	[p3l302t261r629b346],
18	to	TO	O	to	aux	20	SENT_36	[p3l667t271r735b328],
19	be	VB	O	be	cop	20	SENT_36	[p3l775t261r861b328],
20	enantioselective	JJ	O	enantioselective	xcomp	17	SENT_36	[p3l904t261r1492b328],
21	in	IN	O	in	_	0	SENT_36	[p3l1536t261r1605b326],
22	humans	NNS	O	human	prep_in	20	SENT_36	[p3l1643t261r1950b342],
23	,	,	O	,	_	0	SENT_36	[p3l1643t261r1950b342],
24	it	PRP	O	it	nsubj	26	SENT_36	[p3l1995t261r2044b327],
25	is	VBZ	O	be	cop	26	SENT_36	[p3l2083t261r2140b328],
26	important	JJ	O	important	_	0	SENT_36	[p3l17t371r373b456],
27	to	TO	O	to	aux	28	SENT_36	[p3l408t381r477b438],
28	understand	VB	O	understand	xcomp	26	SENT_36	[p3l514t371r922b438],
29	factors	NNS	O	factor	dobj	28	SENT_36	[p3l959t371r1202b438],
30	inﬂuencing	VBG	O	inﬂuencing	partmod	29	SENT_36	[p3l1243t371r1656b457],
31	the	DT	O	the	det	33	SENT_36	[p3l1693t371r1803b438],
32	enantioselective	JJ	O	enantioselective	amod	33	SENT_36	[p3l1843t371r2140b438, p3l19t483r333b549],
33	disposition	NN	O	disposition	dobj	30	SENT_36	[p3l393t483r796b568],
34	of	IN	O	of	_	0	SENT_36	[p3l853t483r938b549],
35	sibutramine	NN	O	sibutramine	prep_of	33	SENT_36	[p3l985t483r1435b564],
36	,	,	O	,	_	0	SENT_36	[p3l985t483r1435b564],
37	M1	NN	O	m1	prep_of	33	SENT_36	[p3l1494t484r1641b564],
38	,	,	O	,	_	0	SENT_36	[p3l1494t484r1641b564],
39	and	CC	O	and	_	0	SENT_36	[p3l1703t483r1834b549],
40	M2	NN	O	m2	conj_and	35	SENT_36	[p3l1889t485r2013b548],
41	in	IN	O	in	_	0	SENT_36	[p3l2073t483r2142b548],
42	humans	NNS	O	human	prep_in	35	SENT_36	[p3l15t594r320b661],
43	.	.	O	.	_	0	SENT_36	[p3l15t594r320b661],

1	CYP2B6	NN	O	cyp2b6	nsubj	38	SENT_37	[p3l130t707r482b786],
2	,	,	O	,	_	0	SENT_37	[p3l130t707r482b786],
3	CYP3A4/5	NN	O	cyp3a4/5	conj_and	1	SENT_37	[p3l514t705r943b786],
4	,	,	O	,	_	0	SENT_37	[p3l514t705r943b786],
5	and	CC	O	and	_	0	SENT_37	[p3l977t705r1108b773],
6	CYP2Cl9	NN	O	cyp2cl9	conj_and	1	SENT_37	[p3l1136t707r1512b773],
7	are	VBP	O	be	auxpass	8	SENT_37	[p3l1544t727r1651b772],
8	known	VBN	O	know	rcmod	1	SENT_37	[p3l1679t705r1932b773],
9	to	TO	O	to	aux	13	SENT_37	[p3l1958t715r2027b772],
10	be	VB	O	be	cop	13	SENT_37	[p3l2054t705r2140b772],
11	the	DT	O	the	det	13	SENT_37	[p3l15t817r125b883],
12	major	JJ	O	major	amod	13	SENT_37	[p3l157t817r373b902],
13	enzymes	NNS	O	enzyme	xcomp	8	SENT_37	[p3l403t838r723b902],
14	catalyzing	VBG	O	catalyze	partmod	13	SENT_37	[p3l757t817r1131b902],
15	the	DT	O	the	det	16	SENT_37	[p3l1163t817r1274b883],
16	formation	NN	O	formation	dobj	14	SENT_37	[p3l1308t817r1668b883],
17	of	IN	O	of	_	0	SENT_37	[p3l1701t817r1786b883],
18	M1	NN	O	m1	prep_of	16	SENT_37	[p3l1806t818r1922b882],
19	from	IN	O	from	_	0	SENT_37	[p3l1966t817r2142b883],
20	sibutramine	NN	O	sibutramine	prep_from	18	SENT_37	[p3l19t928r448b995],
21	and	CC	O	and	_	0	SENT_37	[p3l512t928r644b995],
22	the	DT	O	the	det	24	SENT_37	[p3l703t928r813b995],
23	further	JJ	O	further	amod	24	SENT_37	[p3l878t928r1126b995],
24	metabolism	NN	O	metabolism	conj_and	18	SENT_37	[p3l1184t928r1615b995],
25	of	IN	O	of	_	0	SENT_37	[p3l1677t928r1761b995],
26	M1	NN	O	m1	prep_of	24	SENT_37	[p3l1811t930r1928b993],
27	into	IN	O	into	_	0	SENT_37	[p3l2000t928r2140b995],
28	M2	NN	O	m2	prep_into	14	SENT_37	[p3l16t1021r319b1107],
29	.12	CD	NUMBER	.12	number	30	SENT_37	[p3l16t1021r319b1107],
30	’13	CD	NUMBER	’13	num	32	SENT_37	[p3l16t1021r319b1107],
31	The	DT	O	the	det	32	SENT_37	[p3l364t1040r503b1107],
32	genes	NNS	O	gene	dep	14	SENT_37	[p3l545t1062r751b1126],
33	encoding	VBG	O	encode	partmod	32	SENT_37	[p3l793t1040r1130b1126],
34	these	DT	O	these	det	35	SENT_37	[p3l1169t1040r1356b1107],
35	enzymes	NNS	O	enzyme	dobj	33	SENT_37	[p3l1398t1062r1716b1126],
36	are	VBP	O	be	cop	38	SENT_37	[p3l1759t1062r1866b1107],
37	highly	RB	O	highly	advmod	38	SENT_37	[p3l1905t1040r2142b1126],
38	polymorphic14	JJ	O	polymorphic14	_	0	SENT_37	[p3l14t1133r660b1237],
39	*	NN	O	*	nsubjpass	47	SENT_37	[p3l14t1133r660b1237],
40	19	CD	NUMBER	19	num	39	SENT_37	[p3l14t1133r660b1237],
41	and	CC	O	and	_	0	SENT_37	[p3l715t1152r847b1218],
42	enzyme	NN	O	enzyme	nn	43	SENT_37	[p3l898t1173r1181b1237],
43	activities	NNS	O	activity	conj_and	39	SENT_37	[p3l1235t1152r1562b1218],
44	can	MD	O	can	aux	47	SENT_37	[p3l1616t1173r1742b1218],
45	be	VB	O	be	auxpass	47	SENT_37	[p3l1790t1152r1876b1218],
46	easily	RB	O	easily	advmod	47	SENT_37	[p3l1930t1152r2141b1237],
47	modulated	VBN	O	modulate	ccomp	38	SENT_37	[p3l15t1263r405b1330],
48	by	IN	O	by	_	0	SENT_37	[p3l430t1263r524b1348],
49	inhibitors	NNS	O	inhibitor	agent	47	SENT_37	[p3l551t1263r901b1330],
50	and	CC	O	and	_	0	SENT_37	[p3l931t1263r1062b1330],
51	inducers	NNS	O	inducer	agent	47	SENT_37	[p3l1090t1263r1419b1344],
52	,	,	O	,	_	0	SENT_37	[p3l1090t1263r1419b1344],
53	leading	VBG	O	lead	xcomp	47	SENT_37	[p3l1452t1263r1720b1348],
54	to	TO	O	to	_	0	SENT_37	[p3l1747t1272r1816b1330],
55	changes	NNS	O	change	prep_to	53	SENT_37	[p3l1846t1263r2140b1348],
56	in	IN	O	in	_	0	SENT_37	[p3l17t1373r86b1439],
57	the	DT	O	the	det	59	SENT_37	[p3l105t1373r216b1440],
58	plasma	NN	O	plasma	nn	59	SENT_37	[p3l236t1373r499b1458],
59	levels	NNS	O	level	prep_in	55	SENT_37	[p3l520t1373r730b1440],
60	of	IN	O	of	_	0	SENT_37	[p3l754t1373r839b1440],
61	substrates	NNS	O	substrate	prep_of	59	SENT_37	[p3l851t1373r1208b1440],
62	of	IN	O	of	_	0	SENT_37	[p3l1233t1373r1318b1440],
63	each	DT	O	each	det	64	SENT_37	[p3l1328t1373r1495b1440],
64	enzyme	NN	O	enzyme	prep_of	61	SENT_37	[p3l1517t1395r1799b1459],
65	and	CC	O	and	_	0	SENT_37	[p3l1824t1373r1955b1440],
66	their	PRP$	O	they	poss	68	SENT_37	[p3l1975t1373r2144b1440],
67	pharmacokinetic	JJ	O	pharmacokinetic	amod	68	SENT_37	[p3l14t1485r628b1570],
68	characteristics	NNS	O	characteristic	conj_and	64	SENT_37	[p3l673t1485r1211b1551],
69	.	.	O	.	_	0	SENT_37	[p3l673t1485r1211b1551],

1	Recent	JJ	O	recent	amod	2	SENT_38	[p3l1260t1488r1516b1551],
2	reports	NNS	O	report	nsubj	3	SENT_38	[p3l1555t1494r1807b1570],
3	indicate	VBP	O	indicate	_	0	SENT_38	[p3l1853t1485r2140b1551],
4	that	IN	O	that	complm	7	SENT_38	[p3l15t1596r153b1663],
5	CYPZCI9	NN	O	cypzci9	nn	6	SENT_38	[p3l186t1598r552b1663],
6	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_38	[p3l580t1596r1154b1681],
7	affect	VBP	O	affect	ccomp	3	SENT_38	[p3l1189t1596r1394b1663],
8	the	DT	O	the	det	9	SENT_38	[p3l1422t1596r1532b1663],
9	pharmacokinetics	NNS	O	pharmacokinetic	dobj	7	SENT_38	[p3l1562t1596r2139b1681, p3l17t1706r114b1773],
10	of	IN	O	of	_	0	SENT_38	[p3l141t1706r226b1773],
11	sibutramine	NN	O	sibutramine	nn	12	SENT_38	[p3l242t1687r738b1773],
12	”	NN	O	”	prep_of	9	SENT_38	[p3l242t1687r738b1773],
13	and	CC	O	and	_	0	SENT_38	[p3l768t1706r900b1773],
14	that	IN	O	that	complm	22	SENT_38	[p3l922t1706r1060b1773],
15	the	DT	O	the	det	19	SENT_38	[p3l1082t1706r1192b1773],
16	CYP2B6	NN	O	cyp2b6	nn	19	SENT_38	[p3l1223t1708r1539b1773],
17	*	NN	O	*	nn	19	SENT_38	[p3l1549t1706r1632b1773],
18	6	CD	NUMBER	6	num	19	SENT_38	[p3l1549t1706r1632b1773],
19	allele	NN	O	allele	nsubjpass	22	SENT_38	[p3l1655t1706r1848b1773],
20	may	MD	O	may	aux	22	SENT_38	[p3l1873t1728r2032b1792],
21	be	VB	O	be	auxpass	22	SENT_38	[p3l2054t1706r2140b1773],
22	associated	VBN	O	associate	ccomp	3	SENT_38	[p3l17t1818r393b1884],
23	with	IN	O	with	_	0	SENT_38	[p3l410t1818r574b1884],
24	lower	JJR	O	lower	amod	26	SENT_38	[p3l594t1818r802b1884],
25	metabolic	JJ	O	metabolic	amod	26	SENT_38	[p3l818t1818r1178b1884],
26	clearance	NN	O	clearance	prep_with	22	SENT_38	[p3l1201t1818r1543b1884],
27	of	IN	O	of	_	0	SENT_38	[p3l1565t1818r1649b1884],
28	M1	NN	O	m1	prep_of	26	SENT_38	[p3l1656t1820r1773b1883],
29	in	IN	O	in	_	0	SENT_38	[p3l1803t1818r1872b1883],
30	human	JJ	O	human	amod	31	SENT_38	[p3l1890t1818r2142b1884],
31	subjects	NNS	O	subject	prep_in	22	SENT_38	[p3l19t1912r488b2015],
32	.14	CD	NUMBER	.14	number	33	SENT_38	[p3l19t1912r488b2015],
33	’15	CD	NUMBER	’15	dep	31	SENT_38	[p3l19t1912r488b2015],

1	In	IN	O	in	_	0	SENT_39	[p3l128t2043r203b2106],
2	this	DT	O	this	det	3	SENT_39	[p3l242t2040r372b2107],
3	study	NN	O	study	prep_in	6	SENT_39	[p3l418t2040r634b2126],
4	,	,	O	,	_	0	SENT_39	[p3l418t2040r634b2126],
5	we	PRP	O	we	nsubj	6	SENT_39	[p3l678t2062r783b2107],
6	characterized	VBD	O	characterize	_	0	SENT_39	[p3l827t2040r1315b2107],
7	the	DT	O	the	det	8	SENT_39	[p3l1354t2040r1464b2107],
8	impact	NN	O	impact	dobj	6	SENT_39	[p3l1508t2040r1757b2125],
9	of	IN	O	of	_	0	SENT_39	[p3l1798t2040r1882b2107],
10	potent	JJ	O	potent	amod	11	SENT_39	[p3l1910t2050r2143b2125],
11	CYP3A	NN	O	cyp3a	prep_of	8	SENT_39	[p3l17t2153r308b2218],
12	and	CC	O	and	_	0	SENT_39	[p3l342t2152r473b2218],
13	CYP2B6	NN	O	cyp2b6	nn	14	SENT_39	[p3l505t2153r836b2218],
14	inhibitors	NNS	O	inhibitor	conj_and	11	SENT_39	[p3l871t2152r1220b2218],
15	on	IN	O	on	_	0	SENT_39	[p3l1256t2173r1346b2218],
16	the	DT	O	the	det	18	SENT_39	[p3l1376t2152r1486b2218],
17	enantio-selective	JJ	O	enantio-selective	amod	18	SENT_39	[p3l1520t2152r2140b2218],
18	disposition	NN	O	disposition	prep_on	6	SENT_39	[p3l17t2263r420b2348],
19	of	IN	O	of	_	0	SENT_39	[p3l453t2263r538b2330],
20	sibutramine	NN	O	sibutramine	prep_of	18	SENT_39	[p3l560t2263r989b2330],
21	and	CC	O	and	_	0	SENT_39	[p3l1024t2263r1155b2330],
22	its	PRP$	O	its	poss	25	SENT_39	[p3l1186t2263r1268b2330],
23	two	CD	NUMBER	two	num	25	SENT_39	[p3l1300t2273r1436b2330],
24	active	JJ	O	active	amod	25	SENT_39	[p3l1471t2263r1686b2330],
25	metabolites	NNS	O	metabolite	conj_and	18	SENT_39	[p3l1717t2263r2140b2330],
26	M1	NN	O	m1	dep	25	SENT_39	[p3l16t2375r133b2439],
27	and	CC	O	and	_	0	SENT_39	[p3l183t2373r314b2440],
28	M2	NN	O	m2	conj_and	26	SENT_39	[p3l351t2375r475b2439],
29	in	IN	O	in	_	0	SENT_39	[p3l518t2373r587b2439],
30	healthy	JJ	O	healthy	amod	31	SENT_39	[p3l624t2373r895b2459],
31	subjects	NNS	O	subject	prep_in	6	SENT_39	[p3l936t2373r1248b2459],
32	,	,	O	,	_	0	SENT_39	[p3l936t2373r1248b2459],
33	in	IN	O	in	_	0	SENT_39	[p3l1291t2373r1361b2439],
34	relation	NN	O	relation	prep_in	6	SENT_39	[p3l1397t2373r1677b2440],
35	to	TO	O	to	_	0	SENT_39	[p3l1714t2383r1783b2440],
36	CYP2B6	NN	O	cyp2b6	nn	37	SENT_39	[p3l1828t2375r2145b2440],
37	polymorphisms	NNS	O	polymorphism	prep_to	6	SENT_39	[p3l14t2485r608b2570],
38	.	.	O	.	_	0	SENT_39	[p3l14t2485r608b2570],

1	Clopidogrel	NNP	O	Clopidogrel	nsubjpass	19	SENT_40	[p3l678t2485r1137b2570],
2	,	,	O	,	_	0	SENT_40	[p3l678t2485r1137b2570],
3	a	DT	O	a	det	5	SENT_40	[p3l1205t2506r1244b2551],
4	selective	JJ	O	selective	amod	5	SENT_40	[p3l1308t2485r1623b2551],
5	inhibitor	NN	O	inhibitor	appos	1	SENT_40	[p3l1689t2485r2007b2551],
6	of	IN	O	of	_	0	SENT_40	[p3l2068t2485r2152b2551],
7	CYP2B6	NN	O	cyp2b6	prep_of	5	SENT_40	[p3l17t2598r369b2677],
8	,	,	O	,	_	0	SENT_40	[p3l17t2598r369b2677],
9	and	CC	O	and	_	0	SENT_40	[p3l444t2596r575b2663],
10	clarithromycin	NN	O	clarithromycin	conj_and	5	SENT_40	[p3l645t2596r1203b2681],
11	,	,	O	,	_	0	SENT_40	[p3l645t2596r1203b2681],
12	a	DT	O	a	det	14	SENT_40	[p3l1277t2618r1316b2663],
13	potent	JJ	O	potent	amod	14	SENT_40	[p3l1381t2605r1614b2681],
14	inhibitor	NN	O	inhibitor	appos	10	SENT_40	[p3l1683t2596r2000b2663],
15	of	IN	O	of	_	0	SENT_40	[p3l2068t2596r2152b2663],
16	CYP3A	NN	O	cyp3a	prep_of	14	SENT_40	[p3l17t2709r327b2788],
17	,	,	O	,	_	0	SENT_40	[p3l17t2709r327b2788],
18	were	VBD	O	be	auxpass	19	SENT_40	[p3l374t2729r550b2775],
19	studied	VBN	O	study	_	0	SENT_40	[p3l598t2707r862b2775],
20	to	TO	O	to	aux	21	SENT_40	[p3l903t2717r971b2775],
21	determine	VB	O	determine	xcomp	19	SENT_40	[p3l1018t2707r1381b2775],
22	the	DT	O	the	dobj	21	SENT_40	[p3l1425t2707r1535b2774],
23	in	FW	O	in	nn	24	SENT_40	[p3l1581t2707r1650b2773],
24	vivo	FW	O	vivo	advmod	25	SENT_40	[p3l1692t2707r1854b2775],
25	effects	NNS	O	effect	dep	22	SENT_40	[p3l1901t2707r2139b2775],
26	of	IN	O	of	_	0	SENT_40	[p3l17t2819r101b2885],
27	pretreatment	NN	O	pretreatment	prep_of	25	SENT_40	[p3l116t2828r582b2904],
28	on	IN	O	on	_	0	SENT_40	[p3l610t2840r701b2885],
29	the	DT	O	the	det	30	SENT_40	[p3l727t2819r837b2885],
30	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	27	SENT_40	[p3l864t2819r1514b2904],
31	of	IN	O	of	_	0	SENT_40	[p3l1545t2819r1630b2885],
32	each	DT	O	each	det	33	SENT_40	[p3l1648t2819r1814b2885],
33	enantiomer	NN	O	enantiomer	prep_of	30	SENT_40	[p3l1843t2819r2140b2885, p3l15t2952r159b2997],
34	of	IN	O	of	_	0	SENT_40	[p3l188t2930r273b2997],
35	sibutramine	NN	O	sibutramine	prep_of	33	SENT_40	[p3l295t2930r724b2997],
36	and	CC	O	and	_	0	SENT_40	[p3l757t2930r889b2997],
37	its	PRP$	O	its	poss	38	SENT_40	[p3l919t2930r1001b2997],
38	metabolites	NNS	O	metabolite	conj_and	22	SENT_40	[p3l1032t2930r1472b2997],
39	.	.	O	.	_	0	SENT_40	[p3l1032t2930r1472b2997],

1	Methods	NNS	O	method	_	0	SENT_41	[p3l22t3165r456b3243],

1	Subjects	NNS	O	subject	nsubj	9	SENT_42	[p3l17t3327r316b3412],
2	In	IN	O	in	_	0	SENT_42	[p3l16t3441r91b3503],
3	total	JJ	O	total	amod	8	SENT_42	[p3l130t3438r311b3519],
4	,	,	O	,	_	0	SENT_42	[p3l130t3438r311b3519],
5	17	CD	NUMBER	17	number	6	SENT_42	[p3l364t3440r443b3504],
6	healthy	JJ	O	healthy	amod	8	SENT_42	[p3l487t3438r755b3523],
7	male	JJ	O	male	amod	8	SENT_42	[p3l795t3438r970b3504],
8	volunteers	NNS	O	volunteer	prep_in	9	SENT_42	[p3l1012t3438r1389b3504],
9	participated	VBD	O	participate	_	0	SENT_42	[p3l1430t3438r1862b3523],
10	in	IN	O	in	_	0	SENT_42	[p3l1902t3438r1972b3503],
11	this	DT	O	this	det	12	SENT_42	[p3l2011t3438r2140b3504],
12	study	NN	O	study	prep_in	9	SENT_42	[p3l19t3549r230b3634],
13	.	.	O	.	_	0	SENT_42	[p3l19t3549r230b3634],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_43	[p3l306t3549r608b3634],
2	were	VBD	O	be	auxpass	3	SENT_43	[p3l675t3571r850b3616],
3	genotyped	VBN	O	genotype	_	0	SENT_43	[p3l918t3549r1300b3634],
4	for	IN	O	for	_	0	SENT_43	[p3l1367t3549r1471b3616],
5	the	DT	O	the	det	7	SENT_43	[p3l1534t3549r1644b3616],
6	CYP2B6	NN	O	cyp2b6	nn	7	SENT_43	[p3l1716t3549r2137b3630],
7	*	NN	O	*	prep_for	3	SENT_43	[p3l1716t3549r2137b3630],
8	6	CD	NUMBER	6	dep	7	SENT_43	[p3l1716t3549r2137b3630],
9	,	,	O	,	_	0	SENT_43	[p3l1716t3549r2137b3630],
10	2C19	CD	NUMBER	2c19	num	11	SENT_43	[p3l15t3659r325b3740],
11	*	NN	O	*	appos	7	SENT_43	[p3l15t3659r325b3740],
12	2	CD	NUMBER	2	dep	11	SENT_43	[p3l15t3659r325b3740],
13	,	,	O	,	_	0	SENT_43	[p3l15t3659r325b3740],
14	*	CD	NUMBER	*	number	19	SENT_43	[p3l400t3659r477b3726],
15	3	CD	NUMBER	3	number	19	SENT_43	[p3l400t3659r477b3726],
16	and	CC	O	and	_	0	SENT_43	[p3l542t3659r674b3726],
17	3A5	CD	NUMBER	3a5	conj_and	19	SENT_43	[p3l734t3661r878b3726],
18	*	CD	NUMBER	*	number	19	SENT_43	[p3l891t3659r968b3726],
19	3	CD	NUMBER	3	num	20	SENT_43	[p3l891t3659r968b3726],
20	alleles	NNS	O	allele	appos	7	SENT_43	[p3l1033t3659r1258b3726],
21	by	IN	O	by	_	0	SENT_43	[p3l1318t3659r1412b3745],
22	pyrosequencing	VBG	O	pyrosequence	prepc_by	20	SENT_43	[p3l1469t3640r2140b3745],
23	.20	CD	NUMBER	.20	dobj	22	SENT_43	[p3l1469t3640r2140b3745],

1	Participants	NNS	O	participant	nsubjpass	5	SENT_44	[p4l16t20r441b105],
2	were	VBD	O	be	auxpass	3	SENT_44	[p4l473t41r648b86],
3	selected	VBN	O	select	_	0	SENT_44	[p4l683t20r973b86],
4	and	CC	O	and	_	0	SENT_44	[p4l1004t20r1135b86],
5	allocated	VBN	O	allocate	conj_and	3	SENT_44	[p4l1166t20r1492b86],
6	into	IN	O	into	_	0	SENT_44	[p4l1523t20r1660b86],
7	one	CD	TIME	one	prep_into	3	SENT_44	[p4l1696t41r1824b86],
8	of	IN	TIME	of	_	0	SENT_44	[p4l1858t20r1943b86],
9	three	CD	TIME	three	num	10	SENT_44	[p4l1961t20r2141b86],
10	groups	NNS	O	group	prep_of	7	SENT_44	[p4l17t153r262b216],
11	on	IN	O	on	_	0	SENT_44	[p4l281t153r372b198],
12	the	DT	O	the	det	13	SENT_44	[p4l387t131r497b198],
13	basis	NN	O	basis	prep_on	10	SENT_44	[p4l512t131r693b198],
14	of	IN	O	of	_	0	SENT_44	[p4l712t131r797b198],
15	the	DT	O	the	det	18	SENT_44	[p4l800t131r911b198],
16	CYP2B6	NN	O	cyp2b6	nn	18	SENT_44	[p4l932t133r1247b198],
17	genotype	NN	O	genotype	nn	18	SENT_44	[p4l1260t140r1593b216],
18	*	NN	O	*	prep_of	13	SENT_44	[p4l1621t131r1812b198],
19	1	CD	NUMBER	1	dep	18	SENT_44	[p4l1621t131r1812b198],
20	/	:	O	/	punct	27	SENT_44	[p4l1621t131r1812b198],
21	*	CD	NUMBER	*	number	22	SENT_44	[p4l1621t131r1812b198],
22	1	CD	NUMBER	1	num	27	SENT_44	[p4l1621t131r1812b198],
23	(	NN	O	(	nn	27	SENT_44	[p4l1836t132r1910b216],
24	n	NN	O	n	nn	27	SENT_44	[p4l1836t132r1910b216],
25	=	JJ	O	=	amod	27	SENT_44	[p4l1945t161r2007b184],
26	6	CD	NUMBER	6	num	27	SENT_44	[p4l2047t132r2139b216],
27	)	NN	O	)	dep	18	SENT_44	[p4l2047t132r2139b216],
28	,	,	O	,	_	0	SENT_44	[p4l2047t132r2139b216],
29	*	NN	O	*	appos	27	SENT_44	[p4l26t241r228b308],
30	1	CD	NUMBER	1	num	29	SENT_44	[p4l26t241r228b308],
31	/	:	O	/	punct	27	SENT_44	[p4l26t241r228b308],
32	*	CD	NUMBER	*	number	33	SENT_44	[p4l26t241r228b308],
33	6	CD	NUMBER	6	num	38	SENT_44	[p4l26t241r228b308],
34	(	NN	O	(	nn	38	SENT_44	[p4l275t242r348b326],
35	n	NN	O	n	nn	38	SENT_44	[p4l275t242r348b326],
36	=	JJ	O	=	amod	38	SENT_44	[p4l383t272r446b294],
37	5	CD	NUMBER	5	num	38	SENT_44	[p4l486t242r576b326],
38	)	NN	O	)	dep	18	SENT_44	[p4l486t242r576b326],
39	,	,	O	,	_	0	SENT_44	[p4l486t242r576b326],
40	and	CC	O	and	_	0	SENT_44	[p4l631t241r761b308],
41	*	NN	O	*	conj_and	3	SENT_44	[p4l820t241r1022b308],
42	6	CD	NUMBER	6	dep	41	SENT_44	[p4l820t241r1022b308],
43	/	:	O	/	punct	41	SENT_44	[p4l820t241r1022b308],
44	*	CD	NUMBER	*	num	46	SENT_44	[p4l820t241r1022b308],
45	6	CD	NUMBER	6	num	46	SENT_44	[p4l820t241r1022b308],
46	(	NN	O	(	dep	41	SENT_44	[p4l1069t242r1142b326],
47	11	CD	NUMBER	11	num	50	SENT_44	[p4l1069t242r1142b326],
48	=	JJ	O	=	amod	50	SENT_44	[p4l1177t272r1240b294],
49	6	CD	NUMBER	6	tmod	48	SENT_44	[p4l1279t242r1368b326],
50	)	NN	O	)	dep	46	SENT_44	[p4l1279t242r1368b326],
51	.	.	O	.	_	0	SENT_44	[p4l1279t242r1368b326],

1	Their	PRP$	O	they	poss	3	SENT_45	[p4l1425t241r1622b308],
2	mean	NN	O	mean	nn	3	SENT_45	[p4l1667t263r1866b308],
3	age	NN	O	age	dep	12	SENT_45	[p4l1916t263r2039b327],
4	:1	CD	NUMBER	:1	dep	3	SENT_45	[p4l2076t244r2138b307],
5	:	:	O	:	_	0	SENT_45	[p4l2076t244r2138b307],
6	standard	JJ	O	standard	amod	10	SENT_45	[p4l19t353r325b419],
7	deviation	NN	O	deviation	nn	10	SENT_45	[p4l353t353r690b419],
8	(	CD	NUMBER	(	num	10	SENT_45	[p4l720t353r891b438],
9	SD	NN	O	sd	nn	10	SENT_45	[p4l720t353r891b438],
10	)	NN	O	)	nsubj	12	SENT_45	[p4l720t353r891b438],
11	was	VBD	O	be	cop	12	SENT_45	[p4l921t374r1061b419],
12	23.9	CD	NUMBER	23.9	_	0	SENT_45	[p4l1091t355r1248b419],
13	:	:	O	:	_	0	SENT_45	[p4l1287t356r1349b418],
14	|	CD	NUMBER	|	conj_and	12	SENT_45	[p4l1287t356r1349b418],
15	:	:	O	:	_	0	SENT_45	[p4l1287t356r1349b418],
16	1.7	CD	NUMBER	1.7	conj_and	12	SENT_45	[p4l1395t355r1519b433],
17	,	,	O	,	_	0	SENT_45	[p4l1395t355r1519b433],
18	25.0	CD	NUMBER	25.0	appos	16	SENT_45	[p4l1551t355r1708b419],
19	:	:	O	:	_	0	SENT_45	[p4l1746t355r1808b418],
20	|	CD	NUMBER	|	conj_and	12	SENT_45	[p4l1746t355r1808b418],
21	:	:	O	:	_	0	SENT_45	[p4l1746t355r1808b418],
22	1.5	CD	NUMBER	1.5	conj_and	12	SENT_45	[p4l1855t355r1978b434],
23	,	,	O	,	_	0	SENT_45	[p4l1855t355r1978b434],
24	and	CC	O	and	_	0	SENT_45	[p4l2012t353r2143b419],
25	25.7	CD	NUMBER	25.7	conj_and	12	SENT_45	[p4l16t466r172b531],
26	i	FW	O	i	dep	25	SENT_45	[p4l211t467r274b529],
27	1.6	CD	DURATION	1.6	num	28	SENT_45	[p4l320t466r422b531],
28	years	NNS	NUMBER	year	tmod	25	SENT_45	[p4l454t486r665b549],
29	,	,	O	,	_	0	SENT_45	[p4l454t486r665b549],
30	mean	VB	O	mean	dep	12	SENT_45	[p4l698t486r897b531],
31	body	NN	O	body	nn	33	SENT_45	[p4l925t464r1111b549],
32	mass	NN	O	mass	nn	33	SENT_45	[p4l1140t486r1321b531],
33	index	NN	O	index	dobj	30	SENT_45	[p4l1354t464r1556b531],
34	(	CD	NUMBER	(	num	35	SENT_45	[p4l1589t464r1815b549],
35	BMI	NN	O	bmus	dep	38	SENT_45	[p4l1589t464r1815b549],
36	)	CD	NUMBER	)	dep	35	SENT_45	[p4l1589t464r1815b549],
37	22.7	CD	NUMBER	22.7	dep	38	SENT_45	[p4l1849t466r2005b531],
38	i	FW	O	i	dep	58	SENT_45	[p4l2044t467r2106b529],
39	1.7	CD	NUMBER	1.7	dep	38	SENT_45	[p4l25t592r148b671],
40	,	,	O	,	_	0	SENT_45	[p4l25t592r148b671],
41	21.5	CD	NUMBER	21.5	appos	39	SENT_45	[p4l192t592r346b657],
42	i	FW	O	i	dep	41	SENT_45	[p4l388t593r450b656],
43	2.3	CD	NUMBER	2.3	dep	41	SENT_45	[p4l487t592r620b671],
44	,	,	O	,	_	0	SENT_45	[p4l487t592r620b671],
45	and	CC	O	and	_	0	SENT_45	[p4l664t590r795b657],
46	22.71	CD	NUMBER	22.71	number	47	SENT_45	[p4l834t592r1031b657],
47	:1	CD	NUMBER	:1	conj_and	38	SENT_45	[p4l1076t593r1138b656],
48	:	:	O	:	_	0	SENT_45	[p4l1076t593r1138b656],
49	1.74	CD	NUMBER	1.74	num	50	SENT_45	[p4l1185t592r1333b657],
50	kg/m2	NN	O	kg/m2	dep	47	SENT_45	[p4l1367t571r1608b676],
51	,	,	O	,	_	0	SENT_45	[p4l1367t571r1608b676],
52	in	IN	O	in	_	0	SENT_45	[p4l1653t590r1723b656],
53	the	DT	O	the	det	54	SENT_45	[p4l1760t590r1871b657],
54	*	NN	O	*	prep_in	50	SENT_45	[p4l1921t590r2138b671],
55	1	CD	NUMBER	1	num	54	SENT_45	[p4l1921t590r2138b671],
56	/	:	O	/	punct	58	SENT_45	[p4l1921t590r2138b671],
57	*	CD	NUMBER	*	num	58	SENT_45	[p4l1921t590r2138b671],
58	1	CD	NUMBER	1	dep	30	SENT_45	[p4l1921t590r2138b671],
59	,	,	O	,	_	0	SENT_45	[p4l1921t590r2138b671],
60	*	CD	NUMBER	*	number	61	SENT_45	[p4l26t702r240b783],
61	1	CD	NUMBER	1	dobj	30	SENT_45	[p4l26t702r240b783],
62	/	:	O	/	punct	63	SENT_45	[p4l26t702r240b783],
63	*	CD	NUMBER	*	dep	61	SENT_45	[p4l26t702r240b783],
64	6	CD	NUMBER	6	dep	63	SENT_45	[p4l26t702r240b783],
65	,	,	O	,	_	0	SENT_45	[p4l26t702r240b783],
66	and	CC	O	and	_	0	SENT_45	[p4l276t702r407b768],
67	*	NN	O	*	conj_and	63	SENT_45	[p4l445t702r644b768],
68	6	CD	NUMBER	6	num	67	SENT_45	[p4l445t702r644b768],
69	/	:	O	/	punct	63	SENT_45	[p4l445t702r644b768],
70	*	CD	NUMBER	*	number	71	SENT_45	[p4l445t702r644b768],
71	6	CD	NUMBER	6	num	73	SENT_45	[p4l445t702r644b768],
72	genotype	NN	O	genotype	nn	73	SENT_45	[p4l671t711r1001b787],
73	groups	NNS	O	group	dep	30	SENT_45	[p4l1034t723r1298b787],
74	,	,	O	,	_	0	SENT_45	[p4l1034t723r1298b787],
75	respectively	RB	O	respectively	advmod	12	SENT_45	[p4l1330t702r1782b787],
76	.	.	O	.	_	0	SENT_45	[p4l1330t702r1782b787],

1	The	DT	O	the	det	2	SENT_46	[p4l1818t702r1956b768],
2	subjects	NNS	O	subject	nsubjpass	4	SENT_46	[p4l1989t702r2141b768, p4l7t813r177b898],
3	were	VBD	O	be	auxpass	4	SENT_46	[p4l217t835r391b880],
4	determined	VBN	O	determine	_	0	SENT_46	[p4l434t813r839b880],
5	to	TO	O	to	aux	7	SENT_46	[p4l876t823r945b880],
6	be	VB	O	be	cop	7	SENT_46	[p4l984t813r1070b880],
7	healthy	JJ	O	healthy	xcomp	4	SENT_46	[p4l1109t813r1376b898],
8	by	IN	O	by	_	0	SENT_46	[p4l1414t813r1507b898],
9	medical	JJ	O	medical	amod	10	SENT_46	[p4l1544t813r1830b880],
10	history	NN	O	history	prep_by	7	SENT_46	[p4l1869t813r2139b898],
11	,	,	O	,	_	0	SENT_46	[p4l1869t813r2139b898],
12	physical	JJ	O	physical	amod	13	SENT_46	[p4l13t923r315b1009],
13	examination	NN	O	examination	conj_and	10	SENT_46	[p4l356t923r819b1004],
14	,	,	O	,	_	0	SENT_46	[p4l356t923r819b1004],
15	vital	JJ	O	vital	amod	16	SENT_46	[p4l860t923r1019b990],
16	signs	NNS	O	sign	conj_and	10	SENT_46	[p4l1060t923r1261b1009],
17	,	,	O	,	_	0	SENT_46	[p4l1060t923r1261b1009],
18	and	CC	O	and	_	0	SENT_46	[p4l1304t923r1434b990],
19	clinical	JJ	O	clinical	amod	21	SENT_46	[p4l1473t923r1733b990],
20	laboratory	NN	O	laboratory	nn	21	SENT_46	[p4l1773t923r2143b1009],
21	tests	NNS	O	test	conj_and	10	SENT_46	[p4l15t1044r172b1101],
22	prior	RB	O	prior	_	0	SENT_46	[p4l205t1035r383b1120],
23	to	TO	O	to	_	0	SENT_46	[p4l412t1044r481b1101],
24	inclusion	NN	O	inclusion	prep_prior_to	7	SENT_46	[p4l516t1035r846b1101],
25	in	IN	O	in	_	0	SENT_46	[p4l879t1035r949b1100],
26	the	DT	O	the	det	27	SENT_46	[p4l979t1035r1088b1101],
27	study	NN	O	study	prep_in	7	SENT_46	[p4l1126t1035r1336b1120],
28	.	.	O	.	_	0	SENT_46	[p4l1126t1035r1336b1120],

1	None	NN	O	none	_	0	SENT_47	[p4l1371t1038r1570b1101],
2	of	IN	O	of	_	0	SENT_47	[p4l1604t1035r1689b1101],
3	the	DT	O	the	det	4	SENT_47	[p4l1709t1035r1817b1101],
4	subjects	NNS	O	subject	prep_of	1	SENT_47	[p4l1855t1035r2140b1120],
5	smoked	JJ	O	smoked	amod	6	SENT_47	[p4l19t1146r299b1213],
6	tobacco	NN	O	tobacco	dep	4	SENT_47	[p4l312t1146r592b1213],
7	or	CC	O	or	_	0	SENT_47	[p4l610t1168r685b1213],
8	received	VBN	O	receive	amod	10	SENT_47	[p4l697t1146r1003b1213],
9	continuous	JJ	O	continuous	amod	10	SENT_47	[p4l1018t1146r1412b1213],
10	medication	NN	O	medication	prep_of	1	SENT_47	[p4l1428t1146r1847b1213],
11	.	.	O	.	_	0	SENT_47	[p4l1428t1146r1847b1213],

1	The	DT	O	the	det	2	SENT_48	[p4l1867t1146r2005b1213],
2	use	NN	O	use	nsubjpass	10	SENT_48	[p4l2021t1168r2141b1213],
3	of	IN	O	of	_	0	SENT_48	[p4l17t1256r101b1323],
4	other	JJ	O	other	amod	5	SENT_48	[p4l123t1256r309b1323],
5	drugs	NNS	O	drug	prep_of	2	SENT_48	[p4l340t1256r537b1342],
6	and	CC	O	and	_	0	SENT_48	[p4l573t1256r704b1323],
7	grapefruit	NN	O	grapefruit	nn	8	SENT_48	[p4l736t1256r1089b1342],
8	products	NNS	O	product	prep_of	2	SENT_48	[p4l1118t1256r1429b1341],
9	was	VBD	O	be	auxpass	10	SENT_48	[p4l1462t1278r1601b1323],
10	prohibited	VBN	O	prohibit	conj_and	10	SENT_48	[p4l1634t1256r2008b1341],
11	for	IN	O	for	_	0	SENT_48	[p4l2041t1256r2144b1323],
12	2	CD	DURATION	2	num	13	SENT_48	[p4l16t1370r57b1433],
13	weeks	NNS	NUMBER	week	prep_for	10	SENT_48	[p4l105t1368r331b1434],
14	before	IN	O	before	_	0	SENT_48	[p4l376t1368r606b1434],
15	and	CC	O	and	_	0	SENT_48	[p4l654t1368r785b1434],
16	during	IN	O	during	_	0	SENT_48	[p4l830t1368r1063b1453],
17	the	DT	O	the	det	19	SENT_48	[p4l1109t1368r1218b1434],
18	study	NN	O	study	nn	19	SENT_48	[p4l1268t1368r1462b1453],
19	period	NN	O	period	prep_before	10	SENT_48	[p4l1505t1368r1753b1453],
20	.	.	O	.	_	0	SENT_48	[p4l1505t1368r1753b1453],

1	Vigorous	JJ	O	vigorous	amod	3	SENT_49	[p4l1804t1368r2141b1453],
2	physical	JJ	O	physical	amod	3	SENT_49	[p4l13t1479r315b1564],
3	exercise	NN	O	exercise	nsubjpass	11	SENT_49	[p4l334t1479r623b1546],
4	and	CC	O	and	_	0	SENT_49	[p4l642t1479r773b1546],
5	the	DT	O	the	det	6	SENT_49	[p4l787t1479r895b1546],
6	use	NN	O	use	nsubjpass	11	SENT_49	[p4l912t1501r1031b1546],
7	of	IN	O	of	_	0	SENT_49	[p4l1051t1479r1135b1546],
8	alcohol	NN	O	alcohol	prep_of	6	SENT_49	[p4l1141t1479r1404b1546],
9	were	VBD	O	be	auxpass	11	SENT_49	[p4l1419t1501r1594b1546],
10	also	RB	O	also	advmod	11	SENT_49	[p4l1612t1479r1754b1546],
11	prohibited	VBN	O	prohibit	_	0	SENT_49	[p4l1769t1479r2143b1564],
12	throughout	IN	O	throughout	_	0	SENT_49	[p4l15t1589r414b1675],
13	the	DT	O	the	det	14	SENT_49	[p4l435t1589r543b1656],
14	study	NN	O	study	prep_throughout	11	SENT_49	[p4l570t1589r779b1675],
15	.	.	O	.	_	0	SENT_49	[p4l570t1589r779b1675],

1	Study	NNP	O	Study	nn	5	SENT_50	[p4l17t1812r220b1900],
2	Design	NNP	O	Design	nn	5	SENT_50	[p4l255t1813r498b1898],
3	The	NNP	O	The	nn	5	SENT_50	[p4l17t1922r156b1989],
4	study	NN	O	study	nn	5	SENT_50	[p4l210t1922r407b2008],
5	protocol	NN	O	protocol	nsubjpass	7	SENT_50	[p4l454t1922r762b2007],
6	was	VBD	O	be	auxpass	7	SENT_50	[p4l811t1944r952b1989],
7	approved	VBN	O	approve	_	0	SENT_50	[p4l1005t1922r1348b2007],
8	by	IN	O	by	_	0	SENT_50	[p4l1395t1922r1488b2008],
9	the	DT	O	the	det	12	SENT_50	[p4l1537t1922r1647b1989],
10	Institutional	JJ	ORGANIZATION	institutional	amod	12	SENT_50	[p4l1698t1922r2141b1989],
11	Review	NNP	ORGANIZATION	Review	nn	12	SENT_50	[p4l16t2033r296b2099],
12	Board	NNP	ORGANIZATION	Board	agent	7	SENT_50	[p4l338t2033r563b2099],
13	of	IN	ORGANIZATION	of	_	0	SENT_50	[p4l605t2033r690b2099],
14	Inje	NNP	ORGANIZATION	Inje	nn	18	SENT_50	[p4l720t2033r859b2118],
15	University	NNP	ORGANIZATION	University	nn	18	SENT_50	[p4l901t2033r1290b2118],
16	Busan	NNP	ORGANIZATION	Busan	nn	18	SENT_50	[p4l1332t2036r1563b2099],
17	Paik	NNP	ORGANIZATION	Paik	nn	18	SENT_50	[p4l1604t2033r1767b2099],
18	Hospital	NNP	ORGANIZATION	Hospital	prep_of	12	SENT_50	[p4l1807t2033r2138b2118],
19	,	,	O	,	_	0	SENT_50	[p4l1807t2033r2138b2118],
20	Busan	NNP	ORGANIZATION	Busan	nn	22	SENT_50	[p4l9t2147r259b2225],
21	,	,	O	,	_	0	SENT_50	[p4l9t2147r259b2225],
22	Korea	NNP	LOCATION	Korea	appos	18	SENT_50	[p4l312t2147r554b2210],
23	.	.	O	.	_	0	SENT_50	[p4l312t2147r554b2210],

1	All	DT	O	all	det	2	SENT_51	[p4l608t2144r724b2209],
2	subjects	NNS	O	subject	nsubj	3	SENT_51	[p4l776t2144r1068b2229],
3	provided	VBD	O	provide	_	0	SENT_51	[p4l1116t2144r1448b2229],
4	written	VBN	O	write	amod	6	SENT_51	[p4l1495t2144r1755b2210],
5	informed	VBN	O	inform	amod	6	SENT_51	[p4l1805t2144r2142b2210],
6	consent	NN	O	consent	dobj	3	SENT_51	[p4l10t2264r292b2322],
7	before	IN	O	before	_	0	SENT_51	[p4l319t2255r553b2322],
8	participating	VBG	O	participate	prepc_before	3	SENT_51	[p4l583t2255r1050b2340],
9	in	IN	O	in	_	0	SENT_51	[p4l1082t2255r1152b2320],
10	the	DT	O	the	det	11	SENT_51	[p4l1180t2255r1291b2322],
11	study	NN	O	study	prep_in	8	SENT_51	[p4l1326t2255r1541b2340],
12	.	.	O	.	_	0	SENT_51	[p4l1326t2255r1541b2340],

1	A	DT	O	a	_	0	SENT_52	[p4l120t2367r187b2432],
2	randomized	VBN	O	randomize	csubjpass	17	SENT_52	[p4l221t2365r678b2447],
3	,	,	O	,	_	0	SENT_52	[p4l221t2365r678b2447],
4	open	JJ	O	open	amod	8	SENT_52	[p4l719t2387r917b2451],
5	,	,	O	,	_	0	SENT_52	[p4l719t2387r917b2451],
6	3-phase	JJ	O	3-phase	amod	8	SENT_52	[p4l958t2365r1242b2451],
7	crossover	NN	O	crossover	nn	8	SENT_52	[p4l1280t2387r1635b2433],
8	study	NN	O	study	dobj	2	SENT_52	[p4l1671t2365r1868b2452],
9	with	IN	O	with	_	0	SENT_52	[p4l1903t2365r2067b2433],
10	a	DT	O	a	det	12	SENT_52	[p4l2104t2387r2143b2433],
11	washout	NN	O	washout	nn	12	SENT_52	[p4l8t2478r318b2544],
12	period	NN	O	period	prep_with	8	SENT_52	[p4l335t2478r573b2563],
13	of	IN	O	of	_	0	SENT_52	[p4l593t2478r678b2544],
14	2	CD	DURATION	2	num	15	SENT_52	[p4l686t2480r727b2543],
15	weeks	NNS	NUMBER	week	prep_of	12	SENT_52	[p4l750t2478r978b2544],
16	was	VBD	O	be	auxpass	17	SENT_52	[p4l999t2499r1141b2544],
17	performed	VBN	O	perform	dep	1	SENT_52	[p4l1160t2478r1563b2563],
18	.	.	O	.	_	0	SENT_52	[p4l1160t2478r1563b2563],

1	During	IN	O	during	_	0	SENT_53	[p4l1589t2478r1849b2563],
2	the	DT	O	the	det	8	SENT_53	[p4l1868t2478r1979b2544],
3	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_53	[p4l2000t2478r2143b2544],
4	phase	NN	O	phase	nn	8	SENT_53	[p4l7t2589r217b2674],
5	(	NN	O	(	nn	8	SENT_53	[p4l249t2589r536b2674],
6	control	NN	O	control	nn	8	SENT_53	[p4l249t2589r536b2674],
7	phase	NN	O	phase	nn	8	SENT_53	[p4l563t2589r824b2674],
8	)	NN	O	)	prep_during	18	SENT_53	[p4l563t2589r824b2674],
9	,	,	O	,	_	0	SENT_53	[p4l563t2589r824b2674],
10	after	IN	O	after	_	0	SENT_53	[p4l858t2589r1024b2656],
11	an	DT	O	a	det	13	SENT_53	[p4l1051t2611r1136b2656],
12	overnight	JJ	TIME	overnight	amod	13	SENT_53	[p4l1165t2589r1519b2674],
13	fast	JJ	O	fast	prep_after	18	SENT_53	[p4l1547t2589r1696b2670],
14	,	,	O	,	_	0	SENT_53	[p4l1547t2589r1696b2670],
15	all	DT	O	all	det	16	SENT_53	[p4l1729t2589r1816b2656],
16	subjects	NNS	O	subject	nsubjpass	18	SENT_53	[p4l1848t2589r2139b2674],
17	were	VBD	O	be	auxpass	18	SENT_53	[p4l8t2721r185b2767],
18	given	VBN	O	give	_	0	SENT_53	[p4l249t2699r453b2786],
19	a	DT	O	a	det	21	SENT_53	[p4l517t2721r555b2767],
20	15	CD	NUMBER	15	num	21	SENT_53	[p4l626t2701r702b2767],
21	mg	NN	O	mg	iobj	18	SENT_53	[p4l741t2721r858b2786],
22	oral	JJ	O	oral	amod	23	SENT_53	[p4l922t2699r1061b2767],
23	dose	NN	O	dose	dobj	18	SENT_53	[p4l1125t2699r1290b2767],
24	of	IN	O	of	_	0	SENT_53	[p4l1356t2699r1441b2767],
25	sibutramine	NN	O	sibutramine	prep_of	23	SENT_53	[p4l1494t2699r1924b2767],
26	HCl	NN	O	hcl	nn	28	SENT_53	[p4l1988t2699r2140b2767],
27	(	CD	NUMBER	(	num	28	SENT_53	[p4l11t2812r371b2897],
28	Reductil	NNP	O	Reductil	dep	25	SENT_53	[p4l11t2812r371b2897],
29	,	,	O	,	_	0	SENT_53	[p4l11t2812r371b2897],
30	Abbott	NNP	LOCATION	Abbott	nn	35	SENT_53	[p4l426t2812r685b2878],
31	Korea	NNP	LOCATION	Korea	nn	35	SENT_53	[p4l736t2815r980b2892],
32	,	,	O	,	_	0	SENT_53	[p4l736t2815r980b2892],
33	Seoul	NNP	LOCATION	Seoul	appos	35	SENT_53	[p4l1040t2812r1265b2893],
34	,	,	O	,	_	0	SENT_53	[p4l1040t2812r1265b2893],
35	Korea	NNP	LOCATION	Korea	appos	25	SENT_53	[p4l1321t2812r1573b2897],
36	)	CD	NUMBER	)	num	35	SENT_53	[p4l1321t2812r1573b2897],
37	with	IN	O	with	_	0	SENT_53	[p4l1627t2812r1791b2878],
38	240	CD	NUMBER	240	num	40	SENT_53	[p4l1843t2813r1979b2878],
39	mL	NN	O	ml	nn	40	SENT_53	[p4l2014t2815r2141b2877],
40	water	NN	O	water	prep_with	35	SENT_53	[p4l8t2933r229b2990],
41	.	.	O	.	_	0	SENT_53	[p4l8t2933r229b2990],

1	All	DT	O	all	det	2	SENT_54	[p4l262t2923r378b2988],
2	subjects	NNS	O	subject	nsubj	12	SENT_54	[p4l410t2923r702b3008],
3	remained	VBD	O	remain	cop	4	SENT_54	[p4l731t2923r1075b2990],
4	semi-recumbent	JJ	O	semi-recumbent	_	0	SENT_54	[p4l1106t2923r1698b2990],
5	for	IN	O	for	_	0	SENT_54	[p4l1727t2923r1833b2990],
6	4	CD	DURATION	4	num	7	SENT_54	[p4l1858t2925r1901b2988],
7	hours	NNS	NUMBER	hour	prep_for	4	SENT_54	[p4l1936t2923r2140b2990],
8	after	IN	O	after	_	0	SENT_54	[p4l10t3033r177b3101],
9	taking	VBG	O	take	prepc_after	4	SENT_54	[p4l214t3033r444b3120],
10	sibutramine	NN	O	sibutramine	dobj	9	SENT_54	[p4l489t3033r919b3101],
11	and	CC	O	and	_	0	SENT_54	[p4l963t3033r1095b3101],
12	were	VBD	O	be	conj_and	4	SENT_54	[p4l1134t3055r1310b3101],
13	under	IN	O	under	_	0	SENT_54	[p4l1351t3033r1564b3101],
14	direct	JJ	O	direct	amod	16	SENT_54	[p4l1604t3033r1812b3101],
15	medical	JJ	O	medical	amod	16	SENT_54	[p4l1850t3033r2140b3101],
16	supervision	NN	O	supervision	prep_under	12	SENT_54	[p4l12t3146r435b3231],
17	for	IN	O	for	_	0	SENT_54	[p4l478t3146r584b3212],
18	12	CD	DURATION	12	num	19	SENT_54	[p4l631t3148r710b3211],
19	hours	NNS	NUMBER	hour	prep_for	16	SENT_54	[p4l746t3146r969b3212],
20	.	.	O	.	_	0	SENT_54	[p4l746t3146r969b3212],

1	No	DT	O	no	det	2	SENT_55	[p4l1013t3149r1125b3212],
2	meals	NNS	O	meal	nsubjpass	4	SENT_55	[p4l1167t3146r1380b3212],
3	were	VBD	O	be	auxpass	4	SENT_55	[p4l1422t3167r1599b3212],
4	allowed	VBN	O	allow	_	0	SENT_55	[p4l1643t3146r1934b3212],
5	until	IN	O	until	_	0	SENT_55	[p4l1973t3146r2141b3212],
6	4	CD	DURATION	4	num	7	SENT_55	[p4l8t3259r51b3322],
7	hours	NNS	NUMBER	hour	prep_until	4	SENT_55	[p4l86t3257r289b3324],
8	after	IN	O	after	_	0	SENT_55	[p4l327t3257r494b3324],
9	sibutramine	NN	O	sibutramine	nn	10	SENT_55	[p4l528t3257r959b3324],
10	administration	NN	O	administration	prep_after	4	SENT_55	[p4l996t3257r1545b3324],
11	.	.	O	.	_	0	SENT_55	[p4l996t3257r1545b3324],

1	Blood	NN	O	blood	nn	2	SENT_56	[p4l1585t3257r1812b3324],
2	samples	NNS	O	sample	nsubjpass	44	SENT_56	[p4l1848t3257r2139b3342],
3	(	VBP	O	(	_	0	SENT_56	[p4l11t3368r128b3452],
4	10	CD	NUMBER	10	num	5	SENT_56	[p4l11t3368r128b3452],
5	mL	NN	O	ml	dobj	3	SENT_56	[p4l163t3370r290b3433],
6	each	DT	O	each	det	7	SENT_56	[p4l314t3367r508b3452],
7	)	NN	O	)	nsubjpass	9	SENT_56	[p4l314t3367r508b3452],
8	were	VBD	O	be	auxpass	9	SENT_56	[p4l531t3389r708b3434],
9	drawn	VBN	O	draw	rcmod	5	SENT_56	[p4l733t3367r962b3434],
10	before	IN	O	before	dep	9	SENT_56	[p4l982t3367r1216b3434],
11	and	CC	O	and	_	0	SENT_56	[p4l1241t3367r1373b3434],
12	0.5	CD	NUMBER	0.5	dep	9	SENT_56	[p4l1396t3369r1528b3448],
13	,	,	O	,	_	0	SENT_56	[p4l1396t3369r1528b3448],
14	1	CD	NUMBER	1	conj_and	10	SENT_56	[p4l1563t3369r1618b3448],
15	,	,	O	,	_	0	SENT_56	[p4l1563t3369r1618b3448],
16	1.5	CD	NUMBER	1.5	conj_and	10	SENT_56	[p4l1653t3369r1778b3448],
17	,	,	O	,	_	0	SENT_56	[p4l1653t3369r1778b3448],
18	2	CD	NUMBER	2	conj_and	10	SENT_56	[p4l1804t3369r1868b3448],
19	,	,	O	,	_	0	SENT_56	[p4l1804t3369r1868b3448],
20	3	CD	NUMBER	3	conj_and	10	SENT_56	[p4l1896t3369r1958b3448],
21	,	,	O	,	_	0	SENT_56	[p4l1896t3369r1958b3448],
22	4	CD	NUMBER	4	conj_and	10	SENT_56	[p4l1983t3369r2048b3448],
23	,	,	O	,	_	0	SENT_56	[p4l1983t3369r2048b3448],
24	6	CD	NUMBER	6	conj_and	10	SENT_56	[p4l2075t3369r2137b3448],
25	,	,	O	,	_	0	SENT_56	[p4l2075t3369r2137b3448],
26	8	CD	NUMBER	8	conj_and	12	SENT_56	[p4l13t3481r73b3559],
27	,	,	O	,	_	0	SENT_56	[p4l13t3481r73b3559],
28	12	CD	NUMBER	12	conj_and	12	SENT_56	[p4l149t3481r251b3560],
29	,	,	O	,	_	0	SENT_56	[p4l149t3481r251b3560],
30	24	CD	NUMBER	24	conj_and	12	SENT_56	[p4l318t3480r429b3560],
31	,	,	O	,	_	0	SENT_56	[p4l318t3480r429b3560],
32	48	CD	NUMBER	48	conj_and	12	SENT_56	[p4l496t3480r607b3560],
33	,	,	O	,	_	0	SENT_56	[p4l496t3480r607b3560],
34	and	CC	DURATION	and	_	0	SENT_56	[p4l675t3479r807b3545],
35	72	CD	DURATION	72	num	36	SENT_56	[p4l871t3481r958b3545],
36	hours	NNS	NUMBER	hour	conj_and	10	SENT_56	[p4l993t3479r1197b3545],
37	after	IN	O	after	_	0	SENT_56	[p4l1263t3479r1430b3545],
38	the	DT	O	the	det	39	SENT_56	[p4l1490t3479r1600b3545],
39	ingestion	NN	O	ingestion	prep_after	3	SENT_56	[p4l1666t3479r2004b3564],
40	of	IN	O	of	_	0	SENT_56	[p4l2068t3479r2152b3545],
41	sibutramine	NN	O	sibutramine	prep_of	39	SENT_56	[p4l12t3590r443b3657],
42	and	CC	O	and	_	0	SENT_56	[p4l482t3590r614b3657],
43	were	VBD	O	be	auxpass	44	SENT_56	[p4l649t3612r826b3657],
44	taken	VBN	O	take	conj_and	3	SENT_56	[p4l863t3590r1063b3657],
45	into	IN	O	into	_	0	SENT_56	[p4l1100t3590r1240b3657],
46	heparinized	JJ	O	heparinized	amod	47	SENT_56	[p4l1277t3590r1709b3675],
47	tubes	NNS	O	tube	prep_into	44	SENT_56	[p4l1744t3590r1957b3657],
48	.	.	O	.	_	0	SENT_56	[p4l1744t3590r1957b3657],

1	The	DT	O	the	det	2	SENT_57	[p4l2000t3590r2140b3657],
2	plasma	NN	O	plasma	nsubjpass	4	SENT_57	[p4l7t3700r270b3785],
3	was	VBD	O	be	auxpass	4	SENT_57	[p4l309t3722r451b3767],
4	separated	VBN	O	separate	_	0	SENT_57	[p4l497t3700r841b3785],
5	within	IN	O	within	_	0	SENT_57	[p4l881t3700r1117b3767],
6	15	CD	DURATION	15	num	7	SENT_57	[p4l1167t3702r1243b3767],
7	minutes	NNS	NUMBER	minute	prep_within	4	SENT_57	[p4l1282t3700r1594b3781],
8	,	,	O	,	_	0	SENT_57	[p4l1282t3700r1594b3781],
9	and	CC	O	and	_	0	SENT_57	[p4l1640t3700r1772b3767],
10	stored	VBD	O	store	conj_and	4	SENT_57	[p4l1815t3700r2037b3767],
11	at	IN	O	at	prep	10	SENT_57	[p4l2079t3710r2143b3767],

1	—	NN	O	—	_	0	SENT_58	[p5l15t21r269b86],
2	80	CD	NUMBER	80	number	3	SENT_58	[p5l15t21r269b86],
3	°	CD	NUMBER	°	num	4	SENT_58	[p5l15t21r269b86],
4	C	NN	O	c	dep	1	SENT_58	[p5l15t21r269b86],
5	until	IN	O	until	_	0	SENT_58	[p5l293t20r461b86],
6	analysis	NN	O	analysis	prep_until	4	SENT_58	[p5l486t20r798b105],
7	.	.	O	.	_	0	SENT_58	[p5l486t20r798b105],

1	During	IN	O	during	_	0	SENT_59	[p5l827t20r1087b105],
2	the	DT	O	the	det	6	SENT_59	[p5l1109t20r1220b86],
3	second	JJ	ORDINAL	second	amod	6	SENT_59	[p5l1247t20r1501b86],
4	and	CC	ORDINAL	and	_	0	SENT_59	[p5l1524t20r1656b86],
5	third	JJ	ORDINAL	third	amod	6	SENT_59	[p5l1676t20r1851b86],
6	phases	NNS	O	phase	prep_during	10	SENT_59	[p5l1870t20r2137b105],
7	,	,	O	,	_	0	SENT_59	[p5l1870t20r2137b105],
8	the	DT	O	the	det	9	SENT_59	[p5l8t131r118b198],
9	volunteers	NNS	O	volunteer	nsubj	10	SENT_59	[p5l144t131r526b198],
10	took	VBD	O	take	_	0	SENT_59	[p5l552t131r718b198],
11	either	CC	O	either	dep	13	SENT_59	[p5l743t131r952b198],
12	250	CD	NUMBER	250	num	13	SENT_59	[p5l974t133r1110b198],
13	mg	NN	O	mg	nsubj	28	SENT_59	[p5l1145t153r1262b216],
14	clarithromycin	NN	O	clarithromycin	nn	17	SENT_59	[p5l1289t131r1831b216],
15	(	CD	NUMBER	(	num	17	SENT_59	[p5l1856t131r2143b216],
16	Abbott	NNP	LOCATION	Abbott	nn	17	SENT_59	[p5l1856t131r2143b216],
17	Korea	NNP	LOCATION	Korea	dep	13	SENT_59	[p5l9t244r252b323],
18	,	,	O	,	_	0	SENT_59	[p5l9t244r252b323],
19	Seoul	NNP	LOCATION	Seoul	nn	21	SENT_59	[p5l329t241r554b323],
20	,	,	O	,	_	0	SENT_59	[p5l329t241r554b323],
21	Korea	NNP	LOCATION	Korea	dep	13	SENT_59	[p5l627t242r879b327],
22	)	CD	NUMBER	)	num	21	SENT_59	[p5l627t242r879b327],
23	twice	JJ	O	twice	advmod	28	SENT_59	[p5l949t241r1146b309],
24	daily	JJ	SET	daily	amod	25	SENT_59	[p5l1218t241r1400b328],
25	(	NN	O	(	dep	23	SENT_59	[p5l1471t242r1565b327],
26	at	IN	O	at	_	0	SENT_59	[p5l1471t242r1565b327],
27	8:00	CD	TIME	8:00	prep_at	25	SENT_59	[p5l1636t243r1793b309],
28	am	VBP	TIME	be	ccomp	10	SENT_59	[p5l1830t263r1941b309],
29	and	CC	O	and	_	0	SENT_59	[p5l2010t241r2143b309],
30	8:00	CD	TIME	8:00	num	32	SENT_59	[p5l13t356r169b420],
31	pm	NN	TIME	pm	nn	32	SENT_59	[p5l201t354r369b439],
32	)	NN	O	)	conj_and	28	SENT_59	[p5l201t354r369b439],
33	,	,	O	,	_	0	SENT_59	[p5l201t354r369b439],
34	or	CC	O	or	_	0	SENT_59	[p5l404t375r480b420],
35	75	CD	NUMBER	75	num	37	SENT_59	[p5l508t357r593b420],
36	mg	NN	O	mg	nn	37	SENT_59	[p5l630t375r747b439],
37	clopidogrel	NN	O	clopidogrel	conj_and	28	SENT_59	[p5l779t354r1191b439],
38	bisulfate	NN	O	bisulfate	nn	40	SENT_59	[p5l1220t354r1533b420],
39	(	CD	NUMBER	(	num	40	SENT_59	[p5l1566t354r1845b439],
40	Plavix	NNP	O	Plavix	dep	37	SENT_59	[p5l1566t354r1845b439],
41	,	,	O	,	_	0	SENT_59	[p5l1566t354r1845b439],
42	SanoﬁAventis	NNP	LOCATION	SanoﬁAventis	nn	47	SENT_59	[p5l1882t354r2140b420, p5l8t465r290b532],
43	Korea	NNP	LOCATION	Korea	nn	47	SENT_59	[p5l319t468r563b546],
44	,	,	O	,	_	0	SENT_59	[p5l319t468r563b546],
45	Seoul	NNP	LOCATION	Seoul	appos	47	SENT_59	[p5l599t465r823b546],
46	,	,	O	,	_	0	SENT_59	[p5l599t465r823b546],
47	Korea	NNP	LOCATION	Korea	appos	40	SENT_59	[p5l855t465r1107b550],
48	)	CD	NUMBER	)	num	47	SENT_59	[p5l855t465r1107b550],
49	once	RB	DATE	once	advmod	55	SENT_59	[p5l1138t487r1309b532],
50	daily	JJ	SET	daily	amod	51	SENT_59	[p5l1339t465r1522b550],
51	(	NN	O	(	nsubj	55	SENT_59	[p5l1551t466r1644b550],
52	at	IN	O	at	_	0	SENT_59	[p5l1551t466r1644b550],
53	8:00	CD	TIME	8:00	prep_at	51	SENT_59	[p5l1674t467r1832b532],
54	am	VBP	TIME	be	cop	55	SENT_59	[p5l1869t465r2007b550],
55	)	NN	O	)	dep	32	SENT_59	[p5l1869t465r2007b550],
56	for	IN	O	for	_	0	SENT_59	[p5l2038t465r2144b532],
57	4	CD	DURATION	4	num	58	SENT_59	[p5l8t577r51b642],
58	days	NNS	NUMBER	day	prep_for	55	SENT_59	[p5l83t575r268b662],
59	.	.	O	.	_	0	SENT_59	[p5l83t575r268b662],

1	On	IN	O	on	_	0	SENT_60	[p5l305t577r415b643],
2	day	NN	DURATION	day	prep_on	18	SENT_60	[p5l445t575r577b662],
3	5	CD	NUMBER	5	num	2	SENT_60	[p5l607t578r669b657],
4	,	,	O	,	_	0	SENT_60	[p5l607t578r669b657],
5	after	IN	O	after	_	0	SENT_60	[p5l703t575r869b643],
6	an	DT	O	a	det	8	SENT_60	[p5l897t597r982b643],
7	overnight	JJ	TIME	overnight	amod	8	SENT_60	[p5l1011t575r1366b662],
8	fast	JJ	O	fast	prep_after	18	SENT_60	[p5l1394t575r1543b657],
9	,	,	O	,	_	0	SENT_60	[p5l1394t575r1543b657],
10	the	DT	O	the	det	12	SENT_60	[p5l1574t575r1685b643],
11	last	JJ	O	last	amod	12	SENT_60	[p5l1716t575r1842b643],
12	dose	NN	O	dose	nsubjpass	18	SENT_60	[p5l1871t575r2036b643],
13	of	IN	O	of	_	0	SENT_60	[p5l2068t575r2153b643],
14	the	DT	O	the	det	16	SENT_60	[p5l8t688r118b754],
15	relevant	JJ	O	relevant	amod	16	SENT_60	[p5l147t688r444b754],
16	medication	NN	O	medication	prep_of	12	SENT_60	[p5l470t688r882b754],
17	was	VBD	O	be	auxpass	18	SENT_60	[p5l908t709r1049b754],
18	taken	VBN	O	take	_	0	SENT_60	[p5l1079t688r1279b754],
19	at	IN	O	at	_	0	SENT_60	[p5l1308t697r1372b754],
20	8:00	CD	TIME	8:00	prep_at	18	SENT_60	[p5l1402t690r1559b754],
21	am	VBP	TIME	be	dep	20	SENT_60	[p5l1597t709r1707b754],
22	and	CC	O	and	_	0	SENT_60	[p5l1736t688r1868b754],
23	1	CD	DATE	1	num	24	SENT_60	[p5l1904t690r1929b753],
24	hour	NN	DATE	hour	npadvmod	25	SENT_60	[p5l1972t688r2144b754],
25	later	RB	DATE	later	advmod	29	SENT_60	[p5l10t799r189b880],
26	,	,	O	,	_	0	SENT_60	[p5l10t799r189b880],
27	each	DT	O	each	det	28	SENT_60	[p5l237t799r404b866],
28	participant	NN	O	participant	nsubj	29	SENT_60	[p5l443t799r839b884],
29	ingested	VBD	O	ingest	conj_and	18	SENT_60	[p5l881t799r1188b884],
30	a	DT	O	a	det	34	SENT_60	[p5l1231t821r1270b866],
31	single	JJ	O	single	amod	34	SENT_60	[p5l1314t799r1528b884],
32	15	CD	NUMBER	15	num	34	SENT_60	[p5l1581t801r1658b866],
33	mg	NN	O	mg	nn	34	SENT_60	[p5l1696t821r1813b884],
34	dose	NN	O	dose	dobj	29	SENT_60	[p5l1857t799r2023b866],
35	of	IN	O	of	_	0	SENT_60	[p5l2068t799r2153b866],
36	sibutramine	NN	O	sibutramine	prep_of	34	SENT_60	[p5l12t909r462b976],
37	.	.	O	.	_	0	SENT_60	[p5l12t909r462b976],

1	The	DT	O	the	det	2	SENT_61	[p5l551t909r691b976],
2	procedure	NN	O	procedure	nsubj	4	SENT_61	[p5l773t909r1143b994],
3	was	VBD	O	be	cop	4	SENT_61	[p5l1227t931r1368b976],
4	identical	JJ	O	identical	_	0	SENT_61	[p5l1454t909r1768b976],
5	to	TO	O	to	_	0	SENT_61	[p5l1851t919r1920b976],
6	that	DT	O	that	prep_to	4	SENT_61	[p5l2004t909r2143b976],
7	previously	RB	DATE	previously	advmod	8	SENT_61	[p5l7t1021r399b1106],
8	described	VBN	O	describe	partmod	6	SENT_61	[p5l440t1021r793b1087],
9	for	IN	O	for	_	0	SENT_61	[p5l834t1021r939b1087],
10	the	DT	O	the	det	12	SENT_61	[p5l975t1021r1086b1087],
11	ﬁrst	JJ	O	ﬁrst	amod	12	SENT_61	[p5l1127t1021r1269b1087],
12	phase	NN	O	phase	prep_for	8	SENT_61	[p5l1305t1021r1534b1106],
13	.	.	O	.	_	0	SENT_61	[p5l1305t1021r1534b1106],

1	Determination	NN	O	determination	nsubjpass	17	SENT_62	[p5l14t1246r554b1312],
2	of	IN	O	of	_	0	SENT_62	[p5l591t1246r667b1312],
3	Plasma	NN	O	plasma	nn	4	SENT_62	[p5l697t1246r943b1312],
4	Drug	NN	O	drug	prep_of	1	SENT_62	[p5l978t1246r1165b1333],
5	Concentrations	NNP	O	Concentrations	nn	7	SENT_62	[p5l1197t1246r1775b1312],
6	Plasma	NN	O	plasma	nn	7	SENT_62	[p5l9t1357r275b1423],
7	concentrations	NNS	O	concentration	dep	4	SENT_62	[p5l302t1357r837b1423],
8	of	IN	O	of	_	0	SENT_62	[p5l868t1357r952b1423],
9	enantiomers	NNS	O	enantiomer	prep_of	7	SENT_62	[p5l970t1357r1416b1423],
10	of	IN	O	of	_	0	SENT_62	[p5l1447t1357r1532b1423],
11	sibutramine	NN	O	sibutramine	prep_of	9	SENT_62	[p5l1550t1357r1981b1423],
12	and	CC	O	and	_	0	SENT_62	[p5l2010t1357r2143b1423],
13	M1	NN	O	m1	prep_of	9	SENT_62	[p5l9t1470r126b1533],
14	and	CC	O	and	_	0	SENT_62	[p5l197t1468r329b1535],
15	M2	NN	O	m2	prep_of	9	SENT_62	[p5l386t1470r510b1533],
16	were	VBD	O	be	auxpass	17	SENT_62	[p5l571t1490r749b1535],
17	analyzed	VBN	O	analyze	_	0	SENT_62	[p5l810t1468r1137b1553],
18	using	VBG	O	use	xcomp	17	SENT_62	[p5l1193t1468r1394b1553],
19	a	DT	O	a	dobj	18	SENT_62	[p5l1455t1490r1494b1535],
20	validated	VBN	O	validate	partmod	19	SENT_62	[p5l1551t1468r1889b1535],
21	highperformance	NN	O	highperformance	nn	22	SENT_62	[p5l1946t1468r2140b1553, p5l7t1578r473b1664],
22	liquid	NN	O	liquid	dobj	20	SENT_62	[p5l507t1578r721b1664],
23	chromatographic	JJ	O	chromatographic	amod	25	SENT_62	[p5l752t1578r1608b1665],
24	—	NN	O	—	nn	25	SENT_62	[p5l752t1578r1608b1665],
25	mass	NN	O	mass	tmod	20	SENT_62	[p5l752t1578r1608b1665],
26	spectrometric	JJ	O	spectrometric	amod	30	SENT_62	[p5l1644t1578r2139b1664],
27	method	NN	O	method	nn	30	SENT_62	[p5l8t1691r287b1757],
28	(	NN	O	(	nn	30	SENT_62	[p5l369t1691r1001b1776],
29	HPLC/MS/MS	NN	O	hplc/ms/ms	nn	30	SENT_62	[p5l369t1691r1001b1776],
30	)	NN	O	)	dep	25	SENT_62	[p5l369t1691r1001b1776],
31	.	.	O	.	_	0	SENT_62	[p5l369t1691r1001b1776],

1	Authentic	JJ	MISC	authentic	amod	2	SENT_63	[p5l1088t1691r1451b1757],
2	enantiomers	NNS	O	enantiomer	nsubjpass	10	SENT_63	[p5l1536t1691r1982b1757],
3	of	IN	O	of	_	0	SENT_63	[p5l2068t1691r2152b1757],
4	sibutramine	NN	O	sibutramine	prep_of	2	SENT_63	[p5l12t1802r464b1883],
5	,	,	O	,	_	0	SENT_63	[p5l12t1802r464b1883],
6	M1	NN	O	m1	prep_of	2	SENT_63	[p5l503t1804r620b1867],
7	and	CC	O	and	_	0	SENT_63	[p5l667t1802r799b1869],
8	M2	NN	O	m2	conj_and	4	SENT_63	[p5l834t1804r959b1867],
9	were	VBD	O	be	auxpass	10	SENT_63	[p5l996t1824r1173b1869],
10	purchased	VBN	O	purchase	_	0	SENT_63	[p5l1208t1802r1586b1887],
11	from	IN	O	from	_	0	SENT_63	[p5l1622t1802r1799b1869],
12	SynFine	NNP	ORGANIZATION	SynFine	nn	16	SENT_63	[p5l1838t1802r2140b1887],
13	Research	NNP	ORGANIZATION	Research	nn	16	SENT_63	[p5l9t1912r346b1980],
14	Chemicals	NNPS	ORGANIZATION	Chemicals	nn	16	SENT_63	[p5l390t1912r775b1980],
15	(	NNP	O	(	nn	16	SENT_63	[p5l821t1912r1174b1998],
16	Canada	NNP	LOCATION	Canada	prep_from	10	SENT_63	[p5l821t1912r1174b1998],
17	)	NN	O	)	dep	16	SENT_63	[p5l821t1912r1174b1998],
18	.	.	O	.	_	0	SENT_63	[p5l821t1912r1174b1998],

1	Brieﬂy	NNP	O	Brieﬂy	nsubj	5	SENT_64	[p5l1223t1912r1497b1999],
2	,	,	O	,	_	0	SENT_64	[p5l1223t1912r1497b1999],
3	plasma	NN	O	plasma	nn	4	SENT_64	[p5l1540t1912r1804b1998],
4	samples	NNS	O	sample	nsubj	5	SENT_64	[p5l1848t1912r2139b1998],
5	(	VBP	O	(	_	0	SENT_64	[p5l11t2025r148b2110],
6	0.5	CD	NUMBER	0.5	num	8	SENT_64	[p5l11t2025r148b2110],
7	mL	NN	O	ml	nn	8	SENT_64	[p5l187t2025r342b2110],
8	)	NN	O	)	nsubjpass	24	SENT_64	[p5l187t2025r342b2110],
9	were	VBD	O	be	auxpass	10	SENT_64	[p5l369t2046r546b2091],
10	spiked	VBN	O	spike	ccomp	5	SENT_64	[p5l577t2025r815b2110],
11	with	IN	O	with	_	0	SENT_64	[p5l839t2025r1003b2091],
12	an	DT	O	a	det	17	SENT_64	[p5l1030t2046r1115b2091],
13	intemal	JJ	O	intemal	amod	17	SENT_64	[p5l1142t2025r1419b2091],
14	standard	JJ	O	standard	amod	17	SENT_64	[p5l1449t2025r1759b2091],
15	(	NN	O	(	nn	17	SENT_64	[p5l1787t2025r1900b2110],
16	25	CD	NUMBER	25	num	17	SENT_64	[p5l1787t2025r1900b2110],
17	uL	NN	O	ul	prep_with	10	SENT_64	[p5l1940t2028r2040b2110],
18	of	IN	O	of	_	0	SENT_64	[p5l2068t2025r2153b2091],
19	1.0	CD	NUMBER	1.0	num	22	SENT_64	[p5l18t2138r121b2202],
20	ug/mL	NN	O	ug/ml	nn	22	SENT_64	[p5l158t2136r402b2221],
21	propranolol	NN	O	propranolol	nn	22	SENT_64	[p5l434t2136r917b2221],
22	)	NN	O	)	prep_of	17	SENT_64	[p5l434t2136r917b2221],
23	,	,	O	,	_	0	SENT_64	[p5l434t2136r917b2221],
24	alkalinized	VBN	O	alkalinize	conj_and	10	SENT_64	[p5l954t2136r1358b2203],
25	with	IN	O	with	_	0	SENT_64	[p5l1389t2136r1553b2203],
26	50	CD	NUMBER	50	num	27	SENT_64	[p5l1588t2138r1674b2203],
27	uL	NN	O	ul	prep_with	24	SENT_64	[p5l1711t2139r1811b2221],
28	of	IN	O	of	_	0	SENT_64	[p5l1845t2136r1930b2203],
29	10	CD	NUMBER	10	number	31	SENT_64	[p5l1961t2138r2041b2202],
30	N	NN	O	n	dep	31	SENT_64	[p5l2073t2139r2142b2202],
31	sodium	NN	O	sodium	amod	33	SENT_64	[p5l12t2246r282b2314],
32	hydroxide	NN	O	hydroxide	nn	33	SENT_64	[p5l316t2246r691b2333],
33	solution	NN	O	solution	prep_of	27	SENT_64	[p5l732t2246r1046b2328],
34	,	,	O	,	_	0	SENT_64	[p5l732t2246r1046b2328],
35	and	CC	O	and	_	0	SENT_64	[p5l1088t2246r1220b2314],
36	extracted	VBN	O	extract	ccomp	5	SENT_64	[p5l1255t2246r1591b2314],
37	with	IN	O	with	_	0	SENT_64	[p5l1626t2246r1790b2314],
38	3	CD	NUMBER	3	num	39	SENT_64	[p5l1828t2248r1864b2314],
39	mL	NN	O	ml	prep_with	36	SENT_64	[p5l1903t2249r2030b2313],
40	of	IN	O	of	_	0	SENT_64	[p5l2068t2246r2153b2314],
41	hexanezdiethyl	NN	O	hexanezdiethyl	nn	42	SENT_64	[p5l8t2359r552b2444],
42	ether	NN	O	ether	prep_of	39	SENT_64	[p5l603t2359r786b2425],
43	(	CD	NUMBER	(	number	44	SENT_64	[p5l835t2359r1093b2444],
44	20:80	CD	NUMBER	20:80	dep	42	SENT_64	[p5l835t2359r1093b2444],
45	,	,	O	,	_	0	SENT_64	[p5l835t2359r1093b2444],
46	v/v	NN	O	v/v	nn	47	SENT_64	[p5l1144t2359r1310b2444],
47	)	NN	O	)	appos	42	SENT_64	[p5l1144t2359r1310b2444],
48	.	.	O	.	_	0	SENT_64	[p5l1144t2359r1310b2444],

1	After	IN	O	after	_	0	SENT_65	[p5l1363t2359r1558b2425],
2	vortexing	VBG	O	vortex	prepc_after	7	SENT_65	[p5l1603t2359r1978b2444],
3	,	,	O	,	_	0	SENT_65	[p5l1603t2359r1978b2444],
4	the	DT	O	the	det	5	SENT_65	[p5l2029t2359r2141b2425],
5	mixture	NN	O	mixture	nsubjpass	7	SENT_65	[p5l8t2470r293b2537],
6	was	VBD	O	be	auxpass	7	SENT_65	[p5l378t2492r519b2537],
7	centrifuged	VBN	O	centrifuge	_	0	SENT_65	[p5l606t2470r1025b2555],
8	(	CD	NUMBER	(	num	12	SENT_65	[p5l1110t2470r1390b2555],
9	3000g	CD	NUMBER	3000g	num	12	SENT_65	[p5l1110t2470r1390b2555],
10	,	,	O	,	_	0	SENT_65	[p5l1110t2470r1390b2555],
11	10	CD	DURATION	10	num	12	SENT_65	[p5l1488t2472r1568b2536],
12	minutes	NNS	NUMBER	minute	dobj	7	SENT_65	[p5l1601t2470r1923b2555],
13	)	CD	NUMBER	)	dep	12	SENT_65	[p5l1601t2470r1923b2555],
14	and	CC	O	and	_	0	SENT_65	[p5l2010t2470r2143b2537],
15	immediately	RB	O	immediately	advmod	16	SENT_65	[p5l10t2580r470b2667],
16	deep-frozen	JJ	O	deep-frozen	dep	12	SENT_65	[p5l538t2580r977b2666],
17	for	IN	O	for	_	0	SENT_65	[p5l1045t2580r1151b2648],
18	10	CD	DURATION	10	num	19	SENT_65	[p5l1225t2582r1305b2648],
19	minutes	NNS	NUMBER	minute	prep_for	7	SENT_65	[p5l1339t2580r1650b2648],
20	.	.	O	.	_	0	SENT_65	[p5l1339t2580r1650b2648],

1	The	DT	O	the	det	4	SENT_66	[p5l1724t2580r1863b2648],
2	upper	JJ	O	upper	amod	4	SENT_66	[p5l1930t2602r2144b2666],
3	organic	JJ	O	organic	amod	4	SENT_66	[p5l10t2693r283b2778],
4	phase	NN	O	phase	nsubjpass	11	SENT_66	[p5l321t2693r532b2778],
5	was	VBD	O	be	auxpass	6	SENT_66	[p5l571t2714r712b2759],
6	transferred	VBN	O	transfer	_	0	SENT_66	[p5l751t2693r1149b2759],
7	to	TO	O	to	_	0	SENT_66	[p5l1187t2702r1255b2759],
8	new	JJ	O	new	amod	9	SENT_66	[p5l1295t2714r1449b2759],
9	tubes	NNS	O	tube	prep_to	6	SENT_66	[p5l1487t2693r1680b2759],
10	and	CC	O	and	_	0	SENT_66	[p5l1721t2693r1853b2759],
11	evaporated	VBN	O	evaporate	conj_and	6	SENT_66	[p5l1892t2714r2140b2778, p5l8t2804r192b2871],
12	at	IN	O	at	_	0	SENT_66	[p5l240t2814r304b2871],
13	ambient	JJ	O	ambient	amod	14	SENT_66	[p5l352t2804r648b2871],
14	temperature	NN	O	temperature	prep_at	11	SENT_66	[p5l694t2813r1132b2889],
15	in	IN	O	in	_	0	SENT_66	[p5l1182t2804r1252b2869],
16	a	DT	O	a	det	19	SENT_66	[p5l1300t2826r1339b2871],
17	Speed-Vac	JJ	O	speed-vac	amod	19	SENT_66	[p5l1389t2804r1788b2889],
18	(	NN	O	(	nn	19	SENT_66	[p5l1839t2805r2138b2889],
19	Savant	NN	O	savant	prep_in	14	SENT_66	[p5l1839t2805r2138b2889],
20	,	,	O	,	_	0	SENT_66	[p5l1839t2805r2138b2889],
21	Holbrook	NNP	PERSON	Holbrook	nn	25	SENT_66	[p5l9t2914r383b2996],
22	,	,	O	,	_	0	SENT_66	[p5l9t2914r383b2996],
23	NY	NNP	O	NY	appos	25	SENT_66	[p5l437t2917r592b2996],
24	,	,	O	,	_	0	SENT_66	[p5l437t2917r592b2996],
25	USA	NNP	LOCATION	USA	appos	19	SENT_66	[p5l647t2915r880b3000],
26	)	CD	NUMBER	)	num	25	SENT_66	[p5l647t2915r880b3000],
27	.	.	O	.	_	0	SENT_66	[p5l647t2915r880b3000],

1	The	DT	O	the	det	3	SENT_67	[p5l939t2914r1079b2982],
2	dry	JJ	O	dry	amod	3	SENT_67	[p5l1135t2914r1256b3001],
3	residue	NN	O	residue	nsubjpass	5	SENT_67	[p5l1307t2914r1572b2982],
4	was	VBD	O	be	auxpass	5	SENT_67	[p5l1625t2936r1766b2982],
5	reconstituted	VBN	O	reconstitute	_	0	SENT_67	[p5l1819t2914r2139b2982, p5l8t3027r193b3093],
6	with	IN	O	with	_	0	SENT_67	[p5l264t3027r428b3093],
7	200	CD	NUMBER	200	num	8	SENT_67	[p5l500t3029r636b3093],
8	uL	NN	O	ul	prep_with	5	SENT_67	[p5l673t3030r773b3112],
9	of	IN	O	of	_	0	SENT_67	[p5l848t3027r933b3093],
10	10	CD	PERCENT	10	number	11	SENT_67	[p5l1003t3028r1161b3093],
11	%	NN	PERCENT	%	amod	12	SENT_67	[p5l1003t3028r1161b3093],
12	acetonitrile	NN	O	acetonitrile	prep_of	8	SENT_67	[p5l1236t3027r1646b3093],
13	in	IN	O	in	_	0	SENT_67	[p5l1721t3027r1791b3092],
14	10	CD	NUMBER	10	num	17	SENT_67	[p5l1873t3028r1953b3093],
15	mM	NN	O	mm	nn	17	SENT_67	[p5l1987t3030r2141b3092],
16	ammonium	NN	O	ammonium	nn	17	SENT_67	[p5l10t3138r431b3205],
17	formate	NN	O	formate	prep_in	12	SENT_67	[p5l469t3138r771b3219],
18	,	,	O	,	_	0	SENT_67	[p5l469t3138r771b3219],
19	and	CC	O	and	_	0	SENT_67	[p5l814t3138r945b3205],
20	a	DT	O	a	det	22	SENT_67	[p5l983t3160r1022b3205],
21	5-uL	NN	O	5-ul	nn	22	SENT_67	[p5l1060t3141r1235b3223],
22	aliquot	NN	O	aliquot	nsubjpass	27	SENT_67	[p5l1273t3138r1529b3223],
23	of	IN	O	of	_	0	SENT_67	[p5l1565t3138r1650b3205],
24	this	DT	O	this	det	25	SENT_67	[p5l1674t3138r1805b3205],
25	solution	NN	O	solution	prep_of	22	SENT_67	[p5l1847t3138r2143b3205],
26	was	VBD	O	be	auxpass	27	SENT_67	[p5l8t3270r149b3316],
27	injected	VBN	O	inject	conj_and	5	SENT_67	[p5l181t3248r472b3335],
28	into	IN	O	into	_	0	SENT_67	[p5l500t3248r639b3316],
29	the	DT	O	the	det	34	SENT_67	[p5l669t3248r780b3316],
30	a	DT	O	a	det	33	SENT_67	[p5l812t3270r851b3316],
31	Agilent	NNP	O	Agilent	nn	33	SENT_67	[p5l877t3248r1155b3335],
32	6410	CD	NUMBER	6410	num	33	SENT_67	[p5l1185t3250r1365b3316],
33	LC/MS/MS	NNP	O	LC/MS/MS	nn	34	SENT_67	[p5l1397t3248r1830b3316],
34	system	NN	O	system	prep_into	27	SENT_67	[p5l1865t3258r2137b3335],
35	,	,	O	,	_	0	SENT_67	[p5l1865t3258r2137b3335],
36	equipped	VBN	O	equip	partmod	34	SENT_67	[p5l10t3361r350b3446],
37	with	IN	O	with	_	0	SENT_67	[p5l383t3361r547b3427],
38	an	DT	O	a	det	41	SENT_67	[p5l584t3382r669b3427],
39	Agilent	NNP	O	Agilent	nn	41	SENT_67	[p5l703t3361r981b3446],
40	1200	CD	DATE	1200	num	41	SENT_67	[p5l1025t3362r1198b3427],
41	series	NN	O	series	prep_with	36	SENT_67	[p5l1240t3361r1442b3427],
42	high-performance	JJ	O	high-performance	amod	51	SENT_67	[p5l1479t3361r2141b3446],
43	liquid	JJ	O	liquid	amod	51	SENT_67	[p5l10t3472r224b3557],
44	chromatography	NN	O	chromatography	nn	51	SENT_67	[p5l247t3472r853b3557],
45	system	NN	O	system	nn	51	SENT_67	[p5l878t3481r1131b3557],
46	(	CD	NUMBER	(	num	51	SENT_67	[p5l1154t3472r1477b3557],
47	Agilent	NNP	ORGANIZATION	Agilent	dep	51	SENT_67	[p5l1154t3472r1477b3557],
48	,	,	O	,	_	0	SENT_67	[p5l1154t3472r1477b3557],
49	Wilmington	NNP	LOCATION	Wilmington	dep	47	SENT_67	[p5l1503t3472r1970b3557],
50	,	,	O	,	_	0	SENT_67	[p5l1503t3472r1970b3557],
51	DE	NN	O	de	dep	41	SENT_67	[p5l1996t3475r2137b3553],
52	,	,	O	,	_	0	SENT_67	[p5l1996t3475r2137b3553],
53	USA	NNP	LOCATION	USA	appos	41	SENT_67	[p5l8t3583r241b3668],
54	)	CD	NUMBER	)	num	53	SENT_67	[p5l8t3583r241b3668],
55	.	.	O	.	_	0	SENT_67	[p5l8t3583r241b3668],

1	Chromatographic	JJ	O	chromatographic	amod	2	SENT_68	[p5l296t3582r941b3669],
2	separation	NN	O	separation	nsubjpass	8	SENT_68	[p5l993t3582r1369b3668],
3	of	IN	O	of	_	0	SENT_68	[p5l1418t3582r1503b3650],
4	the	DT	O	the	det	6	SENT_68	[p5l1538t3582r1649b3650],
5	chiral	JJ	O	chiral	amod	6	SENT_68	[p5l1699t3582r1904b3650],
6	compounds	NNS	O	compound	prep_of	2	SENT_68	[p5l1955t3604r2140b3650, p5l7t3695r276b3780],
7	was	VBD	O	be	auxpass	8	SENT_68	[p5l303t3716r445b3761],
8	accomplished	VBN	O	accomplish	_	0	SENT_68	[p5l475t3695r983b3780],
9	using	VBG	O	use	xcomp	8	SENT_68	[p5l1007t3695r1208b3780],
10	a	DT	O	a	det	12	SENT_68	[p5l1237t3716r1276b3761],
11	chiral	JJ	O	chiral	amod	12	SENT_68	[p5l1303t3695r1508b3761],
12	stationary-phase	NN	O	stationary-phase	dobj	9	SENT_68	[p5l1539t3695r2140b3780],
13	column	NN	O	column	nn	15	SENT_68	[p6l10t20r286b87],
14	(	CD	NUMBER	(	num	15	SENT_68	[p6l318t20r812b105],
15	Chiral-AGP	NNP	O	Chiral-AGP	dep	12	SENT_68	[p6l318t20r812b105],
16	,	,	O	,	_	0	SENT_68	[p6l318t20r812b105],
17	2.0	CD	NUMBER	2.0	num	21	SENT_68	[p6l846t22r959b86],
18	mm	NN	O	mm	nn	21	SENT_68	[p6l993t42r1138b85],
19	x	NN	O	x	nn	21	SENT_68	[p6l1182t39r1228b84],
20	100	CD	NUMBER	100	num	21	SENT_68	[p6l1283t22r1409b87],
21	mm	NN	O	mm	appos	12	SENT_68	[p6l1444t42r1589b85],
22	intemal	JJ	O	intemal	dep	23	SENT_68	[p6l1618t20r1896b87],
23	diameter	NN	O	diameter	amod	21	SENT_68	[p6l1929t20r2139b87, p6l10t140r163b212],
24	,	,	O	,	_	0	SENT_68	[p6l1929t20r2139b87, p6l10t140r163b212],
25	5	CD	NUMBER	5	num	28	SENT_68	[p6l223t133r259b198],
26	um	NN	O	um	nn	28	SENT_68	[p6l299t152r416b217],
27	particle	NN	O	particle	nn	28	SENT_68	[p6l465t130r739b216],
28	size	NN	O	size	appos	12	SENT_68	[p6l797t130r955b212],
29	;	:	O	;	_	0	SENT_68	[p6l797t130r955b212],
30	ChromTech	NNP	ORGANIZATION	ChromTech	nn	37	SENT_68	[p6l1014t130r1454b198],
31	Ltd.	NNP	ORGANIZATION	Ltd.	nn	37	SENT_68	[p6l1507t130r1676b212],
32	,	,	O	,	_	0	SENT_68	[p6l1507t130r1676b212],
33	Congleton	NNP	PERSON	Congleton	appos	37	SENT_68	[p6l1734t130r2137b217],
34	,	,	O	,	_	0	SENT_68	[p6l1734t130r2137b217],
35	Cheshire	NNP	LOCATION	Cheshire	appos	37	SENT_68	[p6l10t243r357b324],
36	,	,	O	,	_	0	SENT_68	[p6l10t243r357b324],
37	UK	NNP	LOCATION	UK	dep	28	SENT_68	[p6l409t243r570b328],
38	)	CD	NUMBER	)	num	37	SENT_68	[p6l409t243r570b328],
39	with	IN	O	with	_	0	SENT_68	[p6l621t243r785b309],
40	a	DT	O	a	det	42	SENT_68	[p6l836t264r875b309],
41	mobile	JJ	O	mobile	amod	42	SENT_68	[p6l921t243r1178b309],
42	phase	NN	O	phase	prep_with	37	SENT_68	[p6l1226t243r1436b328],
43	that	WDT	O	that	dep	44	SENT_68	[p6l1487t243r1625b309],
44	consisted	VBD	O	consist	rcmod	42	SENT_68	[p6l1675t243r2017b309],
45	of	IN	O	of	prep	44	SENT_68	[p6l2068t243r2153b309],
46	10	CD	NUMBER	10	num	49	SENT_68	[p6l18t356r98b421],
47	mM	NN	O	mm	nn	49	SENT_68	[p6l133t357r287b419],
48	ammonium	NN	O	ammonium	nn	49	SENT_68	[p6l330t354r751b421],
49	acetate	NN	O	acetate	nsubj	44	SENT_68	[p6l793t364r1043b421],
50	(	CD	NUMBER	(	num	53	SENT_68	[p6l1090t355r1229b439],
51	pH	NN	O	ph	nn	53	SENT_68	[p6l1090t355r1229b439],
52	4.03	CD	NUMBER	4.03	num	53	SENT_68	[p6l1271t354r1461b439],
53	)	NN	O	)	dep	44	SENT_68	[p6l1271t354r1461b439],
54	with	IN	O	with	_	0	SENT_68	[p6l1504t354r1668b421],
55	acetic	JJ	O	acetic	amod	56	SENT_68	[p6l1711t354r1920b421],
56	acid	NN	O	acid	prep_with	44	SENT_68	[p6l1965t354r2135b421],
57	:	:	O	:	_	0	SENT_68	[p6l1965t354r2135b421],
58	acetonitrile	NN	O	acetonitrile	dep	28	SENT_68	[p6l10t464r420b532],
59	(	CD	NUMBER	(	number	60	SENT_68	[p6l459t465r670b550],
60	9426	CD	DATE	9426	dep	58	SENT_68	[p6l459t465r670b550],
61	,	,	O	,	_	0	SENT_68	[p6l459t465r670b550],
62	V/V	NN	O	v/v	nn	63	SENT_68	[p6l709t464r874b550],
63	)	NN	O	)	appos	58	SENT_68	[p6l709t464r874b550],
64	.	.	O	.	_	0	SENT_68	[p6l709t464r874b550],

1	The	DT	O	the	det	3	SENT_69	[p6l916t464r1056b532],
2	guard	NN	O	guard	nn	3	SENT_69	[p6l1093t464r1303b551],
3	column	NN	O	column	nsubj	10	SENT_69	[p6l1338t464r1614b532],
4	used	VBN	O	use	partmod	3	SENT_69	[p6l1647t464r1819b532],
5	was	VBD	O	be	cop	10	SENT_69	[p6l1852t486r1993b532],
6	the	DT	O	the	det	10	SENT_69	[p6l2029t464r2140b532],
7	Phenomenex	NNP	O	Phenomenex	nn	10	SENT_69	[p6l9t577r488b643],
8	amine	NN	O	amine	nn	10	SENT_69	[p6l542t577r763b643],
9	guard	NN	O	guard	nn	10	SENT_69	[p6l819t577r1028b662],
10	column	NN	O	column	_	0	SENT_69	[p6l1081t577r1358b643],
11	(	CD	NUMBER	(	number	12	SENT_69	[p6l1412t577r1482b662],
12	4	CD	NUMBER	4	num	17	SENT_69	[p6l1412t577r1482b662],
13	mm	NN	O	mm	nn	17	SENT_69	[p6l1517t598r1661b642],
14	x	NN	O	x	nn	17	SENT_69	[p6l1706t596r1751b641],
15	2.0	CD	NUMBER	2.0	num	17	SENT_69	[p6l1797t579r1909b643],
16	mm	NN	O	mm	nn	17	SENT_69	[p6l1944t577r2136b662],
17	)	NN	O	)	dep	10	SENT_69	[p6l1944t577r2136b662],
18	.	.	O	.	_	0	SENT_69	[p6l1944t577r2136b662],

1	552	CD	NUMBER	552	_	0	SENT_70	[p6l97t737r156b767],
2	The	DT	O	the	det	3	SENT_70	[p6l1208t740r1257b767],
3	journal	NN	O	journal	dep	1	SENT_70	[p6l1265t740r1368b775],
4	of	IN	O	of	_	0	SENT_70	[p6l1381t740r1413b774],
5	Clinical	JJ	O	clinical	amod	6	SENT_70	[p6l1421t740r1518b767],
6	Pharmacology	NN	O	pharmacology	prep_of	3	SENT_70	[p6l1530t740r1724b776],
7	/	:	O	/	punct	1	SENT_70	[p6l1736t740r1747b767],
8	Vol	NNP	O	Vol	dep	12	SENT_70	[p6l1758t740r1807b767],
9	53	CD	NUMBER	53	dep	8	SENT_70	[p6l1823t740r1856b767],
10	No	DT	O	no	det	11	SENT_70	[p6l1874t740r1920b767],
11	5	CD	NUMBER	5	dep	12	SENT_70	[p6l1935t740r1950b767],
12	(	NN	O	(	dep	16	SENT_70	[p6l1966t740r2025b776],
13	20	CD	NUMBER	20	num	14	SENT_70	[p6l1966t740r2025b776],
14	|	NN	O	|	dep	12	SENT_70	[p6l1966t740r2025b776],
15	3	CD	NUMBER	3	num	16	SENT_70	[p6l2035t740r2061b776],
16	)	NN	O	)	dep	1	SENT_70	[p6l2035t740r2061b776],

1	The	DT	O	the	det	3	SENT_71	[p6l10t913r150b980],
2	column	NN	O	column	nn	3	SENT_71	[p6l181t913r457b980],
3	temperature	NN	O	temperature	nsubjpass	5	SENT_71	[p6l483t922r923b999],
4	was	VBD	O	be	auxpass	5	SENT_71	[p6l952t935r1094b980],
5	maintained	VBN	O	maintain	_	0	SENT_71	[p6l1122t913r1535b980],
6	to	TO	O	to	_	0	SENT_71	[p6l1561t922r1630b980],
7	40	CD	NUMBER	40	number	8	SENT_71	[p6l1659t914r1848b980],
8	°	CD	NUMBER	°	num	9	SENT_71	[p6l1659t914r1848b980],
9	C	NN	O	c	prep_to	5	SENT_71	[p6l1659t914r1848b980],
10	and	CC	O	and	_	0	SENT_71	[p6l1880t913r2013b980],
11	the	DT	O	the	det	13	SENT_71	[p6l2038t913r2149b980],
12	ﬂow	NN	O	ﬂow	nn	13	SENT_71	[p6l9t1025r174b1093],
13	rate	NN	O	rate	nsubj	16	SENT_71	[p6l207t1035r342b1093],
14	was	VBD	O	be	cop	16	SENT_71	[p6l377t1047r518b1093],
15	0.25	CD	NUMBER	0.25	num	16	SENT_71	[p6l556t1027r711b1093],
16	mL/min	NN	O	ml/min	conj_and	5	SENT_71	[p6l750t1025r1066b1093],
17	.	.	O	.	_	0	SENT_71	[p6l750t1025r1066b1093],

1	The	DT	O	the	det	3	SENT_72	[p6l123t1136r263b1204],
2	mass	NN	O	mass	nn	3	SENT_72	[p6l283t1158r466b1204],
3	spectrometer	NN	O	spectrometer	nsubjpass	9	SENT_72	[p6l492t1146r967b1222],
4	with	IN	O	with	_	0	SENT_72	[p6l985t1136r1150b1204],
5	an	DT	O	a	det	7	SENT_72	[p6l1171t1158r1256b1204],
6	electrospray	NN	O	electrospray	nn	7	SENT_72	[p6l1276t1136r1728b1223],
7	source	NN	O	source	prep_with	3	SENT_72	[p6l1749t1158r1986b1204],
8	was	VBD	O	be	auxpass	9	SENT_72	[p6l2007t1158r2149b1204],
9	run	VBN	O	run	_	0	SENT_72	[p6l8t1271r131b1316],
10	in	IN	O	in	_	0	SENT_72	[p6l209t1249r279b1315],
11	the	DT	O	the	det	13	SENT_72	[p6l354t1249r465b1316],
12	positive	JJ	O	positive	amod	13	SENT_72	[p6l542t1249r834b1335],
13	mode	NN	O	mode	prep_in	9	SENT_72	[p6l912t1249r1117b1316],
14	and	CC	O	and	_	0	SENT_72	[p6l1197t1249r1330b1316],
15	m/z	NN	O	m/z	prep_in	9	SENT_72	[p6l1404t1249r1542b1316],
16	280.0	CD	NUMBER	280.0	number	17	SENT_72	[p6l1619t1251r1826b1316],
17	—	CD	NUMBER	—	num	18	SENT_72	[p6l1866t1274r1949b1308],
18	>	JJR	O	>	nsubjpass	37	SENT_72	[p6l1866t1274r1949b1308],
19	125	CD	NUMBER	125	dep	18	SENT_72	[p6l1997t1250r2146b1331],
20	,	,	O	,	_	0	SENT_72	[p6l1997t1250r2146b1331],
21	265.9	CD	NUMBER	265.9	number	22	SENT_72	[p6l9t1364r215b1429],
22	—	CD	NUMBER	—	num	23	SENT_72	[p6l256t1387r339b1421],
23	>	JJR	O	>	conj_and	18	SENT_72	[p6l256t1387r339b1421],
24	125	CD	NUMBER	125	dep	23	SENT_72	[p6l387t1364r536b1443],
25	,	,	O	,	_	0	SENT_72	[p6l387t1364r536b1443],
26	252.1	CD	NUMBER	252.1	number	27	SENT_72	[p6l623t1364r822b1429],
27	—	CD	NUMBER	—	num	28	SENT_72	[p6l870t1387r953b1421],
28	>	JJR	O	>	conj_and	18	SENT_72	[p6l870t1387r953b1421],
29	125	CD	NUMBER	125	dep	28	SENT_72	[p6l1001t1364r1150b1443],
30	,	,	O	,	_	0	SENT_72	[p6l1001t1364r1150b1443],
31	and	CC	NUMBER	and	_	0	SENT_72	[p6l1238t1362r1371b1429],
32	260	CD	NUMBER	260	number	33	SENT_72	[p6l1452t1364r1589b1429],
33	—	CD	NUMBER	—	num	34	SENT_72	[p6l1629t1387r1712b1421],
34	>	JJR	O	>	conj_and	18	SENT_72	[p6l1629t1387r1712b1421],
35	116	CD	NUMBER	116	dep	34	SENT_72	[p6l1760t1364r1886b1429],
36	were	VBD	O	be	auxpass	37	SENT_72	[p6l1971t1384r2149b1429],
37	monitored	VBN	O	monitor	rcmod	13	SENT_72	[p6l8t1473r391b1541],
38	for	IN	O	for	_	0	SENT_72	[p6l437t1473r543b1541],
39	the	DT	O	the	det	40	SENT_72	[p6l585t1473r696b1540],
40	enantiomers	NNS	O	enantiomer	prep_for	37	SENT_72	[p6l744t1473r1192b1541],
41	of	IN	O	of	_	0	SENT_72	[p6l1241t1473r1326b1540],
42	sibutramine	NN	O	sibutramine	prep_of	40	SENT_72	[p6l1363t1473r1817b1554],
43	,	,	O	,	_	0	SENT_72	[p6l1363t1473r1817b1554],
44	the	DT	O	the	det	45	SENT_72	[p6l1864t1473r1976b1540],
45	M1	NN	O	m1	prep_for	37	SENT_72	[p6l2022t1475r2140b1539],
46	and	CC	O	and	_	0	SENT_72	[p6l10t1585r143b1652],
47	M2	NN	O	m2	nn	48	SENT_72	[p6l199t1587r323b1651],
48	metabolites	NNS	O	metabolite	conj_and	40	SENT_72	[p6l383t1585r829b1667],
49	,	,	O	,	_	0	SENT_72	[p6l383t1585r829b1667],
50	and	CC	O	and	_	0	SENT_72	[p6l891t1585r1024b1652],
51	propranolol	NN	O	propranolol	prep_for	37	SENT_72	[p6l1078t1585r1511b1671],
52	as	IN	O	as	_	0	SENT_72	[p6l1571t1607r1642b1652],
53	the	DT	O	the	det	55	SENT_72	[p6l1700t1585r1811b1652],
54	internal	JJ	O	internal	amod	55	SENT_72	[p6l1870t1585r2149b1652],
55	standard	NN	O	standard	prep_as	51	SENT_72	[p6l12t1697r341b1779],
56	,	,	O	,	_	0	SENT_72	[p6l12t1697r341b1779],
57	respectively	RB	O	respectively	advmod	37	SENT_72	[p6l372t1697r837b1783],
58	.	.	O	.	_	0	SENT_72	[p6l372t1697r837b1783],

1	The	DT	O	the	det	3	SENT_73	[p6l871t1697r1012b1765],
2	peak	NN	O	peak	nn	3	SENT_73	[p6l1039t1697r1217b1783],
3	areas	NNS	O	area	nsubjpass	9	SENT_73	[p6l1244t1719r1429b1765],
4	for	IN	O	for	_	0	SENT_73	[p6l1460t1697r1566b1765],
5	all	PDT	O	all	predet	7	SENT_73	[p6l1593t1697r1680b1765],
6	the	DT	O	the	det	7	SENT_73	[p6l1708t1697r1818b1765],
7	analytes	NNS	O	analyte	prep_for	3	SENT_73	[p6l1849t1697r2148b1783],
8	were	VBD	O	be	auxpass	9	SENT_73	[p6l8t1830r185b1876],
9	integrated	VBN	O	integrate	_	0	SENT_73	[p6l217t1808r586b1895],
10	automatically	RB	O	automatically	advmod	9	SENT_73	[p6l615t1808r1118b1895],
11	using	VBG	O	use	xcomp	9	SENT_73	[p6l1145t1808r1346b1895],
12	the	DT	O	the	det	16	SENT_73	[p6l1375t1808r1486b1876],
13	Analyst	NN	O	analyst	nn	16	SENT_73	[p6l1515t1808r1805b1895],
14	software	NN	O	software	nn	16	SENT_73	[p6l1836t1808r2149b1876],
15	(	CD	NUMBER	(	num	16	SENT_73	[p6l11t1921r174b2007],
16	ver	NN	O	ver	dobj	11	SENT_73	[p6l11t1921r174b2007],
17	.	.	O	.	_	0	SENT_73	[p6l11t1921r174b2007],

1	1.4	CD	NUMBER	1.4	_	0	SENT_74	[p6l234t1922r360b2003],
2	;	:	O	;	_	0	SENT_74	[p6l234t1922r360b2003],
3	Applied	NNP	O	Applied	nn	4	SENT_74	[p6l409t1921r709b2007],
4	Biosystem	NNP	O	Biosystem	dep	1	SENT_74	[p6l753t1921r1165b2007],
5	,	,	O	,	_	0	SENT_74	[p6l753t1921r1165b2007],
6	Foster	NNP	LOCATION	Foster	nn	11	SENT_74	[p6l1213t1924r1446b1988],
7	City	NNP	LOCATION	City	nn	11	SENT_74	[p6l1490t1921r1666b2007],
8	,	,	O	,	_	0	SENT_74	[p6l1490t1921r1666b2007],
9	CA	NNP	LOCATION	CA	appos	11	SENT_74	[p6l1717t1922r1863b2002],
10	,	,	O	,	_	0	SENT_74	[p6l1717t1922r1863b2002],
11	USA	NNP	LOCATION	USA	appos	4	SENT_74	[p6l1910t1921r2145b2007],
12	)	CD	NUMBER	)	num	11	SENT_74	[p6l1910t1921r2145b2007],
13	.	.	O	.	_	0	SENT_74	[p6l1910t1921r2145b2007],

1	Calibration	NN	O	calibration	nn	2	SENT_75	[p6l10t2033r425b2101],
2	curves	NNS	O	curve	_	0	SENT_75	[p6l466t2055r703b2101],
3	in	IN	O	in	_	0	SENT_75	[p6l745t2033r815b2099],
4	the	DT	O	the	det	5	SENT_75	[p6l852t2033r964b2101],
5	ranges	NNS	O	range	prep_in	2	SENT_75	[p6l1003t2055r1243b2119],
6	of	IN	O	of	_	0	SENT_75	[p6l1285t2033r1370b2101],
7	0	CD	NUMBER	0	prep_of	2	SENT_75	[p6l1399t2035r1722b2100],
8	.	.	O	.	_	0	SENT_75	[p6l1399t2035r1722b2100],

1	l	NN	O	l	tmod	17	SENT_76	[p6l1399t2035r1722b2100],
2	—	CD	NUMBER	—	number	3	SENT_76	[p6l1399t2035r1722b2100],
3	50.0	CD	NUMBER	50.0	num	4	SENT_76	[p6l1399t2035r1722b2100],
4	ng/mL	NN	O	ng/ml	nsubjpass	17	SENT_76	[p6l1758t2033r2004b2119],
5	for	IN	O	for	_	0	SENT_76	[p6l2046t2033r2152b2101],
6	sibutramine	NN	O	sibutramine	prep_for	4	SENT_76	[p6l12t2144r445b2212],
7	and	CC	O	and	_	0	SENT_76	[p6l482t2144r615b2212],
8	M1	NN	O	m1	prep_for	4	SENT_76	[p6l649t2146r766b2211],
9	and	CC	O	and	_	0	SENT_76	[p6l813t2144r946b2212],
10	0.2	CD	NUMBER	0.2	number	11	SENT_76	[p6l981t2146r1351b2212],
11	—	CD	NUMBER	—	conj_and	4	SENT_76	[p6l981t2146r1351b2212],
12	100.0	CD	NUMBER	100.0	num	13	SENT_76	[p6l981t2146r1351b2212],
13	ng/mL	NN	O	ng/ml	dep	11	SENT_76	[p6l1386t2144r1633b2231],
14	for	IN	O	for	_	0	SENT_76	[p6l1670t2144r1777b2212],
15	M2	NN	O	m2	prep_for	17	SENT_76	[p6l1810t2146r1934b2210],
16	were	VBD	O	be	auxpass	17	SENT_76	[p6l1971t2166r2149b2212],
17	established	VBN	O	establish	_	0	SENT_76	[p6l10t2257r421b2324],
18	(	CD	NUMBER	(	num	19	SENT_76	[p6l477t2238r567b2343],
19	r2	NN	O	r2	dobj	17	SENT_76	[p6l477t2238r567b2343],
20	=	JJ	O	=	amod	19	SENT_76	[p6l606t2288r669b2310],
21	0.9941	CD	NUMBER	0.9941	tmod	20	SENT_76	[p6l708t2259r953b2324],
22	for	IN	O	for	_	0	SENT_76	[p6l1019t2257r1125b2324],
23	sibutramine	NN	O	sibutramine	prep_for	17	SENT_76	[p6l1181t2257r1634b2339],
24	,	,	O	,	_	0	SENT_76	[p6l1181t2257r1634b2339],
25	r2	NN	O	r2	dobj	17	SENT_76	[p6l1692t2238r1754b2323],
26	=	JJ	O	=	amod	25	SENT_76	[p6l1793t2288r1856b2310],
27	0.9963	CD	NUMBER	0.9963	tmod	26	SENT_76	[p6l1895t2259r2143b2324],
28	for	IN	O	for	_	0	SENT_76	[p6l10t2370r117b2438],
29	M1	NN	O	m1	prep_for	17	SENT_76	[p6l148t2372r296b2452],
30	,	,	O	,	_	0	SENT_76	[p6l148t2372r296b2452],
31	r2	NN	O	r2	appos	29	SENT_76	[p6l332t2352r394b2436],
32	:	:	O	:	_	0	SENT_76	[p6l433t2401r497b2424],
33	0.9902	CD	NUMBER	0.9902	dep	31	SENT_76	[p6l535t2372r787b2438],
34	for	IN	O	for	_	0	SENT_76	[p6l826t2370r932b2438],
35	M2	NN	O	m2	nn	36	SENT_76	[p6l962t2371r1139b2456],
36	)	NN	O	)	prep_for	33	SENT_76	[p6l962t2371r1139b2456],
37	.	.	O	.	_	0	SENT_76	[p6l962t2371r1139b2456],

1	For	IN	O	for	_	0	SENT_77	[p6l1178t2373r1307b2438],
2	sibutramine	NN	O	sibutramine	nn	4	SENT_77	[p6l1342t2370r1794b2452],
3	,	,	O	,	_	0	SENT_77	[p6l1342t2370r1794b2452],
4	M1	NN	O	m1	prep_for	18	SENT_77	[p6l1832t2372r1980b2452],
5	,	,	O	,	_	0	SENT_77	[p6l1832t2372r1980b2452],
6	and	CC	O	and	_	0	SENT_77	[p6l2019t2370r2152b2438],
7	M2	NN	O	m2	nn	8	SENT_77	[p6l9t2483r134b2548],
8	enantiomers	NNS	O	enantiomer	conj_and	4	SENT_77	[p6l172t2481r643b2563],
9	,	,	O	,	_	0	SENT_77	[p6l172t2481r643b2563],
10	the	DT	O	the	det	14	SENT_77	[p6l679t2481r790b2549],
11	intra-day	JJ	O	intra-day	amod	14	SENT_77	[p6l826t2481r1158b2568],
12	and	CC	O	and	_	0	SENT_77	[p6l1193t2481r1325b2549],
13	inter-day	JJ	O	inter-day	conj_and	11	SENT_77	[p6l1359t2481r1691b2568],
14	coefﬁcients	NNS	O	coefﬁcients	nsubj	18	SENT_77	[p6l1725t2481r2148b2549],
15	of	IN	O	of	_	0	SENT_77	[p6l10t2594r95b2661],
16	variation	NN	O	variation	prep_of	14	SENT_77	[p6l141t2594r472b2661],
17	were	VBD	O	be	cop	18	SENT_77	[p6l528t2616r706b2661],
18	<	JJR	O	<	_	0	SENT_77	[p6l773t2595r1097b2663],
19	l5	CD	PERCENT	l5	num	21	SENT_77	[p6l773t2595r1097b2663],
20	.1	CD	PERCENT	.1	num	21	SENT_77	[p6l773t2595r1097b2663],
21	%	NN	PERCENT	%	dep	18	SENT_77	[p6l773t2595r1097b2663],
22	.	.	O	.	_	0	SENT_77	[p6l773t2595r1097b2663],

1	The	DT	O	the	det	2	SENT_78	[p6l1162t2594r1302b2661],
2	possibility	NN	O	possibility	nsubjpass	9	SENT_78	[p6l1361t2594r1749b2680],
3	of	IN	O	of	_	0	SENT_78	[p6l1809t2594r1895b2661],
4	chiral	JJ	O	chiral	amod	5	SENT_78	[p6l1943t2594r2149b2661],
5	inversion	NN	O	inversion	prep_of	2	SENT_78	[p6l10t2706r354b2774],
6	between	IN	O	between	_	0	SENT_78	[p6l371t2706r683b2774],
7	enantiomers	NNS	O	enantiomer	prep_between	5	SENT_78	[p6l704t2706r1152b2774],
8	was	VBD	O	be	auxpass	9	SENT_78	[p6l1174t2728r1316b2774],
9	tested	VBN	O	test	_	0	SENT_78	[p6l1337t2706r1553b2774],
10	after	IN	O	after	_	0	SENT_78	[p6l1574t2706r1741b2774],
11	incubation	NN	O	incubation	prep_after	9	SENT_78	[p6l1759t2706r2151b2774],
12	with	IN	O	with	_	0	SENT_78	[p6l8t2817r173b2885],
13	microsomes	NNS	O	microsome	prep_with	9	SENT_78	[p6l198t2817r644b2885],
14	or	CC	O	or	_	0	SENT_78	[p6l675t2839r752b2885],
15	human	JJ	O	human	amod	16	SENT_78	[p6l775t2817r1029b2885],
16	plasma	NN	O	plasma	prep_with	9	SENT_78	[p6l1054t2817r1334b2903],
17	.	.	O	.	_	0	SENT_78	[p6l1054t2817r1334b2903],

1	No	DT	O	no	det	3	SENT_79	[p6l1365t2820r1478b2885],
2	chiral	JJ	O	chiral	amod	3	SENT_79	[p6l1509t2817r1715b2885],
3	conversion	NN	O	conversion	nsubjpass	5	SENT_79	[p6l1744t2817r2150b2885],
4	was	VBD	O	be	auxpass	5	SENT_79	[p6l8t2952r150b2997],
5	observed	VBN	O	observe	_	0	SENT_79	[p6l183t2930r519b2997],
6	in	IN	O	in	_	0	SENT_79	[p6l549t2930r619b2996],
7	our	PRP$	O	we	poss	8	SENT_79	[p6l650t2952r773b2997],
8	system	NN	O	system	prep_in	5	SENT_79	[p6l804t2939r1075b3016],
9	.	.	O	.	_	0	SENT_79	[p6l804t2939r1075b3016],

1	Pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	13	SENT_80	[p6l14t3157r662b3222],
2	The	DT	O	the	det	3	SENT_80	[p6l10t3267r150b3334],
3	pharrnacokinetics	NNS	O	pharrnacokinetic	dep	1	SENT_80	[p6l216t3267r870b3353],
4	of	IN	O	of	_	0	SENT_80	[p6l939t3267r1025b3334],
5	sibutramine	NN	O	sibutramine	nn	7	SENT_80	[p6l1082t3267r1536b3348],
6	,	,	O	,	_	0	SENT_80	[p6l1082t3267r1536b3348],
7	M1	NN	O	m1	prep_of	1	SENT_80	[p6l1606t3268r1754b3348],
8	,	,	O	,	_	0	SENT_80	[p6l1606t3268r1754b3348],
9	and	CC	O	and	_	0	SENT_80	[p6l1825t3267r1958b3334],
10	M2	NN	O	m2	nn	11	SENT_80	[p6l2022t3269r2147b3333],
11	enantiomers	NNS	O	enantiomer	prep_of	1	SENT_80	[p6l10t3380r459b3448],
12	was	VBD	O	be	auxpass	13	SENT_80	[p6l526t3402r668b3448],
13	estimated	VBN	O	estimate	_	0	SENT_80	[p6l738t3380r1092b3448],
14	using	VBG	O	use	xcomp	13	SENT_80	[p6l1155t3380r1356b3466],
15	non-compartmental	JJ	O	non-compartmental	amod	16	SENT_80	[p6l1422t3380r2150b3466],
16	methods	NNS	O	method	dobj	14	SENT_80	[p6l8t3491r321b3559],
17	using	VBG	O	use	xcomp	14	SENT_80	[p6l400t3491r601b3578],
18	the	DT	O	the	det	20	SENT_80	[p6l679t3491r790b3559],
19	WinNonlin	NNP	O	WinNonlin	nn	20	SENT_80	[p6l869t3491r1289b3559],
20	software	NN	O	software	nsubj	22	SENT_80	[p6l1369t3491r1681b3559],
21	(	CD	NUMBER	(	num	22	SENT_80	[p6l1763t3492r1926b3577],
22	ver	NN	O	ver	xcomp	17	SENT_80	[p6l1763t3492r1926b3577],
23	.	.	O	.	_	0	SENT_80	[p6l1763t3492r1926b3577],

1	5.2	CD	NUMBER	5.2	_	0	SENT_81	[p6l2012t3493r2146b3573],
2	;	:	O	;	_	0	SENT_81	[p6l2012t3493r2146b3573],
3	Pharsight	NNP	ORGANIZATION	Pharsight	nn	8	SENT_81	[p6l9t3604r379b3690],
4	,	,	O	,	_	0	SENT_81	[p6l9t3604r379b3690],
5	Cary	NNP	PERSON	Cary	appos	8	SENT_81	[p6l431t3605r628b3690],
6	,	,	O	,	_	0	SENT_81	[p6l431t3605r628b3690],
7	NC	NNP	O	NC	appos	8	SENT_81	[p6l676t3604r856b3690],
8	)	NNP	O	)	dep	1	SENT_81	[p6l676t3604r856b3690],
9	.	.	O	.	_	0	SENT_81	[p6l676t3604r856b3690],

1	The	DT	O	the	det	3	SENT_82	[p6l910t3604r1050b3671],
2	peak	JJ	O	peak	amod	3	SENT_82	[p6l1097t3604r1274b3690],
3	concentrations	NNS	O	concentration	nsubj	4	SENT_82	[p6l1321t3604r1859b3671],
4	(	VBP	O	(	_	0	SENT_82	[p6l1910t3604r2149b3690],
5	Cmax	NN	O	cmax	nn	6	SENT_82	[p6l1910t3604r2149b3690],
6	)	NN	O	)	nsubjpass	8	SENT_82	[p6l1910t3604r2149b3690],
7	were	VBD	O	be	auxpass	8	SENT_82	[p6l8t3738r185b3784],
8	estimated	VBN	O	estimate	ccomp	4	SENT_82	[p6l226t3716r579b3784],
9	directly	RB	O	directly	advmod	8	SENT_82	[p6l617t3716r897b3802],
10	from	IN	O	from	_	0	SENT_82	[p6l937t3716r1114b3784],
11	the	DT	O	the	det	13	SENT_82	[p6l1150t3716r1261b3784],
12	plasma	NN	O	plasma	nn	13	SENT_82	[p6l1297t3716r1562b3802],
13	concentrationtime	NN	O	concentrationtime	prep_from	8	SENT_82	[p6l1600t3716r2152b3784, p7l8t19r170b87],

1	data	NNS	O	datum	_	0	SENT_83	[p7l203t19r372b87],
2	.	.	O	.	_	0	SENT_83	[p7l203t19r372b87],

1	The	DT	O	the	det	2	SENT_84	[p7l408t19r548b87],
2	area	NN	O	area	nsubj	15	SENT_84	[p7l581t41r733b87],
3	under	IN	O	under	_	0	SENT_84	[p7l760t19r974b87],
4	the	DT	O	the	det	9	SENT_84	[p7l1000t19r1111b87],
5	plasma	NN	O	plasma	nn	9	SENT_84	[p7l1141t19r1405b105],
6	concentration	NN	O	concentration	nn	9	SENT_84	[p7l1435t19r2149b87],
7	—	CD	NUMBER	—	num	9	SENT_84	[p7l1435t19r2149b87],
8	time	NN	O	time	nn	9	SENT_84	[p7l1435t19r2149b87],
9	curve	NN	O	curve	prep_under	2	SENT_84	[p7l10t154r212b199],
10	from	IN	O	from	_	0	SENT_84	[p7l264t132r441b199],
11	O	NN	O	o	prep_from	9	SENT_84	[p7l490t134r531b199],
12	to	TO	O	to	_	0	SENT_84	[p7l581t141r650b199],
13	72	CD	DURATION	72	num	14	SENT_84	[p7l702t134r789b199],
14	hours	NNS	NUMBER	hour	prep_to	11	SENT_84	[p7l825t132r1030b199],
15	(	VBP	O	(	_	0	SENT_84	[p7l1082t132r1445b218],
16	AUC0_72	NN	O	auc0_72	nn	18	SENT_84	[p7l1082t132r1445b218],
17	h	NN	O	h	nn	18	SENT_84	[p7l1472t132r1535b218],
18	)	NN	O	)	nsubjpass	20	SENT_84	[p7l1472t132r1535b218],
19	was	VBD	O	be	auxpass	20	SENT_84	[p7l1584t154r1726b199],
20	calculated	VBN	O	calculate	ccomp	15	SENT_84	[p7l1777t132r2151b199],
21	using	VBG	O	use	xcomp	20	SENT_84	[p7l7t244r208b330],
22	the	DT	O	the	det	25	SENT_84	[p7l242t244r353b312],
23	linear	JJ	O	linear	amod	25	SENT_84	[p7l389t244r598b312],
24	trapezoidal	JJ	O	trapezoidal	amod	25	SENT_84	[p7l629t244r1039b330],
25	rule	NN	O	rule	dobj	21	SENT_84	[p7l1072t244r1233b312],
26	.	.	O	.	_	0	SENT_84	[p7l1072t244r1233b312],

1	The	DT	O	the	det	2	SENT_85	[p7l1273t244r1413b312],
2	AUC	NN	O	auc	nsubjpass	11	SENT_85	[p7l1448t246r1642b312],
3	from	IN	O	from	_	0	SENT_85	[p7l1680t244r1857b312],
4	zero	CD	NUMBER	zero	prep_from	2	SENT_85	[p7l1889t266r2044b312],
5	to	TO	O	to	aux	6	SENT_85	[p7l2079t253r2149b312],
6	inﬁnity	VB	O	inﬁnity	infmod	2	SENT_85	[p7l10t355r277b442],
7	(	CD	NUMBER	(	num	9	SENT_85	[p7l317t356r569b441],
8	AUC	NN	O	auc	nn	9	SENT_85	[p7l317t356r569b441],
9	)	NN	O	)	dobj	6	SENT_85	[p7l317t356r569b441],
10	was	VBD	O	be	auxpass	11	SENT_85	[p7l608t377r751b423],
11	calculated	VBN	O	calculate	_	0	SENT_85	[p7l792t355r1166b423],
12	as	IN	O	as	_	0	SENT_85	[p7l1205t377r1278b423],
13	AUC	NN	O	auc	prep_as	11	SENT_85	[p7l1317t357r1510b423],
14	=	JJ	O	=	amod	16	SENT_85	[p7l1550t386r1613b409],
15	AUC0_72	NN	O	auc0_72	nn	16	SENT_85	[p7l1650t357r1985b438],
16	h	NN	O	h	dobj	11	SENT_85	[p7l2013t392r2047b437],
17	+	CC	O	+	_	0	SENT_85	[p7l2084t366r2147b429],
18	Ct/Ke	NN	O	ct/ke	dobj	11	SENT_85	[p7l10t468r227b535],
19	(	CD	NUMBER	(	num	18	SENT_85	[p7l305t468r557b554],
20	where	WRB	O	where	advmod	26	SENT_85	[p7l305t468r557b554],
21	Ct	NN	O	ct	nsubj	26	SENT_85	[p7l634t469r720b535],
22	is	VBZ	O	be	cop	26	SENT_85	[p7l793t468r850b535],
23	the	DT	O	the	det	26	SENT_85	[p7l924t468r1035b535],
24	last	JJ	O	last	amod	26	SENT_85	[p7l1112t468r1238b535],
25	plasma	NN	O	plasma	nn	26	SENT_85	[p7l1308t468r1573b554],
26	concentration	NN	O	concentration	rcmod	18	SENT_85	[p7l1647t468r2150b535],
27	measured	VBN	O	measure	partmod	26	SENT_85	[p7l8t580r412b666],
28	)	NN	O	)	dobj	27	SENT_85	[p7l8t580r412b666],
29	.	.	O	.	_	0	SENT_85	[p7l8t580r412b666],

1	The	DT	O	the	det	3	SENT_86	[p7l487t580r628b648],
2	elimination	NN	O	elimination	nn	3	SENT_86	[p7l700t580r1120b648],
3	rate	NN	O	rate	nsubj	24	SENT_86	[p7l1187t589r1323b648],
4	constant	JJ	O	constant	amod	3	SENT_86	[p7l1395t590r1703b648],
5	(	CD	NUMBER	(	num	7	SENT_86	[p7l1773t581r1936b666],
6	Ke	NNP	O	Ke	nn	7	SENT_86	[p7l1773t581r1936b666],
7	)	NN	O	)	nsubjpass	9	SENT_86	[p7l1773t581r1936b666],
8	was	VBD	O	be	auxpass	9	SENT_86	[p7l2006t602r2149b648],
9	determined	VBN	O	determine	rcmod	3	SENT_86	[p7l10t691r426b759],
10	by	IN	O	by	_	0	SENT_86	[p7l452t691r546b778],
11	linear	JJ	O	linear	amod	13	SENT_86	[p7l576t691r786b759],
12	regression	NN	O	regression	nn	13	SENT_86	[p7l811t691r1192b778],
13	analysis	NN	O	analysis	agent	9	SENT_86	[p7l1222t691r1517b778],
14	of	IN	O	of	_	0	SENT_86	[p7l1549t691r1634b759],
15	the	DT	O	the	det	17	SENT_86	[p7l1651t691r1762b759],
16	log-linear	JJ	O	log-linear	amod	17	SENT_86	[p7l1793t691r2153b778],
17	area	NN	O	area	prep_of	13	SENT_86	[p7l10t827r162b872],
18	of	IN	O	of	_	0	SENT_86	[p7l191t805r276b872],
19	the	DT	O	the	det	21	SENT_86	[p7l292t805r403b872],
20	plasma	NN	O	plasma	nn	21	SENT_86	[p7l431t805r696b891],
21	concentration	NN	O	concentration	prep_of	17	SENT_86	[p7l725t805r1438b872],
22	—	CD	NUMBER	—	num	23	SENT_86	[p7l725t805r1438b872],
23	time	NN	O	time	tmod	17	SENT_86	[p7l725t805r1438b872],
24	curve	NN	O	curve	_	0	SENT_86	[p7l1469t827r1690b872],
25	.	.	O	.	_	0	SENT_86	[p7l1469t827r1690b872],

1	The	DT	O	the	det	2	SENT_87	[p7l1725t805r1866b872],
2	t1/2	NN	O	t1/2	nsubjpass	4	SENT_87	[p7l1895t814r1977b903],
3	was	VBD	O	be	auxpass	4	SENT_87	[p7l2007t826r2149b872],
4	calculated	VBN	O	calculate	_	0	SENT_87	[p7l10t916r384b984],
5	using	VBG	O	use	xcomp	4	SENT_87	[p7l475t916r677b1002],
6	the	DT	O	the	det	10	SENT_87	[p7l770t916r881b984],
7	equation	NN	O	equation	nn	10	SENT_87	[p7l977t916r1295b1002],
8	t1/2	NN	O	t1/2	nn	10	SENT_87	[p7l1387t926r1499b999],
9	=	JJ	O	=	amod	10	SENT_87	[p7l1538t947r1601b969],
10	ln2/Ke	NN	O	ln2/ke	dobj	5	SENT_87	[p7l1640t916r1908b984],
11	.	.	O	.	_	0	SENT_87	[p7l1640t916r1908b984],

1	The	DT	O	the	det	6	SENT_88	[p7l2008t916r2149b984],
2	apparent	JJ	O	apparent	amod	6	SENT_88	[p7l10t1037r328b1113],
3	clearance	NN	O	clearance	nn	6	SENT_88	[p7l373t1027r717b1095],
4	(	CD	NUMBER	(	num	6	SENT_88	[p7l766t1027r1017b1113],
5	CL/F	NN	O	cl/f	nn	6	SENT_88	[p7l766t1027r1017b1113],
6	)	NN	O	)	nsubjpass	17	SENT_88	[p7l766t1027r1017b1113],
7	of	IN	O	of	_	0	SENT_88	[p7l1066t1027r1151b1095],
8	orally	RB	O	orally	advmod	9	SENT_88	[p7l1186t1027r1400b1114],
9	administered	VBN	O	administer	amod	10	SENT_88	[p7l1445t1027r1922b1095],
10	sibutramine	NN	O	sibutramine	prep_of	6	SENT_88	[p7l1969t1027r2148b1095, p7l8t1140r288b1207],
11	(	NN	O	(	nn	15	SENT_88	[p7l359t1140r707b1226],
12	apparent	JJ	O	apparent	amod	15	SENT_88	[p7l359t1140r707b1226],
13	oral	JJ	O	oral	amod	15	SENT_88	[p7l773t1140r912b1207],
14	clearance	NN	O	clearance	nn	15	SENT_88	[p7l982t1140r1357b1226],
15	)	NN	O	)	dep	6	SENT_88	[p7l982t1140r1357b1226],
16	was	VBD	O	be	auxpass	17	SENT_88	[p7l1424t1162r1566b1207],
17	calculated	VBN	O	calculate	_	0	SENT_88	[p7l1635t1140r2009b1207],
18	as	IN	O	as	mark	19	SENT_88	[p7l2076t1162r2149b1207],
19	follows	VBZ	O	follow	advcl	17	SENT_88	[p7l10t1252r305b1320],
20	:	:	O	:	_	0	SENT_88	[p7l10t1252r305b1320],
21	apparent	JJ	O	apparent	amod	24	SENT_88	[p7l343t1262r661b1338],
22	CL/F	NN	O	cl/f	nn	24	SENT_88	[p7l692t1252r883b1320],
23	=	JJ	O	=	amod	24	SENT_88	[p7l923t1283r986b1305],
24	dose/AUC	NN	O	dose/auc	dobj	19	SENT_88	[p7l1025t1252r1433b1320],
25	.	.	O	.	_	0	SENT_88	[p7l1025t1252r1433b1320],

1	Incubation	NN	O	incubation	_	0	SENT_89	[p7l14t1478r388b1544],
2	With	IN	O	with	_	0	SENT_89	[p7l420t1477r608b1544],
3	Human	JJ	O	human	amod	4	SENT_89	[p7l648t1478r905b1544],
4	Intestinal	JJ	O	intestinal	prep_with	1	SENT_89	[p7l944t1478r1261b1544],
5	and	CC	O	and	_	0	SENT_89	[p7l1297t1478r1422b1544],
6	Liver	NN	O	liver	nn	7	SENT_89	[p7l1460t1478r1639b1544],
7	Microsomes	NNS	O	microsome	prep_with	1	SENT_89	[p7l1673t1478r2117b1544],
8	All	DT	O	all	det	10	SENT_89	[p7l8t1589r125b1655],
9	microsomal	JJ	O	microsomal	amod	10	SENT_89	[p7l170t1589r607b1657],
10	incubations	NNS	O	incubation	nsubjpass	12	SENT_89	[p7l655t1589r1079b1657],
11	were	VBD	O	be	auxpass	12	SENT_89	[p7l1127t1611r1304b1657],
12	conducted	VBN	O	conduct	dep	1	SENT_89	[p7l1353t1589r1735b1657],
13	similar	JJ	O	similar	acomp	12	SENT_89	[p7l1783t1589r2036b1657],
14	to	TO	O	to	_	0	SENT_89	[p7l2079t1598r2149b1657],
15	those	DT	O	those	det	23	SENT_89	[p7l8t1700r202b1768],
16	reported	VBN	O	report	amod	23	SENT_89	[p7l283t1700r593b1786],
17	previously	RB	DATE	previously	advmod	18	SENT_89	[p7l670t1681r1132b1787],
18	”	RB	O	”	amod	23	SENT_89	[p7l670t1681r1132b1787],
19	in	IN	O	in	_	0	SENT_89	[p7l1217t1700r1287b1767],
20	100	CD	NUMBER	100	num	22	SENT_89	[p7l1376t1702r1503b1768],
21	mM	NN	O	mm	nn	22	SENT_89	[p7l1538t1703r1692b1767],
22	phosphate	NN	O	phosphate	prep_in	18	SENT_89	[p7l1771t1700r2149b1786],
23	buffer	NN	O	buffer	prep_to	13	SENT_89	[p7l7t1813r252b1894],
24	,	,	O	,	_	0	SENT_89	[p7l7t1813r252b1894],
25	pH	NN	O	ph	appos	23	SENT_89	[p7l290t1816r404b1899],
26	7.4	CD	NUMBER	7.4	num	25	SENT_89	[p7l441t1814r553b1880],
27	using	VBG	O	use	partmod	25	SENT_89	[p7l588t1813r790b1899],
28	0.5	CD	NUMBER	0.5	num	29	SENT_89	[p7l827t1815r935b1880],
29	mg	NN	O	mg	dobj	27	SENT_89	[p7l974t1835r1091b1899],
30	of	IN	O	of	_	0	SENT_89	[p7l1128t1813r1214b1880],
31	microsomal	JJ	O	microsomal	amod	32	SENT_89	[p7l1236t1813r1673b1880],
32	protein	NN	O	protein	prep_of	29	SENT_89	[p7l1707t1813r1971b1899],
33	in	IN	O	in	_	0	SENT_89	[p7l2007t1813r2077b1879],
34	a	DT	O	a	det	36	SENT_89	[p7l2112t1835r2151b1880],
35	ﬁnal	JJ	O	ﬁnal	amod	36	SENT_89	[p7l9t1925r172b1992],
36	volume	NN	O	volume	prep_in	27	SENT_89	[p7l216t1925r494b1993],
37	of	IN	O	of	_	0	SENT_89	[p7l542t1925r627b1993],
38	100	CD	NUMBER	100	num	39	SENT_89	[p7l669t1927r797b1992],
39	uL	NN	O	ul	prep_of	36	SENT_89	[p7l834t1928r954b2011],
40	,	,	O	,	_	0	SENT_89	[p7l834t1928r954b2011],
41	initiated	VBN	O	initiate	dep	1	SENT_89	[p7l1004t1925r1305b1993],
42	by	IN	O	by	_	0	SENT_89	[p7l1347t1925r1442b2011],
43	the	DT	O	the	det	44	SENT_89	[p7l1485t1925r1596b1993],
44	addition	NN	O	addition	prep_by	41	SENT_89	[p7l1644t1925r1947b1993],
45	of	IN	O	of	_	0	SENT_89	[p7l1993t1925r2078b1993],
46	a	DT	O	a	det	48	SENT_89	[p7l2113t1947r2152b1993],
47	NADPH	NN	O	nadph	nn	48	SENT_89	[p7l6t2038r328b2103],
48	(	NN	O	(	prep_of	44	SENT_89	[p7l370t2037r433b2122],
49	1	CD	NUMBER	1	num	50	SENT_89	[p7l370t2037r433b2122],
50	mM	NN	O	mm	npadvmod	51	SENT_89	[p7l476t2039r630b2103],
51	ﬁnal	JJ	O	ﬁnal	amod	52	SENT_89	[p7l670t2036r833b2104],
52	concentration	NN	O	concentration	dobj	41	SENT_89	[p7l874t2036r1830b2123],
53	)	SYM	O	)	dep	52	SENT_89	[p7l874t2036r1830b2123],
54	-	:	O	-	_	0	SENT_89	[p7l874t2036r1830b2123],
55	generating	VBG	O	generate	parataxis	41	SENT_89	[p7l874t2036r1830b2123],
56	system	NN	O	system	dobj	55	SENT_89	[p7l1873t2046r2144b2123],
57	.	.	O	.	_	0	SENT_89	[p7l1873t2046r2144b2123],

1	The	DT	O	the	det	2	SENT_90	[p7l10t2149r150b2216],
2	reaction	NN	O	reaction	nsubjpass	4	SENT_90	[p7l171t2149r469b2216],
3	was	VBD	O	be	auxpass	4	SENT_90	[p7l488t2171r630b2216],
4	stopped	VBN	O	stop	_	0	SENT_90	[p7l655t2149r942b2235],
5	by	IN	O	by	_	0	SENT_90	[p7l959t2149r1053b2235],
6	the	DT	O	the	det	7	SENT_90	[p7l1071t2149r1182b2216],
7	addition	NN	O	addition	agent	4	SENT_90	[p7l1205t2149r1508b2216],
8	of	IN	O	of	_	0	SENT_90	[p7l1529t2149r1614b2216],
9	0.1	CD	NUMBER	0.1	num	10	SENT_90	[p7l1625t2151r1728b2216],
10	mL	NN	O	ml	prep_of	7	SENT_90	[p7l1771t2152r1898b2215],
11	of	IN	O	of	_	0	SENT_90	[p7l1921t2149r2006b2216],
12	icecold	JJ	O	icecold	amod	13	SENT_90	[p7l2015t2149r2149b2216, p7l10t2261r169b2329],
13	acetonitrile	NN	O	acetonitrile	prep_of	10	SENT_90	[p7l219t2261r630b2329],
14	containing	VBG	O	contain	xcomp	4	SENT_90	[p7l684t2261r1072b2347],
15	propranolol	NN	O	propranolol	dobj	14	SENT_90	[p7l1123t2261r1556b2347],
16	as	IN	O	as	_	0	SENT_90	[p7l1609t2283r1681b2329],
17	an	DT	O	a	det	19	SENT_90	[p7l1734t2283r1820b2329],
18	internal	JJ	O	internal	amod	19	SENT_90	[p7l1870t2261r2149b2329],
19	standard	NN	O	standard	prep_as	14	SENT_90	[p7l12t2372r340b2440],
20	.	.	O	.	_	0	SENT_90	[p7l12t2372r340b2440],

1	The	DT	O	the	det	6	SENT_91	[p7l377t2372r517b2440],
2	apparent	JJ	O	apparent	amod	6	SENT_91	[p7l549t2382r868b2458],
3	enzyme	NN	O	enzyme	nn	6	SENT_91	[p7l897t2394r1182b2459],
4	kinetic	JJ	O	kinetic	amod	6	SENT_91	[p7l1212t2372r1462b2440],
5	constants	NNS	O	constant	nn	6	SENT_91	[p7l1495t2382r1837b2440],
6	Km	NN	O	km	nsubjpass	22	SENT_91	[p7l1868t2375r1989b2454],
7	and	CC	O	and	_	0	SENT_91	[p7l2019t2372r2152b2440],
8	Vmax	NN	O	vmax	nsubjpass	22	SENT_91	[p7l8t2488r195b2567],
9	of	IN	O	of	_	0	SENT_91	[p7l221t2485r306b2552],
10	M1	NN	O	m1	nn	13	SENT_91	[p7l321t2486r438b2550],
11	and	CC	O	and	_	0	SENT_91	[p7l475t2485r608b2552],
12	M2	NN	O	m2	conj_and	10	SENT_91	[p7l632t2487r757b2550],
13	formation	NN	O	formation	prep_of	8	SENT_91	[p7l787t2485r1150b2552],
14	from	IN	O	from	_	0	SENT_91	[p7l1177t2485r1354b2552],
15	sibutramine	NN	O	sibutramine	prep_from	13	SENT_91	[p7l1381t2485r1835b2566],
16	,	,	O	,	_	0	SENT_91	[p7l1381t2485r1835b2566],
17	and	CC	O	and	_	0	SENT_91	[p7l1865t2485r1998b2552],
18	M2	NN	O	m2	conj_and	13	SENT_91	[p7l2022t2487r2147b2550],
19	from	IN	O	from	_	0	SENT_91	[p7l10t2596r188b2664],
20	M1	NN	O	m1	prep_from	18	SENT_91	[p7l242t2598r359b2662],
21	were	VBD	O	be	auxpass	22	SENT_91	[p7l423t2618r601b2664],
22	determined	VBN	O	determine	_	0	SENT_91	[p7l659t2596r1075b2664],
23	by	IN	O	by	_	0	SENT_91	[p7l1127t2596r1221b2682],
24	ﬁtting	VBG	O	ﬁtting	agent	22	SENT_91	[p7l1276t2596r1494b2682],
25	the	DT	O	the	det	28	SENT_91	[p7l1549t2596r1660b2664],
26	unweighted	JJ	O	unweighted	amod	28	SENT_91	[p7l1715t2596r2151b2682],
27	kinetic	JJ	O	kinetic	amod	28	SENT_91	[p7l8t2707r258b2775],
28	data	NNS	O	datum	dobj	24	SENT_91	[p7l280t2707r433b2775],
29	from	IN	O	from	_	0	SENT_91	[p7l452t2707r629b2775],
30	human	JJ	O	human	amod	31	SENT_91	[p7l646t2707r900b2775],
31	intestinal	JJ	O	intestinal	prep_from	24	SENT_91	[p7l920t2707r1255b2775],
32	and	CC	O	and	_	0	SENT_91	[p7l1277t2707r1410b2775],
33	liver	NN	O	liver	nn	34	SENT_91	[p7l1428t2707r1597b2775],
34	microsomes	NNS	O	microsome	conj_and	31	SENT_91	[p7l1612t2707r2058b2775],
35	to	TO	O	to	_	0	SENT_91	[p7l2079t2717r2149b2775],
36	a	DT	O	a	det	38	SENT_91	[p7l10t2842r49b2887],
37	single-site	JJ	O	single-site	amod	38	SENT_91	[p7l70t2820r445b2906],
38	Michalis	NNP	PERSON	Michalis	prep_to	24	SENT_91	[p7l466t2820r1122b2887],
39	.	.	O	.	_	0	SENT_91	[p7l466t2820r1122b2887],

1	—	NN	O	—	_	0	SENT_92	[p7l466t2820r1122b2887],
2	.	.	O	.	_	0	SENT_92	[p7l466t2820r1122b2887],

1	Menten	JJ	MISC	menten	amod	2	SENT_93	[p7l466t2820r1122b2887],
2	equation	NN	O	equation	_	0	SENT_93	[p7l1143t2820r1480b2906],
3	,	,	O	,	_	0	SENT_93	[p7l1143t2820r1480b2906],
4	a	DT	O	a	det	6	SENT_93	[p7l1505t2842r1544b2887],
5	sigmoidal	JJ	O	sigmoidal	amod	6	SENT_93	[p7l1566t2820r1927b2906],
6	(	NN	O	(	appos	2	SENT_93	[p7l1950t2820r2148b2906],
7	Hill	NNP	PERSON	Hill	nn	9	SENT_93	[p7l1950t2820r2148b2906],
8	)	NN	O	)	nn	9	SENT_93	[p7l1950t2820r2148b2906],
9	equation	NN	O	equation	dep	6	SENT_93	[p7l10t2932r348b3018],
10	,	,	O	,	_	0	SENT_93	[p7l10t2932r348b3018],
11	or	CC	O	or	_	0	SENT_93	[p7l394t2954r471b3000],
12	a	DT	O	a	det	14	SENT_93	[p7l510t2954r549b2999],
13	two-enzyme	JJ	O	two-enzyme	amod	14	SENT_93	[p7l588t2941r1046b3018],
14	model	NN	O	model	appos	2	SENT_93	[p7l1088t2932r1337b3000],
15	.	.	O	.	_	0	SENT_93	[p7l1088t2932r1337b3000],

1	Eadie	NNP	PERSON	Eadie	_	0	SENT_94	[p7l1385t2932r1928b3000],
2	.	.	O	.	_	0	SENT_94	[p7l1385t2932r1928b3000],

1	—	NN	O	—	_	0	SENT_95	[p7l1385t2932r1928b3000],
2	.	.	O	.	_	0	SENT_95	[p7l1385t2932r1928b3000],

1	Hofstee	NNP	PERSON	Hofstee	nn	2	SENT_96	[p7l1385t2932r1928b3000],
2	plots	NNS	O	plot	nsubjpass	9	SENT_96	[p7l1969t2932r2149b3018],
3	and	CC	O	and	_	0	SENT_96	[p7l10t3043r143b3111],
4	the	DT	O	the	det	7	SENT_96	[p7l171t3043r282b3111],
5	Akaike	NNP	MISC	Akaike	nn	7	SENT_96	[p7l313t3043r579b3111],
6	information	NN	O	information	nn	7	SENT_96	[p7l611t3043r1048b3111],
7	criterion	NN	O	criterion	conj_and	2	SENT_96	[p7l1079t3043r1388b3111],
8	were	VBD	O	be	auxpass	9	SENT_96	[p7l1417t3065r1595b3111],
9	used	VBN	O	use	_	0	SENT_96	[p7l1625t3043r1797b3111],
10	to	TO	O	to	aux	11	SENT_96	[p7l1824t3053r1893b3111],
11	assess	VB	O	assess	xcomp	9	SENT_96	[p7l1927t3065r2148b3111],
12	and	CC	O	and	_	0	SENT_96	[p7l10t3157r143b3224],
13	select	VB	O	select	conj_and	11	SENT_96	[p7l176t3157r382b3224],
14	the	DT	O	the	det	17	SENT_96	[p7l410t3157r521b3224],
15	best	JJS	O	best	amod	17	SENT_96	[p7l551t3157r702b3224],
16	ﬁt	NN	O	ﬁt	nn	17	SENT_96	[p7l732t3157r808b3224],
17	model	NN	O	model	dobj	11	SENT_96	[p7l836t3157r1086b3224],
18	.	.	O	.	_	0	SENT_96	[p7l836t3157r1086b3224],

1	Statistical	JJ	O	statistical	amod	2	SENT_97	[p7l11t3270r350b3337],
2	Analyses	NNS	O	analysis	nsubjpass	6	SENT_97	[p7l384t3270r705b3358],
3	The	DT	O	the	det	4	SENT_97	[p7l9t3381r150b3448],
4	results	NNS	O	result	dep	2	SENT_97	[p7l171t3381r410b3448],
5	were	VBD	O	be	auxpass	6	SENT_97	[p7l432t3403r609b3448],
6	expressed	VBN	O	express	_	0	SENT_97	[p7l633t3381r996b3466],
7	as	IN	O	as	_	0	SENT_97	[p7l1018t3403r1089b3448],
8	mean	JJ	O	mean	amod	11	SENT_97	[p7l1112t3403r1312b3448],
9	j	NN	O	j	nn	11	SENT_97	[p7l1348t3384r1411b3446],
10	:	:	O	:	_	0	SENT_97	[p7l1348t3384r1411b3446],
11	SD	NN	O	sd	prep_as	6	SENT_97	[p7l1453t3383r1583b3448],
12	.	.	O	.	_	0	SENT_97	[p7l1453t3383r1583b3448],

1	The	DT	O	the	det	4	SENT_98	[p7l1611t3381r1751b3448],
2	geometric	JJ	O	geometric	amod	4	SENT_98	[p7l1774t3381r2139b3466],
3	mean	NN	O	mean	nn	4	SENT_98	[p7l8t3513r208b3558],
4	ratio	NN	O	ratio	nsubj	11	SENT_98	[p7l236t3491r402b3558],
5	and	CC	O	and	_	0	SENT_98	[p7l436t3491r568b3558],
6	its	PRP$	O	its	poss	10	SENT_98	[p7l598t3491r679b3558],
7	90	CD	PERCENT	90	number	8	SENT_98	[p7l714t3493r879b3558],
8	%	NN	PERCENT	%	amod	10	SENT_98	[p7l714t3493r879b3558],
9	conﬁdence	NN	O	conﬁdence	nn	10	SENT_98	[p7l911t3491r1309b3558],
10	intervals	NNS	O	interval	conj_and	4	SENT_98	[p7l1342t3491r1655b3558],
11	(	VBP	O	(	_	0	SENT_98	[p7l1689t3492r1885b3576],
12	90	CD	PERCENT	90	number	13	SENT_98	[p7l1689t3492r1885b3576],
13	%	NN	PERCENT	%	amod	15	SENT_98	[p7l1689t3492r1885b3576],
14	CI	NN	O	ci	nn	15	SENT_98	[p7l1918t3492r2035b3576],
15	)	NN	O	)	nsubjpass	24	SENT_98	[p7l1918t3492r2035b3576],
16	of	IN	O	of	_	0	SENT_98	[p7l2068t3491r2153b3558],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_98	[p7l7t3603r623b3688],
18	parameters	NNS	O	parameter	prep_of	15	SENT_98	[p7l657t3612r1061b3688],
19	between	IN	O	between	_	0	SENT_98	[p7l1096t3603r1406b3669],
20	the	DT	O	the	det	22	SENT_98	[p7l1439t3603r1550b3669],
21	two	CD	NUMBER	two	num	22	SENT_98	[p7l1585t3612r1721b3669],
22	treatments	NNS	O	treatment	prep_between	18	SENT_98	[p7l1758t3612r2140b3669],
23	were	VBD	O	be	auxpass	24	SENT_98	[p7l8t3736r185b3781],
24	calculated	VBN	O	calculate	ccomp	11	SENT_98	[p7l232t3714r620b3781],
25	.	.	O	.	_	0	SENT_98	[p7l232t3714r620b3781],

1	The	DT	O	the	det	3	SENT_99	[p7l672t3714r812b3781],
2	pharrnacokinetic	JJ	O	pharrnacokinetic	amod	3	SENT_99	[p7l855t3714r1471b3799],
3	parameters	NNS	O	parameter	nsubjpass	5	SENT_99	[p7l1515t3724r1917b3799],
4	were	VBD	O	be	auxpass	5	SENT_99	[p7l1963t3736r2140b3781],
5	analyzed	VBN	O	analyze	_	0	SENT_99	[p8l10t19r338b106],
6	using	VBG	O	use	xcomp	5	SENT_99	[p8l372t19r572b106],
7	a	DT	O	a	det	9	SENT_99	[p8l611t41r650b87],
8	2-way	JJ	O	2-way	amod	9	SENT_99	[p8l686t21r916b106],
9	analysis	NN	O	analysis	dobj	6	SENT_99	[p8l954t19r1248b106],
10	of	IN	O	of	_	0	SENT_99	[p8l1288t19r1372b87],
11	Variance	NNP	O	Variance	prep_of	9	SENT_99	[p8l1398t19r1707b87],
12	(	CD	NUMBER	(	num	11	SENT_99	[p8l1748t20r2140b105],
13	ANOVA	NNP	ORGANIZATION	ANOVA	dep	6	SENT_99	[p8l1748t20r2140b105],
14	)	CD	NUMBER	)	num	13	SENT_99	[p8l1748t20r2140b105],
15	with	IN	O	with	_	0	SENT_99	[p8l8t132r172b198],
16	treatment	NN	O	treatment	nn	19	SENT_99	[p8l211t141r560b198],
17	and	CC	O	and	_	0	SENT_99	[p8l601t132r733b198],
18	CYP2B6	NN	O	cyp2b6	nn	19	SENT_99	[p8l775t133r1106b198],
19	genotype	NN	O	genotype	prep_with	6	SENT_99	[p8l1151t141r1487b217],
20	as	IN	O	as	_	0	SENT_99	[p8l1531t153r1603b198],
21	main	JJ	O	main	amod	22	SENT_99	[p8l1644t132r1829b198],
22	factors	NNS	O	factor	prep_as	6	SENT_99	[p8l1871t132r2135b198],
23	.	.	O	.	_	0	SENT_99	[p8l1871t132r2135b198],

1	Molar	JJ	O	molar	amod	3	SENT_100	[p8l9t243r235b310],
2	AUC	NN	O	auc	nn	3	SENT_100	[p8l290t245r483b310],
3	ratios	NNS	O	ratio	nsubjpass	14	SENT_100	[p8l543t243r744b310],
4	of	IN	O	of	_	0	SENT_100	[p8l806t243r890b310],
5	metabolites	NNS	O	metabolite	prep_of	3	SENT_100	[p8l936t243r1360b310],
6	to	TO	O	to	_	0	SENT_100	[p8l1418t253r1487b310],
7	parent	NN	O	parent	prep_to	5	SENT_100	[p8l1545t253r1777b328],
8	between	IN	O	between	_	0	SENT_100	[p8l1833t243r2142b310],
9	the	DT	O	the	det	12	SENT_100	[p8l8t353r118b421],
10	different	JJ	O	different	amod	12	SENT_100	[p8l158t353r473b421],
11	treatment	NN	O	treatment	nn	12	SENT_100	[p8l507t363r855b421],
12	groups	NNS	O	group	prep_between	7	SENT_100	[p8l892t375r1141b440],
13	were	VBD	O	be	auxpass	14	SENT_100	[p8l1178t375r1355b421],
14	compared	VBN	O	compare	_	0	SENT_100	[p8l1395t353r1758b439],
15	using	VBG	O	use	xcomp	14	SENT_100	[p8l1792t353r1993b440],
16	the	DT	O	the	det	20	SENT_100	[p8l2029t353r2140b421],
17	Wilcoxon	NNP	PERSON	Wilcoxon	nn	20	SENT_100	[p8l8t466r374b532],
18	rank	NN	O	rank	nn	20	SENT_100	[p8l410t466r576b532],
19	sum	NN	O	sum	nn	20	SENT_100	[p8l615t487r767b532],
20	test	NN	O	test	dobj	15	SENT_100	[p8l802t475r930b532],
21	after	IN	O	after	_	0	SENT_100	[p8l969t466r1135b532],
22	normality	NN	O	normality	nn	23	SENT_100	[p8l1170t466r1528b551],
23	test	NN	O	test	prep_after	15	SENT_100	[p8l1565t475r1710b532],
24	.	.	O	.	_	0	SENT_100	[p8l1565t475r1710b532],

1	Data	NNS	O	datum	nsubjpass	3	SENT_101	[p8l1754t469r1927b532],
2	were	VBD	O	be	auxpass	3	SENT_101	[p8l1963t487r2140b532],
3	analyzed	VBN	O	analyze	_	0	SENT_101	[p8l10t577r338b662],
4	using	VBG	O	use	xcomp	3	SENT_101	[p8l360t577r560b662],
5	the	DT	O	the	det	7	SENT_101	[p8l585t577r695b644],
6	SAS	NNP	O	SAS	nn	7	SENT_101	[p8l725t579r886b644],
7	software	NN	O	software	dobj	4	SENT_101	[p8l917t577r1229b644],
8	Version	NNP	O	Version	tmod	4	SENT_101	[p8l1254t577r1526b644],
9	9.2	CD	NUMBER	9.2	num	8	SENT_101	[p8l1552t579r1683b644],
10	.	.	O	.	_	0	SENT_101	[p8l1552t579r1683b644],

1	Differences	NNS	O	difference	nsubjpass	3	SENT_102	[p8l1713t577r2139b644],
2	were	VBD	O	be	auxpass	3	SENT_102	[p8l8t709r184b755],
3	considered	VBN	O	consider	_	0	SENT_102	[p8l214t687r613b755],
4	statistically	RB	O	statistically	advmod	5	SENT_102	[p8l642t687r1056b774],
5	signiﬁcant	JJ	O	signiﬁcant	acomp	3	SENT_102	[p8l1085t687r1468b774],
6	when	WRB	O	when	advmod	10	SENT_102	[p8l1491t687r1693b755],
7	the	DT	O	the	det	8	SENT_102	[p8l1717t687r1828b755],
8	P-Value	NN	O	p-value	nsubj	10	SENT_102	[p8l1852t687r2140b755],
9	was	VBD	O	be	cop	10	SENT_102	[p8l8t820r149b865],
10	<	JJR	O	<	advcl	3	SENT_102	[p8l188t800r386b867],
11	.	.	O	.	_	0	SENT_102	[p8l188t800r386b867],

1	O5	NN	O	o5	_	0	SENT_103	[p8l188t800r386b867],
2	.	.	O	.	_	0	SENT_103	[p8l188t800r386b867],

1	Results	NNS	O	result	_	0	SENT_104	[p8l16t1036r374b1114],

1	Enantioselective	JJ	O	enantioselective	amod	3	SENT_105	[p8l14t1198r606b1263],
2	Pharmaco	NNP	O	Pharmaco	nn	3	SENT_105	[p8l643t1198r1289b1263],
3	|	NN	O	|	nsubj	25	SENT_105	[p8l643t1198r1289b1263],
4	<	JJR	O	<	amod	5	SENT_105	[p8l643t1198r1289b1263],
5	inetics	NNS	O	inetic	nsubjpass	20	SENT_105	[p8l643t1198r1289b1263],
6	of	IN	O	of	_	0	SENT_105	[p8l1323t1197r1398b1263],
7	Sibutramine	NN	MISC	sibutramine	prep_of	5	SENT_105	[p8l1426t1197r1866b1263],
8	and	CC	O	and	_	0	SENT_105	[p8l1898t1198r2025b1263],
9	its	PRP$	O	its	poss	11	SENT_105	[p8l13t1312r90b1373],
10	Active	JJ	O	active	amod	11	SENT_105	[p8l122t1308r358b1373],
11	Metabolites	NNPS	O	Metabolites	prep_of	5	SENT_105	[p8l396t1308r819b1373],
12	Plasma	NN	O	plasma	nn	13	SENT_105	[p8l9t1419r275b1485],
13	concentrations	NNS	O	concentration	dep	11	SENT_105	[p8l331t1419r866b1485],
14	of	IN	O	of	_	0	SENT_105	[p8l925t1419r1009b1485],
15	R	NN	O	r	prep_of	13	SENT_105	[p8l1050t1422r1136b1484],
16	-	:	O	-	_	0	SENT_105	[p8l1050t1422r1136b1484],
17	and	CC	O	and	_	0	SENT_105	[p8l1194t1419r1327b1485],
18	S-enantiomers	NNS	O	s-enantiomer	conj_and	7	SENT_105	[p8l1380t1419r1907b1486],
19	were	VBD	O	be	auxpass	20	SENT_105	[p8l1963t1440r2140b1485],
20	assessed	VBN	O	assess	rcmod	3	SENT_105	[p8l10t1530r322b1597],
21	following	VBG	O	follow	_	0	SENT_105	[p8l343t1530r699b1615],
22	oral	JJ	O	oral	amod	23	SENT_105	[p8l721t1530r860b1597],
23	administration	NN	O	administration	prep_following	20	SENT_105	[p8l883t1530r1415b1597],
24	(	CD	NUMBER	(	num	25	SENT_105	[p8l1437t1530r1551b1615],
25	15	CD	NUMBER	15	_	0	SENT_105	[p8l1437t1530r1551b1615],
26	mg	NN	O	mg	nn	27	SENT_105	[p8l1589t1531r1734b1615],
27	)	NN	O	)	dobj	25	SENT_105	[p8l1589t1531r1734b1615],
28	of	IN	O	of	_	0	SENT_105	[p8l1758t1530r1843b1597],
29	racemic	JJ	O	racemic	amod	30	SENT_105	[p8l1851t1530r2139b1597],
30	sibutramine	NN	O	sibutramine	prep_of	27	SENT_105	[p8l12t1640r443b1708],
31	to	TO	O	to	_	0	SENT_105	[p8l471t1650r540b1708],
32	healthy	JJ	O	healthy	amod	33	SENT_105	[p8l569t1640r842b1727],
33	subjects	NNS	O	subject	npadvmod	34	SENT_105	[p8l873t1640r1164b1727],
34	(	JJ	O	(	amod	37	SENT_105	[p8l1197t1640r1463b1727],
35	Figure	NN	O	figure	nn	37	SENT_105	[p8l1197t1640r1463b1727],
36	1	CD	NUMBER	1	num	37	SENT_105	[p8l1502t1641r1586b1726],
37	)	NN	O	)	prep_to	25	SENT_105	[p8l1502t1641r1586b1726],
38	.	.	O	.	_	0	SENT_105	[p8l1502t1641r1586b1726],

1	R-sibutramine	NN	O	r-sibutramine	nsubj	2	SENT_106	[p8l1616t1640r2140b1708],
2	showed	VBD	O	show	_	0	SENT_106	[p8l12t1753r293b1819],
3	higher	JJR	O	higher	amod	5	SENT_106	[p8l315t1753r553b1838],
4	plasma	NN	O	plasma	nn	5	SENT_106	[p8l573t1753r837b1838],
5	concentrations	NNS	O	concentration	dobj	2	SENT_106	[p8l862t1753r1397b1819],
6	than	IN	O	than	_	0	SENT_106	[p8l1422t1753r1581b1819],
7	S-sibutramine	NN	O	s-sibutramine	prep_than	2	SENT_106	[p8l1605t1753r2138b1834],
8	,	,	O	,	_	0	SENT_106	[p8l1605t1753r2138b1834],
9	with	IN	O	with	_	0	SENT_106	[p8l8t1864r172b1931],
10	a	DT	O	a	det	14	SENT_106	[p8l200t1886r239b1931],
11	longer	RBR	O	longer	advmod	12	SENT_106	[p8l266t1864r502b1949],
12	terminal	JJ	O	terminal	amod	14	SENT_106	[p8l526t1864r831b1931],
13	elimination	NN	O	elimination	nn	14	SENT_106	[p8l862t1864r1279b1931],
14	half-life	NN	O	half-life	prep_with	2	SENT_106	[p8l1306t1864r1618b1931],
15	.	.	O	.	_	0	SENT_106	[p8l1306t1864r1618b1931],

1	The	DT	O	the	det	3	SENT_107	[p8l1652t1864r1792b1931],
2	R/S	NN	O	r/s	nn	3	SENT_107	[p8l1817t1864r1952b1931],
3	ratio	NN	O	ratio	nsubj	13	SENT_107	[p8l1974t1864r2139b1931],
4	in	IN	O	in	_	0	SENT_107	[p8l10t1974r79b2040],
5	the	DT	O	the	det	6	SENT_107	[p8l113t1974r223b2041],
6	AUC	NN	O	auc	prep_in	3	SENT_107	[p8l260t1976r452b2041],
7	and	CC	O	and	_	0	SENT_107	[p8l491t1974r624b2041],
8	the	DT	O	the	det	9	SENT_107	[p8l657t1974r768b2041],
9	Cmax	NN	MISC	cmax	prep_in	3	SENT_107	[p8l806t1976r985b2056],
10	of	IN	O	of	_	0	SENT_107	[p8l1021t1974r1106b2041],
11	sibutramine	NN	O	sibutramine	prep_of	9	SENT_107	[p8l1133t1974r1563b2041],
12	were	VBD	O	be	cop	13	SENT_107	[p8l1599t1996r1775b2041],
13	2.52	CD	NUMBER	2.52	_	0	SENT_107	[p8l1812t1976r1970b2041],
14	and	CC	O	and	_	0	SENT_107	[p8l2010t1974r2142b2041],
15	2.00	CD	NUMBER	2.00	conj_and	13	SENT_107	[p8l9t2088r190b2166],
16	,	,	O	,	_	0	SENT_107	[p8l9t2088r190b2166],
17	respectively	RB	O	respectively	advmod	13	SENT_107	[p8l211t2086r676b2171],
18	.	.	O	.	_	0	SENT_107	[p8l211t2086r676b2171],

1	In	IN	O	in	_	0	SENT_108	[p8l700t2089r776b2151],
2	contrast	NN	O	contrast	prep_in	7	SENT_108	[p8l795t2095r1103b2167],
3	,	,	O	,	_	0	SENT_108	[p8l795t2095r1103b2167],
4	M1	NN	O	m1	nsubj	7	SENT_108	[p8l1126t2087r1243b2151],
5	did	VBD	O	do	aux	7	SENT_108	[p8l1273t2086r1390b2152],
6	not	RB	O	not	neg	7	SENT_108	[p8l1407t2095r1526b2152],
7	show	VB	O	show	_	0	SENT_108	[p8l1546t2086r1739b2152],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_108	[p8l1760t2086r2142b2171],
9	differences	NNS	O	difference	dobj	7	SENT_108	[p8l10t2198r415b2265],
10	between	IN	O	between	_	0	SENT_108	[p8l442t2198r752b2265],
11	the	DT	O	the	det	12	SENT_108	[p8l777t2198r887b2265],
12	enantiomers	NNS	O	enantiomer	prep_between	9	SENT_108	[p8l917t2198r1386b2279],
13	,	,	O	,	_	0	SENT_108	[p8l917t2198r1386b2279],
14	with	IN	O	with	_	0	SENT_108	[p8l1416t2198r1580b2265],
15	an	DT	O	a	det	17	SENT_108	[p8l1608t2220r1693b2265],
16	R/S	NN	O	r/s	nn	17	SENT_108	[p8l1716t2198r1851b2265],
17	ratio	NN	O	ratio	prep_with	7	SENT_108	[p8l1872t2198r2037b2265],
18	of	IN	O	of	_	0	SENT_108	[p8l2068t2198r2153b2265],
19	1.12	CD	NUMBER	1.12	prep_of	17	SENT_108	[p8l18t2310r167b2376],
20	and	CC	O	and	_	0	SENT_108	[p8l190t2308r323b2376],
21	1.25	CD	NUMBER	1.25	prep_of	17	SENT_108	[p8l349t2310r496b2376],
22	in	IN	O	in	_	0	SENT_108	[p8l520t2308r590b2375],
23	the	DT	O	the	det	24	SENT_108	[p8l607t2308r717b2376],
24	AUC	NN	O	auc	prep_in	17	SENT_108	[p8l736t2310r929b2376],
25	and	CC	O	and	_	0	SENT_108	[p8l952t2308r1084b2376],
26	Cmax	NN	O	cmax	prep_in	17	SENT_108	[p8l1103t2310r1301b2391],
27	,	,	O	,	_	0	SENT_108	[p8l1103t2310r1301b2391],
28	respectively	RB	O	respectively	advmod	24	SENT_108	[p8l1322t2308r1768b2395],
29	(	CD	NUMBER	(	num	30	SENT_108	[p8l1788t2308r2023b2394],
30	Table	NNP	O	Table	dep	24	SENT_108	[p8l1788t2308r2023b2394],
31	1	CD	NUMBER	1	number	32	SENT_108	[p8l2053t2309r2136b2394],
32	)	CD	NUMBER	)	dep	30	SENT_108	[p8l2053t2309r2136b2394],
33	.	.	O	.	_	0	SENT_108	[p8l2053t2309r2136b2394],

1	No	DT	O	no	det	2	SENT_109	[p8l6t2424r118b2487],
2	difference	NN	O	difference	nsubjpass	4	SENT_109	[p8l150t2421r518b2487],
3	was	VBD	O	be	auxpass	4	SENT_109	[p8l546t2442r688b2487],
4	noted	VBN	O	note	_	0	SENT_109	[p8l716t2421r923b2487],
5	in	IN	O	in	_	0	SENT_109	[p8l951t2421r1021b2486],
6	the	DT	O	the	det	8	SENT_109	[p8l1046t2421r1157b2487],
7	elimination	NN	O	elimination	nn	8	SENT_109	[p8l1188t2421r1606b2487],
8	half-life	NN	O	half-life	prep_in	4	SENT_109	[p8l1632t2421r1925b2487],
9	of	IN	O	of	_	0	SENT_109	[p8l1955t2421r2041b2487],
10	Ror	NNP	O	Ror	nn	11	SENT_109	[p8l2053t2424r2140b2486, p8l10t2554r86b2599],
11	S-M1	NN	O	s-m1	prep_of	8	SENT_109	[p8l117t2534r340b2599],
12	.	.	O	.	_	0	SENT_109	[p8l117t2534r340b2599],

1	In	IN	O	in	_	0	SENT_110	[p8l381t2535r456b2597],
2	the	DT	O	the	det	3	SENT_110	[p8l489t2532r599b2599],
3	case	NN	O	case	prep_in	11	SENT_110	[p8l636t2554r790b2599],
4	of	IN	O	of	_	0	SENT_110	[p8l827t2532r912b2599],
5	M2	NN	O	m2	prep_of	3	SENT_110	[p8l935t2534r1082b2613],
6	,	,	O	,	_	0	SENT_110	[p8l935t2534r1082b2613],
7	only	RB	O	only	advmod	9	SENT_110	[p8l1122t2532r1284b2617],
8	the	DT	O	the	det	9	SENT_110	[p8l1317t2532r1428b2599],
9	R-enantiomer	NN	MISC	r-enantiomer	nsubjpass	11	SENT_110	[p8l1459t2532r1967b2599],
10	was	VBD	O	be	auxpass	11	SENT_110	[p8l1998t2554r2140b2599],
11	detected	VBN	O	detect	_	0	SENT_110	[p8l10t2643r334b2724],
12	,	,	O	,	_	0	SENT_110	[p8l10t2643r334b2724],
13	with	IN	O	with	_	0	SENT_110	[p8l383t2643r548b2711],
14	no	DT	O	no	det	15	SENT_110	[p8l592t2665r682b2711],
15	S-enantiomer	NN	O	s-enantiomer	prep_with	11	SENT_110	[p8l730t2643r1224b2711],
16	of	IN	O	of	_	0	SENT_110	[p8l1269t2643r1354b2711],
17	M2	NN	O	m2	prep_of	15	SENT_110	[p8l1389t2645r1513b2709],
18	detected	VBN	O	detect	partmod	17	SENT_110	[p8l1564t2643r1869b2711],
19	in	IN	O	in	_	0	SENT_110	[p8l1915t2643r1985b2709],
20	the	DT	O	the	det	21	SENT_110	[p8l2029t2643r2140b2710],
21	plasma	NN	O	plasma	prep_in	18	SENT_110	[p8l7t2755r270b2840],
22	throughout	IN	O	throughout	_	0	SENT_110	[p8l298t2755r707b2840],
23	the	DT	O	the	det	26	SENT_110	[p8l735t2755r847b2821],
24	entire	JJ	O	entire	amod	26	SENT_110	[p8l880t2755r1084b2821],
25	time	NN	O	time	nn	26	SENT_110	[p8l1115t2755r1276b2821],
26	period	NN	O	period	prep_throughout	21	SENT_110	[p8l1306t2755r1560b2840],
27	.	.	O	.	_	0	SENT_110	[p8l1306t2755r1560b2840],

1	Effects	NNS	O	effect	nsubj	12	SENT_111	[p8l14t2980r249b3046],
2	of	IN	O	of	_	0	SENT_111	[p8l283t2980r358b3046],
3	Clopidogrel	NNP	O	Clopidogrel	prep_of	1	SENT_111	[p8l386t2980r817b3067],
4	and	CC	O	and	_	0	SENT_111	[p8l854t2980r980b3046],
5	Clarithromycin	NNP	O	Clarithromycin	conj_and	3	SENT_111	[p8l1017t2980r1576b3068],
6	on	IN	O	on	_	0	SENT_111	[p8l1614t3001r1702b3046],
7	the	DT	O	the	det	8	SENT_111	[p8l1736t2980r1855b3046],
8	Pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_111	[p8l14t3092r659b3157],
9	of	IN	O	of	_	0	SENT_111	[p8l693t3091r769b3157],
10	Sibutramine	NNP	O	Sibutramine	prep_of	8	SENT_111	[p8l796t3091r1236b3157],
11	We	PRP	O	we	nsubj	12	SENT_111	[p8l8t3205r134b3269],
12	evaluated	VBD	O	evaluate	_	0	SENT_111	[p8l155t3202r508b3269],
13	the	DT	O	the	det	14	SENT_111	[p8l524t3202r635b3269],
14	effects	NNS	O	effect	dobj	12	SENT_111	[p8l656t3202r895b3269],
15	of	IN	O	of	_	0	SENT_111	[p8l917t3202r1002b3269],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_111	[p8l1011t3202r1429b3287],
17	and	CC	O	and	_	0	SENT_111	[p8l1449t3202r1581b3269],
18	clarithromycin	NN	O	clarithromycin	prep_of	14	SENT_111	[p8l1600t3202r2141b3287],
19	on	IN	O	on	_	0	SENT_111	[p8l10t3334r101b3379],
20	the	DT	O	the	det	21	SENT_111	[p8l135t3312r246b3379],
21	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	12	SENT_111	[p8l280t3312r933b3397],
22	of	IN	O	of	_	0	SENT_111	[p8l971t3312r1056b3379],
23	sibutramine	NN	O	sibutramine	prep_of	21	SENT_111	[p8l1084t3312r1514b3379],
24	and	CC	O	and	_	0	SENT_111	[p8l1553t3312r1685b3379],
25	its	PRP$	O	its	poss	26	SENT_111	[p8l1720t3312r1802b3379],
26	metabolites	NNS	O	metabolite	prep_of	21	SENT_111	[p8l1839t3312r2139b3379, p8l10t3424r177b3490],
27	.	.	O	.	_	0	SENT_111	[p8l1839t3312r2139b3379, p8l10t3424r177b3490],

1	The	DT	O	the	det	3	SENT_112	[p8l239t3424r379b3490],
2	plasma	NN	O	plasma	nn	3	SENT_112	[p8l433t3424r697b3509],
3	concentrations	NNS	O	concentration	nsubj	8	SENT_112	[p8l752t3424r1288b3490],
4	of	IN	O	of	_	0	SENT_112	[p8l1345t3424r1431b3490],
5	sibutramine	NN	O	sibutramine	prep_of	3	SENT_112	[p8l1477t3424r1907b3490],
6	were	VBD	O	be	cop	8	SENT_112	[p8l1963t3445r2140b3490],
7	consistently	RB	O	consistently	advmod	8	SENT_112	[p8l10t3535r451b3620],
8	higher	JJR	O	higher	dep	24	SENT_112	[p8l479t3535r717b3620],
9	in	IN	O	in	_	0	SENT_112	[p8l746t3535r816b3600],
10	the	DT	O	the	det	14	SENT_112	[p8l844t3535r954b3602],
11	clopidogrel	NN	O	clopidogrel	nn	14	SENT_112	[p8l988t3535r1405b3620],
12	and	CC	O	and	_	0	SENT_112	[p8l1438t3535r1570b3602],
13	clarithromycin	NN	O	clarithromycin	conj_and	11	SENT_112	[p8l1600t3535r2141b3620],
14	phases	NNS	O	phase	prep_in	8	SENT_112	[p8l7t3645r252b3730],
15	compared	VBN	O	compare	_	0	SENT_112	[p8l285t3645r649b3730],
16	with	IN	O	with	prepc_compared_with	8	SENT_112	[p8l675t3645r839b3712],
17	the	DT	O	the	det	19	SENT_112	[p8l866t3645r977b3712],
18	control	NN	O	control	nn	19	SENT_112	[p8l1008t3645r1267b3712],
19	phase	NN	O	phase	pobj	8	SENT_112	[p8l1293t3645r1525b3730],
20	,	,	O	,	_	0	SENT_112	[p8l1293t3645r1525b3730],
21	but	CC	O	but	prep	8	SENT_112	[p8l1556t3645r1676b3712],
22	their	PRP$	O	they	poss	23	SENT_112	[p8l1702t3645r1872b3712],
23	effects	NNS	O	effect	dep	21	SENT_112	[p8l1900t3645r2139b3712],
24	differed	VBD	O	differ	_	0	SENT_112	[p9l10t20r299b86],
25	between	IN	O	between	_	0	SENT_112	[p9l325t20r634b86],
26	enantiomers	NNS	O	enantiomer	prep_between	24	SENT_112	[p9l663t20r1111b86],
27	(	CD	NUMBER	(	num	30	SENT_112	[p9l1143t20r1409b105],
28	Figure	NN	O	figure	nn	30	SENT_112	[p9l1143t20r1409b105],
29	2	CD	NUMBER	2	num	30	SENT_112	[p9l1439t20r1531b105],
30	)	NN	O	)	nsubj	24	SENT_112	[p9l1439t20r1531b105],
31	.	.	O	.	_	0	SENT_112	[p9l1439t20r1531b105],

1	Compared	VBN	O	compare	_	0	SENT_113	[p9l1567t20r1952b105],
2	with	IN	O	with	_	0	SENT_113	[p9l1978t20r2142b86],
3	the	DT	O	the	det	4	SENT_113	[p9l8t131r119b198],
4	results	NNS	O	result	prep_with	1	SENT_113	[p9l163t131r402b198],
5	following	VBG	O	follow	_	0	SENT_113	[p9l451t131r806b216],
6	the	DT	O	the	det	7	SENT_113	[p9l852t131r962b198],
7	administration	NN	O	administration	prep_following	4	SENT_113	[p9l1010t131r1541b198],
8	of	IN	O	of	_	0	SENT_113	[p9l1588t131r1672b198],
9	sibutramine	NN	O	sibutramine	prep_of	7	SENT_113	[p9l1709t131r2140b198],
10	alone	RB	O	alone	advmod	9	SENT_113	[p9l10t241r227b322],
11	,	,	O	,	_	0	SENT_113	[p9l10t241r227b322],
12	the	DT	O	the	det	13	SENT_113	[p9l255t241r366b308],
13	AUCs	NNS	O	auc	appos	9	SENT_113	[p9l391t243r621b308],
14	of	IN	O	of	_	0	SENT_113	[p9l649t241r734b308],
15	S-sibutramine	NN	O	s-sibutramine	prep_of	13	SENT_113	[p9l746t241r1258b308],
16	were	VBD	O	be	cop	18	SENT_113	[p9l1284t263r1461b308],
17	122	CD	PERCENT	122	num	18	SENT_113	[p9l1497t243r1702b308],
18	%	NN	PERCENT	%	auxpass	1	SENT_113	[p9l1497t243r1702b308],
19	(	CD	NUMBER	(	num	20	SENT_113	[p9l1729t242r1814b326],
20	P	NN	O	p	npadvmod	21	SENT_113	[p9l1729t242r1814b326],
21	<	JJR	O	<	amod	18	SENT_113	[p9l1852t255r1909b310],
22	.001	CD	NUMBER	.001	num	23	SENT_113	[p9l1954t242r2139b326],
23	)	NN	O	)	nsubjpass	1	SENT_113	[p9l1954t242r2139b326],

1	and	CC	O	and	cc	2	SENT_114	[p9l10t353r142b419],
2	309	CD	PERCENT	309	num	3	SENT_114	[p9l198t354r410b420],
3	%	NN	PERCENT	%	_	0	SENT_114	[p9l198t354r410b420],
4	(	CD	NUMBER	(	num	5	SENT_114	[p9l467t353r552b438],
5	P	NN	O	p	npadvmod	6	SENT_114	[p9l467t353r552b438],
6	<	JJR	O	<	amod	3	SENT_114	[p9l589t367r647b422],
7	.001	CD	NUMBER	.001	number	8	SENT_114	[p9l691t353r877b438],
8	)	CD	NUMBER	)	npadvmod	9	SENT_114	[p9l691t353r877b438],
9	higher	JJR	O	higher	amod	3	SENT_114	[p9l932t353r1187b438],
10	,	,	O	,	_	0	SENT_114	[p9l932t353r1187b438],
11	in	IN	O	in	_	0	SENT_114	[p9l1246t353r1316b418],
12	the	DT	O	the	det	16	SENT_114	[p9l1368t353r1479b419],
13	clopidogrel	NN	O	clopidogrel	nn	16	SENT_114	[p9l1536t353r1954b438],
14	and	CC	O	and	_	0	SENT_114	[p9l2010t353r2142b419],
15	clarithromycin	NN	O	clarithromycin	nn	16	SENT_114	[p9l10t464r552b549],
16	phases	NNS	O	phase	prep_in	3	SENT_114	[p9l584t464r852b549],
17	,	,	O	,	_	0	SENT_114	[p9l584t464r852b549],
18	respectively	RB	O	respectively	advmod	16	SENT_114	[p9l890t464r1336b549],
19	(	CD	NUMBER	(	num	20	SENT_114	[p9l1373t464r1609b549],
20	Table	NNP	O	Table	dep	16	SENT_114	[p9l1373t464r1609b549],
21	1	CD	NUMBER	1	number	22	SENT_114	[p9l1655t465r1738b549],
22	)	CD	NUMBER	)	dep	20	SENT_114	[p9l1655t465r1738b549],
23	.	.	O	.	_	0	SENT_114	[p9l1655t465r1738b549],

1	However	RB	O	however	advmod	12	SENT_115	[p9l1780t467r2137b545],
2	,	,	O	,	_	0	SENT_115	[p9l1780t467r2137b545],
3	the	DT	O	the	det	4	SENT_115	[p9l8t574r118b641],
4	increases	NNS	O	increase	nsubj	12	SENT_115	[p9l167t574r500b641],
5	in	IN	O	in	_	0	SENT_115	[p9l549t574r618b640],
6	the	DT	O	the	det	7	SENT_115	[p9l663t574r773b641],
7	AUC	NN	O	auc	prep_in	4	SENT_115	[p9l819t576r1013b641],
8	of	IN	O	of	_	0	SENT_115	[p9l1063t574r1148b641],
9	R-sibutramine	NN	O	r-sibutramine	prep_of	7	SENT_115	[p9l1178t574r1702b641],
10	were	VBD	O	be	cop	12	SENT_115	[p9l1749t596r1925b641],
11	82	CD	PERCENT	82	num	12	SENT_115	[p9l1976t576r2140b641],
12	%	NN	PERCENT	%	_	0	SENT_115	[p9l1976t576r2140b641],

1	(	NN	O	(	nn	2	SENT_116	[p9l11t686r96b771],
2	P	NN	O	p	_	0	SENT_116	[p9l11t686r96b771],
3	<	JJR	O	<	dep	2	SENT_116	[p9l133t700r191b755],
4	.001	CD	NUMBER	.001	num	5	SENT_116	[p9l235t686r421b771],
5	)	NN	O	)	dep	3	SENT_116	[p9l235t686r421b771],
6	and	CC	O	and	_	0	SENT_116	[p9l465t686r597b752],
7	101	CD	PERCENT	101	num	8	SENT_116	[p9l646t687r851b752],
8	%	NN	PERCENT	%	dep	2	SENT_116	[p9l646t687r851b752],
9	(	CD	NUMBER	(	num	10	SENT_116	[p9l896t686r980b771],
10	P	NN	O	p	npadvmod	11	SENT_116	[p9l896t686r980b771],
11	<	JJR	O	<	amod	8	SENT_116	[p9l1018t700r1076b755],
12	.001	CD	NUMBER	.001	num	13	SENT_116	[p9l1120t686r1305b771],
13	)	NN	O	)	dep	2	SENT_116	[p9l1120t686r1305b771],
14	in	IN	O	in	_	0	SENT_116	[p9l1349t686r1419b751],
15	the	DT	O	the	det	17	SENT_116	[p9l1458t686r1569b752],
16	corresponding	JJ	O	corresponding	amod	17	SENT_116	[p9l1613t686r2140b771],
17	phases	NNS	O	phase	prep_in	13	SENT_116	[p9l7t797r272b882],
18	.	.	O	.	_	0	SENT_116	[p9l7t797r272b882],

1	The	DT	O	the	det	3	SENT_117	[p9l306t797r446b864],
2	Cmax	NNP	O	Cmax	nn	3	SENT_117	[p9l477t799r655b879],
3	Values	NNS	O	value	nsubj	9	SENT_117	[p9l682t797r916b864],
4	of	IN	O	of	_	0	SENT_117	[p9l946t797r1031b864],
5	R	NN	O	r	prep_of	3	SENT_117	[p9l1043t800r1130b862],
6	-	:	O	-	_	0	SENT_117	[p9l1043t800r1130b862],
7	and	CC	O	and	_	0	SENT_117	[p9l1161t797r1293b864],
8	S-sibutramine	NN	O	s-sibutramine	prep_of	3	SENT_117	[p9l1318t797r1829b864],
9	showed	VBD	O	show	_	0	SENT_117	[p9l1862t797r2142b864],
10	similar	JJ	O	similar	amod	11	SENT_117	[p9l12t907r264b975],
11	proﬁles	NNS	O	proﬁles	dobj	9	SENT_117	[p9l283t907r560b993],
12	in	IN	O	in	_	0	SENT_117	[p9l586t907r655b974],
13	both	CC	O	both	preconj	15	SENT_117	[p9l676t907r842b975],
14	the	DT	O	the	det	15	SENT_117	[p9l864t907r975b975],
15	clopidogrel	NN	O	clopidogrel	prep_in	9	SENT_117	[p9l1001t907r1419b994],
16	and	CC	O	and	_	0	SENT_117	[p9l1444t907r1577b975],
17	clarithromycin	NN	O	clarithromycin	nn	18	SENT_117	[p9l1600t907r2141b994],
18	phases	NNS	O	phase	prep_in	9	SENT_117	[p9l7t1020r274b1105],
19	,	,	O	,	_	0	SENT_117	[p9l7t1020r274b1105],
20	although	IN	O	although	mark	25	SENT_117	[p9l321t1020r644b1105],
21	the	DT	O	the	det	22	SENT_117	[p9l684t1020r795b1086],
22	fold-increase	NN	O	fold-increase	nsubj	25	SENT_117	[p9l840t1020r1317b1086],
23	was	VBD	O	be	cop	25	SENT_117	[p9l1359t1041r1501b1086],
24	relatively	RB	O	relatively	advmod	25	SENT_117	[p9l1543t1020r1891b1105],
25	lower	JJR	O	lower	advcl	9	SENT_117	[p9l1934t1020r2144b1086],
26	than	IN	O	than	_	0	SENT_117	[p9l8t1131r167b1198],
27	the	DT	O	the	det	29	SENT_117	[p9l198t1131r309b1198],
28	corresponding	JJ	O	corresponding	amod	29	SENT_117	[p9l344t1131r872b1216],
29	changes	NNS	O	change	prep_than	25	SENT_117	[p9l906t1131r1201b1216],
30	in	IN	O	in	_	0	SENT_117	[p9l1236t1131r1306b1196],
31	the	DT	O	the	det	33	SENT_117	[p9l1336t1131r1447b1198],
32	AUC	NN	O	auc	nn	33	SENT_117	[p9l1480t1133r1673b1198],
33	Values	NNS	O	value	prep_in	29	SENT_117	[p9l1708t1131r1961b1198],
34	.	.	O	.	_	0	SENT_117	[p9l1708t1131r1961b1198],

1	The	DT	O	the	det	2	SENT_118	[p9l2000t1131r2140b1198],
2	pretreatment	NN	O	pretreatment	nsubj	11	SENT_118	[p9l7t1251r475b1327],
3	of	IN	O	of	_	0	SENT_118	[p9l526t1241r611b1309],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_118	[p9l652t1241r1070b1328],
5	or	CC	O	or	_	0	SENT_118	[p9l1124t1263r1200b1309],
6	clarithromycin	NN	O	clarithromycin	prep_of	2	SENT_118	[p9l1250t1241r1791b1328],
7	prior	RB	O	prior	_	0	SENT_118	[p9l1841t1241r2023b1327],
8	to	TO	O	to	_	0	SENT_118	[p9l2071t1251r2139b1309],
9	sibutramine	NN	O	sibutramine	prep_prior_to	2	SENT_118	[p9l12t1354r443b1420],
10	also	RB	O	also	advmod	11	SENT_118	[p9l472t1354r615b1420],
11	affected	VBD	O	affect	_	0	SENT_118	[p9l646t1354r939b1420],
12	the	DT	O	the	det	14	SENT_118	[p9l964t1354r1075b1420],
13	plasma	NN	O	plasma	nn	14	SENT_118	[p9l1101t1354r1364b1439],
14	concentrations	NNS	O	concentration	dobj	11	SENT_118	[p9l1391t1354r1926b1420],
15	of	IN	O	of	_	0	SENT_118	[p9l1956t1354r2042b1420],
16	Rand	NNP	O	Rand	nn	17	SENT_118	[p9l2053t1357r2140b1419, p9l10t1465r142b1532],
17	S-M1	NN	O	s-m1	prep_of	14	SENT_118	[p9l176t1467r401b1546],
18	,	,	O	,	_	0	SENT_118	[p9l176t1467r401b1546],
19	but	CC	O	but	_	0	SENT_118	[p9l439t1465r559b1532],
20	the	DT	O	the	det	21	SENT_118	[p9l592t1465r703b1532],
21	effects	NNS	O	effect	nsubj	22	SENT_118	[p9l741t1465r980b1532],
22	differed	VBD	O	differ	conj_but	11	SENT_118	[p9l1020t1465r1308b1532],
23	when	WRB	O	when	advmod	24	SENT_118	[p9l1343t1465r1544b1532],
24	compared	VBN	O	compare	advcl	22	SENT_118	[p9l1580t1465r1944b1550],
25	with	IN	O	with	_	0	SENT_118	[p9l1978t1465r2142b1532],
26	those	DT	O	those	prep_with	24	SENT_118	[p9l8t1575r201b1643],
27	of	IN	O	of	_	0	SENT_118	[p9l255t1575r340b1643],
28	R	NN	O	r	prep_of	26	SENT_118	[p9l376t1578r462b1642],
29	-	:	O	-	_	0	SENT_118	[p9l376t1578r462b1642],
30	and	CC	O	and	_	0	SENT_118	[p9l516t1575r649b1643],
31	S-sibutramine	NN	O	s-sibutramine	nn	33	SENT_118	[p9l697t1575r1208b1643],
32	(	CD	NUMBER	(	num	33	SENT_118	[p9l1263t1575r1498b1661],
33	Table	NNP	O	Table	conj_and	26	SENT_118	[p9l1263t1575r1498b1661],
34	1	CD	NUMBER	1	number	35	SENT_118	[p9l1560t1576r1643b1661],
35	)	CD	NUMBER	)	dep	33	SENT_118	[p9l1560t1576r1643b1661],
36	.	.	O	.	_	0	SENT_118	[p9l1560t1576r1643b1661],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	2	SENT_119	[p9l1701t1575r2141b1662],
2	increased	VBD	O	increase	_	0	SENT_119	[p9l9t1688r357b1754],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	2	SENT_119	[p9l386t1688r840b1773],
4	the	DT	O	the	det	5	SENT_119	[p9l865t1688r976b1754],
5	AUC	NN	O	auc	dobj	2	SENT_119	[p9l1004t1689r1197b1754],
6	of	IN	O	of	_	0	SENT_119	[p9l1228t1688r1313b1754],
7	S	NN	O	s	prep_of	5	SENT_119	[p9l1327t1689r1401b1754],
8	-	:	O	-	_	0	SENT_119	[p9l1327t1689r1401b1754],
9	and	CC	O	and	_	0	SENT_119	[p9l1432t1688r1564b1754],
10	R-M1	NN	O	r-m1	prep_of	5	SENT_119	[p9l1585t1690r1824b1768],
11	,	,	O	,	_	0	SENT_119	[p9l1585t1690r1824b1768],
12	by	IN	O	by	_	0	SENT_119	[p9l1853t1688r1946b1773],
13	86	CD	PERCENT	86	num	14	SENT_119	[p9l1976t1689r2140b1754],
14	%	NN	PERCENT	%	prep_by	2	SENT_119	[p9l1976t1689r2140b1754],

1	Shinde	NNP	O	Shinde	_	0	SENT_120	[p9l97t1851r187b1878],
2	et	FW	O	et	nn	3	SENT_120	[p9l202t1857r228b1878],
3	al	FW	O	al	dep	1	SENT_120	[p9l241t1851r265b1878],
4	553	CD	NUMBER	553	dep	1	SENT_120	[p9l2003t1848r2060b1878],

1	E	NN	O	e	nn	2	SENT_121	[p9l193t2244r246b2322],
2	U	NN	O	u	_	0	SENT_121	[p9l206t2327r259b2364],
3	:	:	O	:	_	0	SENT_121	[p9l206t2327r259b2364],
4	E.	NNP	O	E.	dep	2	SENT_121	[p9l193t2368r258b2427],
5	:	:	O	:	_	0	SENT_121	[p9l206t2453r245b2490],
6	.9	CD	NUMBER	.9	num	7	SENT_121	[p9l193t2495r246b2551],
7	E	NNP	O	E	dep	4	SENT_121	[p9l195t2554r245b2609],
8	&	CC	O	&	_	0	SENT_121	[p9l206t2612r245b2636],
9	3	CD	NUMBER	3	num	12	SENT_121	[p9l195t2644r245b2663],
10	c	NN	O	c	nn	12	SENT_121	[p9l206t2665r245b2702],
11	o	NN	O	o	nn	12	SENT_121	[p9l206t2706r245b2739],
12	o	NN	O	o	dep	4	SENT_121	[p9l206t2745r245b2778],
13	:	:	O	:	_	0	SENT_121	[p9l206t2783r245b2820],
14	o	NN	O	o	nn	15	SENT_121	[p9l206t2828r245b2863],
15	o	NN	O	o	dep	2	SENT_121	[p9l206t2869r245b2901],
16	as	IN	O	as	dep	2	SENT_121	[p9l206t2923r246b2958],
17	E	NN	O	e	nn	19	SENT_121	[p9l206t2963r245b3018],
18	(	NN	O	(	nn	19	SENT_121	[p9l206t3023r246b3056],
19	D	NN	O	d	pobj	16	SENT_121	[p9l206t3023r246b3056],
20	2	CD	NUMBER	2	dep	19	SENT_121	[p9l193t3059r246b3113],
21	a.	IN	O	a.	dep	2	SENT_121	[p9l193t3115r246b3155],

1	Figure	NNP	O	Figure	nn	2	SENT_122	[p9l14t3568r230b3637],
2	I.	NNP	O	I.	_	0	SENT_122	[p9l303t3568r346b3621],
3	Mean	NN	O	mean	nn	5	SENT_122	[p9l392t3568r543b3621],
4	plasma	NN	O	plasma	nn	5	SENT_122	[p9l609t3568r807b3638],
5	concentrations	NNS	O	concentration	dep	10	SENT_122	[p9l868t3572r1310b3621],
6	of	IN	O	of	_	0	SENT_122	[p9l1372t3568r1433b3621],
7	R-enantiomers	NNS	O	r-enantiomer	prep_of	5	SENT_122	[p9l1490t3568r1921b3621],
8	(	CD	NUMBER	(	dep	10	SENT_122	[p9l1985t3568r2140b3638],
9	solid	JJ	O	solid	amod	10	SENT_122	[p9l1985t3568r2140b3638],
10	symbols	NNS	O	symbol	dep	17	SENT_122	[p9l11t3662r269b3733],
11	)	NN	O	)	dep	10	SENT_122	[p9l11t3662r269b3733],
12	and	CC	O	and	_	0	SENT_122	[p9l305t3663r405b3715],
13	S-enantiomers	NNS	O	s-enantiomer	conj_and	10	SENT_122	[p9l442t3663r865b3715],
14	(	RB	O	(	advmod	15	SENT_122	[p9l901t3662r1068b3732],
15	open	JJ	O	open	amod	16	SENT_122	[p9l901t3662r1068b3732],
16	symbols	NNS	O	symbol	dep	13	SENT_122	[p9l1103t3662r1361b3733],
17	)	NN	O	)	dep	2	SENT_122	[p9l1103t3662r1361b3733],
18	of	IN	O	of	_	0	SENT_122	[p9l1398t3662r1458b3715],
19	sibutramine	NN	O	sibutramine	nn	21	SENT_122	[p9l1486t3663r1832b3715],
20	(	CD	NUMBER	(	num	21	SENT_122	[p9l1867t3662r2016b3732],
21	o	NN	O	o	prep_of	17	SENT_122	[p9l1867t3662r2016b3732],
22	;	:	O	;	_	0	SENT_122	[p9l1867t3662r2016b3732],
23	o	NN	O	o	nn	24	SENT_122	[p9l1867t3662r2016b3732],
24	)	NN	O	)	dep	2	SENT_122	[p9l1867t3662r2016b3732],
25	,	,	O	,	_	0	SENT_122	[p9l1867t3662r2016b3732],
26	MI	NNP	O	MI	appos	24	SENT_122	[p9l2054t3662r2129b3715],

1	(	NN	O	(	nn	2	SENT_123	[p10l13t18r222b88],
2	V	NN	O	v	_	0	SENT_123	[p10l13t18r222b88],
3	;	:	O	;	_	0	SENT_123	[p10l13t18r222b88],
4	EI	NN	O	eus	dep	2	SENT_123	[p10l13t18r222b88],
5	)	NN	O	)	dep	4	SENT_123	[p10l13t18r222b88],
6	,	,	O	,	_	0	SENT_123	[p10l13t18r222b88],
7	and	CC	O	and	_	0	SENT_123	[p10l258t19r359b72],
8	M2	NN	O	m2	dep	2	SENT_123	[p10l398t19r486b71],
9	(	CD	NUMBER	(	num	8	SENT_123	[p10l524t18r638b88],
10	I	PRP	O	I	nsubj	11	SENT_123	[p10l524t18r638b88],
11	)	VBP	O	)	rcmod	8	SENT_123	[p10l524t18r638b88],
12	following	VBG	O	follow	_	0	SENT_123	[p10l674t18r946b88],
13	the	DT	O	the	det	14	SENT_123	[p10l976t19r1071b72],
14	administration	NN	O	administration	prep_following	11	SENT_123	[p10l1106t19r1527b72],
15	of	IN	O	of	_	0	SENT_123	[p10l1565t18r1626b72],
16	a	DT	O	a	det	18	SENT_123	[p10l1655t36r1685b72],
17	single	JJ	O	single	amod	18	SENT_123	[p10l1719t19r1879b88],
18	dose	NN	O	dose	prep_of	14	SENT_123	[p10l1915t19r2052b72],
19	of	IN	O	of	_	0	SENT_123	[p10l2086t18r2147b72],
20	racemic	JJ	O	racemic	amod	21	SENT_123	[p10l14t116r242b165],
21	sibutramine	NN	O	sibutramine	prep_of	18	SENT_123	[p10l261t113r607b165],
22	in	IN	O	in	_	0	SENT_123	[p10l627t116r673b165],
23	I7	NN	O	i7	nn	25	SENT_123	[p10l707t112r766b165],
24	healthy	JJ	O	healthy	amod	25	SENT_123	[p10l786t113r996b183],
25	subjects	NNS	O	subject	prep_in	21	SENT_123	[p10l1013t113r1262b181],
26	.	.	O	.	_	0	SENT_123	[p10l1013t113r1262b181],

1	S-M2	NN	O	s-m2	nsubjpass	4	SENT_124	[p10l1284t112r1431b165],
2	was	VBD	O	be	auxpass	4	SENT_124	[p10l1447t130r1559b165],
3	not	RB	O	not	neg	4	SENT_124	[p10l1579t124r1678b165],
4	detected	VBN	O	detect	_	0	SENT_124	[p10l1695t113r1950b165],
5	in	IN	O	in	_	0	SENT_124	[p10l1971t116r2017b165],
6	our	PRP$	O	we	poss	8	SENT_124	[p10l2038t130r2143b165],
7	analytical	JJ	O	analytical	amod	8	SENT_124	[p10l10t207r274b277],
8	system	NN	O	system	prep_in	4	SENT_124	[p10l303t218r519b277],
9	.	.	O	.	_	0	SENT_124	[p10l303t218r519b277],

1	(	NN	O	(	nn	2	SENT_125	[p10l12t446r97b531],
2	P	NN	O	p	dep	3	SENT_125	[p10l12t446r97b531],
3	<	JJR	O	<	nsubj	11	SENT_125	[p10l135t460r192b514],
4	.001	CD	NUMBER	.001	num	5	SENT_125	[p10l236t446r422b531],
5	)	NN	O	)	dep	3	SENT_125	[p10l236t446r422b531],
6	and	CC	O	and	_	0	SENT_125	[p10l483t446r615b512],
7	56	CD	PERCENT	56	num	8	SENT_125	[p10l674t447r839b512],
8	%	NN	PERCENT	%	conj_and	3	SENT_125	[p10l674t447r839b512],
9	(	CD	NUMBER	(	num	10	SENT_125	[p10l900t446r985b531],
10	P	NN	O	p	dep	8	SENT_125	[p10l900t446r985b531],
11	=	JJ	O	=	_	0	SENT_125	[p10l1019t476r1082b499],
12	.003	CD	NUMBER	.003	num	13	SENT_125	[p10l1125t446r1331b531],
13	)	NN	O	)	dobj	11	SENT_125	[p10l1125t446r1331b531],
14	,	,	O	,	_	0	SENT_125	[p10l1125t446r1331b531],
15	respectively	RB	O	respectively	advmod	13	SENT_125	[p10l1391t446r1857b531],
16	,	,	O	,	_	0	SENT_125	[p10l1391t446r1857b531],
17	whilst	IN	O	whilst	mark	19	SENT_125	[p10l1917t446r2144b512],
18	clarithromycin	NN	O	clarithromycin	nsubj	19	SENT_125	[p10l11t557r553b642],
19	did	VBD	O	do	dep	13	SENT_125	[p10l580t557r697b623],
20	not	RB	O	not	neg	22	SENT_125	[p10l720t566r840b623],
21	signiﬁcantly	JJ	O	signiﬁcantly	amod	22	SENT_125	[p10l868t557r1321b642],
22	increase	NN	O	increase	iobj	19	SENT_125	[p10l1348t557r1645b623],
23	the	DT	O	the	det	24	SENT_125	[p10l1672t557r1783b623],
24	AUCs	NNS	O	auc	dobj	19	SENT_125	[p10l1810t558r2040b623],
25	of	IN	O	of	_	0	SENT_125	[p10l2069t557r2153b623],
26	S	NN	O	s	prep_of	24	SENT_125	[p10l9t670r83b735],
27	-	:	O	-	_	0	SENT_125	[p10l9t670r83b735],
28	(	CD	PERCENT	(	num	31	SENT_125	[p10l142t668r338b753],
29	22	CD	PERCENT	22	number	30	SENT_125	[p10l142t668r338b753],
30	%	NN	PERCENT	%	amod	31	SENT_125	[p10l142t668r338b753],
31	increase	NN	O	increase	dep	24	SENT_125	[p10l395t668r714b749],
32	,	,	O	,	_	0	SENT_125	[p10l395t668r714b749],
33	P	NN	O	p	dep	24	SENT_125	[p10l770t671r830b733],
34	=	JJ	O	=	amod	33	SENT_125	[p10l865t698r927b721],
35	.10	CD	NUMBER	.10	number	36	SENT_125	[p10l970t669r1108b753],
36	)	CD	NUMBER	)	dep	34	SENT_125	[p10l970t669r1108b753],
37	or	CC	O	or	_	0	SENT_125	[p10l1166t690r1242b735],
38	R-Ml	NN	O	r-ml	dep	24	SENT_125	[p10l1291t670r1499b733],
39	(	CD	PERCENT	(	num	42	SENT_125	[p10l1567t669r1762b753],
40	23	CD	PERCENT	23	number	41	SENT_125	[p10l1567t669r1762b753],
41	%	NN	PERCENT	%	amod	42	SENT_125	[p10l1567t669r1762b753],
42	increase	NN	O	increase	dep	38	SENT_125	[p10l1819t668r2139b749],
43	,	,	O	,	_	0	SENT_125	[p10l1819t668r2139b749],
44	P	NN	O	p	dep	13	SENT_125	[p10l6t782r67b844],
45	=	JJ	O	=	amod	47	SENT_125	[p10l102t809r165b832],
46	.090	CD	NUMBER	.090	tmod	45	SENT_125	[p10l206t779r411b864],
47	)	NN	O	)	dep	44	SENT_125	[p10l206t779r411b864],
48	.	.	O	.	_	0	SENT_125	[p10l206t779r411b864],

1	The	DT	O	the	det	3	SENT_126	[p10l448t779r588b845],
2	Cmax	NN	MISC	cmax	nn	3	SENT_126	[p10l620t780r799b861],
3	values	NNS	O	value	nsubj	5	SENT_126	[p10l828t779r1062b845],
4	also	RB	O	also	advmod	5	SENT_126	[p10l1095t779r1239b845],
5	showed	VBD	O	show	_	0	SENT_126	[p10l1274t779r1554b845],
6	similar	JJ	O	similar	amod	7	SENT_126	[p10l1586t779r1839b845],
7	proﬁles	NNS	O	proﬁles	dobj	5	SENT_126	[p10l1864t779r2141b864],
8	in	IN	O	in	_	0	SENT_126	[p10l11t890r80b955],
9	the	DT	O	the	det	12	SENT_126	[p10l117t890r227b956],
10	two	CD	NUMBER	two	num	12	SENT_126	[p10l265t899r402b956],
11	pretreatment	NN	O	pretreatment	nn	12	SENT_126	[p10l439t899r907b975],
12	phases	NNS	O	phase	prep_in	5	SENT_126	[p10l941t890r1206b975],
13	.	.	O	.	_	0	SENT_126	[p10l941t890r1206b975],

1	Neither	DT	O	neither	det	2	SENT_127	[p10l1247t890r1527b956],
2	clopidogrel	NN	O	clopidogrel	nsubj	5	SENT_127	[p10l1564t890r1983b975],
3	nor	CC	O	nor	_	0	SENT_127	[p10l2019t911r2145b956],
4	clarithromycin	NN	O	clarithromycin	conj_nor	2	SENT_127	[p10l11t1001r553b1086],
5	altered	VBD	O	alter	_	0	SENT_127	[p10l581t1001r830b1068],
6	the	DT	O	the	det	8	SENT_127	[p10l855t1001r966b1068],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_127	[p10l992t1001r1608b1086],
8	parameters	NNS	O	parameter	dobj	5	SENT_127	[p10l1635t1011r2038b1086],
9	of	IN	O	of	_	0	SENT_127	[p10l2069t1001r2154b1068],
10	R-M2	NN	O	r-m2	prep_of	8	SENT_127	[p10l6t1113r242b1178],
11	.	.	O	.	_	0	SENT_127	[p10l6t1113r242b1178],

1	Differential	JJ	O	differential	amod	2	SENT_128	[p10l291t1112r716b1178],
2	effects	NNS	O	effect	nsubj	12	SENT_128	[p10l762t1112r1001b1178],
3	of	IN	O	of	_	0	SENT_128	[p10l1047t1112r1132b1178],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_128	[p10l1165t1112r1583b1197],
5	and	CC	O	and	_	0	SENT_128	[p10l1628t1112r1760b1178],
6	clarithromycin	NN	O	clarithromycin	prep_of	2	SENT_128	[p10l1803t1112r2141b1178, p10l9t1223r241b1308],
7	on	IN	O	on	_	0	SENT_128	[p10l287t1244r378b1289],
8	the	DT	O	the	det	10	SENT_128	[p10l422t1223r533b1289],
9	enantioselective	JJ	O	enantioselective	amod	10	SENT_128	[p10l581t1223r1171b1289],
10	disposition	NN	O	disposition	prep_on	4	SENT_128	[p10l1220t1223r1626b1308],
11	were	VBD	O	be	cop	12	SENT_128	[p10l1670t1244r1846b1289],
12	further	JJ	O	further	_	0	SENT_128	[p10l1896t1223r2144b1289],
13	conﬁrmed	VBN	O	conﬁrmed	partmod	12	SENT_128	[p10l10t1334r385b1400],
14	by	IN	O	by	_	0	SENT_128	[p10l409t1334r503b1419],
15	changes	NNS	O	change	agent	13	SENT_128	[p10l530t1334r824b1419],
16	in	IN	O	in	_	0	SENT_128	[p10l854t1334r924b1399],
17	the	DT	O	the	det	19	SENT_128	[p10l949t1334r1060b1400],
18	R/S	NN	O	r/s	nn	19	SENT_128	[p10l1084t1334r1219b1401],
19	ratio	NN	O	ratio	prep_in	15	SENT_128	[p10l1241t1334r1406b1400],
20	of	IN	O	of	_	0	SENT_128	[p10l1437t1334r1522b1400],
21	the	DT	O	the	det	23	SENT_128	[p10l1536t1334r1646b1400],
22	pharmacokinetic	JJ	O	pharmacokinetic	amod	23	SENT_128	[p10l1673t1334r2140b1419, p10l8t1445r184b1512],
23	parameters	NNS	O	parameter	prep_of	19	SENT_128	[p10l214t1455r636b1530],
24	.	.	O	.	_	0	SENT_128	[p10l214t1455r636b1530],

1	The	DT	O	the	det	3	SENT_129	[p10l674t1445r814b1512],
2	R/S	NN	O	r/s	nn	3	SENT_129	[p10l842t1445r977b1512],
3	ratios	NNS	O	ratio	nsubj	9	SENT_129	[p10l1001t1445r1203b1512],
4	of	IN	O	of	_	0	SENT_129	[p10l1236t1445r1322b1512],
5	the	DT	O	the	det	7	SENT_129	[p10l1339t1445r1450b1512],
6	sibutramine	NN	O	sibutramine	nn	7	SENT_129	[p10l1484t1445r1915b1512],
7	AUC	NN	O	auc	prep_of	3	SENT_129	[p10l1945t1447r2139b1512],
8	were	VBD	O	be	cop	9	SENT_129	[p10l8t1577r185b1623],
9	2.52	CD	NUMBER	2.52	_	0	SENT_129	[p10l215t1557r396b1637],
10	,	,	O	,	_	0	SENT_129	[p10l215t1557r396b1637],
11	2.03	CD	NUMBER	2.03	num	9	SENT_129	[p10l427t1557r608b1637],
12	,	,	O	,	_	0	SENT_129	[p10l427t1557r608b1637],
13	and	CC	O	and	_	0	SENT_129	[p10l642t1555r774b1623],
14	1.21	CD	NUMBER	1.21	conj_and	9	SENT_129	[p10l809t1557r951b1623],
15	in	IN	O	in	_	0	SENT_129	[p10l990t1555r1060b1622],
16	the	DT	O	the	det	17	SENT_129	[p10l1086t1555r1197b1623],
17	control	NN	O	control	prep_in	9	SENT_129	[p10l1227t1555r1505b1637],
18	,	,	O	,	_	0	SENT_129	[p10l1227t1555r1505b1637],
19	clopidogrel	NN	O	clopidogrel	prep_in	9	SENT_129	[p10l1539t1555r1977b1642],
20	,	,	O	,	_	0	SENT_129	[p10l1539t1555r1977b1642],
21	and	CC	O	and	_	0	SENT_129	[p10l2010t1555r2143b1623],
22	clarithromycin	NN	O	clarithromycin	nn	23	SENT_129	[p10l10t1668r552b1753],
23	phases	NNS	O	phase	prep_in	9	SENT_129	[p10l594t1668r861b1753],
24	,	,	O	,	_	0	SENT_129	[p10l594t1668r861b1753],
25	respectively	RB	O	respectively	advmod	17	SENT_129	[p10l909t1668r1355b1753],
26	(	CD	NUMBER	(	num	27	SENT_129	[p10l1402t1668r1638b1753],
27	Table	NNP	O	Table	dep	17	SENT_129	[p10l1402t1668r1638b1753],
28	1	CD	NUMBER	1	number	29	SENT_129	[p10l1693t1668r1777b1753],
29	)	CD	NUMBER	)	dep	27	SENT_129	[p10l1693t1668r1777b1753],
30	.	.	O	.	_	0	SENT_129	[p10l1693t1668r1777b1753],

1	The	DT	O	the	det	3	SENT_130	[p10l1828t1668r1968b1734],
2	R/S	NN	O	r/s	nn	3	SENT_130	[p10l2011t1668r2146b1734],
3	ratio	NN	O	ratio	nsubj	8	SENT_130	[p10l8t1779r173b1846],
4	of	IN	O	of	_	0	SENT_130	[p10l235t1779r320b1846],
5	the	DT	O	the	det	7	SENT_130	[p10l365t1779r476b1846],
6	M1	NN	O	m1	nn	7	SENT_130	[p10l535t1781r652b1844],
7	AUC	NN	O	auc	prep_of	3	SENT_130	[p10l720t1781r913b1846],
8	showed	VBD	O	show	_	0	SENT_130	[p10l976t1779r1257b1846],
9	no	DT	O	no	det	10	SENT_130	[p10l1313t1801r1404b1846],
10	change	NN	O	change	dobj	8	SENT_130	[p10l1465t1779r1723b1864],
11	following	VBG	O	follow	_	0	SENT_130	[p10l1784t1779r2141b1864],
12	pretreatment	NN	O	pretreatment	prep_following	10	SENT_130	[p10l7t1899r474b1975],
13	with	IN	O	with	_	0	SENT_130	[p10l502t1889r667b1957],
14	clopidogrel	NN	O	clopidogrel	prep_with	12	SENT_130	[p10l698t1889r1116b1976],
15	or	CC	O	or	_	0	SENT_130	[p10l1149t1911r1225b1957],
16	clarithromycin	NN	O	clarithromycin	conj_or	14	SENT_130	[p10l1254t1889r1813b1976],
17	.	.	O	.	_	0	SENT_130	[p10l1254t1889r1813b1976],

1	The	DT	O	the	det	3	SENT_131	[p10l122t2003r262b2070],
2	metabolic	JJ	O	metabolic	amod	3	SENT_131	[p10l286t2003r648b2070],
3	ratios	NNS	O	ratio	nsubjpass	13	SENT_131	[p10l673t2003r875b2070],
4	of	IN	O	of	_	0	SENT_131	[p10l902t2003r987b2070],
5	sibutramine	NN	O	sibutramine	prep_of	3	SENT_131	[p10l1002t2003r1453b2084],
6	,	,	O	,	_	0	SENT_131	[p10l1002t2003r1453b2084],
7	M1	NN	O	m1	prep_of	3	SENT_131	[p10l1481t2004r1628b2084],
8	,	,	O	,	_	0	SENT_131	[p10l1481t2004r1628b2084],
9	and	CC	O	and	_	0	SENT_131	[p10l1658t2003r1790b2070],
10	M2	NN	O	m2	prep_of	3	SENT_131	[p10l1812t2005r1937b2068],
11	were	VBD	O	be	auxpass	13	SENT_131	[p10l1963t2025r2140b2070],
12	then	RB	O	then	advmod	13	SENT_131	[p10l8t2114r167b2181],
13	analyzed	VBN	O	analyze	_	0	SENT_131	[p10l188t2114r515b2199],
14	(	RB	O	(	advmod	13	SENT_131	[p10l536t2114r771b2199],
15	Table	NNP	O	Table	prep	13	SENT_131	[p10l536t2114r771b2199],
16	2	CD	NUMBER	2	num	17	SENT_131	[p10l792t2115r885b2199],
17	)	CD	NUMBER	)	dep	15	SENT_131	[p10l792t2115r885b2199],
18	.	.	O	.	_	0	SENT_131	[p10l792t2115r885b2199],

1	Compared	VBN	O	compare	_	0	SENT_132	[p10l912t2114r1297b2199],
2	with	IN	O	with	prepc_compared_with	16	SENT_132	[p10l1314t2114r1478b2181],
3	the	DT	O	the	det	5	SENT_132	[p10l1497t2114r1607b2181],
4	control	NN	O	control	nn	5	SENT_132	[p10l1630t2114r1888b2181],
5	phase	NN	O	phase	pobj	16	SENT_132	[p10l1907t2114r2137b2199],
6	,	,	O	,	_	0	SENT_132	[p10l1907t2114r2137b2199],
7	the	DT	O	the	det	9	SENT_132	[p10l8t2224r118b2292],
8	AUC	NN	O	auc	nn	9	SENT_132	[p10l143t2226r336b2292],
9	ratios	NNS	O	ratio	nsubj	16	SENT_132	[p10l361t2224r563b2292],
10	of	IN	O	of	_	0	SENT_132	[p10l590t2224r675b2292],
11	M1	NN	O	m1	prep_of	9	SENT_132	[p10l687t2226r804b2291],
12	over	IN	O	over	_	0	SENT_132	[p10l840t2246r1004b2292],
13	sibutramine	NN	O	sibutramine	prep_over	11	SENT_132	[p10l1028t2224r1458b2292],
14	were	VBD	O	be	cop	16	SENT_132	[p10l1483t2246r1660b2292],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_132	[p10l1688t2224r2141b2311],
16	lower	JJR	O	lower	_	0	SENT_132	[p10l10t2337r220b2403],
17	following	VBG	O	follow	_	0	SENT_132	[p10l261t2337r616b2422],
18	clarithromycin	NN	O	clarithromycin	nn	19	SENT_132	[p10l660t2337r1202b2422],
19	treatment	NN	O	treatment	prep_following	16	SENT_132	[p10l1241t2346r1608b2417],
20	,	,	O	,	_	0	SENT_132	[p10l1241t2346r1608b2417],
21	regardless	RB	O	regardless	_	0	SENT_132	[p10l1652t2337r2023b2422],
22	of	IN	O	of	_	0	SENT_132	[p10l2068t2337r2153b2403],
23	the	DT	O	the	det	24	SENT_132	[p10l8t2448r118b2515],
24	enantio-conﬁguration	NN	O	enantio-conﬁguration	prep_regardless_of	19	SENT_132	[p10l192t2448r988b2533],
25	(	CD	NUMBER	(	num	26	SENT_132	[p10l1061t2449r1146b2533],
26	P	NN	O	p	npadvmod	27	SENT_132	[p10l1061t2449r1146b2533],
27	<	JJR	O	<	amod	24	SENT_132	[p10l1183t2462r1241b2517],
28	.01	CD	NUMBER	.01	num	29	SENT_132	[p10l1285t2448r1443b2533],
29	)	NN	O	)	dep	19	SENT_132	[p10l1285t2448r1443b2533],
30	.	.	O	.	_	0	SENT_132	[p10l1285t2448r1443b2533],

1	However	RB	O	however	advmod	7	SENT_133	[p10l1520t2451r1878b2529],
2	,	,	O	,	_	0	SENT_133	[p10l1520t2451r1878b2529],
3	these	DT	O	these	det	4	SENT_133	[p10l1952t2448r2140b2515],
4	values	NNS	O	value	nsubj	7	SENT_133	[p10l8t2558r242b2626],
5	did	VBD	O	do	aux	7	SENT_133	[p10l264t2558r380b2626],
6	not	RB	O	not	neg	7	SENT_133	[p10l397t2568r516b2626],
7	decrease	VB	O	decrease	_	0	SENT_133	[p10l535t2558r848b2626],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_133	[p10l871t2558r1325b2645],
9	following	VBG	O	follow	_	0	SENT_133	[p10l1345t2558r1701b2645],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_133	[p10l1722t2558r2141b2645],
11	treatment	NN	O	treatment	prep_following	7	SENT_133	[p10l8t2680r357b2737],
12	(	CD	NUMBER	(	num	13	SENT_133	[p10l431t2671r516b2756],
13	P	NN	O	p	npadvmod	14	SENT_133	[p10l431t2671r516b2756],
14	>	JJR	O	>	amod	11	SENT_133	[p10l553t2685r610b2740],
15	.40	CD	NUMBER	.40	num	16	SENT_133	[p10l655t2671r813b2756],
16	)	NN	O	)	dep	11	SENT_133	[p10l655t2671r813b2756],
17	.	.	O	.	_	0	SENT_133	[p10l655t2671r813b2756],

1	The	DT	O	the	det	3	SENT_134	[p10l893t2671r1033b2737],
2	reverse	JJ	O	reverse	amod	3	SENT_134	[p10l1107t2692r1371b2737],
3	phenomenon	NN	O	phenomenon	nsubjpass	5	SENT_134	[p10l1444t2671r1926b2756],
4	was	VBD	O	be	auxpass	5	SENT_134	[p10l1998t2692r2140b2737],
5	observed	VBN	O	observe	_	0	SENT_134	[p10l10t2782r344b2849],
6	in	IN	O	in	_	0	SENT_134	[p10l397t2782r467b2847],
7	the	DT	O	the	det	8	SENT_134	[p10l519t2782r630b2849],
8	case	NN	O	case	prep_in	5	SENT_134	[p10l687t2804r841b2849],
9	of	IN	O	of	_	0	SENT_134	[p10l898t2782r982b2849],
10	the	DT	O	the	det	12	SENT_134	[p10l1024t2782r1134b2849],
11	metabolic	JJ	O	metabolic	amod	12	SENT_134	[p10l1189t2782r1551b2849],
12	conversion	NN	O	conversion	prep_of	8	SENT_134	[p10l1608t2782r2013b2849],
13	of	IN	O	of	_	0	SENT_134	[p10l2068t2782r2153b2849],
14	Ml	NN	O	ml	prep_of	12	SENT_134	[p10l9t2894r331b2959],
15	.	.	O	.	_	0	SENT_134	[p10l9t2894r331b2959],

1	—	NN	O	—	_	0	SENT_135	[p10l9t2894r331b2959],
2	.	.	O	.	_	0	SENT_135	[p10l9t2894r331b2959],

1	M2	NN	O	m2	_	0	SENT_136	[p10l9t2894r331b2959],
2	.	.	O	.	_	0	SENT_136	[p10l9t2894r331b2959],

1	The	DT	O	the	det	3	SENT_137	[p10l388t2892r527b2959],
2	AUC	NN	O	auc	nn	3	SENT_137	[p10l579t2894r771b2959],
3	ratio	NN	O	ratio	nsubjpass	13	SENT_137	[p10l824t2892r989b2959],
4	of	IN	O	of	_	0	SENT_137	[p10l1043t2892r1128b2959],
5	R-M2	NN	O	r-m2	prep_of	3	SENT_137	[p10l1163t2894r1378b2958],
6	over	IN	O	over	_	0	SENT_137	[p10l1434t2914r1597b2959],
7	R-Ml	NN	O	r-ml	prep_over	5	SENT_137	[p10l1642t2894r1849b2958],
8	in	IN	O	in	_	0	SENT_137	[p10l1911t2892r1981b2958],
9	the	DT	O	the	det	11	SENT_137	[p10l2029t2892r2140b2959],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_137	[p10l10t3004r429b3089],
11	phase	NN	O	phase	prep_in	7	SENT_137	[p10l470t3004r680b3089],
12	was	VBD	O	be	auxpass	13	SENT_137	[p10l724t3025r865b3070],
13	decreased	VBN	O	decrease	_	0	SENT_137	[p10l911t3004r1274b3070],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_137	[p10l1319t3004r1792b3089],
15	,	,	O	,	_	0	SENT_137	[p10l1319t3004r1792b3089],
16	by	IN	O	by	_	0	SENT_137	[p10l1837t3004r1930b3089],
17	34	CD	PERCENT	34	num	18	SENT_137	[p10l1975t3005r2140b3070],
18	%	NN	PERCENT	%	agent	13	SENT_137	[p10l1975t3005r2140b3070],
19	compared	VBN	O	compare	_	0	SENT_137	[p10l10t3115r374b3200],
20	with	IN	O	with	prepc_compared_with	18	SENT_137	[p10l410t3115r575b3182],
21	the	DT	O	the	det	25	SENT_137	[p10l612t3115r723b3182],
22	control	NN	O	control	nn	25	SENT_137	[p10l765t3115r1023b3182],
23	phase	NN	O	phase	nn	25	SENT_137	[p10l1061t3115r1271b3200],
24	(	CD	NUMBER	(	num	25	SENT_137	[p10l1313t3116r1398b3200],
25	P	NN	O	p	pobj	18	SENT_137	[p10l1313t3116r1398b3200],
26	=	JJ	O	=	amod	25	SENT_137	[p10l1434t3145r1496b3168],
27	.047	CD	NUMBER	.047	num	28	SENT_137	[p10l1538t3116r1745b3200],
28	)	NN	O	)	dep	26	SENT_137	[p10l1538t3116r1745b3200],
29	,	,	O	,	_	0	SENT_137	[p10l1538t3116r1745b3200],
30	while	IN	O	while	mark	37	SENT_137	[p10l1787t3115r1990b3182],
31	the	DT	O	the	det	32	SENT_137	[p10l2029t3115r2140b3182],
32	values	NNS	O	value	nsubj	37	SENT_137	[p10l8t3225r242b3293],
33	in	IN	O	in	_	0	SENT_137	[p10l272t3225r342b3291],
34	the	DT	O	the	det	36	SENT_137	[p10l367t3225r478b3293],
35	clarithromycin	NN	O	clarithromycin	nn	36	SENT_137	[p10l508t3225r1049b3312],
36	phase	NN	O	phase	prep_in	32	SENT_137	[p10l1073t3225r1284b3311],
37	increased	VBN	O	increase	dep	25	SENT_137	[p10l1314t3225r1661b3293],
38	by	IN	O	by	_	0	SENT_137	[p10l1685t3225r1779b3312],
39	12	CD	PERCENT	12	num	40	SENT_137	[p10l1815t3227r1994b3307],
40	%	NN	PERCENT	%	prep_by	37	SENT_137	[p10l1815t3227r1994b3307],
41	,	,	O	,	_	0	SENT_137	[p10l1815t3227r1994b3307],
42	but	CC	O	but	_	0	SENT_137	[p10l2023t3225r2143b3293],
43	this	DT	O	this	nsubj	49	SENT_137	[p10l8t3338r139b3404],
44	was	VBD	O	be	cop	49	SENT_137	[p10l170t3359r311b3404],
45	not	RB	O	not	neg	49	SENT_137	[p10l342t3347r461b3404],
46	statistically	RB	O	statistically	advmod	47	SENT_137	[p10l493t3338r908b3423],
47	signiﬁcant	JJ	O	signiﬁcant	amod	49	SENT_137	[p10l941t3338r1324b3423],
48	(	NN	O	(	nn	49	SENT_137	[p10l1355t3338r1440b3423],
49	P	NN	O	p	conj_but	13	SENT_137	[p10l1355t3338r1440b3423],
50	=	JJ	O	=	amod	49	SENT_137	[p10l1475t3368r1537b3391],
51	.80	CD	NUMBER	.80	num	52	SENT_137	[p10l1580t3338r1737b3423],
52	)	NN	O	)	dep	50	SENT_137	[p10l1580t3338r1737b3423],
53	.	.	O	.	_	0	SENT_137	[p10l1580t3338r1737b3423],

1	In	IN	O	in	_	0	SENT_138	[p10l14t3563r72b3628],
2	Vitro	NNP	O	Vitro	nn	3	SENT_138	[p10l106t3563r298b3628],
3	Metabolism	NNP	O	Metabolism	pobj	1	SENT_138	[p10l334t3563r754b3628],
4	of	IN	O	of	_	0	SENT_138	[p10l791t3563r866b3628],
5	Sibutramine	NNP	O	Sibutramine	nn	6	SENT_138	[p10l893t3563r1333b3628],
6	Enantiomers	NNPS	O	Enantiomers	prep_of	3	SENT_138	[p10l1371t3563r1831b3628],
7	in	IN	O	in	_	0	SENT_138	[p10l1867t3567r1924b3628],
8	Human	JJ	O	human	amod	9	SENT_138	[p10l14t3675r274b3740],
9	Liver	NN	O	liver	prep_in	6	SENT_138	[p10l315t3675r496b3740],
10	and	CC	O	and	_	0	SENT_138	[p10l526t3675r653b3740],
11	Intestinal	JJ	O	intestinal	amod	12	SENT_138	[p10l692t3675r1016b3740],
12	Microsomes	NNS	O	microsome	conj_and	9	SENT_138	[p10l1057t3675r1506b3740],

1	The	DT	O	the	det	4	SENT_139	[p11l9t29r150b96],
2	in	IN	O	in	amod	4	SENT_139	[p11l177t29r247b94],
3	Vitro	NNP	O	Vitro	nn	4	SENT_139	[p11l271t29r442b96],
4	metabolism	NN	O	metabolism	nsubjpass	22	SENT_139	[p11l468t29r899b96],
5	of	IN	O	of	_	0	SENT_139	[p11l926t29r1011b96],
6	sibutramine	NN	O	sibutramine	prep_of	4	SENT_139	[p11l1027t29r1458b96],
7	and	CC	O	and	_	0	SENT_139	[p11l1486t29r1618b96],
8	M1	NN	O	m1	prep_of	4	SENT_139	[p11l1642t31r1759b94],
9	in	IN	O	in	_	0	SENT_139	[p11l1796t29r1866b94],
10	human	JJ	O	human	amod	14	SENT_139	[p11l1889t29r2142b96],
11	intestinal	JJ	O	intestinal	amod	14	SENT_139	[p11l10t139r345b206],
12	(	CD	NUMBER	(	tmod	11	SENT_139	[p11l387t140r657b224],
13	HIMS	NN	O	him	nn	14	SENT_139	[p11l387t140r657b224],
14	)	NN	O	)	prep_in	4	SENT_139	[p11l387t140r657b224],
15	and	CC	O	and	_	0	SENT_139	[p11l700t139r832b206],
16	hepatic	JJ	O	hepatic	amod	18	SENT_139	[p11l869t139r1133b224],
17	(	NN	O	(	nn	18	SENT_139	[p11l1176t140r1473b224],
18	HLMS	NN	O	hlm	prep_in	4	SENT_139	[p11l1176t140r1473b224],
19	)	CD	NUMBER	)	num	20	SENT_139	[p11l1176t140r1473b224],
20	microsomes	NNS	O	microsome	dep	14	SENT_139	[p11l1513t139r1958b206],
21	was	VBD	O	be	auxpass	22	SENT_139	[p11l1998t161r2140b206],
22	assessed	VBN	O	assess	_	0	SENT_139	[p11l10t251r340b332],
23	,	,	O	,	_	0	SENT_139	[p11l10t251r340b332],
24	to	TO	O	to	aux	25	SENT_139	[p11l404t260r472b317],
25	explain	VB	O	explain	xcomp	22	SENT_139	[p11l537t251r807b336],
26	the	DT	O	the	dep	25	SENT_139	[p11l866t251r977b317],
27	in	IN	O	in	_	0	SENT_139	[p11l1039t251r1109b316],
28	Vivo	NNP	O	Vivo	nn	29	SENT_139	[p11l1168t251r1331b317],
29	effects	NNS	O	effect	prep_in	25	SENT_139	[p11l1395t251r1634b317],
30	of	IN	O	of	_	0	SENT_139	[p11l1698t251r1783b317],
31	the	DT	O	the	det	33	SENT_139	[p11l1832t251r1942b317],
32	two	CD	NUMBER	two	num	33	SENT_139	[p11l2003t260r2139b317],
33	inhibitors	NNS	O	inhibitor	prep_of	29	SENT_139	[p11l9t362r360b429],
34	on	IN	O	on	_	0	SENT_139	[p11l405t384r496b429],
35	the	DT	O	the	det	36	SENT_139	[p11l536t362r647b429],
36	disposition	NN	O	disposition	prep_on	25	SENT_139	[p11l691t362r1097b447],
37	of	IN	O	of	_	0	SENT_139	[p11l1139t362r1224b429],
38	sibutramine	NN	O	sibutramine	nn	40	SENT_139	[p11l1257t362r1688b429],
39	(	CD	NUMBER	(	num	40	SENT_139	[p11l1734t362r2000b447],
40	Figure	NNP	O	Figure	prep_of	36	SENT_139	[p11l1734t362r2000b447],
41	3	CD	NUMBER	3	num	42	SENT_139	[p11l2045t362r2135b447],
42	)	NN	O	)	dep	40	SENT_139	[p11l2045t362r2135b447],
43	.	.	O	.	_	0	SENT_139	[p11l2045t362r2135b447],

1	The	DT	O	the	det	2	SENT_140	[p11l9t472r150b539],
2	formation	NN	O	formation	nsubj	9	SENT_140	[p11l179t472r540b539],
3	of	IN	O	of	_	0	SENT_140	[p11l567t472r652b539],
4	M1	NN	O	m1	prep_of	2	SENT_140	[p11l666t474r783b538],
5	from	IN	O	from	_	0	SENT_140	[p11l821t472r998b539],
6	sibutramine	NN	O	sibutramine	prep_from	4	SENT_140	[p11l1026t472r1457b539],
7	in	IN	O	in	_	0	SENT_140	[p11l1484t472r1554b538],
8	HIMS	NNP	O	HIMS	prep_in	6	SENT_140	[p11l1580t475r1792b539],
9	occurred	VBD	O	occur	_	0	SENT_140	[p11l1821t472r2143b539],
10	at	IN	O	at	_	0	SENT_140	[p11l10t593r74b650],
11	a	DT	O	a	det	13	SENT_140	[p11l98t605r137b650],
12	greater	JJR	O	greater	amod	13	SENT_140	[p11l161t593r415b669],
13	rate	NN	O	rate	prep_at	9	SENT_140	[p11l435t593r570b650],
14	than	IN	O	than	prep	9	SENT_140	[p11l595t584r754b650],
15	in	IN	O	in	pcomp	14	SENT_140	[p11l778t584r848b649],
16	HLMs	NNS	O	hlm	pobj	15	SENT_140	[p11l871t587r1130b650],
17	.	.	O	.	_	0	SENT_140	[p11l871t587r1130b650],

1	Additionally	RB	O	additionally	_	0	SENT_141	[p11l1159t584r1645b669],
2	,	,	O	,	_	0	SENT_141	[p11l1159t584r1645b669],
3	the	DT	O	the	det	4	SENT_141	[p11l1673t584r1784b650],
4	rate	NN	O	rate	dep	5	SENT_141	[p11l1808t593r1943b650],
5	of	IN	O	of	dep	1	SENT_141	[p11l1970t584r2054b650],
6	STable	JJ	O	stable	pobj	5	SENT_141	[p11l2066t585r2140b650, p11l93t744r179b768],

1	I.	NN	O	i.	_	0	SENT_142	[p11l192t744r212b768],
2	Pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_142	[p11l232t744r449b768],
3	Parameters	NNS	O	parameter	dep	1	SENT_142	[p11l458t744r606b768],
4	of	IN	O	of	_	0	SENT_142	[p11l614t744r642b768],
5	Enantiomers	NNS	O	enantiomer	nn	44	SENT_142	[p11l649t744r812b768],
6	of	IN	O	of	_	0	SENT_142	[p11l821t744r848b768],
7	Sibutramine	NN	O	sibutramine	prep_of	5	SENT_142	[p11l854t744r1010b768],
8	and	CC	O	and	_	0	SENT_142	[p11l1018t744r1064b768],
9	M	NN	O	m	prep_of	5	SENT_142	[p11l1074t744r1095b768],
10	I	NN	O	i	dobj	18	SENT_142	[p11l1104t744r1107b768],
11	and	CC	O	and	_	0	SENT_142	[p11l1121t744r1166b768],
12	M2	NN	O	m2	conj_and	10	SENT_142	[p11l1176t744r1216b768],
13	After	IN	O	after	_	0	SENT_142	[p11l1223t744r1293b768],
14	a	DT	O	a	det	15	SENT_142	[p11l1300t752r1314b768],
15	Single	JJ	O	single	prep_after	10	SENT_142	[p11l1321t744r1395b775],
16	I	PRP	O	I	nsubj	18	SENT_142	[p11l1409t744r1412b768],
17	5	CD	NUMBER	5	num	18	SENT_142	[p11l1420t744r1434b768],
18	mg	NN	O	mg	rcmod	7	SENT_142	[p11l1448t752r1487b775],
19	Oral	JJ	O	oral	amod	20	SENT_142	[p11l1494t744r1552b768],
20	Dose	NN	O	dose	dobj	18	SENT_142	[p11l1563t744r1632b768],
21	of	IN	O	of	_	0	SENT_142	[p11l1640t744r1667b768],
22	Racemic	JJ	O	racemic	amod	23	SENT_142	[p11l1674t744r1782b768],
23	Sibutramine	NN	O	sibutramine	prep_of	20	SENT_142	[p11l1791t744r1947b768],
24	in	IN	O	in	_	0	SENT_142	[p11l1956t746r1976b768],
25	the	DT	O	the	det	28	SENT_142	[p11l1985t744r2027b768],
26	I7	NN	O	i7	nn	28	SENT_142	[p11l2041t744r2067b768],
27	Healthy	JJ	O	healthy	amod	28	SENT_142	[p11l94t784r195b816],
28	Subjects	NNS	O	subject	prep_in	23	SENT_142	[p11l207t784r314b815],
29	Without	IN	O	without	_	0	SENT_142	[p11l326t784r442b808],
30	Pretreatment	NN	O	pretreatment	nn	34	SENT_142	[p11l454t784r631b808],
31	(	CD	NUMBER	(	num	34	SENT_142	[p11l643t784r758b816],
32	Control	NN	O	control	nn	34	SENT_142	[p11l643t784r758b816],
33	Phase	NN	O	phase	nn	34	SENT_142	[p11l773t784r863b816],
34	)	NN	O	)	prep_without	18	SENT_142	[p11l773t784r863b816],
35	,	,	O	,	_	0	SENT_142	[p11l773t784r863b816],
36	and	CC	O	and	_	0	SENT_142	[p11l876t784r921b808],
37	With	IN	O	with	nn	44	SENT_142	[p11l934t784r1001b808],
38	the	DT	O	the	det	39	SENT_142	[p11l1014t784r1057b808],
39	Pretreatment	NN	O	pretreatment	pobj	37	SENT_142	[p11l1071t784r1247b808],
40	of	IN	O	of	_	0	SENT_142	[p11l1259t784r1286b808],
41	Clopidogrel	NNP	O	Clopidogrel	prep_of	39	SENT_142	[p11l1297t784r1451b816],
42	75	CD	NUMBER	75	num	41	SENT_142	[p11l1466t784r1496b808],
43	mg	NN	O	mg	nn	44	SENT_142	[p11l1510t792r1548b816],
44	qd	NN	O	qd	prep_of	3	SENT_142	[p11l1560t784r1591b816],
45	for	IN	O	for	_	0	SENT_142	[p11l1604t784r1644b808],
46	4	CD	DURATION	4	num	47	SENT_142	[p11l1655t784r1671b808],
47	Days	NNS	DURATION	day	prep_for	3	SENT_142	[p11l1685t784r1748b816],
48	(	CD	NUMBER	(	num	51	SENT_142	[p11l1762t784r1926b816],
49	Clopidogrel	NNP	O	Clopidogrel	nn	51	SENT_142	[p11l1762t784r1926b816],
50	Phase	NN	O	phase	nn	51	SENT_142	[p11l1941t784r2023b816],
51	)	NN	O	)	dep	47	SENT_142	[p11l1941t784r2023b816],
52	or	CC	O	or	_	0	SENT_142	[p11l2038t792r2068b808],
53	Clarithromycin	NN	O	clarithromycin	nn	56	SENT_142	[p11l94t825r292b857],
54	250	CD	NUMBER	250	num	56	SENT_142	[p11l305t825r353b849],
55	mg	NN	O	mg	nn	56	SENT_142	[p11l367t833r405b857],
56	bid	NN	O	bid	prep_for	3	SENT_142	[p11l416t825r454b849],
57	for	IN	O	for	_	0	SENT_142	[p11l465t825r505b849],
58	4	CD	DURATION	4	num	59	SENT_142	[p11l515t825r530b849],
59	Days	NNS	DURATION	day	prep_for	56	SENT_142	[p11l543t825r606b857],
60	(	CD	NUMBER	(	num	63	SENT_142	[p11l619t825r828b857],
61	Clarithromycin	NNP	O	Clarithromycin	nn	63	SENT_142	[p11l619t825r828b857],
62	Phase	NN	O	phase	nn	63	SENT_142	[p11l841t825r923b857],
63	)	NN	O	)	dep	1	SENT_142	[p11l841t825r923b857],

1	Drug	NN	O	drug	dep	16	SENT_143	[p11l94t907r157b937],
2	Parameter	NNP	O	Parameter	nn	5	SENT_143	[p11l369t907r497b930],
3	Control	NNP	O	Control	nn	5	SENT_143	[p11l597t907r695b930],
4	Phase	NN	O	phase	nn	5	SENT_143	[p11l709t907r777b930],
5	Clopidogrel	NNP	O	Clopidogrel	dep	1	SENT_143	[p11l872t907r1016b937],
6	Phase	NN	O	phase	nn	7	SENT_143	[p11l1031t907r1099b930],
7	Fold	NN	O	fold	dep	5	SENT_143	[p11l1206t907r1256b930],
8	(	CD	PERCENT	(	number	9	SENT_143	[p11l1270t907r1330b937],
9	90	CD	PERCENT	90	num	10	SENT_143	[p11l1270t907r1330b937],
10	%	NN	PERCENT	%	dep	7	SENT_143	[p11l1270t907r1330b937],
11	Cl	NN	O	cl	dep	16	SENT_143	[p11l1342t905r1391b937],
12	)	CD	NUMBER	)	num	11	SENT_143	[p11l1342t905r1391b937],
13	“	CD	NUMBER	“	num	16	SENT_143	[p11l1342t905r1391b937],
14	Clarithromycin	NNP	O	Clarithromycin	nn	16	SENT_143	[p11l1496t907r1682b937],
15	Phase	NN	O	phase	nn	16	SENT_143	[p11l1697t907r1765b930],
16	Fold	NN	O	fold	dep	20	SENT_143	[p11l1872t907r1922b930],
17	(	CD	PERCENT	(	num	19	SENT_143	[p11l1936t907r1996b937],
18	90	CD	PERCENT	90	num	19	SENT_143	[p11l1936t907r1996b937],
19	%	NN	PERCENT	%	dep	16	SENT_143	[p11l1936t907r1996b937],
20	Cl	NN	O	cl	dep	22	SENT_143	[p11l2008t905r2057b937],
21	)	CD	NUMBER	)	num	20	SENT_143	[p11l2008t905r2057b937],
22	“	NN	O	“	_	0	SENT_143	[p11l2008t905r2057b937],

1	S-Sibutramine	NN	O	s-sibutramine	_	0	SENT_144	[p11l8t1003r377b1051],
2	cm	NN	O	cm	dep	1	SENT_144	[p11l675t1003r805b1062],
3	.	.	O	.	_	0	SENT_144	[p11l675t1003r805b1062],

1	2.28	CD	NUMBER	2.28	_	0	SENT_145	[p11l1127t1003r1239b1051],
2	3	CD	NUMBER	3	dep	1	SENT_145	[p11l1267t1004r1312b1050],
3	2.09	CD	NUMBER	2.09	dep	2	SENT_145	[p11l1340t1003r1452b1051],
4	3.72	CD	NUMBER	3.72	number	5	SENT_145	[p11l1752t1003r1862b1051],
5	3	CD	NUMBER	3	num	7	SENT_145	[p11l1890t1004r1935b1050],
6	3.39	CD	NUMBER	3.39	number	7	SENT_145	[p11l1965t987r2119b1051],
7	**	CD	NUMBER	**	dep	1	SENT_145	[p11l1965t987r2119b1051],
8	AUC	NN	O	auc	dep	7	SENT_145	[p11l669t1096r806b1145],
9	3.89	CD	NUMBER	3.89	dep	1	SENT_145	[p11l1129t1096r1238b1145],
10	3	CD	NUMBER	3	number	11	SENT_145	[p11l1267t1098r1312b1144],
11	3.15	CD	NUMBER	3.15	dep	9	SENT_145	[p11l1342t1096r1450b1145],
12	9.01	CD	NUMBER	9.01	number	13	SENT_145	[p11l1750t1096r1851b1145],
13	3	CD	NUMBER	3	dep	1	SENT_145	[p11l1890t1098r1935b1144],
14	8.56	CD	NUMBER	8.56	num	16	SENT_145	[p11l1963t1081r2119b1145],
15	**	CD	NUMBER	**	num	16	SENT_145	[p11l1963t1081r2119b1145],
16	Half-life	NN	O	half-life	dep	13	SENT_145	[p11l589t1191r791b1239],
17	(	CD	NUMBER	(	num	18	SENT_145	[p11l819t1191r889b1254],
18	h	NN	O	h	dep	1	SENT_145	[p11l819t1191r889b1254],
19	)	CD	NUMBER	)	dep	18	SENT_145	[p11l819t1191r889b1254],
20	1.5	CD	NUMBER	1.5	number	21	SENT_145	[p11l1172t1191r1237b1239],
21	3	CD	NUMBER	3	dep	1	SENT_145	[p11l1267t1192r1312b1238],
22	0.7	CD	NUMBER	0.7	num	23	SENT_145	[p11l1340t1191r1420b1239],
23	6.0	CD	NUMBER	6.0	dep	21	SENT_145	[p11l1769t1191r1860b1239],
24	.	.	O	.	_	0	SENT_145	[p11l1769t1191r1860b1239],

1	3	CD	NUMBER	3	number	2	SENT_146	[p11l1890t1193r1935b1238],
2	6.5	CD	NUMBER	6.5	_	0	SENT_146	[p11l1964t1175r2085b1239],
3	**	NN	O	**	nn	5	SENT_146	[p11l1964t1175r2085b1239],
4	R-Sibutramine	NN	O	r-sibutramine	nn	5	SENT_146	[p11l8t1285r382b1333],
5	cm	NN	O	cm	dep	2	SENT_146	[p11l675t1285r805b1345],
6	...	:	O	...	_	0	SENT_146	[p11l675t1285r805b1345],
7	4.57	CD	NUMBER	4.57	number	8	SENT_146	[p11l1125t1286r1240b1333],
8	3	CD	NUMBER	3	num	10	SENT_146	[p11l1267t1287r1312b1333],
9	4.15	CD	NUMBER	4.15	number	10	SENT_146	[p11l1338t1285r1450b1333],
10	6.81	CD	NUMBER	6.81	dep	2	SENT_146	[p11l1750t1285r1851b1333],
11	3	CD	NUMBER	3	number	12	SENT_146	[p11l1890t1287r1935b1333],
12	5.81	CD	NUMBER	5.81	num	10	SENT_146	[p11l1964t1269r2119b1333],
13	**	CD	NUMBER	**	num	14	SENT_146	[p11l1964t1269r2119b1333],
14	AUC	NN	O	auc	dep	10	SENT_146	[p11l669t1380r806b1428],
15	8.92	CD	NUMBER	8.92	number	16	SENT_146	[p11l1127t1380r1238b1428],
16	3	CD	NUMBER	3	dep	2	SENT_146	[p11l1267t1381r1312b1427],
17	7.37	CD	NUMBER	7.37	num	18	SENT_146	[p11l1341t1380r1453b1428],
18	17.51	CD	NUMBER	17.51	dep	16	SENT_146	[p11l1727t1380r1851b1428],
19	3	CD	NUMBER	3	number	20	SENT_146	[p11l1890t1381r1935b1427],
20	15.52	CD	NUMBER	15.52	num	21	SENT_146	[p11l1974t1364r2153b1428],
21	**	NN	O	**	dep	16	SENT_146	[p11l1974t1364r2153b1428],

1	Half-life	NN	O	half-life	nn	3	SENT_147	[p11l589t1473r791b1521],
2	(	CD	NUMBER	(	num	3	SENT_147	[p11l819t1473r889b1536],
3	h	NN	O	h	dep	16	SENT_147	[p11l819t1473r889b1536],
4	)	CD	NUMBER	)	number	5	SENT_147	[p11l819t1473r889b1536],
5	5.6	CD	NUMBER	5.6	num	7	SENT_147	[p11l1162t1473r1239b1521],
6	3	CD	NUMBER	3	number	7	SENT_147	[p11l1267t1475r1312b1521],
7	5.8	CD	NUMBER	5.8	dep	3	SENT_147	[p11l1341t1473r1418b1521],
8	6.8	CD	NUMBER	6.8	number	9	SENT_147	[p11l1784t1473r1862b1521],
9	3	CD	NUMBER	3	num	7	SENT_147	[p11l1890t1475r1935b1521],
10	7.2	CD	NUMBER	7.2	num	12	SENT_147	[p11l1964t1458r2085b1521],
11	**	NN	O	**	nn	12	SENT_147	[p11l1964t1458r2085b1521],
12	S-MI	NN	O	s-mi	dep	7	SENT_147	[p11l8t1568r130b1616],
13	cm	NN	O	cm	dep	16	SENT_147	[p11l675t1568r805b1627],
14	1.42	CD	NUMBER	1.42	num	13	SENT_147	[p11l1138t1568r1238b1616],
15	3	CD	NUMBER	3	num	16	SENT_147	[p11l1267t1570r1312b1616],
16	0.58	CD	NUMBER	0.58	dep	21	SENT_147	[p11l1340t1568r1452b1616],
17	2.05	CD	NUMBER	2.05	num	18	SENT_147	[p11l1750t1568r1860b1616],
18	3	CD	NUMBER	3	dep	16	SENT_147	[p11l1890t1570r1935b1616],
19	0.78	CD	NUMBER	0.78	number	20	SENT_147	[p11l1963t1552r2119b1616],
20	**	CD	NUMBER	**	dep	18	SENT_147	[p11l1963t1552r2119b1616],
21	AUC	NN	O	auc	dep	24	SENT_147	[p11l669t1662r806b1711],
22	20.8	CD	NUMBER	20.8	num	21	SENT_147	[p11l1127t1662r1239b1711],
23	3	CD	NUMBER	3	num	24	SENT_147	[p11l1267t1664r1312b1710],
24	|	NN	O	|	_	0	SENT_147	[p11l1351t1662r1452b1711],
25	2.8	CD	NUMBER	2.8	num	26	SENT_147	[p11l1351t1662r1452b1711],
26	37.5	CD	NUMBER	37.5	dep	24	SENT_147	[p11l1752t1662r1860b1711],
27	3	CD	NUMBER	3	number	28	SENT_147	[p11l1890t1664r1935b1710],
28	17.7	CD	NUMBER	17.7	num	29	SENT_147	[p11l1974t1646r2119b1711],
29	**	NN	O	**	dep	26	SENT_147	[p11l1974t1646r2119b1711],

1	Half-life	NN	O	half-life	_	0	SENT_148	[p11l589t1758r791b1806],
2	(	CD	NUMBER	(	num	1	SENT_148	[p11l819t1758r889b1821],
3	h	NN	O	h	dep	1	SENT_148	[p11l819t1758r889b1821],
4	)	CD	NUMBER	)	num	3	SENT_148	[p11l819t1758r889b1821],
5	20.0	CD	NUMBER	20.0	number	6	SENT_148	[p11l1127t1758r1239b1806],
6	3	CD	NUMBER	3	num	8	SENT_148	[p11l1267t1759r1312b1805],
7	15.7	CD	NUMBER	15.7	number	8	SENT_148	[p11l1351t1758r1453b1806],
8	20.0	CD	NUMBER	20.0	dep	3	SENT_148	[p11l1750t1758r1862b1806],
9	3	CD	NUMBER	3	number	10	SENT_148	[p11l1890t1759r1935b1805],
10	9.3	CD	NUMBER	9.3	num	8	SENT_148	[p11l1963t1758r2039b1806],

1	R-MI	NN	O	r-mi	_	0	SENT_149	[p11l8t1852r135b1900],
2	cm	NN	O	cm	dep	1	SENT_149	[p11l675t1852r805b1912],
3	.	.	O	.	_	0	SENT_149	[p11l675t1852r805b1912],

1	1.78	CD	NUMBER	1.78	number	2	SENT_150	[p11l1138t1852r1239b1900],
2	3	CD	NUMBER	3	num	4	SENT_150	[p11l1267t1854r1312b1900],
3	0.70	CD	NUMBER	0.70	number	4	SENT_150	[p11l1340t1852r1452b1900],
4	2.53	CD	NUMBER	2.53	_	0	SENT_150	[p11l1750t1852r1859b1900],
5	3	CD	NUMBER	3	number	6	SENT_150	[p11l1890t1854r1935b1900],
6	1.00	CD	NUMBER	1.00	num	4	SENT_150	[p11l1974t1837r2119b1900],
7	**	CD	NUMBER	**	num	8	SENT_150	[p11l1974t1837r2119b1900],
8	AUC	NN	O	auc	dep	4	SENT_150	[p11l669t1947r806b1995],
9	22.5	CD	NUMBER	22.5	number	10	SENT_150	[p11l1127t1947r1237b1995],
10	3	CD	NUMBER	3	num	12	SENT_150	[p11l1267t1948r1312b1994],
11	12.2	CD	NUMBER	12.2	number	12	SENT_150	[p11l1351t1947r1452b1995],
12	36.3	CD	NUMBER	36.3	dep	4	SENT_150	[p11l1752t1947r1859b1995],
13	3	CD	NUMBER	3	number	14	SENT_150	[p11l1890t1948r1935b1994],
14	17.4	CD	NUMBER	17.4	num	15	SENT_150	[p11l1974t1931r2119b1995],
15	**	NN	O	**	dep	12	SENT_150	[p11l1974t1931r2119b1995],

1	Half-life	NN	O	half-life	dep	12	SENT_151	[p11l589t2041r791b2090],
2	(	CD	NUMBER	(	num	1	SENT_151	[p11l819t2041r889b2104],
3	11	CD	NUMBER	11	num	4	SENT_151	[p11l819t2041r889b2104],
4	)	NN	O	)	dep	1	SENT_151	[p11l819t2041r889b2104],
5	20.1	CD	NUMBER	20.1	number	6	SENT_151	[p11l1127t2041r1228b2090],
6	3	CD	NUMBER	3	num	8	SENT_151	[p11l1267t2043r1312b2089],
7	11.4	CD	NUMBER	11.4	number	8	SENT_151	[p11l1351t2041r1452b2089],
8	20.1	CD	NUMBER	20.1	dep	4	SENT_151	[p11l1750t2041r1851b2090],
9	3	CD	NUMBER	3	dep	12	SENT_151	[p11l1890t2043r1935b2089],
10	11.0	CD	NUMBER	11.0	num	12	SENT_151	[p11l1974t2041r2075b2090],
11	R-M2	NN	O	r-m2	nn	12	SENT_151	[p11l7t2137r146b2184],
12	cm	NN	O	cm	_	0	SENT_151	[p11l675t2137r805b2196],
13	3.27	CD	NUMBER	3.27	num	14	SENT_151	[p11l1129t2137r1240b2185],
14	3	CD	NUMBER	3	dep	12	SENT_151	[p11l1267t2139r1312b2184],
15	1.13	CD	NUMBER	1.13	number	16	SENT_151	[p11l1351t2137r1449b2185],
16	2.92	CD	NUMBER	2.92	num	18	SENT_151	[p11l1750t2137r1862b2185],
17	3	CD	NUMBER	3	number	18	SENT_151	[p11l1890t2139r1935b2184],
18	2.12	CD	NUMBER	2.12	dep	14	SENT_151	[p11l1963t2121r2098b2185],
19	*	CD	NUMBER	*	num	20	SENT_151	[p11l1963t2121r2098b2185],
20	AUC	NN	O	auc	dep	14	SENT_151	[p11l669t2231r806b2279],
21	38.2	CD	NUMBER	38.2	number	22	SENT_151	[p11l1129t2231r1238b2279],
22	3	CD	NUMBER	3	num	24	SENT_151	[p11l1267t2233r1312b2279],
23	24.9	CD	NUMBER	24.9	number	24	SENT_151	[p11l1340t2231r1452b2279],
24	40.2	CD	NUMBER	40.2	dep	20	SENT_151	[p11l1748t2231r1862b2279],
25	3	CD	NUMBER	3	number	26	SENT_151	[p11l1890t2233r1935b2279],
26	31.7	CD	NUMBER	31.7	num	24	SENT_151	[p11l1965t2231r2077b2279],

1	Half-life	NN	O	half-life	nn	3	SENT_152	[p11l589t2327r791b2375],
2	(	CD	NUMBER	(	num	3	SENT_152	[p11l819t2327r889b2390],
3	h	NN	O	h	_	0	SENT_152	[p11l819t2327r889b2390],
4	)	CD	NUMBER	)	number	5	SENT_152	[p11l819t2327r889b2390],
5	12.4	CD	NUMBER	12.4	num	7	SENT_152	[p11l1138t2327r1239b2375],
6	3	CD	NUMBER	3	number	7	SENT_152	[p11l1267t2328r1312b2374],
7	7.8	CD	NUMBER	7.8	dep	3	SENT_152	[p11l1341t2327r1418b2375],
8	|	NN	O	|	dep	3	SENT_152	[p11l1761t2327r1862b2375],
9	2.8	CD	NUMBER	2.8	num	8	SENT_152	[p11l1761t2327r1862b2375],
10	3	CD	NUMBER	3	number	11	SENT_152	[p11l1890t2328r1935b2374],
11	6.2	CD	NUMBER	6.2	dep	8	SENT_152	[p11l1964t2327r2041b2375],

1	R/S-Sibu	NN	O	r/s-sibu	nn	2	SENT_153	[p11l8t2420r219b2469],
2	AUC	NN	O	auc	_	0	SENT_153	[p11l669t2420r806b2469],
3	2.52	CD	NUMBER	2.52	number	4	SENT_153	[p11l1127t2420r1238b2469],
4	3	CD	NUMBER	3	dep	2	SENT_153	[p11l1267t2422r1312b2468],
5	1.14	CD	NUMBER	1.14	num	6	SENT_153	[p11l1351t2420r1452b2468],
6	2.03	CD	NUMBER	2.03	dep	4	SENT_153	[p11l1750t2420r1859b2469],
7	3	CD	NUMBER	3	number	8	SENT_153	[p11l1890t2422r1935b2468],
8	0.89	CD	NUMBER	0.89	amod	9	SENT_153	[p11l1963t2405r2119b2469],
9	**	NN	O	**	dep	2	SENT_153	[p11l1963t2405r2119b2469],
10	R/S-MI	NN	O	r/s-mi	nn	11	SENT_153	[p11l7t2515r183b2563],
11	AUC	NN	O	auc	dep	9	SENT_153	[p11l669t2515r806b2563],
12	1.12	CD	NUMBER	1.12	number	13	SENT_153	[p11l1138t2515r1239b2563],
13	3	CD	NUMBER	3	dep	2	SENT_153	[p11l1267t2517r1312b2562],
14	0.15	CD	NUMBER	0.15	num	15	SENT_153	[p11l1340t2515r1450b2563],
15	0.95	CD	NUMBER	0.95	dep	13	SENT_153	[p11l1749t2515r1860b2563],
16	3	CD	NUMBER	3	num	17	SENT_153	[p11l1890t2517r1935b2562],
17	0.19	CD	NUMBER	0.19	dep	2	SENT_153	[p11l1963t2499r2119b2563],
18	**	CD	NUMBER	**	num	19	SENT_153	[p11l1963t2499r2119b2563],
19	1.61	CD	NUMBER	1.61	dep	17	SENT_153	[p11l19t2616r122b2671],
20	(	NN	O	(	dep	2	SENT_153	[p11l167t2616r333b2688],
21	1.27	CD	NUMBER	1.27	num	20	SENT_153	[p11l167t2616r333b2688],
22	,	,	O	,	_	0	SENT_153	[p11l167t2616r333b2688],
23	2.04	CD	NUMBER	2.04	number	24	SENT_153	[p11l365t2616r492b2671],
24	6.76	CD	NUMBER	6.76	appos	20	SENT_153	[p11l873t2616r1000b2671],
25	3	CD	NUMBER	3	num	27	SENT_153	[p11l1031t2618r1083b2670],
26	4.83	CD	NUMBER	4.83	num	27	SENT_153	[p11l1113t2598r1292b2671],
27	**	NN	O	**	dep	2	SENT_153	[p11l1113t2598r1292b2671],
28	2.70	CD	NUMBER	2.70	number	29	SENT_153	[p11l1645t2616r1773b2671],
29	(	CD	NUMBER	(	num	31	SENT_153	[p11l1805t2616r1971b2688],
30	|	NN	O	|	nn	31	SENT_153	[p11l1805t2616r1971b2688],
31	.85	NN	NUMBER	.85	dep	27	SENT_153	[p11l1805t2616r1971b2688],
32	,	,	O	,	_	0	SENT_153	[p11l1805t2616r1971b2688],
33	3.95	CD	NUMBER	3.95	number	34	SENT_153	[p11l2004t2616r2152b2688],
34	)	CD	NUMBER	)	appos	2	SENT_153	[p11l2004t2616r2152b2688],
35	2.22	CD	NUMBER	2.22	num	36	SENT_153	[p11l7t2723r134b2778],
36	(	CD	NUMBER	(	dep	34	SENT_153	[p11l167t2723r333b2795],
37	|	NN	O	|	dep	2	SENT_153	[p11l167t2723r333b2795],
38	.64	CD	NUMBER	.64	num	37	SENT_153	[p11l167t2723r333b2795],
39	,	,	O	,	_	0	SENT_153	[p11l167t2723r333b2795],
40	3.02	CD	NUMBER	3.02	number	41	SENT_153	[p11l366t2723r514b2795],
41	)	CD	NUMBER	)	appos	37	SENT_153	[p11l366t2723r514b2795],
42	17.0	CD	NUMBER	17.0	number	43	SENT_153	[p11l885t2723r1000b2779],
43	3	CD	NUMBER	3	dep	2	SENT_153	[p11l1031t2726r1083b2778],
44	13.2	CD	NUMBER	13.2	dep	43	SENT_153	[p11l1127t2706r1292b2779],
45	**	CD	NUMBER	**	number	46	SENT_153	[p11l1127t2706r1292b2779],
46	4.09	CD	NUMBER	4.09	dep	2	SENT_153	[p11l1643t2724r1772b2779],
47	(	NN	O	(	dep	46	SENT_153	[p11l1805t2723r1971b2795],
48	2.87	CD	NUMBER	2.87	num	47	SENT_153	[p11l1805t2723r1971b2795],
49	,	,	O	,	_	0	SENT_153	[p11l1805t2723r1971b2795],
50	5.8	CD	NUMBER	5.8	number	51	SENT_153	[p11l2003t2723r2152b2795],
51	|	CD	NUMBER	|	appos	2	SENT_153	[p11l2003t2723r2152b2795],
52	)	NN	O	)	dep	51	SENT_153	[p11l2003t2723r2152b2795],
53	2.85	CD	NUMBER	2.85	number	54	SENT_153	[p11l7t2831r132b2886],
54	(	CD	NUMBER	(	dep	2	SENT_153	[p11l167t2831r333b2903],
55	2.28	CD	NUMBER	2.28	dep	54	SENT_153	[p11l167t2831r333b2903],
56	,	,	O	,	_	0	SENT_153	[p11l167t2831r333b2903],
57	5.38	CD	NUMBER	5.38	appos	2	SENT_153	[p11l365t2831r514b2903],
58	)	CD	NUMBER	)	number	59	SENT_153	[p11l365t2831r514b2903],
59	4.8	CD	NUMBER	4.8	dep	57	SENT_153	[p11l909t2831r1000b2886],
60	3	CD	NUMBER	3	number	61	SENT_153	[p11l1031t2833r1083b2885],
61	4.5	CD	NUMBER	4.5	dep	2	SENT_153	[p11l1113t2813r1254b2886],
62	**	NN	O	**	dep	61	SENT_153	[p11l1113t2813r1254b2886],
63	2.64	CD	NUMBER	2.64	num	64	SENT_153	[p11l1645t2831r1773b2886],
64	(	NN	O	(	dep	2	SENT_153	[p11l1805t2831r1971b2903],
65	2	CD	NUMBER	2	dep	64	SENT_153	[p11l1805t2831r1971b2903],
66	.	.	O	.	_	0	SENT_153	[p11l1805t2831r1971b2903],

1	|	NN	O	|	dep	108	SENT_154	[p11l1805t2831r1971b2903],
2	6	CD	NUMBER	6	dep	108	SENT_154	[p11l1805t2831r1971b2903],
3	,	,	O	,	_	0	SENT_154	[p11l1805t2831r1971b2903],
4	4.53	CD	NUMBER	4.53	dep	108	SENT_154	[p11l2001t2831r2152b2903],
5	)	CD	NUMBER	)	dep	108	SENT_154	[p11l2001t2831r2152b2903],
6	1.47	CD	NUMBER	1.47	dep	108	SENT_154	[p11l19t2936r136b2991],
7	(	NN	O	(	dep	108	SENT_154	[p11l167t2936r333b3008],
8	1.21	CD	NUMBER	1.21	dep	108	SENT_154	[p11l167t2936r333b3008],
9	,	,	O	,	_	0	SENT_154	[p11l167t2936r333b3008],
10	1.78	CD	NUMBER	1.78	dep	108	SENT_154	[p11l377t2936r514b3008],
11	)	NN	O	)	dep	108	SENT_154	[p11l377t2936r514b3008],
12	8.04	CD	NUMBER	8.04	dep	108	SENT_154	[p11l872t2936r1000b2991],
13	3	CD	NUMBER	3	dep	108	SENT_154	[p11l1031t2939r1083b2991],
14	5.60	CD	NUMBER	5.60	dep	108	SENT_154	[p11l1115t2918r1268b2991],
15	*	NN	O	*	dep	108	SENT_154	[p11l1115t2918r1268b2991],
16	1.59	CD	NUMBER	1.59	dep	108	SENT_154	[p11l1658t2936r1772b2991],
17	(	CD	NUMBER	(	dep	108	SENT_154	[p11l1805t2936r1971b3008],
18	1.13	CD	NUMBER	1.13	dep	108	SENT_154	[p11l1805t2936r1971b3008],
19	,	,	O	,	_	0	SENT_154	[p11l1805t2936r1971b3008],
20	2.22	CD	NUMBER	2.22	dep	108	SENT_154	[p11l2003t2936r2152b3008],
21	)	CD	NUMBER	)	dep	108	SENT_154	[p11l2003t2936r2152b3008],
22	|	NN	O	|	dep	108	SENT_154	[p11l19t3045r134b3100],
23	.82	CD	NUMBER	.82	dep	108	SENT_154	[p11l19t3045r134b3100],
24	(	CD	NUMBER	(	dep	108	SENT_154	[p11l167t3045r333b3117],
25	1.45	CD	NUMBER	1.45	dep	108	SENT_154	[p11l167t3045r333b3117],
26	,	,	O	,	_	0	SENT_154	[p11l167t3045r333b3117],
27	2.30	CD	NUMBER	2.30	dep	108	SENT_154	[p11l365t3045r514b3117],
28	)	CD	NUMBER	)	dep	108	SENT_154	[p11l365t3045r514b3117],
29	19.2	CD	NUMBER	19.2	dep	108	SENT_154	[p11l885t3045r1000b3100],
30	3	CD	NUMBER	3	dep	108	SENT_154	[p11l1031t3047r1083b3099],
31	13.6	CD	NUMBER	13.6	dep	108	SENT_154	[p11l1127t3027r1292b3100],
32	**	CD	NUMBER	**	dep	108	SENT_154	[p11l1127t3027r1292b3100],
33	2.01	CD	NUMBER	2.01	dep	108	SENT_154	[p11l1645t3045r1760b3100],
34	(	NN	O	(	dep	108	SENT_154	[p11l1805t3045r1971b3117],
35	1.49	CD	NUMBER	1.49	dep	108	SENT_154	[p11l1805t3045r1971b3117],
36	,	,	O	,	_	0	SENT_154	[p11l1805t3045r1971b3117],
37	2.70	CD	NUMBER	2.70	dep	108	SENT_154	[p11l2002t3045r2152b3117],
38	)	NN	O	)	dep	108	SENT_154	[p11l2002t3045r2152b3117],
39	1.18	CD	NUMBER	1.18	dep	108	SENT_154	[p11l19t3152r135b3207],
40	(	CD	NUMBER	(	dep	108	SENT_154	[p11l167t3152r333b3224],
41	0.63	CD	NUMBER	0.63	dep	108	SENT_154	[p11l167t3152r333b3224],
42	,	,	O	,	_	0	SENT_154	[p11l167t3152r333b3224],
43	3.16	CD	NUMBER	3.16	dep	108	SENT_154	[p11l366t3152r514b3224],
44	)	NN	O	)	dep	108	SENT_154	[p11l366t3152r514b3224],
45	8.5	CD	NUMBER	8.5	dep	108	SENT_154	[p11l911t3152r997b3207],
46	3	CD	NUMBER	3	dep	108	SENT_154	[p11l1031t3154r1083b3207],
47	5.6	CD	NUMBER	5.6	dep	108	SENT_154	[p11l1115t3135r1254b3207],
48	**	CD	NUMBER	**	dep	108	SENT_154	[p11l1115t3135r1254b3207],
49	1.81	CD	NUMBER	1.81	dep	108	SENT_154	[p11l1658t3152r1760b3207],
50	(	NN	O	(	dep	108	SENT_154	[p11l1805t3152r1971b3224],
51	1.49	CD	NUMBER	1.49	dep	108	SENT_154	[p11l1805t3152r1971b3224],
52	,	,	O	,	_	0	SENT_154	[p11l1805t3152r1971b3224],
53	3.48	CD	NUMBER	3.48	dep	108	SENT_154	[p11l2004t3152r2152b3224],
54	)	CD	NUMBER	)	dep	108	SENT_154	[p11l2004t3152r2152b3224],
55	1.45	CD	NUMBER	1.45	dep	108	SENT_154	[p11l19t3259r132b3313],
56	(	CD	NUMBER	(	dep	108	SENT_154	[p11l167t3259r333b3330],
57	|	NN	O	|	dep	108	SENT_154	[p11l167t3259r333b3330],
58	.28	CD	NUMBER	.28	dep	108	SENT_154	[p11l167t3259r333b3330],
59	,	,	O	,	_	0	SENT_154	[p11l167t3259r333b3330],
60	1.65	CD	NUMBER	1.65	dep	108	SENT_154	[p11l377t3259r514b3330],
61	)	CD	NUMBER	)	dep	108	SENT_154	[p11l377t3259r514b3330],
62	1.51	CD	NUMBER	1.51	dep	108	SENT_154	[p11l885t3259r987b3313],
63	3	CD	NUMBER	3	dep	108	SENT_154	[p11l1031t3261r1083b3313],
64	0.67	CD	NUMBER	0.67	dep	108	SENT_154	[p11l1114t3259r1243b3313],
65	1.04	CD	NUMBER	1.04	dep	108	SENT_154	[p11l1658t3259r1773b3313],
66	(	NN	O	(	dep	108	SENT_154	[p11l1805t3259r1971b3330],
67	0.89	CD	NUMBER	0.89	dep	108	SENT_154	[p11l1805t3259r1971b3330],
68	,	,	O	,	_	0	SENT_154	[p11l1805t3259r1971b3330],
69	1.21	CD	NUMBER	1.21	dep	108	SENT_154	[p11l2015t3259r2152b3330],
70	)	CD	NUMBER	)	dep	108	SENT_154	[p11l2015t3259r2152b3330],
71	1.86	CD	NUMBER	1.86	dep	108	SENT_154	[p11l19t3366r134b3421],
72	(	NN	O	(	dep	108	SENT_154	[p11l167t3366r333b3437],
73	1.53	CD	NUMBER	1.53	dep	108	SENT_154	[p11l167t3366r333b3437],
74	,	,	O	,	_	0	SENT_154	[p11l167t3366r333b3437],
75	2.25	CD	NUMBER	2.25	dep	108	SENT_154	[p11l364t3366r514b3437],
76	)	CD	NUMBER	)	dep	108	SENT_154	[p11l364t3366r514b3437],
77	24.3	CD	NUMBER	24.3	dep	108	SENT_154	[p11l872t3366r996b3421],
78	3	CD	NUMBER	3	dep	108	SENT_154	[p11l1031t3368r1083b3420],
79	11.1	CD	NUMBER	11.1	dep	108	SENT_154	[p11l1127t3366r1229b3420],
80	1.22	CD	NUMBER	1.22	dep	108	SENT_154	[p11l1658t3366r1772b3420],
81	(	NN	O	(	dep	108	SENT_154	[p11l1805t3366r1971b3437],
82	1.00	CD	NUMBER	1.00	dep	108	SENT_154	[p11l1805t3366r1971b3437],
83	,	,	O	,	_	0	SENT_154	[p11l1805t3366r1971b3437],
84	1.49	CD	NUMBER	1.49	dep	108	SENT_154	[p11l2015t3366r2152b3437],
85	)	CD	NUMBER	)	dep	108	SENT_154	[p11l2015t3366r2152b3437],
86	1.13	CD	NUMBER	1.13	dep	108	SENT_154	[p11l19t3475r131b3529],
87	(	NN	O	(	dep	108	SENT_154	[p11l167t3475r333b3546],
88	0.72	CD	NUMBER	0.72	dep	108	SENT_154	[p11l167t3475r333b3546],
89	,	,	O	,	_	0	SENT_154	[p11l167t3475r333b3546],
90	2.25	CD	NUMBER	2.25	dep	108	SENT_154	[p11l365t3475r514b3546],
91	)	CD	NUMBER	)	dep	108	SENT_154	[p11l365t3475r514b3546],
92	24.5	CD	NUMBER	24.5	dep	108	SENT_154	[p11l873t3475r997b3529],
93	3	CD	NUMBER	3	dep	108	SENT_154	[p11l1031t3477r1083b3528],
94	14.0	CD	NUMBER	14.0	dep	108	SENT_154	[p11l1127t3475r1242b3529],
95	1.33	CD	NUMBER	1.33	dep	108	SENT_154	[p11l1657t3475r1769b3529],
96	(	NN	O	(	dep	108	SENT_154	[p11l1805t3475r1971b3546],
97	0.55	CD	NUMBER	0.55	dep	108	SENT_154	[p11l1805t3475r1971b3546],
98	,	,	O	,	_	0	SENT_154	[p11l1805t3475r1971b3546],
99	3.96	CD	NUMBER	3.96	dep	108	SENT_154	[p11l2004t3475r2152b3546],
100	)	NN	O	)	dep	108	SENT_154	[p11l2004t3475r2152b3546],
101	1.42	CD	NUMBER	1.42	dep	108	SENT_154	[p11l20t3580r333b3651],
102	(	CD	NUMBER	(	dep	108	SENT_154	[p11l20t3580r333b3651],
103	1.25	CD	NUMBER	1.25	dep	108	SENT_154	[p11l20t3580r333b3651],
104	,	,	O	,	_	0	SENT_154	[p11l20t3580r333b3651],
105	1.62	CD	NUMBER	1.62	dep	108	SENT_154	[p11l377t3580r514b3651],
106	)	CD	NUMBER	)	dep	108	SENT_154	[p11l377t3580r514b3651],
107	2.2131.17	CD	NUMBER	2.2131.17	dep	108	SENT_154	[p11l873t3580r1243b3634],
108	|	NN	O	|	_	0	SENT_154	[p11l1658t3580r1971b3651],
109	.	.	O	.	_	0	SENT_154	[p11l1658t3580r1971b3651],

1	|	NN	O	|	_	0	SENT_155	[p11l1658t3580r1971b3651],
2	8	CD	NUMBER	8	number	3	SENT_155	[p11l1658t3580r1971b3651],
3	(	CD	NUMBER	(	num	4	SENT_155	[p11l1658t3580r1971b3651],
4	|	NN	O	|	dep	1	SENT_155	[p11l1658t3580r1971b3651],
5	.0	CD	NUMBER	.0	num	6	SENT_155	[p11l1658t3580r1971b3651],
6	|	NN	O	|	dep	1	SENT_155	[p11l1658t3580r1971b3651],
7	,	,	O	,	_	0	SENT_155	[p11l1658t3580r1971b3651],
8	1.37	CD	NUMBER	1.37	number	9	SENT_155	[p11l2015t3580r2152b3651],
9	)	CD	NUMBER	)	appos	6	SENT_155	[p11l2015t3580r2152b3651],
10	1.56	CD	NUMBER	1.56	num	11	SENT_155	[p11l19t3689r134b3743],
11	(	NN	O	(	dep	9	SENT_155	[p11l167t3689r333b3760],
12	1.24	CD	NUMBER	1.24	dep	9	SENT_155	[p11l167t3689r333b3760],
13	,	,	O	,	_	0	SENT_155	[p11l167t3689r333b3760],
14	1.95	CD	NUMBER	1.95	number	15	SENT_155	[p11l377t3689r514b3760],
15	)	CD	NUMBER	)	num	17	SENT_155	[p11l377t3689r514b3760],
16	27.6	CD	NUMBER	27.6	number	17	SENT_155	[p11l873t3689r1000b3743],
17	313.4	CD	NUMBER	313.4	appos	6	SENT_155	[p11l1031t3689r1242b3743],
18	1.23	CD	NUMBER	1.23	num	19	SENT_155	[p11l1657t3689r1971b3760],
19	(	NN	O	(	dep	17	SENT_155	[p11l1657t3689r1971b3760],
20	1.01	CD	NUMBER	1.01	dep	17	SENT_155	[p11l1657t3689r1971b3760],
21	,	,	O	,	_	0	SENT_155	[p11l1657t3689r1971b3760],
22	1.51	CD	NUMBER	1.51	num	23	SENT_155	[p11l2015t3689r2152b3760],
23	)	NN	O	)	appos	20	SENT_155	[p11l2015t3689r2152b3760],

1	Data	NNS	O	datum	_	0	SENT_156	[p12l94t694r152b716],
2	are	VBP	O	be	cop	4	SENT_156	[p12l162t701r201b716],
3	mean	JJ	O	mean	amod	4	SENT_156	[p12l212t701r276b716],
4	values	NNS	O	value	rcmod	1	SENT_156	[p12l288t694r362b716],
5	:	:	O	:	_	0	SENT_156	[p12l375t704r396b716],
6	:	:	O	:	_	0	SENT_156	[p12l375t704r396b716],
7	SD	NN	O	sd	dep	1	SENT_156	[p12l409t694r451b716],
8	.	.	O	.	_	0	SENT_156	[p12l409t694r451b716],

1	AUC	NN	O	auc	_	0	SENT_157	[p12l92t736r162b762],
2	,	,	O	,	_	0	SENT_157	[p12l92t736r162b762],
3	area	NN	O	area	appos	1	SENT_157	[p12l174t743r226b759],
4	under	IN	O	under	_	0	SENT_157	[p12l237t736r309b759],
5	the	DT	O	the	det	10	SENT_157	[p12l319t736r359b759],
6	plasma	NN	O	plasma	nn	10	SENT_157	[p12l370t736r453b766],
7	concentration	NN	O	concentration	nn	10	SENT_157	[p12l464t738r708b759],
8	—	CD	NUMBER	—	num	10	SENT_157	[p12l464t738r708b759],
9	time	NN	O	time	nn	10	SENT_157	[p12l464t738r708b759],
10	curve	NN	O	curve	prep_under	3	SENT_157	[p12l720t743r788b759],
11	from	IN	O	from	_	0	SENT_157	[p12l798t736r857b759],
12	o	NN	O	o	nn	13	SENT_157	[p12l869t736r883b759],
13	h	NN	O	h	prep_from	10	SENT_157	[p12l896t736r909b759],
14	to	TO	O	to	_	0	SENT_157	[p12l920t741r946b759],
15	inﬁnity	NN	O	inﬁnity	nn	19	SENT_157	[p12l958t736r1039b766],
16	(	CD	NUMBER	(	num	19	SENT_157	[p12l1051t736r1088b766],
17	ng	NN	O	ng	nn	19	SENT_157	[p12l1051t736r1088b766],
18	h/mL	NN	O	h/ml	nn	19	SENT_157	[p12l1100t736r1177b766],
19	)	NN	O	)	prep_to	13	SENT_157	[p12l1100t736r1177b766],
20	;	:	O	;	_	0	SENT_157	[p12l1100t736r1177b766],
21	Cmax	NNP	O	Cmax	dep	1	SENT_157	[p12l1189t736r1255b764],
22	,	,	O	,	_	0	SENT_157	[p12l1189t736r1255b764],
23	peak	JJ	O	peak	amod	28	SENT_157	[p12l1267t736r1324b766],
24	plasma	NN	O	plasma	nn	28	SENT_157	[p12l1334t736r1417b766],
25	concentration	NN	O	concentration	nn	28	SENT_157	[p12l1428t738r1600b759],
26	(	CD	NUMBER	(	num	28	SENT_157	[p12l1613t736r1713b766],
27	ng/mL	NN	O	ng/ml	nn	28	SENT_157	[p12l1613t736r1713b766],
28	)	NN	O	)	appos	21	SENT_157	[p12l1613t736r1713b766],
29	.	.	O	.	_	0	SENT_157	[p12l1613t736r1713b766],

1	*	NN	O	*	_	0	SENT_158	[p12l92t773r116b803],
2	3	CD	NUMBER	3	num	3	SENT_158	[p12l92t773r116b803],
3	<	JJR	O	<	dep	1	SENT_158	[p12l129t785r148b804],
4	.05	CD	NUMBER	.05	dep	3	SENT_158	[p12l162t780r204b803],
5	.	.	O	.	_	0	SENT_158	[p12l162t780r204b803],

1	“	NN	O	“	nn	2	SENT_159	[p12l92t815r126b845],
2	P	NN	O	p	dep	3	SENT_159	[p12l92t815r126b845],
3	<	JJR	O	<	_	0	SENT_159	[p12l139t828r158b846],
4	.	.	O	.	_	0	SENT_159	[p12l172t823r203b845],

1	o	NN	O	o	_	0	SENT_160	[p12l172t823r203b845],
2	|	CD	NUMBER	|	num	1	SENT_160	[p12l172t823r203b845],
3	vs.	CC	O	vs.	prep	1	SENT_160	[p12l218t830r249b845],
4	control	NN	O	control	nn	5	SENT_160	[p12l261t823r350b845],
5	phase	NN	O	phase	dep	3	SENT_160	[p12l363t823r438b852],
6	.	.	O	.	_	0	SENT_160	[p12l363t823r438b852],

1	“	NN	O	“	nn	3	SENT_161	[p12l93t863r155b887],
2	Fold	NN	O	fold	nn	3	SENT_161	[p12l93t863r155b887],
3	changes	NNS	O	change	_	0	SENT_161	[p12l166t865r262b894],
4	as	IN	O	as	amod	3	SENT_161	[p12l273t872r296b887],
5	compared	VBN	O	compare	_	0	SENT_161	[p12l308t865r431b894],
6	to	TO	O	to	prepc_compared_to	4	SENT_161	[p12l442t870r468b887],
7	the	DT	O	the	det	9	SENT_161	[p12l478t865r518b887],
8	control	NN	O	control	nn	9	SENT_161	[p12l529t865r619b887],
9	phase	NN	O	phase	pobj	4	SENT_161	[p12l631t865r706b894],
10	.	.	O	.	_	0	SENT_161	[p12l631t865r706b894],

1	554	CD	NUMBER	554	_	0	SENT_162	[p12l94t969r154b998],
2	The	DT	O	the	det	3	SENT_162	[p12l1204t972r1254b998],
3	journal	NN	O	journal	dep	1	SENT_162	[p12l1262t972r1365b1006],
4	of	IN	O	of	_	0	SENT_162	[p12l1378t972r1410b1005],
5	Clinical	JJ	O	clinical	amod	6	SENT_162	[p12l1418t972r1515b998],
6	Pharmacology	NN	O	pharmacology	prep_of	3	SENT_162	[p12l1527t972r1721b1007],
7	/	:	O	/	punct	1	SENT_162	[p12l1733t972r1744b998],
8	Vol	NNP	O	Vol	dep	12	SENT_162	[p12l1755t972r1804b998],
9	53	CD	NUMBER	53	dep	8	SENT_162	[p12l1820t971r1853b998],
10	No	DT	O	no	det	11	SENT_162	[p12l1871t972r1917b998],
11	5	CD	NUMBER	5	dep	12	SENT_162	[p12l1932t972r1947b998],
12	(	NN	O	(	dep	16	SENT_162	[p12l1963t971r2022b1007],
13	20	CD	NUMBER	20	num	14	SENT_162	[p12l1963t971r2022b1007],
14	|	NN	O	|	dep	12	SENT_162	[p12l1963t971r2022b1007],
15	3	CD	NUMBER	3	num	16	SENT_162	[p12l2032t971r2058b1007],
16	)	NN	O	)	dep	1	SENT_162	[p12l2032t971r2058b1007],

1	A	DT	O	a	det	6	SENT_163	[p12l189t1119r224b1156],
2	C01lt1	NN	O	c01lt1	nn	6	SENT_163	[p12l424t1127r572b1157],
3	‘	CD	NUMBER	‘	num	6	SENT_163	[p12l424t1127r572b1157],
4	01	NN	NUMBER	01	nn	6	SENT_163	[p12l424t1127r572b1157],
5	B	NN	O	b	nn	6	SENT_163	[p12l795t1119r826b1155],
6	Clopidogrel	NN	O	clopidogrel	_	0	SENT_163	[p12l1010t1132r1236b1172],
7	C	NN	O	c	nn	9	SENT_163	[p12l1404t1119r1437b1155],
8	Clarithromycin	JJ	O	clarithromycin	amod	9	SENT_163	[p12l1598t1134r1899b1174],
9	%	NN	O	%	dep	6	SENT_163	[p12l190t1196r218b1248],
10	10	CD	NUMBER	10	num	11	SENT_163	[p12l242t1192r266b1214],
11	E	NN	O	e	dep	9	SENT_163	[p12l795t1194r818b1236],
12	10	CD	NUMBER	10	num	13	SENT_163	[p12l847t1200r871b1222],
13	E	NN	O	e	dep	6	SENT_163	[p12l1407t1192r1431b1234],
14	10	CD	NUMBER	10	number	15	SENT_163	[p12l1465t1203r1489b1224],
15	5	CD	NUMBER	5	dep	13	SENT_163	[p12l190t1251r219b1276],
16	2	CD	NUMBER	2	num	17	SENT_163	[p12l1407t1236r1437b1280],
17	§	NN	O	§	dep	6	SENT_163	[p12l195t1288r213b1332],
18	3	CD	NUMBER	3	dep	17	SENT_163	[p12l253t1281r266b1302],
19	3	CD	NUMBER	3	number	20	SENT_163	[p12l800t1294r818b1328],
20	3	CD	NUMBER	3	num	22	SENT_163	[p12l858t1286r871b1308],
21	3	CD	NUMBER	3	number	22	SENT_163	[p12l1413t1292r1431b1326],
22	8	CD	NUMBER	8	dep	6	SENT_163	[p12l1476t1290r1489b1310],
23	+	CC	O	+	_	0	SENT_163	[p12l190t1335r213b1345],
24	o	NN	O	o	dep	6	SENT_163	[p12l190t1335r213b1345],
25	‘	CD	NUMBER	‘	number	26	SENT_163	[p12l795t1333r818b1349],
26	.5	CD	NUMBER	.5	dep	6	SENT_163	[p12l795t1333r818b1349],
27	53	CD	NUMBER	53	num	29	SENT_163	[p12l1407t1329r1431b1360],
28	‘	NN	O	‘	nn	29	SENT_163	[p12l190t1345r213b1401],
29	E	NN	O	e	dep	26	SENT_163	[p12l190t1345r213b1401],
30	5	CD	NUMBER	5	number	31	SENT_163	[p12l253t1368r266b1390],
31	‘	CD	NUMBER	‘	dep	6	SENT_163	[p12l795t1349r818b1405],
32	E	NN	O	e	nn	35	SENT_163	[p12l795t1349r818b1405],
33	8	CD	NUMBER	8	num	35	SENT_163	[p12l858t1374r871b1396],
34	‘	NN	O	‘	nn	35	SENT_163	[p12l1407t1363r1431b1401],
35	E	NN	O	e	dep	31	SENT_163	[p12l1407t1363r1431b1401],
36	6	CD	NUMBER	6	num	38	SENT_163	[p12l1476t1378r1489b1398],
37	o	NN	O	o	nn	38	SENT_163	[p12l195t1404r213b1418],
38	.1	NN	NUMBER	.1	dep	6	SENT_163	[p12l801t1410r818b1424],
39	,	,	O	,	_	0	SENT_163	[p12l801t1410r818b1424],
40	o	NN	O	o	nn	43	SENT_163	[p12l1413t1404r1431b1418],
41	o	NN	O	o	nn	43	SENT_163	[p12l195t1421r213b1435],
42	o	NN	O	o	nn	43	SENT_163	[p12l801t1427r818b1440],
43	o	NN	O	o	appos	38	SENT_163	[p12l1413t1421r1431b1435],
44	5	CD	NUMBER	5	number	45	SENT_163	[p12l195t1440r213b1474],
45	4	CD	NUMBER	4	num	46	SENT_163	[p12l251t1456r266b1478],
46	E	NN	O	e	dep	6	SENT_163	[p12l800t1443r818b1478],
47	5	CD	NUMBER	5	number	48	SENT_163	[p12l1413t1438r1431b1472],
48	o	NN	O	o	amod	46	SENT_163	[p12l190t1477r213b1497],
49	Q	NNP	O	Q	nn	51	SENT_163	[p12l795t1481r818b1501],
50	4	CD	NUMBER	4	num	51	SENT_163	[p12l856t1462r871b1483],
51	o	NN	O	o	dep	6	SENT_163	[p12l1407t1475r1431b1495],
52	4	CD	NUMBER	4	number	53	SENT_163	[p12l1474t1464r1489b1483],
53	2	CD	NUMBER	2	dep	51	SENT_163	[p12l195t1509r213b1542],
54	2	CD	NUMBER	2	num	55	SENT_163	[p12l253t1546r265b1568],
55	3	CD	NUMBER	3	dep	6	SENT_163	[p12l801t1513r818b1546],
56	'	''	O	'	_	0	SENT_163	[p12l1413t1505r1431b1548],
57	2	CD	NUMBER	2	dep	55	SENT_163	[p12l1413t1505r1431b1548],
58	’	CD	NUMBER	’	number	59	SENT_163	[p12l1413t1505r1431b1548],
59	§	CD	NUMBER	§	num	55	SENT_163	[p12l195t1547r213b1577],
60	"	``	O	"	punct	55	SENT_163	[p12l795t1548r818b1553],
61	2	CD	NUMBER	2	num	62	SENT_163	[p12l858t1548r871b1570],
62	s	NNS	O	s	dep	55	SENT_163	[p12l1413t1550r1431b1574],
63	2	CD	NUMBER	2	number	64	SENT_163	[p12l1476t1550r1489b1570],
64	3	CD	NUMBER	3	dep	62	SENT_163	[p12l195t1581r213b1607],
65	5	CD	NUMBER	5	number	66	SENT_163	[p12l800t1558r818b1598],
66	3	CD	NUMBER	3	num	67	SENT_163	[p12l1413t1575r1431b1603],
67	*	NN	O	*	dep	6	SENT_163	[p12l190t1610r213b1637],
68	5	CD	NUMBER	5	number	70	SENT_163	[p12l190t1610r213b1637],
69	{	NN	O	{	dep	70	SENT_163	[p12l795t1599r818b1639],
70	=	JJ	O	=	amod	67	SENT_163	[p12l795t1599r818b1639],
71	3	CD	NUMBER	3	num	72	SENT_163	[p12l795t1599r818b1639],
72	*	NN	O	*	dep	6	SENT_163	[p12l1407t1605r1431b1632],
73	5	CD	NUMBER	5	num	76	SENT_163	[p12l1407t1605r1431b1632],
74	.3	NN	NUMBER	.3	nn	76	SENT_163	[p12l190t1640r213b1665],
75	o	NN	O	o	nn	76	SENT_163	[p12l253t1634r266b1656],
76	_	NN	O	_	dep	72	SENT_163	[p12l795t1642r818b1667],
77	.	.	O	.	_	0	SENT_163	[p12l795t1642r818b1667],

1	¢	RB	O	¢	dep	2	SENT_164	[p12l795t1642r818b1667],
2	_	CD	NUMBER	_	_	0	SENT_164	[p12l795t1642r818b1667],
3	:	:	O	:	_	0	SENT_164	[p12l795t1642r818b1667],
4	o	NN	O	o	nn	6	SENT_164	[p12l858t1636r871b1658],
5	-2	CD	NUMBER	-2	num	6	SENT_164	[p12l1407t1634r1431b1658],
6	D	NN	O	d	dep	16	SENT_164	[p12l1476t1636r1489b1656],
7	<	JJR	O	<	amod	9	SENT_164	[p12l190t1668r213b1686],
8	o	NN	O	o	nn	9	SENT_164	[p12l190t1668r213b1686],
9	o	NN	O	o	dep	6	SENT_164	[p12l274t1670r286b1692],
10	2	CD	NUMBER	2	number	11	SENT_164	[p12l355t1670r367b1691],
11	4	CD	NUMBER	4	num	13	SENT_164	[p12l433t1670r447b1691],
12	3	CD	NUMBER	3	number	13	SENT_164	[p12l515t1670r528b1691],
13	3	CD	NUMBER	3	dep	9	SENT_164	[p12l596t1670r608b1691],
14	10	CD	NUMBER	10	num	15	SENT_164	[p12l671t1670r693b1691],
15	w	NN	O	w	dep	16	SENT_164	[p12l795t1670r818b1688],
16	o	NN	O	o	dep	29	SENT_164	[p12l881t1672r893b1693],
17	2	CD	NUMBER	2	num	16	SENT_164	[p12l965t1672r978b1693],
18	4	CD	NUMBER	4	number	19	SENT_164	[p12l1048t1672r1062b1693],
19	3	CD	NUMBER	3	num	21	SENT_164	[p12l1132t1672r1144b1693],
20	3	CD	NUMBER	3	number	21	SENT_164	[p12l1216t1672r1229b1693],
21	10	CD	NUMBER	10	dep	16	SENT_164	[p12l1297t1672r1318b1693],
22	"	``	O	"	punct	21	SENT_164	[p12l1407t1661r1431b1678],
23	’	NN	O	’	nn	24	SENT_164	[p12l1407t1661r1431b1678],
24	o	NN	O	o	dep	21	SENT_164	[p12l1499t1670r1511b1690],
25	2	CD	NUMBER	2	number	26	SENT_164	[p12l1581t1670r1594b1690],
26	4	CD	NUMBER	4	num	27	SENT_164	[p12l1662t1670r1676b1690],
27	3	CD	NUMBER	3	dep	24	SENT_164	[p12l1746t1670r1759b1690],
28	3	CD	NUMBER	3	num	29	SENT_164	[p12l1829t1670r1841b1690],
29	10	CD	NUMBER	10	dep	2	SENT_164	[p12l1905t1670r1929b1690],

1	Time	NNP	O	Time	nn	3	SENT_165	[p12l472t1730r532b1754],
2	(	CD	NUMBER	(	num	3	SENT_165	[p12l538t1730r571b1760],
3	h	NN	O	h	dep	10	SENT_165	[p12l538t1730r571b1760],
4	)	NN	O	)	nn	6	SENT_165	[p12l538t1730r571b1760],
5	'	''	O	'	_	0	SENT_165	[p12l1087t1730r1149b1754],
6	l'Ime	NN	O	l'ime	dep	3	SENT_165	[p12l1087t1730r1149b1754],
7	(	CD	NUMBER	(	num	8	SENT_165	[p12l1156t1730r1187b1760],
8	h	NN	O	h	dep	10	SENT_165	[p12l1156t1730r1187b1760],
9	)	CD	NUMBER	)	num	10	SENT_165	[p12l1156t1730r1187b1760],
10	Time	NNP	O	Time	_	0	SENT_165	[p12l1697t1730r1759b1754],
11	(	CD	NUMBER	(	num	10	SENT_165	[p12l1765t1730r1796b1760],
12	h	NN	O	h	dep	10	SENT_165	[p12l1765t1730r1796b1760],
13	)	CD	NUMBER	)	num	12	SENT_165	[p12l1765t1730r1796b1760],

1	__	NN	O	__	_	0	SENT_166	[p12l182t1890r211b1898],
2	3.0	CD	NUMBER	3.0	num	1	SENT_166	[p12l246t1867r275b1887],
3	A	DT	O	a	det	6	SENT_166	[p12l793t1892r822b1900],
4	3.0	CD	NUMBER	3.0	number	5	SENT_166	[p12l847t1869r876b1889],
5	3	CD	NUMBER	3	num	6	SENT_166	[p12l1461t1854r1491b1874],
6	*	NN	O	*	dep	1	SENT_166	[p12l1461t1854r1491b1874],
7	”	CD	NUMBER	”	num	8	SENT_166	[p12l1461t1854r1491b1874],
8	E	NN	O	e	dep	6	SENT_166	[p12l182t1903r206b1935],
9	E	NN	O	e	nn	11	SENT_166	[p12l793t1904r816b1937],
10	E	NN	O	e	nn	11	SENT_166	[p12l1407t1908r1431b1939],
11	E	NN	O	e	dep	1	SENT_166	[p12l182t1948r211b1993],
12	2.4	CD	NUMBER	2.4	num	13	SENT_166	[p12l246t1947r275b1967],
13	E	NN	O	e	dep	11	SENT_166	[p12l793t1949r822b1995],
14	2.4	CD	NUMBER	2.4	num	16	SENT_166	[p12l847t1949r876b1969],
15	E	NN	O	e	nn	16	SENT_166	[p12l1407t1949r1436b1993],
16	C	NN	O	c	dep	1	SENT_166	[p12l188t2005r205b2021],
17	C	NN	O	c	nn	19	SENT_166	[p12l799t2007r816b2023],
18	C	NN	O	c	nn	19	SENT_166	[p12l1413t2004r1431b2019],
19	.2	NN	NUMBER	.2	dep	16	SENT_166	[p12l182t2025r205b2050],
20	1.3	CD	NUMBER	1.3	num	21	SENT_166	[p12l248t2030r275b2050],
21	.2	NN	NUMBER	.2	dep	1	SENT_166	[p12l793t2027r816b2052],
22	1.3	CD	NUMBER	1.3	number	23	SENT_166	[p12l849t2030r876b2050],
23	§	CD	NUMBER	§	dep	21	SENT_166	[p12l1407t2021r1431b2057],
24	15	CD	NUMBER	15	num	26	SENT_166	[p12l1463t2022r1491b2042],
25	«	NN	O	«	nn	26	SENT_166	[p12l182t2053r205b2063],
26	I-5	NN	O	i-5	dep	1	SENT_166	[p12l182t2053r205b2063],
27	I-o	NN	O	i-o	nn	30	SENT_166	[p12l793t2053r816b2063],
28	6	CD	NUMBER	6	num	30	SENT_166	[p12l1413t2057r1431b2072],
29	E	NN	O	e	nn	30	SENT_166	[p12l188t2063r206b2091],
30	E	NN	O	e	dep	26	SENT_166	[p12l799t2064r816b2093],
31	.	.	O	.	_	0	SENT_166	[p12l1407t2073r1431b2095],

1	-	:	O	-	_	0	SENT_167	[p12l1407t2073r1431b2095],
2	.	.	O	.	_	0	SENT_167	[p12l1407t2073r1431b2095],

1	-	:	O	-	_	0	SENT_168	[p12l1407t2073r1431b2095],
2	.	.	O	.	_	0	SENT_168	[p12l1407t2073r1431b2095],

1	‘	NN	O	‘	nn	2	SENT_169	[p12l182t2094r205b2121],
2	E	NN	O	e	_	0	SENT_169	[p12l182t2094r205b2121],
3	2	CD	NUMBER	2	number	4	SENT_169	[p12l263t2110r275b2130],
4	‘	CD	NUMBER	‘	num	6	SENT_169	[p12l793t2094r816b2123],
5	E	NN	O	e	nn	6	SENT_169	[p12l793t2094r816b2123],
6	‘	NN	O	‘	dep	2	SENT_169	[p12l1413t2096r1431b2111],
7	=	JJ	O	=	amod	6	SENT_169	[p12l1413t2096r1431b2111],
8	12	CD	NUMBER	12	tmod	7	SENT_169	[p12l1463t2105r1491b2125],
9	,	,	O	,	_	0	SENT_169	[p12l188t2124r205b2138],
10	,	,	O	,	_	0	SENT_169	[p12l188t2124r205b2138],
11	1	CD	NUMBER	1	appos	6	SENT_169	[p12l248t2111r262b2130],
12	.	.	O	.	_	0	SENT_169	[p12l248t2111r262b2130],

1	,	,	O	,	_	0	SENT_170	[p12l799t2126r816b2140],
2	,	,	O	,	_	0	SENT_170	[p12l799t2126r816b2140],
3	1.2	CD	NUMBER	1.2	nsubj	7	SENT_170	[p12l849t2112r876b2132],
4	3	CD	NUMBER	3	dep	7	SENT_170	[p12l1413t2114r1431b2143],
5	8	CD	NUMBER	8	number	6	SENT_170	[p12l188t2142r206b2175],
6	3	CD	NUMBER	3	num	7	SENT_170	[p12l799t2142r816b2177],
7	‘	NN	O	‘	_	0	SENT_170	[p12l1413t2146r1431b2162],
8	=	JJ	O	=	amod	10	SENT_170	[p12l1413t2146r1431b2162],
9	o	NN	O	o	nn	10	SENT_170	[p12l188t2180r205b2196],
10	o	NN	O	o	dep	19	SENT_170	[p12l799t2180r816b2196],
11	8	CD	NUMBER	8	num	14	SENT_170	[p12l1407t2165r1431b2201],
12	Q	NNP	O	Q	nn	14	SENT_170	[p12l182t2199r205b2218],
13	0.6	CD	NUMBER	0.6	num	14	SENT_170	[p12l246t2193r275b2213],
14	Q	NNP	O	Q	dep	10	SENT_170	[p12l793t2199r816b2218],
15	I16	NN	O	i16	nn	16	SENT_170	[p12l847t2193r876b2213],
16	F	NN	O	f	dep	19	SENT_170	[p12l1407t2215r1431b2226],
17	'15	CD	NUMBER	'15	num	19	SENT_170	[p12l1461t2189r1491b2209],
18	E	NN	O	e	nn	19	SENT_170	[p12l182t2234r206b2270],
19	E	NN	O	e	dep	7	SENT_170	[p12l793t2236r816b2272],
20	2	CD	NUMBER	2	dep	19	SENT_170	[p12l1407t2228r1431b2250],
21	'	''	O	'	_	0	SENT_170	[p12l472t2358r563b2385],

1	l'1me	NN	O	l'1me	nn	3	SENT_171	[p12l472t2358r563b2385],
2	(	CD	NUMBER	(	num	3	SENT_171	[p12l472t2358r563b2385],
3	h	NN	O	h	dep	12	SENT_171	[p12l472t2358r563b2385],
4	)	CD	NUMBER	)	num	5	SENT_171	[p12l472t2358r563b2385],
5	1	CD	NUMBER	1	dep	3	SENT_171	[p12l1081t2354r1174b2381],
6	'	''	O	'	_	0	SENT_171	[p12l1081t2354r1174b2381],
7	Ime	NNP	O	Ime	dep	5	SENT_171	[p12l1081t2354r1174b2381],
8	(	CD	NUMBER	(	num	7	SENT_171	[p12l1081t2354r1174b2381],
9	h	NN	O	h	dep	12	SENT_171	[p12l1081t2354r1174b2381],
10	)	NN	O	)	nn	12	SENT_171	[p12l1081t2354r1174b2381],
11	'	''	O	'	_	0	SENT_171	[p12l1673t2356r1762b2385],
12	line	NN	O	line	dep	15	SENT_171	[p12l1673t2356r1762b2385],
13	(	NN	O	(	nn	14	SENT_171	[p12l1673t2356r1762b2385],
14	h	NN	O	h	dep	12	SENT_171	[p12l1673t2356r1762b2385],
15	)	CD	NUMBER	)	_	0	SENT_171	[p12l1673t2356r1762b2385],

1	Figure	NN	O	figure	_	0	SENT_172	[p12l94t2448r190b2479],
2	2	CD	NUMBER	2	dep	1	SENT_172	[p12l201t2448r225b2472],
3	.	.	O	.	_	0	SENT_172	[p12l201t2448r225b2472],

1	Mean	NN	O	mean	nn	3	SENT_173	[p12l245t2449r313b2472],
2	plasma	NN	O	plasma	nn	3	SENT_173	[p12l325t2449r414b2480],
3	concentration	NN	O	concentration	dep	11	SENT_173	[p12l423t2450r678b2472],
4	—	CD	NUMBER	—	num	6	SENT_173	[p12l423t2450r678b2472],
5	time	NN	O	time	nn	6	SENT_173	[p12l423t2450r678b2472],
6	proﬁles	NNS	O	proﬁles	dep	3	SENT_173	[p12l689t2448r785b2480],
7	of	IN	O	of	_	0	SENT_173	[p12l795t2448r822b2472],
8	R-enantiomers	NNS	O	r-enantiomer	prep_of	6	SENT_173	[p12l831t2449r1022b2472],
9	(	CD	NUMBER	(	dep	11	SENT_173	[p12l1034t2448r1103b2480],
10	solid	JJ	O	solid	amod	11	SENT_173	[p12l1034t2448r1103b2480],
11	symbols	NNS	O	symbol	dep	18	SENT_173	[p12l1114t2448r1229b2480],
12	)	NN	O	)	dep	11	SENT_173	[p12l1114t2448r1229b2480],
13	and	CC	O	and	_	0	SENT_173	[p12l1240t2449r1285b2472],
14	S-enantiomers	NNS	O	s-enantiomer	conj_and	11	SENT_173	[p12l1297t2448r1486b2472],
15	(	RB	O	(	advmod	16	SENT_173	[p12l1497t2448r1571b2480],
16	open	JJ	O	open	amod	17	SENT_173	[p12l1497t2448r1571b2480],
17	symbols	NNS	O	symbol	dep	14	SENT_173	[p12l1583t2448r1697b2480],
18	)	NN	O	)	dep	24	SENT_173	[p12l1583t2448r1697b2480],
19	of	IN	O	of	_	0	SENT_173	[p12l1709t2448r1736b2472],
20	sibutramine	NN	O	sibutramine	nn	22	SENT_173	[p12l1744t2449r1899b2472],
21	(	CD	NUMBER	(	num	22	SENT_173	[p12l1910t2448r1968b2480],
22	o	NN	O	o	prep_of	18	SENT_173	[p12l1910t2448r1968b2480],
23	;	:	O	;	_	0	SENT_173	[p12l1910t2448r1968b2480],
24	o	NN	O	o	_	0	SENT_173	[p12l1910t2448r1968b2480],
25	)	CD	NUMBER	)	number	26	SENT_173	[p12l1910t2448r1968b2480],
26	(	CD	NUMBER	(	num	29	SENT_173	[p12l1980t2448r2068b2480],
27	upper	JJ	O	upper	amod	29	SENT_173	[p12l1980t2448r2068b2480],
28	panel	NN	O	panel	nn	29	SENT_173	[p12l94t2490r179b2522],
29	)	NN	O	)	dep	24	SENT_173	[p12l94t2490r179b2522],
30	,	,	O	,	_	0	SENT_173	[p12l94t2490r179b2522],
31	MI	NNP	O	MI	appos	24	SENT_173	[p12l192t2490r225b2514],
32	(	CD	NUMBER	(	num	31	SENT_173	[p12l243t2490r291b2522],
33	I	PRP	O	I	dep	31	SENT_173	[p12l243t2490r291b2522],
34	;	:	O	;	_	0	SENT_173	[p12l243t2490r291b2522],
35	)	CD	NUMBER	)	number	36	SENT_173	[p12l319t2490r328b2522],
36	(	CD	NUMBER	(	npadvmod	37	SENT_173	[p12l341t2490r428b2522],
37	lower	JJR	O	lower	amod	39	SENT_173	[p12l341t2490r428b2522],
38	panel	NN	O	panel	nn	39	SENT_173	[p12l439t2490r516b2522],
39	)	NN	O	)	appos	24	SENT_173	[p12l439t2490r516b2522],
40	after	IN	O	after	mark	48	SENT_173	[p12l528t2490r589b2514],
41	single	JJ	O	single	amod	43	SENT_173	[p12l599t2490r671b2522],
42	oral	JJ	O	oral	amod	43	SENT_173	[p12l681t2490r731b2514],
43	doses	NNS	O	dose	nsubj	48	SENT_173	[p12l743t2490r816b2514],
44	of	IN	O	of	prep	43	SENT_173	[p12l827t2490r854b2514],
45	IS	VBZ	O	be	cop	48	SENT_173	[p12l868t2490r893b2514],
46	mg	NN	O	mg	nn	48	SENT_173	[p12l908t2498r946b2522],
47	sibutramine	NN	O	sibutramine	nn	48	SENT_173	[p12l956t2490r1111b2514],
48	racemate	NN	O	racemate	dep	39	SENT_173	[p12l1122t2496r1243b2514],
49	into	IN	O	into	_	0	SENT_173	[p12l1254t2492r1305b2514],
50	I7	NN	O	i7	nn	52	SENT_173	[p12l1321t2490r1347b2514],
51	healthy	JJ	O	healthy	amod	52	SENT_173	[p12l1359t2490r1452b2522],
52	subjects	NNS	O	subject	prep_into	48	SENT_173	[p12l1463t2490r1567b2521],
53	in	IN	O	in	_	0	SENT_173	[p12l1579t2492r1599b2514],
54	the	DT	O	the	det	58	SENT_173	[p12l1611t2490r1653b2514],
55	control	NN	O	control	nn	58	SENT_173	[p12l1664t2490r1759b2514],
56	phase	NN	O	phase	nn	58	SENT_173	[p12l1772t2490r1845b2522],
57	(	NN	O	(	nn	58	SENT_173	[p12l1857t2490r1937b2522],
58	A	NN	O	a	prep_in	52	SENT_173	[p12l1857t2490r1937b2522],
59	,	,	O	,	_	0	SENT_173	[p12l1857t2490r1937b2522],
60	D	NN	O	d	nn	61	SENT_173	[p12l1857t2490r1937b2522],
61	)	NN	O	)	appos	58	SENT_173	[p12l1857t2490r1937b2522],
62	,	,	O	,	_	0	SENT_173	[p12l1857t2490r1937b2522],
63	following	VBG	O	follow	_	0	SENT_173	[p12l1947t2490r2068b2522],
64	pretreatment	NN	O	pretreatment	prep_following	48	SENT_173	[p12l94t2537r271b2563],
65	with	IN	O	with	_	0	SENT_173	[p12l280t2532r337b2556],
66	clopidogrel	NN	O	clopidogrel	nn	68	SENT_173	[p12l350t2532r495b2563],
67	(	NN	O	(	nn	68	SENT_173	[p12l509t2532r569b2563],
68	B	NN	O	b	prep_with	64	SENT_173	[p12l509t2532r569b2563],
69	,	,	O	,	_	0	SENT_173	[p12l509t2532r569b2563],
70	E	NN	O	e	nn	71	SENT_173	[p12l509t2532r569b2563],
71	)	NN	O	)	appos	68	SENT_173	[p12l509t2532r569b2563],
72	and	CC	O	and	_	0	SENT_173	[p12l581t2532r627b2556],
73	following	VBG	O	follow	amod	74	SENT_173	[p12l638t2532r759b2563],
74	pre-treatment	NN	O	pre-treatment	conj_and	31	SENT_173	[p12l770t2537r958b2563],
75	with	IN	O	with	_	0	SENT_173	[p12l967t2532r1024b2556],
76	Clarithromycin	NN	MISC	clarithromycin	nn	78	SENT_173	[p12l1037t2532r1227b2563],
77	(	NN	O	(	nn	78	SENT_173	[p12l1241t2532r1312b2563],
78	C	NN	O	c	prep_with	74	SENT_173	[p12l1241t2532r1312b2563],
79	,	,	O	,	_	0	SENT_173	[p12l1241t2532r1312b2563],
80	F	NN	MISC	f	nn	81	SENT_173	[p12l1241t2532r1312b2563],
81	)	NN	O	)	appos	78	SENT_173	[p12l1241t2532r1312b2563],
82	.	.	O	.	_	0	SENT_173	[p12l1241t2532r1312b2563],

1	M1	NN	O	m1	nn	2	SENT_174	[p12l93t2632r145b2660],
2	formation	NN	O	formation	nsubj	4	SENT_174	[p12l171t2631r333b2661],
3	was	VBD	O	be	cop	4	SENT_174	[p12l353t2641r416b2661],
4	greater	JJR	O	greater	_	0	SENT_174	[p12l438t2635r552b2669],
5	than	IN	O	than	_	0	SENT_174	[p12l572t2631r643b2661],
6	that	DT	O	that	prep_than	4	SENT_174	[p12l663t2631r725b2661],
7	of	IN	O	of	_	0	SENT_174	[p12l746t2631r784b2661],
8	R-Ml	NN	O	r-ml	prep_of	6	SENT_174	[p12l798t2632r891b2660],
9	in	IN	O	in	_	0	SENT_174	[p12l917t2631r948b2660],
10	both	CC	O	both	dep	11	SENT_174	[p12l968t2631r1042b2661],
11	R-M2	NN	O	r-m2	prep_in	4	SENT_174	[p12l1116t2632r1212b2660],
12	in	IN	O	in	_	0	SENT_174	[p12l1233t2631r1265b2660],
13	HLMs	NNS	O	hlm	prep_in	11	SENT_174	[p12l1284t2632r1390b2661],
14	while	IN	O	while	mark	18	SENT_174	[p12l1410t2631r1501b2661],
15	the	DT	O	the	det	16	SENT_174	[p12l1521t2631r1570b2661],
16	reverse	NN	O	reverse	nsubjpass	18	SENT_174	[p12l1590t2641r1707b2661],
17	was	VBD	O	be	auxpass	18	SENT_174	[p12l1727t2641r1790b2661],
18	noted	VBN	O	note	advcl	4	SENT_174	[p12l1810t2631r1902b2661],
19	in	IN	O	in	_	0	SENT_174	[p12l1921t2631r1953b2660],
20	HIMs	NNS	O	him	nn	21	SENT_174	[p12l1972t2632r2067b2661],
21	HIMS	NNS	O	him	prep_in	18	SENT_174	[p12l93t2681r187b2710],
22	and	CC	O	and	_	0	SENT_174	[p12l205t2680r264b2710],
23	HLMs	NNS	O	hlm	conj_and	21	SENT_174	[p12l280t2681r395b2710],
24	.	.	O	.	_	0	SENT_174	[p12l280t2681r395b2710],

1	The	DT	O	the	det	3	SENT_175	[p12l414t2680r476b2710],
2	intrinsic	JJ	O	intrinsic	amod	3	SENT_175	[p12l494t2680r626b2710],
3	clearances	NNS	O	clearance	_	0	SENT_175	[p12l644t2680r813b2710],
4	of	IN	O	of	_	0	SENT_175	[p12l830t2680r868b2710],
5	R	NN	O	r	prep_of	3	SENT_175	[p12l878t2681r916b2710],
6	-	:	O	-	_	0	SENT_175	[p12l878t2681r916b2710],
7	and	CC	O	and	_	0	SENT_175	[p12l934t2680r993b2710],
8	S	NN	O	s	prep_of	3	SENT_175	[p12l1008t2681r1041b2710],
9	-	:	O	-	_	0	SENT_175	[p12l1008t2681r1041b2710],
10	(	CD	NUMBER	(	num	12	SENT_175	[p12l1119t2680r1237b2719],
11	Figure	NNP	O	Figure	nn	12	SENT_175	[p12l1119t2680r1237b2719],
12	3B	NN	O	3b	dep	3	SENT_175	[p12l1254t2681r1310b2717],
13	,	,	O	,	_	0	SENT_175	[p12l1254t2681r1310b2717],
14	Table	NNP	O	Table	nn	16	SENT_175	[p12l1327t2680r1419b2710],
15	3	CD	NUMBER	3	num	16	SENT_175	[p12l1436t2680r1476b2719],
16	)	NN	O	)	appos	12	SENT_175	[p12l1436t2680r1476b2719],
17	.	.	O	.	_	0	SENT_175	[p12l1436t2680r1476b2719],

1	sibutramine	NN	O	sibutramine	nsubj	7	SENT_176	[p12l94t2730r286b2760],
2	were	VBD	O	be	cop	7	SENT_176	[p12l303t2740r383b2760],
3	87.7	CD	NUMBER	87.7	num	7	SENT_176	[p12l402t2731r471b2760],
4	and	CC	O	and	_	0	SENT_176	[p12l491t2730r550b2760],
5	115.7	CD	NUMBER	115.7	num	7	SENT_176	[p12l571t2731r658b2760],
6	uL/min/mg	NN	O	ul/min/mg	nn	7	SENT_176	[p12l675t2730r859b2768],
7	protein	NN	O	protein	conj_but	7	SENT_176	[p12l876t2730r994b2768],
8	in	IN	O	in	_	0	SENT_176	[p12l1011t2730r1043b2759],
9	HIMS	NNP	O	HIMS	prep_in	7	SENT_176	[p12l93t2780r197b2815],
10	,	,	O	,	_	0	SENT_176	[p12l93t2780r197b2815],
11	but	CC	O	but	_	0	SENT_176	[p12l216t2779r269b2809],
12	28.6	CD	NUMBER	28.6	num	16	SENT_176	[p12l286t2780r357b2809],
13	and	CC	O	and	_	0	SENT_176	[p12l376t2779r435b2809],
14	30.8	CD	NUMBER	30.8	num	16	SENT_176	[p12l453t2780r522b2809],
15	uL/min/mg	NN	O	ul/min/mg	nn	16	SENT_176	[p12l540t2779r724b2818],
16	protein	NN	O	protein	npadvmod	7	SENT_176	[p12l741t2779r858b2818],
17	in	IN	O	in	_	0	SENT_176	[p12l876t2779r907b2809],
18	HLMS	NNS	O	hlm	prep_in	16	SENT_176	[p12l925t2780r1040b2816],
19	,	,	O	,	_	0	SENT_176	[p12l925t2780r1040b2816],
20	Effects	NNS	O	effect	appos	18	SENT_176	[p12l1120t2779r1225b2809],
21	of	IN	O	of	_	0	SENT_176	[p12l1240t2779r1274b2809],
22	the	DT	O	the	det	24	SENT_176	[p12l1284t2779r1337b2809],
23	CYPZB6	NNP	O	CYPZB6	nn	24	SENT_176	[p12l1352t2779r1474b2809],
24	Genotype	NN	O	genotype	prep_of	20	SENT_176	[p12l1491t2779r1654b2819],
25	on	IN	O	on	_	0	SENT_176	[p12l1669t2789r1709b2809],
26	the	DT	O	the	det	27	SENT_176	[p12l1723t2779r1777b2809],
27	respectively	RB	O	respectively	prep_on	7	SENT_176	[p12l92t2828r298b2867],
28	.	.	O	.	_	0	SENT_176	[p12l92t2828r298b2867],

1	In	IN	O	in	_	0	SENT_177	[p12l317t2829r350b2858],
2	contrast	NN	O	contrast	prep_in	5	SENT_177	[p12l366t2832r503b2865],
3	,	,	O	,	_	0	SENT_177	[p12l366t2832r503b2865],
4	HLMS	NN	O	hlm	nsubj	5	SENT_177	[p12l520t2829r627b2858],
5	showed	VBD	O	show	_	0	SENT_177	[p12l644t2828r769b2858],
6	higher	JJR	O	higher	amod	8	SENT_177	[p12l784t2828r890b2867],
7	catalytic	JJ	O	catalytic	amod	8	SENT_177	[p12l905t2828r1041b2867],
8	Pharmacokinetics	NNS	O	pharmacokinetic	dobj	5	SENT_177	[p12l1120t2829r1408b2858],
9	of	IN	O	of	_	0	SENT_177	[p12l1423t2828r1457b2858],
10	Sibutramine	NNP	O	Sibutramine	nn	12	SENT_177	[p12l1468t2828r1665b2858],
11	Enantiomers	NNPS	O	Enantiomers	nn	12	SENT_177	[p12l1681t2829r1886b2858],
12	activity	NN	O	activity	prep_of	8	SENT_177	[p12l93t2878r215b2916],
13	towards	IN	O	towards	_	0	SENT_177	[p12l238t2878r368b2908],
14	the	DT	O	the	det	15	SENT_177	[p12l392t2878r441b2908],
15	formation	NN	O	formation	prep_towards	12	SENT_177	[p12l466t2878r628b2908],
16	of	IN	O	of	_	0	SENT_177	[p12l651t2878r689b2908],
17	M2	NN	O	m2	prep_of	15	SENT_177	[p12l708t2879r763b2907],
18	from	IN	O	from	_	0	SENT_177	[p12l789t2878r868b2908],
19	M1	NN	O	m1	prep_from	5	SENT_177	[p12l891t2879r943b2907],
20	than	IN	O	than	_	0	SENT_177	[p12l971t2878r1042b2908],
21	The	DT	O	the	det	22	SENT_177	[p12l1118t2878r1181b2908],
22	effects	NNS	O	effect	prep_than	5	SENT_177	[p12l1193t2878r1300b2908],
23	of	IN	O	of	_	0	SENT_177	[p12l1312t2878r1350b2908],
24	the	DT	O	the	det	26	SENT_177	[p12l1355t2878r1405b2908],
25	CYPZB6	NN	O	cypzb6	nn	26	SENT_177	[p12l1418t2879r1560b2908],
26	genotypes	NNS	O	genotype	prep_of	22	SENT_177	[p12l1570t2882r1736b2916],
27	on	IN	O	on	_	0	SENT_177	[p12l1748t2888r1789b2908],
28	the	DT	O	the	det	29	SENT_177	[p12l1799t2878r1848b2908],
29	pharmacoki	NN	O	pharmacokus	prep_on	5	SENT_177	[p12l1859t2878r2067b2916],
30	—	CD	NUMBER	—	num	31	SENT_177	[p12l1859t2878r2067b2916],
31	HIMs	NNS	O	him	dep	29	SENT_177	[p12l93t2928r196b2957],
32	.	.	O	.	_	0	SENT_177	[p12l93t2928r196b2957],

1	The	DT	O	the	det	3	SENT_178	[p12l209t2927r271b2957],
2	formation	NN	O	formation	nn	3	SENT_178	[p12l283t2927r444b2957],
3	rate	NN	O	rate	nsubj	7	SENT_178	[p12l453t2931r514b2957],
4	of	IN	O	of	_	0	SENT_178	[p12l525t2927r563b2957],
5	S-M2	NN	O	s-m2	prep_of	3	SENT_178	[p12l567t2928r658b2957],
6	was	VBD	O	be	cop	7	SENT_178	[p12l669t2937r732b2957],
7	higher	JJR	O	higher	_	0	SENT_178	[p12l742t2927r849b2965],
8	than	IN	O	than	mark	15	SENT_178	[p12l857t2927r928b2957],
9	that	DT	O	that	nsubjpass	15	SENT_178	[p12l937t2927r999b2957],
10	of	IN	O	of	_	0	SENT_178	[p12l1009t2927r1047b2957],
11	netics	NNS	O	netic	prep_of	9	SENT_178	[p12l1117t2927r1212b2957],
12	of	IN	O	of	_	0	SENT_178	[p12l1233t2927r1270b2957],
13	sibutramine	NN	O	sibutramine	prep_of	11	SENT_178	[p12l1285t2927r1477b2957],
14	were	VBD	O	be	auxpass	15	SENT_178	[p12l1496t2937r1575b2957],
15	evaluated	VBN	O	evaluate	ccomp	7	SENT_178	[p12l1595t2927r1752b2957],
16	in	IN	O	in	_	0	SENT_178	[p12l1771t2927r1802b2956],
17	subject	JJ	O	subject	amod	18	SENT_178	[p12l1822t2927r1937b2965],
18	groups	NNS	O	group	prep_in	15	SENT_178	[p12l1956t2937r2067b2965],

1	Table	NNP	O	Table	_	0	SENT_179	[p12l93t3040r179b3064],
2	2	CD	NUMBER	2	dep	1	SENT_179	[p12l189t3040r213b3064],
3	.	.	O	.	_	0	SENT_179	[p12l189t3040r213b3064],

1	AUC	NN	O	auc	nn	2	SENT_180	[p12l231t3040r298b3064],
2	Ratios	NNS	O	ratio	_	0	SENT_180	[p12l309t3040r388b3064],
3	of	IN	O	of	_	0	SENT_180	[p12l397t3040r425b3064],
4	Sibutramine	NNP	O	Sibutramine	prep_of	2	SENT_180	[p12l432t3040r595b3067],
5	,	,	O	,	_	0	SENT_180	[p12l432t3040r595b3067],
6	MI	NNP	O	MI	prep_of	2	SENT_180	[p12l606t3040r640b3063],
7	and	CC	O	and	_	0	SENT_180	[p12l654t3040r699b3064],
8	M2	NN	O	m2	conj_and	4	SENT_180	[p12l710t3040r750b3063],
9	After	IN	O	after	dep	2	SENT_180	[p12l758t3040r828b3064],
10	a	DT	O	a	det	14	SENT_180	[p12l836t3048r850b3064],
11	Single	JJ	O	single	amod	14	SENT_180	[p12l858t3040r932b3071],
12	I5	NN	O	i5	nn	14	SENT_180	[p12l947t3040r972b3064],
13	mg	NN	O	mg	nn	14	SENT_180	[p12l986t3048r1024b3071],
14	Dose	NN	O	dose	pobj	9	SENT_180	[p12l1034t3040r1102b3064],
15	in	IN	O	in	_	0	SENT_180	[p12l1112t3042r1132b3063],
16	the	DT	O	the	det	18	SENT_180	[p12l1141t3040r1184b3064],
17	Control	NN	O	control	nn	18	SENT_180	[p12l1194t3040r1298b3064],
18	Phase	NN	O	phase	prep_in	14	SENT_180	[p12l1309t3040r1382b3064],
19	and	CC	O	and	_	0	SENT_180	[p12l1390t3040r1436b3064],
20	After	IN	O	after	_	0	SENT_180	[p12l1444t3040r1515b3064],
21	Pretreatment	NN	O	pretreatment	prep_after	14	SENT_180	[p12l1524t3040r1701b3064],
22	With	IN	O	with	dep	2	SENT_180	[p12l1708t3040r1775b3064],
23	Either	CC	O	either	preconj	24	SENT_180	[p12l1787t3040r1865b3064],
24	Clopidogrel	NN	O	clopidogrel	pobj	22	SENT_180	[p12l1873t3040r2027b3071],
25	or	CC	O	or	_	0	SENT_180	[p12l2038t3048r2068b3064],
26	Clarithromycin	NN	O	clarithromycin	pobj	22	SENT_180	[p12l93t3081r292b3113],

1	Control	NNP	O	Control	nn	2	SENT_181	[p12l518t3162r616b3185],
2	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_181	[p12l790t3162r934b3192],
3	Mean	NN	O	mean	nn	4	SENT_181	[p12l1137t3163r1200b3185],
4	Ratio	NN	O	ratio	dep	2	SENT_181	[p12l1215t3161r1288b3185],
5	“	CD	NUMBER	“	num	8	SENT_181	[p12l1215t3161r1288b3185],
6	Clarithromycin	NNP	O	Clarithromycin	nn	8	SENT_181	[p12l1480t3162r1667b3192],
7	Mean	NN	O	mean	nn	8	SENT_181	[p12l1867t3163r1931b3185],
8	Ratio	NN	O	ratio	dep	2	SENT_181	[p12l1945t3163r2008b3185],

1	AUC	NN	O	auc	nn	6	SENT_182	[p12l92t3202r156b3224],
2	ratio	NN	O	ratio	nn	6	SENT_182	[p12l169t3203r226b3224],
3	Phase	NN	O	phase	nn	6	SENT_182	[p12l534t3202r602b3224],
4	Phase	NN	O	phase	nn	6	SENT_182	[p12l829t3202r897b3224],
5	(	NN	O	(	nn	6	SENT_182	[p12l1082t3202r1246b3231],
6	lnterquartile	NN	O	lnterquartile	_	0	SENT_182	[p12l1082t3202r1246b3231],
7	Range	NNP	O	Range	nn	12	SENT_182	[p12l1259t3202r1340b3231],
8	)	NNP	O	)	nn	12	SENT_182	[p12l1259t3202r1340b3231],
9	Phase	NN	O	phase	nn	12	SENT_182	[p12l1541t3202r1609b3224],
10	(	NN	O	(	nn	12	SENT_182	[p12l1808t3202r1971b3231],
11	lnterquartile	NN	O	lnterquartile	nn	12	SENT_182	[p12l1808t3202r1971b3231],
12	Range	NNP	O	Range	dep	6	SENT_182	[p12l1985t3202r2066b3231],
13	)	CD	NUMBER	)	dep	6	SENT_182	[p12l1985t3202r2066b3231],

1	S-Ml/S-sibu	NN	O	s-ml/s-sibu	_	0	SENT_183	[p12l93t3284r237b3306],
2	9.04	CD	NUMBER	9.04	dep	1	SENT_183	[p12l492t3284r544b3306],
3	:	:	O	:	_	0	SENT_183	[p12l557t3295r578b3306],
4	:	:	O	:	_	0	SENT_183	[p12l557t3295r578b3306],
5	6.75	CD	NUMBER	6.75	num	6	SENT_183	[p12l591t3284r642b3306],
6	6.97	CD	NUMBER	6.97	dep	1	SENT_183	[p12l782t3284r834b3306],
7	:	:	O	:	_	0	SENT_183	[p12l847t3295r868b3306],
8	:	:	O	:	_	0	SENT_183	[p12l847t3295r868b3306],
9	4.82	CD	NUMBER	4.82	number	10	SENT_183	[p12l880t3284r933b3306],
10	0.77	CD	NUMBER	0.77	dep	6	SENT_183	[p12l1107t3284r1160b3306],
11	(	NN	O	(	dep	10	SENT_183	[p12l1173t3284r1240b3313],
12	0.54	CD	NUMBER	0.54	num	11	SENT_183	[p12l1173t3284r1240b3313],
13	,	,	O	,	_	0	SENT_183	[p12l1173t3284r1240b3313],
14	l.	NN	O	l.	appos	10	SENT_183	[p12l1258t3284r1314b3313],
15	38	CD	NUMBER	38	num	14	SENT_183	[p12l1258t3284r1314b3313],
16	)	CD	NUMBER	)	num	18	SENT_183	[p12l1258t3284r1314b3313],
17	2.7	CD	NUMBER	2.7	num	18	SENT_183	[p12l1489t3284r1536b3306],
18	l	NN	O	l	dep	14	SENT_183	[p12l1489t3284r1536b3306],
19	:	:	O	:	_	0	SENT_183	[p12l1554t3295r1575b3306],
20	:	:	O	:	_	0	SENT_183	[p12l1554t3295r1575b3306],
21	2.24	CD	NUMBER	2.24	number	22	SENT_183	[p12l1588t3277r1660b3306],
22	“	CD	NUMBER	“	dep	6	SENT_183	[p12l1588t3277r1660b3306],
23	0.30	CD	NUMBER	0.30	dep	6	SENT_183	[p12l1833t3284r1885b3306],
24	(	NN	O	(	prep	6	SENT_183	[p12l1898t3284r1966b3313],
25	0	CD	NUMBER	0	dep	24	SENT_183	[p12l1898t3284r1966b3313],
26	.	.	O	.	_	0	SENT_183	[p12l1898t3284r1966b3313],

1	l7	NN	O	l7	_	0	SENT_184	[p12l1898t3284r1966b3313],
2	,	,	O	,	_	0	SENT_184	[p12l1898t3284r1966b3313],
3	0.44	CD	NUMBER	0.44	num	4	SENT_184	[p12l1978t3284r2040b3313],
4	)	CD	NUMBER	)	appos	1	SENT_184	[p12l1978t3284r2040b3313],
5	R-Ml/R-sibu	NN	O	r-ml/r-sibu	dep	4	SENT_184	[p12l93t3325r241b3348],
6	4.20	CD	NUMBER	4.20	num	5	SENT_184	[p12l492t3325r544b3348],
7	:	:	O	:	_	0	SENT_184	[p12l557t3336r578b3348],
8	:	:	O	:	_	0	SENT_184	[p12l557t3336r578b3348],
9	3.35	CD	NUMBER	3.35	number	10	SENT_184	[p12l592t3325r642b3348],
10	4.02	CD	NUMBER	4.02	dep	5	SENT_184	[p12l781t3325r834b3348],
11	:	:	O	:	_	0	SENT_184	[p12l847t3336r868b3348],
12	:	:	O	:	_	0	SENT_184	[p12l847t3336r868b3348],
13	5.07	CD	NUMBER	5.07	number	14	SENT_184	[p12l881t3325r933b3348],
14	0.96	CD	NUMBER	0.96	dep	10	SENT_184	[p12l1107t3325r1159b3348],
15	(	NN	O	(	dep	14	SENT_184	[p12l1173t3325r1240b3355],
16	0.58	CD	NUMBER	0.58	num	15	SENT_184	[p12l1173t3325r1240b3355],
17	,	,	O	,	_	0	SENT_184	[p12l1173t3325r1240b3355],
18	I46	CD	NUMBER	i46	appos	14	SENT_184	[p12l1258t3325r1307b3355],
19	)	CD	NUMBER	)	number	20	SENT_184	[p12l1258t3325r1307b3355],
20	2.86	CD	NUMBER	2.86	dep	18	SENT_184	[p12l1489t3325r1541b3348],
21	:	:	O	:	_	0	SENT_184	[p12l1554t3336r1575b3348],
22	:	:	O	:	_	0	SENT_184	[p12l1554t3336r1575b3348],
23	2.82	CD	NUMBER	2.82	number	24	SENT_184	[p12l1588t3318r1650b3348],
24	*	CD	NUMBER	*	dep	18	SENT_184	[p12l1588t3318r1650b3348],
25	0.68	CD	NUMBER	0.68	num	26	SENT_184	[p12l1833t3325r1885b3348],
26	(	NN	O	(	dep	24	SENT_184	[p12l1898t3325r1966b3355],
27	0.44	CD	NUMBER	0.44	dep	24	SENT_184	[p12l1898t3325r1966b3355],
28	,	,	O	,	_	0	SENT_184	[p12l1898t3325r1966b3355],
29	0.82	CD	NUMBER	0.82	appos	24	SENT_184	[p12l1978t3325r2040b3355],
30	)	CD	NUMBER	)	num	31	SENT_184	[p12l1978t3325r2040b3355],
31	R-M2	NN	O	r-m2	rcmod	29	SENT_184	[p12l93t3367r241b3389],
32	/	:	O	/	punct	33	SENT_184	[p12l93t3367r241b3389],
33	R-sibu	NN	O	r-sibu	dep	31	SENT_184	[p12l93t3367r241b3389],
34	8.86	CD	NUMBER	8.86	num	33	SENT_184	[p12l492t3367r544b3389],
35	:	:	O	:	_	0	SENT_184	[p12l557t3377r578b3389],
36	:	:	O	:	_	0	SENT_184	[p12l557t3377r578b3389],
37	9.00	CD	NUMBER	9.00	number	38	SENT_184	[p12l591t3367r643b3389],
38	6.85	CD	NUMBER	6.85	dep	31	SENT_184	[p12l782t3367r833b3389],
39	:	:	O	:	_	0	SENT_184	[p12l847t3377r868b3389],
40	:	:	O	:	_	0	SENT_184	[p12l847t3377r868b3389],
41	|	CD	NUMBER	|	number	42	SENT_184	[p12l886t3359r943b3389],
42	3.4	CD	NUMBER	3.4	num	44	SENT_184	[p12l886t3359r943b3389],
43	*	CD	NUMBER	*	number	44	SENT_184	[p12l886t3359r943b3389],
44	0.77	CD	NUMBER	0.77	dep	18	SENT_184	[p12l1107t3367r1160b3389],
45	(	NN	O	(	nn	47	SENT_184	[p12l1173t3366r1240b3396],
46	0.3	CD	NUMBER	0.3	num	47	SENT_184	[p12l1173t3366r1240b3396],
47	|	NN	O	|	dep	44	SENT_184	[p12l1173t3366r1240b3396],
48	,	,	O	,	_	0	SENT_184	[p12l1173t3366r1240b3396],
49	0.93	CD	NUMBER	0.93	number	50	SENT_184	[p12l1253t3367r1314b3396],
50	)	CD	NUMBER	)	appos	10	SENT_184	[p12l1253t3367r1314b3396],
51	9.40	CD	NUMBER	9.40	dep	50	SENT_184	[p12l1489t3367r1541b3389],
52	:	:	O	:	_	0	SENT_184	[p12l1554t3377r1575b3389],
53	:	:	O	:	_	0	SENT_184	[p12l1554t3377r1575b3389],
54	l8	NN	O	l8	dep	1	SENT_184	[p12l1593t3366r1635b3389],
55	.	.	O	.	_	0	SENT_184	[p12l1593t3366r1635b3389],

1	|	NN	O	|	_	0	SENT_185	[p12l1593t3366r1635b3389],
2	l.	SYM	O	l.	dep	4	SENT_185	[p12l1838t3366r1885b3389],
3	06	CD	NUMBER	06	num	4	SENT_185	[p12l1838t3366r1885b3389],
4	(	NN	O	(	rcmod	1	SENT_185	[p12l1898t3366r1966b3396],
5	0.4	CD	NUMBER	0.4	num	6	SENT_185	[p12l1898t3366r1966b3396],
6	|	NN	O	|	dep	1	SENT_185	[p12l1898t3366r1966b3396],
7	,	,	O	,	_	0	SENT_185	[p12l1898t3366r1966b3396],
8	0.84	CD	NUMBER	0.84	appos	6	SENT_185	[p12l1978t3366r2040b3396],
9	)	CD	NUMBER	)	num	11	SENT_185	[p12l1978t3366r2040b3396],
10	S-Ml	NN	O	s-ml	nn	11	SENT_185	[p12l93t3408r150b3431],
11	S-M2	NN	O	s-m2	rcmod	8	SENT_185	[p12l202t3408r346b3431],
12	/	:	O	/	punct	13	SENT_185	[p12l202t3408r346b3431],
13	S-sibu	NN	O	s-sibu	dep	11	SENT_185	[p12l202t3408r346b3431],
14	9.04	CD	NUMBER	9.04	num	13	SENT_185	[p12l492t3408r544b3431],
15	:	:	O	:	_	0	SENT_185	[p12l557t3419r578b3431],
16	:	:	O	:	_	0	SENT_185	[p12l557t3419r578b3431],
17	6.75	CD	NUMBER	6.75	number	18	SENT_185	[p12l591t3409r642b3431],
18	6.97	CD	NUMBER	6.97	dep	11	SENT_185	[p12l782t3408r834b3431],
19	:	:	O	:	_	0	SENT_185	[p12l847t3419r868b3431],
20	:	:	O	:	_	0	SENT_185	[p12l847t3419r868b3431],
21	4.82	CD	NUMBER	4.82	number	22	SENT_185	[p12l880t3408r933b3431],
22	0.77	CD	NUMBER	0.77	dep	8	SENT_185	[p12l1107t3408r1160b3431],
23	(	NN	O	(	dep	22	SENT_185	[p12l1173t3408r1240b3438],
24	0.54	CD	NUMBER	0.54	num	23	SENT_185	[p12l1173t3408r1240b3438],
25	,	,	O	,	_	0	SENT_185	[p12l1173t3408r1240b3438],
26	|	CD	NUMBER	|	number	27	SENT_185	[p12l1258t3408r1314b3438],
27	.38	CD	NUMBER	.38	num	28	SENT_185	[p12l1258t3408r1314b3438],
28	)	NN	O	)	appos	6	SENT_185	[p12l1258t3408r1314b3438],
29	2.7	CD	NUMBER	2.7	num	30	SENT_185	[p12l1489t3408r1536b3431],
30	l	NN	O	l	tmod	28	SENT_185	[p12l1489t3408r1536b3431],
31	:	:	O	:	_	0	SENT_185	[p12l1554t3419r1575b3431],
32	:	:	O	:	_	0	SENT_185	[p12l1554t3419r1575b3431],
33	2.24	CD	PERCENT	2.24	num	34	SENT_185	[p12l1588t3401r1660b3431],
34	%	NN	PERCENT	%	dep	1	SENT_185	[p12l1588t3401r1660b3431],
35	0.30	CD	NUMBER	0.30	num	36	SENT_185	[p12l1833t3408r1885b3431],
36	(	NN	O	(	dep	34	SENT_185	[p12l1898t3408r1966b3438],
37	0	CD	NUMBER	0	dep	34	SENT_185	[p12l1898t3408r1966b3438],
38	.	.	O	.	_	0	SENT_185	[p12l1898t3408r1966b3438],

1	l7	NN	O	l7	_	0	SENT_186	[p12l1898t3408r1966b3438],
2	,	,	O	,	_	0	SENT_186	[p12l1898t3408r1966b3438],
3	0.44	CD	NUMBER	0.44	appos	1	SENT_186	[p12l1978t3408r2040b3438],
4	)	CD	NUMBER	)	num	6	SENT_186	[p12l1978t3408r2040b3438],
5	R-Ml	NN	O	r-ml	nn	6	SENT_186	[p12l93t3450r152b3472],
6	R-M2	NN	O	r-m2	dep	3	SENT_186	[p12l204t3450r352b3473],
7	/	:	O	/	punct	9	SENT_186	[p12l204t3450r352b3473],
8	R-sibu	NN	O	r-sibu	nn	9	SENT_186	[p12l204t3450r352b3473],
9	l3	NN	O	l3	dep	6	SENT_186	[p12l497t3450r539b3473],
10	.	.	O	.	_	0	SENT_186	[p12l497t3450r539b3473],

1	|	NN	O	|	_	0	SENT_187	[p12l497t3450r539b3473],
2	:	:	O	:	_	0	SENT_187	[p12l557t3461r578b3472],
3	:	:	O	:	_	0	SENT_187	[p12l557t3461r578b3472],
4	l2	NN	O	l2	dep	1	SENT_187	[p12l596t3450r638b3472],
5	.	.	O	.	_	0	SENT_187	[p12l596t3450r638b3472],

1	l	NN	O	l	_	0	SENT_188	[p12l596t3450r638b3472],
2	l0	NN	O	l0	dep	1	SENT_188	[p12l787t3450r834b3472],
3	.9	CD	NUMBER	.9	num	2	SENT_188	[p12l787t3450r834b3472],
4	:	:	O	:	_	0	SENT_188	[p12l847t3461r868b3472],
5	:	:	O	:	_	0	SENT_188	[p12l847t3461r868b3472],
6	l8	NN	O	l8	dep	2	SENT_188	[p12l886t3443r943b3473],
7	.4	CD	NUMBER	.4	num	6	SENT_188	[p12l886t3443r943b3473],
8	*	CD	NUMBER	*	number	9	SENT_188	[p12l886t3443r943b3473],
9	0.83	CD	NUMBER	0.83	num	10	SENT_188	[p12l1107t3450r1158b3472],
10	(	NN	O	(	dep	6	SENT_188	[p12l1173t3450r1240b3479],
11	0.4	CD	NUMBER	0.4	num	12	SENT_188	[p12l1173t3450r1240b3479],
12	|	NN	O	|	dep	6	SENT_188	[p12l1173t3450r1240b3479],
13	,	,	O	,	_	0	SENT_188	[p12l1173t3450r1240b3479],
14	0.95	CD	NUMBER	0.95	appos	6	SENT_188	[p12l1253t3450r1314b3479],
15	)	CD	NUMBER	)	num	17	SENT_188	[p12l1253t3450r1314b3479],
16	l2	NN	O	l2	nn	17	SENT_188	[p12l1494t3450r1540b3472],
17	.3	NN	NUMBER	.3	dep	14	SENT_188	[p12l1494t3450r1540b3472],
18	:	:	O	:	_	0	SENT_188	[p12l1554t3461r1575b3472],
19	:	:	O	:	_	0	SENT_188	[p12l1554t3461r1575b3472],
20	20.5	CD	NUMBER	20.5	number	21	SENT_188	[p12l1588t3443r1651b3472],
21	*	CD	NUMBER	*	dep	14	SENT_188	[p12l1588t3443r1651b3472],
22	0.94	CD	NUMBER	0.94	num	23	SENT_188	[p12l1833t3450r1885b3472],
23	(	NN	O	(	dep	21	SENT_188	[p12l1898t3450r1966b3479],
24	0.42	CD	NUMBER	0.42	dep	21	SENT_188	[p12l1898t3450r1966b3479],
25	,	,	O	,	_	0	SENT_188	[p12l1898t3450r1966b3479],
26	0.83	CD	NUMBER	0.83	number	27	SENT_188	[p12l1978t3450r2040b3479],
27	)	CD	NUMBER	)	num	28	SENT_188	[p12l1978t3450r2040b3479],
28	R-M2	NN	O	r-m2	appos	21	SENT_188	[p12l93t3491r227b3514],
29	/	:	O	/	punct	30	SENT_188	[p12l93t3491r227b3514],
30	R-Ml	NN	O	r-ml	dep	28	SENT_188	[p12l93t3491r227b3514],
31	|	CD	NUMBER	|	num	32	SENT_188	[p12l498t3491r544b3514],
32	.89	CD	NUMBER	.89	dep	30	SENT_188	[p12l498t3491r544b3514],
33	:	:	O	:	_	0	SENT_188	[p12l557t3502r578b3514],
34	:	:	O	:	_	0	SENT_188	[p12l557t3502r578b3514],
35	l.	NN	O	l.	dep	14	SENT_188	[p12l596t3491r643b3514],
36	02	CD	NUMBER	02	num	35	SENT_188	[p12l596t3491r643b3514],
37	l.	NN	O	l.	dep	35	SENT_188	[p12l787t3491r834b3514],
38	38	CD	NUMBER	38	num	37	SENT_188	[p12l787t3491r834b3514],
39	:	:	O	:	_	0	SENT_188	[p12l847t3502r868b3514],
40	:	:	O	:	_	0	SENT_188	[p12l847t3502r868b3514],
41	|	NN	O	|	dep	1	SENT_188	[p12l886t3484r943b3514],
42	.	.	O	.	_	0	SENT_188	[p12l886t3484r943b3514],

1	|	NN	O	|	_	0	SENT_189	[p12l886t3484r943b3514],
2	2	CD	NUMBER	2	num	1	SENT_189	[p12l886t3484r943b3514],
3	*	CD	NUMBER	*	num	4	SENT_189	[p12l886t3484r943b3514],
4	0.73	CD	NUMBER	0.73	dep	1	SENT_189	[p12l1107t3491r1158b3514],
5	(	NN	O	(	dep	4	SENT_189	[p12l1173t3491r1240b3521],
6	0.28	CD	NUMBER	0.28	num	5	SENT_189	[p12l1173t3491r1240b3521],
7	,	,	O	,	_	0	SENT_189	[p12l1173t3491r1240b3521],
8	0.92	CD	NUMBER	0.92	number	9	SENT_189	[p12l1253t3491r1314b3521],
9	)	CD	NUMBER	)	appos	4	SENT_189	[p12l1253t3491r1314b3521],
10	2.33	CD	NUMBER	2.33	dep	9	SENT_189	[p12l1489t3491r1540b3514],
11	:	:	O	:	_	0	SENT_189	[p12l1554t3502r1575b3514],
12	:	:	O	:	_	0	SENT_189	[p12l1554t3502r1575b3514],
13	|	CD	NUMBER	|	number	14	SENT_189	[p12l1593t3491r1640b3514],
14	.86	CD	NUMBER	.86	num	15	SENT_189	[p12l1593t3491r1640b3514],
15	l.	NN	O	l.	dep	4	SENT_189	[p12l1838t3491r1884b3514],
16	23	CD	NUMBER	23	num	17	SENT_189	[p12l1838t3491r1884b3514],
17	(	NN	O	(	dep	1	SENT_189	[p12l1898t3491r1966b3521],
18	0.6	CD	NUMBER	0.6	num	19	SENT_189	[p12l1898t3491r1966b3521],
19	|	NN	O	|	dep	17	SENT_189	[p12l1898t3491r1966b3521],
20	,	,	O	,	_	0	SENT_189	[p12l1898t3491r1966b3521],
21	2	CD	NUMBER	2	appos	1	SENT_189	[p12l1979t3491r2040b3521],
22	.	.	O	.	_	0	SENT_189	[p12l1979t3491r2040b3521],

1	l7	NN	O	l7	_	0	SENT_190	[p12l1979t3491r2040b3521],
2	)	SYM	O	)	dep	1	SENT_190	[p12l1979t3491r2040b3521],

1	AUC	NN	O	auc	nn	2	SENT_191	[p12l92t3585r156b3608],
2	ratios	NNS	O	ratio	nsubj	19	SENT_191	[p12l166t3586r235b3608],
3	of	IN	O	of	_	0	SENT_191	[p12l244t3585r270b3608],
4	S-M2	NN	O	s-m2	prep_of	2	SENT_191	[p12l277t3585r420b3608],
5	/	:	O	/	punct	6	SENT_191	[p12l277t3585r420b3608],
6	S-sibu	NN	O	s-sibu	dep	4	SENT_191	[p12l277t3585r420b3608],
7	and	CC	O	and	_	0	SENT_191	[p12l430t3585r472b3608],
8	S-M2	NN	O	s-m2	dep	4	SENT_191	[p12l483t3585r612b3608],
9	/	:	O	/	punct	6	SENT_191	[p12l483t3585r612b3608],
10	S-Ml	NN	O	s-ml	nsubjpass	14	SENT_191	[p12l483t3585r612b3608],
11	could	MD	O	could	aux	14	SENT_191	[p12l626t3585r692b3608],
12	not	RB	O	not	neg	14	SENT_191	[p12l703t3590r745b3608],
13	be	VB	O	be	auxpass	14	SENT_191	[p12l754t3585r782b3608],
14	calculated	VBN	O	calculate	rcmod	4	SENT_191	[p12l791t3585r912b3608],
15	because	IN	O	because	_	0	SENT_191	[p12l922t3585r1019b3608],
16	plasma	NN	O	plasma	nn	17	SENT_191	[p12l1029t3585r1112b3615],
17	concentrations	NNS	O	concentration	prep_because	14	SENT_191	[p12l1121t3587r1306b3608],
18	were	VBD	O	be	cop	19	SENT_191	[p12l1314t3592r1378b3608],
19	lower	JJR	O	lower	_	0	SENT_191	[p12l1388t3585r1459b3608],
20	than	IN	O	than	_	0	SENT_191	[p12l1467t3585r1520b3608],
21	quantitation	NN	O	quantitation	nn	22	SENT_191	[p12l1530t3586r1677b3615],
22	limit	NN	O	limit	prep_than	19	SENT_191	[p12l1688t3585r1741b3608],
23	in	IN	O	in	_	0	SENT_191	[p12l1750t3587r1769b3607],
24	our	PRP$	O	we	poss	26	SENT_191	[p12l1780t3592r1824b3608],
25	analytical	JJ	O	analytical	amod	26	SENT_191	[p12l1832t3585r1942b3615],
26	methods	NNS	O	method	prep_in	22	SENT_191	[p12l1953t3585r2066b3608],
27	.	.	O	.	_	0	SENT_191	[p12l1953t3585r2066b3608],

1	Data	NNS	O	datum	_	0	SENT_192	[p12l94t3628r152b3651],
2	are	VBP	O	be	cop	4	SENT_192	[p12l162t3636r201b3651],
3	mean	JJ	O	mean	amod	4	SENT_192	[p12l212t3635r276b3651],
4	values	NNS	O	value	rcmod	1	SENT_192	[p12l288t3628r362b3651],
5	:	:	O	:	_	0	SENT_192	[p12l375t3639r396b3651],
6	:	:	O	:	_	0	SENT_192	[p12l375t3639r396b3651],
7	SD	NN	O	sd	dep	1	SENT_192	[p12l409t3628r451b3651],
8	.	.	O	.	_	0	SENT_192	[p12l409t3628r451b3651],

1	*	NN	O	*	nn	2	SENT_193	[p12l92t3665r116b3695],
2	P	NN	O	p	_	0	SENT_193	[p12l92t3665r116b3695],
3	<	JJR	O	<	dep	2	SENT_193	[p12l129t3677r148b3696],
4	0.05	CD	NUMBER	0.05	dep	3	SENT_193	[p12l162t3672r220b3695],
5	.	.	O	.	_	0	SENT_193	[p12l162t3672r220b3695],

1	MP	NN	O	mp	dep	2	SENT_194	[p12l92t3707r126b3737],
2	<	JJR	O	<	_	0	SENT_194	[p12l139t3720r158b3738],
3	o.	CD	NUMBER	o.	num	4	SENT_194	[p12l171t3714r218b3737],
4	ol	NN	O	ol	dep	2	SENT_194	[p12l171t3714r218b3737],
5	vs.	CC	O	vs.	prep	4	SENT_194	[p12l234t3722r264b3737],
6	control	NN	O	control	nn	7	SENT_194	[p12l277t3715r366b3737],
7	phase	NN	O	phase	dep	5	SENT_194	[p12l379t3715r453b3744],
8	.	.	O	.	_	0	SENT_194	[p12l379t3715r453b3744],

1	“	NN	O	“	nn	3	SENT_195	[p12l93t3755r155b3779],
2	Fold	NN	O	fold	nn	3	SENT_195	[p12l93t3755r155b3779],
3	changes	NNS	O	change	_	0	SENT_195	[p12l166t3757r262b3786],
4	as	IN	O	as	amod	3	SENT_195	[p12l273t3764r296b3779],
5	compared	VBN	O	compare	_	0	SENT_195	[p12l308t3757r431b3786],
6	to	TO	O	to	prepc_compared_to	4	SENT_195	[p12l442t3762r468b3779],
7	the	DT	O	the	det	9	SENT_195	[p12l478t3757r518b3779],
8	control	NN	O	control	nn	9	SENT_195	[p12l529t3757r619b3779],
9	phase	NN	O	phase	pobj	4	SENT_195	[p12l631t3757r706b3786],
10	.	.	O	.	_	0	SENT_195	[p12l631t3757r706b3786],

1	Shinde	NNP	O	Shinde	_	0	SENT_196	[p13l94t61r184b87],
2	et	FW	O	et	nn	3	SENT_196	[p13l199t66r225b87],
3	al	FW	O	al	dep	1	SENT_196	[p13l238t61r262b87],
4	555	CD	NUMBER	555	dep	1	SENT_196	[p13l2000t58r2058b87],

1	A	DT	O	a	det	2	SENT_197	[p13l248t207r283b244],
2	7500	CD	NUMBER	7500	_	0	SENT_197	[p13l334t218r395b239],
3	6000	CD	NUMBER	6000	dep	2	SENT_197	[p13l335t305r395b326],

1	B	NN	O	b	_	0	SENT_198	[p13l1128t207r1160b244],
2	600	CD	NUMBER	600	num	3	SENT_198	[p13l1203t220r1250b241],
3	500	CD	NUMBER	500	dep	1	SENT_198	[p13l1203t294r1250b315],

1	A	DT	O	a	det	4	SENT_199	[p13l334t394r349b415],
2	Lil	NN	O	lil	nn	4	SENT_199	[p13l350t393r362b415],
3	O	NN	O	o	nn	4	SENT_199	[p13l366t393r380b416],
4	O	NN	O	o	_	0	SENT_199	[p13l381t393r395b416],
5	-	:	O	-	_	0	SENT_199	[p13l1201t367r1217b388],
6	I3	NN	O	i3	nn	8	SENT_199	[p13l1201t367r1217b388],
7	O	NN	O	o	nn	8	SENT_199	[p13l1219t366r1233b388],
8	o	NN	O	o	dep	4	SENT_199	[p13l1235t366r1250b388],

1	Formation	NN	O	formation	nn	2	SENT_200	[p13l237t457r259b600],
2	rate	NN	O	rate	_	0	SENT_200	[p13l238t397r259b450],
3	of	IN	O	of	_	0	SENT_200	[p13l237t361r259b388],
4	M1	NN	O	m1	nn	8	SENT_200	[p13l237t312r259b355],
5	(	CD	NUMBER	(	num	8	SENT_200	[p13l274t410r302b599],
6	pmol/min/mg	NN	O	pmol/min/mg	nn	8	SENT_200	[p13l274t410r302b599],
7	protein	NN	O	protein	nn	8	SENT_200	[p13l274t298r302b404],
8	)	NN	O	)	prep_of	2	SENT_200	[p13l274t298r302b404],
9	.	.	O	.	_	0	SENT_200	[p13l337t570r345b592],

1	_	NN	O	_	_	0	SENT_201	[p13l337t570r345b592],
2	a	DT	O	a	det	4	SENT_201	[p13l337t570r345b592],
3	0.1	CD	NUMBER	0.1	num	4	SENT_201	[p13l335t481r347b502],
4	U	NN	O	u	dep	1	SENT_201	[p13l350t570r362b592],
5	:	:	O	:	_	0	SENT_201	[p13l350t570r362b592],
6	O	NN	O	o	nn	10	SENT_201	[p13l350t481r364b502],
7	O	NN	O	o	nn	10	SENT_201	[p13l366t570r380b592],
8	O	NN	O	o	nn	10	SENT_201	[p13l366t481r380b502],
9	O	NN	O	o	nn	10	SENT_201	[p13l381t570r395b592],
10	O	NN	O	o	dep	4	SENT_201	[p13l381t481r395b502],

1	Formation	NN	O	formation	nn	2	SENT_202	[p13l1115t461r1137b602],
2	rate	NN	O	rate	_	0	SENT_202	[p13l1116t399r1137b452],
3	of	IN	O	of	_	0	SENT_202	[p13l1115t363r1137b390],
4	M2	NN	O	m2	nn	7	SENT_202	[p13l1115t312r1137b357],
5	(	CD	NUMBER	(	num	7	SENT_202	[p13l1152t412r1180b600],
6	pmal/min/mg	NN	O	pmal/min/mg	nn	7	SENT_202	[p13l1152t412r1180b600],
7	protein	NN	O	protein	prep_of	2	SENT_202	[p13l1152t300r1180b406],
8	)	CD	NUMBER	)	number	9	SENT_202	[p13l1152t300r1180b406],
9	8	CD	NUMBER	8	num	11	SENT_202	[p13l1205t586r1233b608],
10	8	CD	NUMBER	8	number	11	SENT_202	[p13l1203t513r1233b535],
11	8	CD	NUMBER	8	dep	2	SENT_202	[p13l1203t439r1233b461],
12	o	NN	O	o	nn	14	SENT_202	[p13l1235t586r1250b608],
13	o	NN	O	o	nn	14	SENT_202	[p13l1235t513r1250b535],
14	o	NN	O	o	dep	11	SENT_202	[p13l1235t439r1250b461],

1	O	NN	O	o	nn	2	SENT_203	[p13l381t657r395b678],
2	O	NN	O	o	_	0	SENT_203	[p13l1235t661r1250b682],

1	o	NN	O	o	_	0	SENT_204	[p13l410t697r424b718],
2	100 200 300 400	CD	NUMBER	100 200 300 400	num	1	SENT_204	[p13l881t697r928b718],[p13l519t697r562b718],
3	500	CD	NUMBER	500	num	4	SENT_204	[p13l1005t697r1050b718],
4	o	NN	O	o	dep	1	SENT_204	[p13l1264t700r1279b721],
5	100 200 300 400	CD	NUMBER	100 200 300 400	number	6	SENT_204	[p13l1749t700r1796b722],[p13l1377t700r1420b721],
6	500	CD	NUMBER	500	dep	4	SENT_204	[p13l1876t700r1923b721],

1	Sibutramine	NN	O	sibutramine	nn	3	SENT_205	[p13l604t748r767b769],
2	(	CD	NUMBER	(	num	3	SENT_205	[p13l776t748r841b774],
3	uM	NN	O	um	_	0	SENT_205	[p13l776t748r841b774],
4	)	CD	NUMBER	)	num	5	SENT_205	[p13l776t748r841b774],
5	M1	NN	O	m1	dep	3	SENT_205	[p13l1522t752r1567b773],
6	(	CD	NUMBER	(	num	7	SENT_205	[p13l1578t752r1645b778],
7	um	NN	O	um	dep	3	SENT_205	[p13l1578t752r1645b778],

1	Figure	NNP	O	Figure	_	0	SENT_206	[p13l94t842r191b873],
2	3	CD	NUMBER	3	dep	1	SENT_206	[p13l199t842r223b866],
3	.	.	O	.	_	0	SENT_206	[p13l199t842r223b866],

1	Representative	NNP	O	Representative	nn	3	SENT_207	[p13l244t843r439b874],
2	Michae	NNP	PERSON	Michae	nn	3	SENT_207	[p13l449t843r683b866],
3	|	NNP	O	|	nsubj	4	SENT_207	[p13l449t843r683b866],
4	is	VBZ	O	be	_	0	SENT_207	[p13l449t843r683b866],
5	.	.	O	.	_	0	SENT_207	[p13l449t843r683b866],

1	—	NN	O	—	_	0	SENT_208	[p13l449t843r683b866],
2	.	.	O	.	_	0	SENT_208	[p13l449t843r683b866],

1	Menten	JJ	O	menten	amod	2	SENT_209	[p13l449t843r683b866],
2	plots	NNS	O	plot	nsubj	3	SENT_209	[p13l693t843r756b874],
3	ofthe	VBP	O	ofthe	_	0	SENT_209	[p13l764t842r839b866],
4	formation	NN	O	formation	dobj	3	SENT_209	[p13l846t842r976b866],
5	of	IN	O	of	_	0	SENT_209	[p13l986t842r1013b866],
6	MI	NNP	O	MI	prep_of	4	SENT_209	[p13l1020t842r1054b866],
7	from	IN	O	from	_	0	SENT_209	[p13l1067t842r1131b866],
8	sibutramine	NN	O	sibutramine	prep_from	3	SENT_209	[p13l1140t843r1295b866],
9	(	CD	NUMBER	(	num	8	SENT_209	[p13l1304t842r1343b874],
10	A	DT	O	a	det	11	SENT_209	[p13l1304t842r1343b874],
11	)	NN	O	)	dobj	3	SENT_209	[p13l1304t842r1343b874],
12	and	CC	O	and	_	0	SENT_209	[p13l1353t843r1398b866],
13	M2	NN	O	m2	conj_and	11	SENT_209	[p13l1408t842r1448b866],
14	from	IN	O	from	_	0	SENT_209	[p13l1455t842r1519b866],
15	M	NN	O	m	prep_from	11	SENT_209	[p13l1530t843r1551b866],
16	I	PRP	O	I	nsubj	17	SENT_209	[p13l1560t842r1563b866],
17	(	VBP	O	(	rcmod	11	SENT_209	[p13l1578t842r1615b874],
18	B	NN	O	b	nn	19	SENT_209	[p13l1578t842r1615b874],
19	)	NN	O	)	dobj	17	SENT_209	[p13l1578t842r1615b874],
20	in	IN	O	in	_	0	SENT_209	[p13l1625t844r1646b866],
21	H	NN	O	h	nn	23	SENT_209	[p13l1657t843r1724b866],
22	|	CD	NUMBER	|	num	23	SENT_209	[p13l1657t843r1724b866],
23	Ms	NN	O	m	prep_in	19	SENT_209	[p13l1657t843r1724b866],
24	(	CD	NUMBER	(	num	23	SENT_209	[p13l1733t842r1803b874],
25	solid	JJ	O	solid	amod	27	SENT_209	[p13l1733t842r1803b874],
26	symbols	NNS	O	symbol	nn	27	SENT_209	[p13l1812t842r1927b874],
27	)	NN	O	)	tmod	17	SENT_209	[p13l1812t842r1927b874],
28	and	CC	O	and	_	0	SENT_209	[p13l1936t843r1981b866],
29	HLMs	NNS	O	hlm	conj_and	27	SENT_209	[p13l1992t843r2067b866],

1	(	RB	O	(	advmod	2	SENT_210	[p13l12t896r178b966],
2	open	JJ	O	open	amod	3	SENT_210	[p13l12t896r178b966],
3	symbols	NNS	O	symbol	_	0	SENT_210	[p13l207t896r481b967],
4	)	NN	O	)	dep	3	SENT_210	[p13l207t896r481b967],
5	.	.	O	.	_	0	SENT_210	[p13l207t896r481b967],

1	possessing	VBG	O	possess	_	0	SENT_211	[p13l7t1136r404b1221],
2	allele	NN	O	allele	nn	3	SENT_211	[p13l425t1136r619b1202],
3	pairs	NNS	O	pair	dobj	1	SENT_211	[p13l637t1136r815b1221],
4	of	IN	O	of	prep	3	SENT_211	[p13l837t1136r922b1202],
5	CYP2B6	NN	O	cyp2b6	nn	6	SENT_211	[p13l934t1137r1251b1202],
6	*	NN	O	*	dep	4	SENT_211	[p13l1261t1136r1454b1202],
7	1	CD	NUMBER	1	dep	6	SENT_211	[p13l1261t1136r1454b1202],
8	/	:	O	/	punct	6	SENT_211	[p13l1261t1136r1454b1202],
9	*	CD	NUMBER	*	num	10	SENT_211	[p13l1261t1136r1454b1202],
10	1	CD	NUMBER	1	dep	6	SENT_211	[p13l1261t1136r1454b1202],
11	,	,	O	,	_	0	SENT_211	[p13l1466t1192r1481b1217],
12	*	CD	NUMBER	*	number	13	SENT_211	[p13l1514t1136r1734b1216],
13	1	CD	NUMBER	1	amod	10	SENT_211	[p13l1514t1136r1734b1216],
14	/	:	O	/	punct	15	SENT_211	[p13l1514t1136r1734b1216],
15	*	CD	NUMBER	*	dep	13	SENT_211	[p13l1514t1136r1734b1216],
16	6	CD	NUMBER	6	dep	15	SENT_211	[p13l1514t1136r1734b1216],
17	,	,	O	,	_	0	SENT_211	[p13l1514t1136r1734b1216],
18	and	CC	O	and	_	0	SENT_211	[p13l1758t1136r1890b1202],
19	*	NN	O	*	dep	13	SENT_211	[p13l1918t1136r2035b1203],
20	6	CD	NUMBER	6	num	19	SENT_211	[p13l1918t1136r2035b1203],
21	/	:	O	/	punct	6	SENT_211	[p13l1918t1136r2035b1203],
22	*	CD	NUMBER	*	num	23	SENT_211	[p13l2037t1136r2136b1202],
23	6	CD	NUMBER	6	dep	6	SENT_211	[p13l2037t1136r2136b1202],
24	.	.	O	.	_	0	SENT_211	[p13l2037t1136r2136b1202],

1	The	DT	O	the	det	3	SENT_212	[p13l10t1247r150b1314],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_212	[p13l182t1247r798b1332],
3	parameters	NNS	O	parameter	_	0	SENT_212	[p13l832t1256r1235b1332],
4	of	IN	O	of	_	0	SENT_212	[p13l1272t1247r1357b1314],
5	sibutramine	NN	O	sibutramine	nn	8	SENT_212	[p13l1382t1247r1813b1314],
6	and	CC	O	and	_	0	SENT_212	[p13l1849t1247r1981b1314],
7	M1	NN	O	m1	nn	8	SENT_212	[p13l2014t1249r2131b1312],
8	enantiomers	NNS	O	enantiomer	prep_of	3	SENT_212	[p13l10t1357r457b1425],
9	in	IN	O	in	_	0	SENT_212	[p13l535t1357r605b1423],
10	the	DT	O	the	det	11	SENT_212	[p13l677t1357r788b1425],
11	subjects	NNS	O	subject	prep_in	3	SENT_212	[p13l866t1357r1158b1444],
12	with	IN	O	with	_	0	SENT_212	[p13l1233t1357r1397b1425],
13	the	DT	O	the	det	15	SENT_212	[p13l1470t1357r1581b1425],
14	CYP2B	NN	O	cyp2b	nn	15	SENT_212	[p13l1661t1359r1928b1425],
15	*	NN	O	*	prep_with	11	SENT_212	[p13l1941t1357r2144b1425],
16	6	CD	NUMBER	6	dep	15	SENT_212	[p13l1941t1357r2144b1425],
17	/	:	O	/	punct	3	SENT_212	[p13l1941t1357r2144b1425],
18	*	CD	NUMBER	*	number	19	SENT_212	[p13l1941t1357r2144b1425],
19	6	CD	NUMBER	6	num	20	SENT_212	[p13l1941t1357r2144b1425],
20	genotype	NN	O	genotype	nsubj	21	SENT_212	[p13l10t1479r346b1555],
21	were	VBD	O	be	dep	3	SENT_212	[p13l371t1491r548b1536],
22	consistently	RB	O	consistently	advmod	23	SENT_212	[p13l574t1470r1014b1555],
23	higher	JJR	O	higher	advmod	21	SENT_212	[p13l1036t1470r1274b1555],
24	than	IN	O	than	mark	33	SENT_212	[p13l1294t1470r1454b1536],
25	the	DT	O	the	dep	27	SENT_212	[p13l1476t1470r1587b1536],
26	corresponding	JJ	O	corresponding	amod	27	SENT_212	[p13l1613t1470r2141b1555],
27	Values	NNS	O	value	dep	31	SENT_212	[p13l8t1581r242b1648],
28	in	IN	O	in	_	0	SENT_212	[p13l272t1581r342b1646],
29	the	DT	O	the	det	30	SENT_212	[p13l367t1581r477b1648],
30	C	NN	O	c	prep_in	27	SENT_212	[p13l510t1583r570b1648],
31	YP2B6	NN	O	yp2b6	dep	33	SENT_212	[p13l575t1583r827b1647],
32	*	CD	NUMBER	*	num	31	SENT_212	[p13l837t1581r955b1648],
33	I	PRP	O	I	dep	23	SENT_212	[p13l837t1581r955b1648],
34	/	:	O	/	punct	33	SENT_212	[p13l837t1581r955b1648],
35	*	CD	NUMBER	*	num	36	SENT_212	[p13l956t1581r1031b1646],
36	1	CD	NUMBER	1	dep	33	SENT_212	[p13l956t1581r1031b1646],
37	genotype	NN	O	genotype	dep	36	SENT_212	[p13l1065t1591r1424b1666],
38	,	,	O	,	_	0	SENT_212	[p13l1065t1591r1424b1666],
39	except	IN	O	except	_	0	SENT_212	[p13l1456t1591r1696b1666],
40	the	DT	O	the	det	41	SENT_212	[p13l1720t1581r1831b1648],
41	Cmax	NN	MISC	cmax	prep_except	21	SENT_212	[p13l1861t1583r2040b1663],
42	of	IN	O	of	_	0	SENT_212	[p13l2068t1581r2153b1648],
43	M1	NN	O	m1	prep_of	41	SENT_212	[p13l9t1693r156b1773],
44	,	,	O	,	_	0	SENT_212	[p13l9t1693r156b1773],
45	regardless	RB	O	regardless	_	0	SENT_212	[p13l203t1691r574b1778],
46	of	IN	O	of	_	0	SENT_212	[p13l623t1691r707b1759],
47	the	DT	O	the	det	48	SENT_212	[p13l739t1691r849b1759],
48	enantio-conﬁguration	NN	O	enantio-conﬁguration	prep_regardless_of	21	SENT_212	[p13l897t1691r1710b1778],
49	.	.	O	.	_	0	SENT_212	[p13l897t1691r1710b1778],

1	The	DT	O	the	det	3	SENT_213	[p13l1761t1691r1901b1759],
2	AUC	NN	ORGANIZATION	auc	nn	3	SENT_213	[p13l1946t1693r2139b1759],
3	Values	NNS	ORGANIZATION	value	_	0	SENT_213	[p13l8t1804r242b1870],
4	of	IN	ORGANIZATION	of	_	0	SENT_213	[p13l299t1804r385b1870],
5	S	NN	ORGANIZATION	s	prep_of	3	SENT_213	[p13l427t1805r501b1870],
6	-	:	O	-	_	0	SENT_213	[p13l427t1805r501b1870],
7	and	CC	O	and	_	0	SENT_213	[p13l558t1804r690b1870],
8	R-sibutramine	NN	O	r-sibutramine	prep_of	3	SENT_213	[p13l739t1804r1263b1870],
9	in	IN	O	in	_	0	SENT_213	[p13l1321t1804r1390b1869],
10	the	DT	O	the	det	12	SENT_213	[p13l1443t1804r1554b1870],
11	CYPZB6	NN	O	cypzb6	nn	12	SENT_213	[p13l1614t1805r1932b1870],
12	*	NN	O	*	prep_in	3	SENT_213	[p13l1941t1804r2059b1870],
13	6	CD	NUMBER	6	dep	12	SENT_213	[p13l1941t1804r2059b1870],
14	/	:	O	/	punct	3	SENT_213	[p13l1941t1804r2059b1870],
15	*	CD	NUMBER	*	number	16	SENT_213	[p13l2060t1804r2144b1870],
16	6	CD	NUMBER	6	num	17	SENT_213	[p13l2060t1804r2144b1870],
17	genotype	NN	O	genotype	nsubj	20	SENT_213	[p13l10t1925r347b2000],
18	were	VBD	O	be	cop	20	SENT_213	[p13l401t1937r577b1982],
19	55	CD	PERCENT	55	num	20	SENT_213	[p13l635t1917r799b1982],
20	%	NN	PERCENT	%	dep	3	SENT_213	[p13l635t1917r799b1982],
21	(	CD	NUMBER	(	num	22	SENT_213	[p13l856t1916r941b2000],
22	P	NN	O	p	attr	20	SENT_213	[p13l856t1916r941b2000],
23	=	JJ	O	=	amod	25	SENT_213	[p13l975t1945r1038b1968],
24	.303	CD	NUMBER	.303	tmod	23	SENT_213	[p13l1080t1916r1265b2000],
25	)	NN	O	)	dep	22	SENT_213	[p13l1080t1916r1265b2000],
26	and	CC	O	and	_	0	SENT_213	[p13l1322t1915r1454b1982],
27	83	CD	PERCENT	83	num	28	SENT_213	[p13l1510t1917r1673b1982],
28	%	NN	PERCENT	%	attr	20	SENT_213	[p13l1510t1917r1673b1982],
29	(	CD	NUMBER	(	num	30	SENT_213	[p13l1730t1916r1815b2000],
30	P	NN	O	p	npadvmod	31	SENT_213	[p13l1730t1916r1815b2000],
31	=	JJ	O	=	amod	28	SENT_213	[p13l1849t1945r1912b1968],
32	.210	CD	NUMBER	.210	number	33	SENT_213	[p13l1954t1915r2140b2000],
33	)	CD	NUMBER	)	npadvmod	34	SENT_213	[p13l1954t1915r2140b2000],
34	higher	JJR	O	higher	amod	28	SENT_213	[p13l8t2025r246b2112],
35	than	IN	O	than	_	0	SENT_213	[p13l314t2025r473b2093],
36	Values	NNS	O	value	prep_than	34	SENT_213	[p13l542t2025r776b2093],
37	of	IN	O	of	_	0	SENT_213	[p13l850t2025r935b2093],
38	the	DT	O	the	det	40	SENT_213	[p13l993t2025r1104b2093],
39	CYP2B6	NN	O	cyp2b6	nn	40	SENT_213	[p13l1181t2025r1700b2093],
40	*	NN	O	*	prep_of	36	SENT_213	[p13l1181t2025r1700b2093],
41	1	CD	NUMBER	1	dep	40	SENT_213	[p13l1181t2025r1700b2093],
42	/	:	O	/	punct	44	SENT_213	[p13l1181t2025r1700b2093],
43	*	CD	NUMBER	*	number	44	SENT_213	[p13l1181t2025r1700b2093],
44	1	CD	NUMBER	1	dep	34	SENT_213	[p13l1181t2025r1700b2093],
45	genotype	NN	O	genotype	dep	44	SENT_213	[p13l1780t2035r2137b2112],
46	,	,	O	,	_	0	SENT_213	[p13l1780t2035r2137b2112],
47	respectively	RB	O	respectively	advmod	44	SENT_213	[p13l8t2138r453b2223],
48	(	CD	NUMBER	(	dep	44	SENT_213	[p13l525t2138r1114b2223],
49	Supplementary	NNP	O	Supplementary	nn	52	SENT_213	[p13l525t2138r1114b2223],
50	Table	NNP	O	Table	nn	52	SENT_213	[p13l1184t2138r1390b2204],
51	S1	NN	O	s1	nn	52	SENT_213	[p13l1465t2138r1605b2223],
52	)	NN	O	)	dep	48	SENT_213	[p13l1465t2138r1605b2223],
53	.	.	O	.	_	0	SENT_213	[p13l1465t2138r1605b2223],

1	Despite	IN	O	despite	dep	18	SENT_214	[p13l1680t2138r1960b2223],
2	the	DT	O	the	det	5	SENT_214	[p13l2029t2138r2140b2204],
3	relatively	RB	O	relatively	advmod	4	SENT_214	[p13l8t2249r355b2334],
4	higher	JJR	O	higher	amod	5	SENT_214	[p13l411t2249r649b2334],
5	increases	NNS	O	increase	pobj	1	SENT_214	[p13l704t2249r1037b2316],
6	of	IN	O	of	_	0	SENT_214	[p13l1098t2249r1182b2316],
7	AUC	NN	O	auc	prep_of	5	SENT_214	[p13l1226t2251r1419b2316],
8	and	CC	O	and	_	0	SENT_214	[p13l1480t2249r1612b2316],
9	Cmax	NN	O	cmax	prep_of	5	SENT_214	[p13l1669t2251r1848b2331],
10	in	IN	O	in	_	0	SENT_214	[p13l1905t2249r1975b2314],
11	the	DT	O	the	det	13	SENT_214	[p13l2029t2249r2140b2316],
12	CYP2B6	NN	O	cyp2b6	nn	13	SENT_214	[p13l14t2359r544b2427],
13	*	NN	O	*	prep_in	5	SENT_214	[p13l14t2359r544b2427],
14	6	CD	NUMBER	6	tmod	5	SENT_214	[p13l14t2359r544b2427],
15	/	:	O	/	punct	18	SENT_214	[p13l14t2359r544b2427],
16	*	CD	NUMBER	*	num	18	SENT_214	[p13l14t2359r544b2427],
17	6	CD	NUMBER	6	num	18	SENT_214	[p13l14t2359r544b2427],
18	genotype	NN	O	genotype	_	0	SENT_214	[p13l588t2369r925b2446],
19	compared	VBN	O	compare	_	0	SENT_214	[p13l974t2359r1338b2445],
20	with	IN	O	with	prepc_compared_with	29	SENT_214	[p13l1382t2359r1546b2427],
21	those	DT	O	those	pobj	29	SENT_214	[p13l1591t2359r1784b2427],
22	in	IN	O	in	_	0	SENT_214	[p13l1833t2359r1903b2426],
23	wildtype	JJ	O	wildtype	prep_in	21	SENT_214	[p13l1947t2359r2140b2427, p13l8t2481r186b2557],
24	,	,	O	,	_	0	SENT_214	[p13l1947t2359r2140b2427, p13l8t2481r186b2557],
25	the	DT	O	the	det	26	SENT_214	[p13l253t2472r363b2538],
26	difference	NN	O	difference	nsubj	29	SENT_214	[p13l430t2472r798b2538],
27	did	VBD	O	do	aux	29	SENT_214	[p13l866t2472r982b2538],
28	not	RB	O	not	neg	29	SENT_214	[p13l1044t2481r1163b2538],
29	reach	VB	O	reach	rcmod	18	SENT_214	[p13l1224t2472r1424b2538],
30	to	TO	O	to	_	0	SENT_214	[p13l1486t2481r1555b2538],
31	the	DT	O	the	det	33	SENT_214	[p13l1620t2472r1731b2538],
32	statistical	JJ	O	statistical	amod	33	SENT_214	[p13l1799t2472r2140b2538],
33	signiﬁcance	NN	O	signiﬁcance	prep_to	29	SENT_214	[p13l12t2583r449b2668],
34	in	IN	O	in	_	0	SENT_214	[p13l482t2583r552b2648],
35	this	DT	O	this	det	38	SENT_214	[p13l581t2583r712b2650],
36	exploratory	JJ	O	exploratory	amod	38	SENT_214	[p13l746t2583r1170b2668],
37	clinical	JJ	O	clinical	amod	38	SENT_214	[p13l1203t2583r1470b2650],
38	trial	NN	O	trial	prep_in	33	SENT_214	[p13l1501t2583r1646b2650],
39	due	JJ	O	due	_	0	SENT_214	[p13l1680t2583r1809b2650],
40	to	TO	O	to	_	0	SENT_214	[p13l1841t2592r1910b2650],
41	small	JJ	O	small	amod	43	SENT_214	[p13l1947t2583r2141b2650],
42	sample	NN	O	sample	nn	43	SENT_214	[p13l12t2693r267b2779],
43	size	NN	O	size	prep_due_to	38	SENT_214	[p13l301t2693r457b2761],
44	.	.	O	.	_	0	SENT_214	[p13l301t2693r457b2761],

1	The	DT	O	the	det	2	SENT_215	[p13l492t2693r632b2761],
2	effects	NNS	O	effect	_	0	SENT_215	[p13l664t2693r903b2761],
3	of	IN	O	of	_	0	SENT_215	[p13l935t2693r1021b2761],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_215	[p13l1039t2693r1457b2780],
5	on	IN	O	on	_	0	SENT_215	[p13l1489t2715r1579b2761],
6	the	DT	O	the	det	7	SENT_215	[p13l1607t2693r1717b2761],
7	phannacoTable	JJ	O	phannacotable	prep_on	2	SENT_215	[p13l1745t2693r2139b2779, p13l9t2949r203b3002],

1	3	LS	NUMBER	3	_	0	SENT_216	[p13l221t2949r275b3002],
2	.	.	O	.	_	0	SENT_216	[p13l221t2949r275b3002],

1	Kinetic	JJ	O	kinetic	amod	2	SENT_217	[p13l320t2949r523b3002],
2	Parameters	NNS	O	parameter	_	0	SENT_217	[p13l544t2949r876b3002],
3	for	IN	O	for	_	0	SENT_217	[p13l891t2949r979b3002],
4	the	DT	O	the	det	5	SENT_217	[p13l993t2949r1088b3002],
5	Formation	NN	O	formation	prep_for	2	SENT_217	[p13l1109t2949r1412b3002],
6	of	IN	O	of	_	0	SENT_217	[p13l1431t2949r1492b3002],
7	M	NN	O	m	prepc_of	5	SENT_217	[p13l1507t2949r1555b3001],
8	I	PRP	O	I	dobj	7	SENT_217	[p13l1574t2949r1582b3001],
9	From	IN	O	from	dep	2	SENT_217	[p13l1616t2949r1769b3002],
10	Sibutramine	NN	O	sibutramine	pobj	9	SENT_217	[p13l1789t2949r2141b3002],
11	and	CC	O	and	_	0	SENT_217	[p13l9t3043r110b3096],
12	M2	NN	O	m2	conj_and	10	SENT_217	[p13l141t3043r229b3095],
13	From	IN	O	from	dep	2	SENT_217	[p13l259t3043r412b3096],
14	MI	NNP	O	MI	pobj	13	SENT_217	[p13l443t3043r518b3095],
15	in	IN	O	in	_	0	SENT_217	[p13l559t3046r605b3095],
16	Human	JJ	O	human	amod	17	SENT_217	[p13l637t3043r845b3096],
17	Intestinal	JJ	O	intestinal	prep_in	14	SENT_217	[p13l876t3043r1135b3096],
18	and	CC	O	and	_	0	SENT_217	[p13l1164t3043r1265b3096],
19	Liver	NN	O	liver	nn	20	SENT_217	[p13l1295t3043r1440b3096],
20	Microsomes	NNS	O	microsome	prep_in	14	SENT_217	[p13l1468t3043r1826b3096],

1	R-isomer	NN	O	r-isomer	nn	2	SENT_218	[p13l913t3230r1164b3278],
2	S-isomer	NN	O	s-isomer	_	0	SENT_218	[p13l1714t3229r1959b3278],

1	Kinetic	JJ	O	kinetic	amod	2	SENT_219	[p13l12t3405r203b3453],
2	Parameters	NNS	O	parameter	_	0	SENT_219	[p13l233t3405r545b3453],
3	Intestine	NN	O	intestine	dep	2	SENT_219	[p13l735t3405r969b3453],
4	HLM	NNP	O	HLM	nn	6	SENT_219	[p13l1184t3405r1314b3453],
5	Intestine	NNP	O	Intestine	nn	6	SENT_219	[p13l1532t3405r1767b3453],
6	HLM	NNP	O	HLM	dep	2	SENT_219	[p13l1982t3405r2112b3453],

1	Substrate	NN	O	substrate	_	0	SENT_220	[p13l10t3659r282b3708],
2	:	:	O	:	_	0	SENT_220	[p13l10t3659r282b3708],
3	sibutramine	NN	O	sibutramine	dep	1	SENT_220	[p13l312t3660r638b3708],
4	and	CC	O	and	_	0	SENT_220	[p13l664t3660r759b3708],
5	metabolite	NN	O	metabolite	dep	1	SENT_220	[p13l789t3660r1096b3708],
6	:	:	O	:	_	0	SENT_220	[p13l789t3660r1096b3708],
7	Ml	NN	O	ml	dep	3	SENT_220	[p13l1128t3659r1198b3708],

1	Vmax	NN	O	vmax	_	0	SENT_221	[p14l78t31r208b92],
2	3238	CD	NUMBER	3238	num	1	SENT_221	[p14l759t31r894b81],
3	I	PRP	O	I	dep	9	SENT_221	[p14l1167t31r1175b80],
4	392 7568 3078	CD	NUMBER	392 7568 3078	num	5	SENT_221	[p14l1955t31r2090b81],[p14l1192t31r1292b81],
5	Km	NN	O	km	dep	3	SENT_221	[p14l82t128r161b188],
6	38.7	CD	NUMBER	38.7	number	7	SENT_221	[p14l829t127r945b178],
7	48.7	CD	NUMBER	48.7	dep	5	SENT_221	[p14l1225t127r1344b178],
8	65.4	CD	NUMBER	65.4	dep	9	SENT_221	[p14l1625t128r1742b178],
9	Ioo	NN	O	ioo	dep	14	SENT_221	[p14l2000t127r2090b178],
10	CLint	NN	O	clint	dep	9	SENT_221	[p14l81t226r217b287],
11	87.7	CD	NUMBER	87.7	number	12	SENT_221	[p14l827t226r945b276],
12	28.6	CD	NUMBER	28.6	dep	10	SENT_221	[p14l1226t226r1343b276],
13	I	PRP	O	I	nsubj	14	SENT_221	[p14l1601t226r1609b275],
14	I6	VBP	O	i6	dep	1	SENT_221	[p14l1637t226r1691b276],
15	30.8	CD	NUMBER	30.8	dobj	14	SENT_221	[p14l2025t226r2140b276],

1	Substrate	NN	O	substrate	_	0	SENT_222	[p14l10t422r282b471],
2	:	:	O	:	_	0	SENT_222	[p14l10t422r282b471],
3	MI	NNP	O	MI	dep	1	SENT_222	[p14l315t422r386b470],
4	and	CC	O	and	_	0	SENT_222	[p14l424t422r519b471],
5	metabolite	NN	O	metabolite	dep	1	SENT_222	[p14l549t422r856b471],
6	:	:	O	:	_	0	SENT_222	[p14l549t422r856b471],
7	M2	NN	O	m2	dep	1	SENT_222	[p14l888t422r970b470],

1	Vmax	NN	O	vmax	dep	5	SENT_223	[p14l78t520r208b581],
2	387	CD	NUMBER	387	dep	1	SENT_223	[p14l794t519r895b570],
3	I	PRP	O	I	dep	5	SENT_223	[p14l1202t519r1210b569],
4	62 320 546	CD	NUMBER	62 320 546	num	5	SENT_223	[p14l1989t520r2089b570],[p14l1226t519r1292b570],
5	Km	NN	O	km	dep	8	SENT_223	[p14l82t616r161b677],
6	I	NN	O	i	dep	5	SENT_223	[p14l839t616r846b666],
7	7.7	CD	NUMBER	7.7	num	8	SENT_223	[p14l863t617r945b666],
8	4	CD	NUMBER	4	_	0	SENT_223	[p14l1225t617r1258b666],
9	I	PRP	O	I	nsubj	10	SENT_223	[p14l1273t616r1280b666],
10	.9	VBP	NUMBER	.9	rcmod	8	SENT_223	[p14l1298t616r1342b666],
11	38.0	CD	NUMBER	38.0	number	12	SENT_223	[p14l1627t616r1742b666],
12	27.4	CD	NUMBER	27.4	dobj	10	SENT_223	[p14l2024t616r2141b666],
13	CLi	NN	O	cli	dep	12	SENT_223	[p14l81t715r217b777],
14	,	,	O	,	_	0	SENT_223	[p14l81t715r217b777],
15	,	,	O	,	_	0	SENT_223	[p14l81t715r217b777],
16	t	NN	O	t	tmod	10	SENT_223	[p14l81t715r217b777],
17	2	CD	NUMBER	2	num	16	SENT_223	[p14l827t715r858b765],
18	I	PRP	O	I	nsubj	19	SENT_223	[p14l874t715r881b765],
19	.9	VBP	NUMBER	.9	rcmod	16	SENT_223	[p14l898t715r943b765],
20	3.9	CD	NUMBER	3.9	num	21	SENT_223	[p14l1263t715r1342b766],
21	8.4	CD	NUMBER	8.4	nsubj	22	SENT_223	[p14l1660t715r1742b766],
22	I	PRP	O	I	xcomp	19	SENT_223	[p14l2035t715r2043b765],
23	9.9	CD	NUMBER	9.9	dep	16	SENT_223	[p14l2059t715r2140b765],

1	*	NN	O	*	nsubjpass	5	SENT_224	[p14l8t922r163b974],
2	Each	DT	O	each	det	3	SENT_224	[p14l8t922r163b974],
3	value	NN	O	value	dep	1	SENT_224	[p14l202t925r344b974],
4	is	VBZ	O	be	auxpass	5	SENT_224	[p14l384t928r421b974],
5	expressed	VBN	O	express	_	0	SENT_224	[p14l460t925r739b989],
6	as	IN	O	as	_	0	SENT_224	[p14l779t941r831b974],
7	mean	NN	O	mean	prep_as	5	SENT_224	[p14l872t941r1015b974],
8	of	IN	O	of	_	0	SENT_224	[p14l1057t924r1114b974],
9	estimates	NNS	O	estimate	prep_of	7	SENT_224	[p14l1148t928r1406b974],
10	obtained	VBN	O	obtain	partmod	9	SENT_224	[p14l1446t925r1684b974],
11	from	IN	O	from	_	0	SENT_224	[p14l1722t924r1855b974],
12	triplicate	NN	O	triplicate	nn	13	SENT_224	[p14l1894t925r2141b989],
13	experiments	NNS	O	experiment	prep_from	10	SENT_224	[p14l10t1026r369b1088],
14	.	.	O	.	_	0	SENT_224	[p14l10t1026r369b1088],

1	The	DT	O	the	det	2	SENT_225	[p14l8t1111r116b1160],
2	values	NNS	O	value	nsubjpass	4	SENT_225	[p14l144t1111r312b1160],
3	are	VBP	O	be	auxpass	4	SENT_225	[p14l342t1127r430b1160],
4	represented	VBN	O	represent	_	0	SENT_225	[p14l462t1111r796b1175],
5	as	IN	O	as	_	0	SENT_225	[p14l827t1127r880b1160],
6	Vmax	NN	O	vmax	prep_as	4	SENT_225	[p14l909t1111r1052b1171],
7	,	,	O	,	_	0	SENT_225	[p14l909t1111r1052b1171],
8	pmol/min/mg	NN	O	pmol/min/mg	nn	9	SENT_225	[p14l1085t1110r1450b1175],
9	protein	NN	O	protein	dep	11	SENT_225	[p14l1480t1114r1697b1175],
10	;	:	O	;	_	0	SENT_225	[p14l1480t1114r1697b1175],
11	Km	NN	O	km	ccomp	4	SENT_225	[p14l1731t1111r1825b1171],
12	,	,	O	,	_	0	SENT_225	[p14l1731t1111r1825b1171],
13	pM	NN	O	pm	appos	11	SENT_225	[p14l1860t1111r1959b1173],
14	;	:	O	;	_	0	SENT_225	[p14l1860t1111r1959b1173],
15	CLi	NN	O	cli	dep	13	SENT_225	[p14l1991t1110r2140b1171],
16	,	,	O	,	_	0	SENT_225	[p14l1991t1110r2140b1171],
17	,	,	O	,	_	0	SENT_225	[p14l1991t1110r2140b1171],
18	t	NN	O	t	dep	21	SENT_225	[p14l1991t1110r2140b1171],
19	,	,	O	,	_	0	SENT_225	[p14l1991t1110r2140b1171],
20	pL/min/mg	NN	O	pl/min/mg	nn	21	SENT_225	[p14l13t1199r306b1264],
21	protein	NN	O	protein	ccomp	4	SENT_225	[p14l331t1202r546b1264],
22	.	.	O	.	_	0	SENT_225	[p14l331t1202r546b1264],

1	kinetics	NNS	O	kinetics	nsubjpass	10	SENT_226	[p14l9t1432r294b1498],
2	of	IN	O	of	_	0	SENT_226	[p14l347t1432r432b1498],
3	sibutramine	NN	O	sibutramine	prep_of	1	SENT_226	[p14l473t1432r903b1498],
4	within	IN	O	within	_	0	SENT_226	[p14l953t1432r1189b1498],
5	the	DT	O	the	det	7	SENT_226	[p14l1237t1432r1348b1498],
6	CYP2B6	NN	O	cyp2b6	nn	7	SENT_226	[p14l1403t1433r1720b1498],
7	genotypes	NNS	O	genotype	prep_within	3	SENT_226	[p14l1768t1441r2141b1517],
8	were	VBD	O	be	auxpass	10	SENT_226	[p14l9t1565r186b1610],
9	then	RB	O	then	advmod	10	SENT_226	[p14l224t1543r383b1610],
10	analyzed	VBN	O	analyze	_	0	SENT_226	[p14l421t1543r765b1628],
11	.	.	O	.	_	0	SENT_226	[p14l421t1543r765b1628],

1	The	DT	O	the	det	3	SENT_227	[p14l809t1543r949b1610],
2	AUC	NN	O	auc	nn	3	SENT_227	[p14l987t1545r1179b1610],
3	differences	NNS	O	difference	_	0	SENT_227	[p14l1220t1543r1625b1610],
4	of	IN	O	of	_	0	SENT_227	[p14l1666t1543r1751b1610],
5	S	NN	O	s	prep_of	3	SENT_227	[p14l1775t1545r1850b1610],
6	-	:	O	-	_	0	SENT_227	[p14l1775t1545r1850b1610],
7	and	CC	O	and	_	0	SENT_227	[p14l1890t1543r2022b1610],
8	Rsibutramine	NN	O	rsibutramine	prep_of	3	SENT_227	[p14l2054t1546r2141b1608, p14l13t1653r444b1720],
9	between	IN	O	between	_	0	SENT_227	[p14l463t1653r772b1720],
10	CYP2B6	NN	O	cyp2b6	nn	11	SENT_227	[p14l797t1653r1317b1720],
11	*	NN	O	*	prep_between	3	SENT_227	[p14l797t1653r1317b1720],
12	1	CD	NUMBER	1	dep	11	SENT_227	[p14l797t1653r1317b1720],
13	/	:	O	/	punct	19	SENT_227	[p14l797t1653r1317b1720],
14	*	CD	NUMBER	*	number	19	SENT_227	[p14l797t1653r1317b1720],
15	1	CD	NUMBER	1	number	19	SENT_227	[p14l797t1653r1317b1720],
16	and	CC	O	and	_	0	SENT_227	[p14l1345t1653r1477b1720],
17	CYP2B6	CD	NUMBER	cyp2b6	conj_and	19	SENT_227	[p14l1500t1653r2056b1720],
18	*	CD	NUMBER	*	number	19	SENT_227	[p14l1500t1653r2056b1720],
19	6	CD	NUMBER	6	dep	12	SENT_227	[p14l1500t1653r2056b1720],
20	/	:	O	/	punct	19	SENT_227	[p14l1500t1653r2056b1720],
21	*	CD	NUMBER	*	dep	12	SENT_227	[p14l1500t1653r2056b1720],
22	/	:	O	/	punct	3	SENT_227	[p14l1500t1653r2056b1720],
23	6	CD	NUMBER	6	nsubj	31	SENT_227	[p14l1500t1653r2056b1720],
24	in	IN	O	in	_	0	SENT_227	[p14l2073t1653r2143b1719],
25	the	DT	O	the	det	27	SENT_227	[p14l9t1765r120b1831],
26	clopidogrel	NN	O	clopidogrel	nn	27	SENT_227	[p14l188t1765r605b1850],
27	phase	NN	O	phase	prep_in	23	SENT_227	[p14l669t1765r879b1850],
28	were	VBD	O	be	cop	31	SENT_227	[p14l945t1786r1122b1831],
29	21	CD	NUMBER	21	number	30	SENT_227	[p14l1189t1766r1269b1830],
30	(	CD	NUMBER	(	num	31	SENT_227	[p14l1347t1765r1432b1850],
31	P	NN	O	p	dep	3	SENT_227	[p14l1347t1765r1432b1850],
32	=	JJ	O	=	amod	34	SENT_227	[p14l1466t1795r1529b1818],
33	.42	CD	NUMBER	.42	tmod	32	SENT_227	[p14l1571t1765r1709b1850],
34	)	NN	O	)	dep	31	SENT_227	[p14l1571t1765r1709b1850],
35	and	CC	O	and	_	0	SENT_227	[p14l1778t1765r1910b1831],
36	65	CD	PERCENT	65	num	37	SENT_227	[p14l1976t1766r2141b1831],
37	%	NN	PERCENT	%	dep	3	SENT_227	[p14l1976t1766r2141b1831],
38	(	CD	NUMBER	(	num	39	SENT_227	[p14l12t1877r97b1961],
39	P	NN	O	p	dep	37	SENT_227	[p14l12t1877r97b1961],
40	=	JJ	O	=	amod	42	SENT_227	[p14l132t1906r195b1929],
41	.58	CD	NUMBER	.58	tmod	40	SENT_227	[p14l237t1877r397b1961],
42	)	NN	O	)	dep	39	SENT_227	[p14l237t1877r397b1961],
43	.	.	O	.	_	0	SENT_227	[p14l237t1877r397b1961],

1	while	IN	O	while	mark	22	SENT_228	[p14l452t1876r656b1943],
2	the	DT	O	the	det	3	SENT_228	[p14l709t1876r819b1943],
3	differences	NNS	O	difference	nsubj	22	SENT_228	[p14l874t1876r1278b1943],
4	in	IN	O	in	_	0	SENT_228	[p14l1334t1876r1404b1941],
5	the	DT	O	the	det	7	SENT_228	[p14l1455t1876r1566b1943],
6	control	NN	O	control	nn	7	SENT_228	[p14l1621t1876r1879b1943],
7	phase	NN	O	phase	prep_in	3	SENT_228	[p14l1931t1876r2141b1961],
8	were	VBD	O	be	cop	22	SENT_228	[p14l9t2008r186b2054],
9	55	CD	NUMBER	55	number	10	SENT_228	[p14l228t1989r311b2054],
10	(	CD	NUMBER	(	num	11	SENT_228	[p14l356t1987r441b2072],
11	P	NN	O	p	nn	22	SENT_228	[p14l356t1987r441b2072],
12	:	:	O	:	_	0	SENT_228	[p14l475t2017r538b2040],
13	.30	CD	NUMBER	.30	num	14	SENT_228	[p14l580t1987r718b2072],
14	)	NN	O	)	dep	11	SENT_228	[p14l580t1987r718b2072],
15	and	CC	O	and	_	0	SENT_228	[p14l760t1986r892b2054],
16	91	CD	PERCENT	91	num	17	SENT_228	[p14l930t1988r1096b2054],
17	%	NN	PERCENT	%	dep	11	SENT_228	[p14l930t1988r1096b2054],
18	(	CD	NUMBER	(	num	19	SENT_228	[p14l1136t1987r1221b2072],
19	P	NN	O	p	dep	17	SENT_228	[p14l1136t1987r1221b2072],
20	=	JJ	O	=	amod	22	SENT_228	[p14l1255t2017r1318b2040],
21	21	CD	NUMBER	21	tmod	20	SENT_228	[p14l1361t1987r1520b2072],
22	)	NN	O	)	dep	24	SENT_228	[p14l1361t1987r1520b2072],
23	,	,	O	,	_	0	SENT_228	[p14l1361t1987r1520b2072],
24	respectively	RB	O	respectively	_	0	SENT_228	[p14l1561t1986r2024b2073],
25	.	.	O	.	_	0	SENT_228	[p14l1561t1986r2024b2073],

1	In	IN	O	in	_	0	SENT_229	[p14l2068t1989r2143b2053],
2	contrast	NN	O	contrast	prep_in	6	SENT_229	[p14l11t2108r320b2180],
3	,	,	O	,	_	0	SENT_229	[p14l11t2108r320b2180],
4	clarithromycin	NN	O	clarithromycin	nn	5	SENT_229	[p14l350t2099r890b2184],
5	pretreatment	NN	O	pretreatment	nsubj	6	SENT_229	[p14l913t2108r1381b2184],
6	increased	VBD	O	increase	_	0	SENT_229	[p14l1405t2099r1752b2165],
7	the	DT	O	the	det	8	SENT_229	[p14l1774t2099r1885b2165],
8	differences	NNS	O	difference	dobj	6	SENT_229	[p14l1911t2099r2141b2165, p14l11t2232r212b2277],
9	in	IN	O	in	_	0	SENT_229	[p14l262t2210r332b2276],
10	AUC	NN	O	auc	nn	13	SENT_229	[p14l378t2212r570b2277],
11	and	CC	O	and	_	0	SENT_229	[p14l623t2210r754b2277],
12	Cmax	NN	O	cmax	conj_and	10	SENT_229	[p14l802t2212r981b2292],
13	Values	NNS	O	value	prep_in	6	SENT_229	[p14l1028t2210r1261b2277],
14	between	IN	O	between	_	0	SENT_229	[p14l1309t2210r1618b2277],
15	the	DT	O	the	det	18	SENT_229	[p14l1664t2210r1775b2277],
16	CYPZB6	NN	O	cypzb6	nn	18	SENT_229	[p14l1828t2212r2145b2277],
17	genotype	NN	O	genotype	nn	18	SENT_229	[p14l11t2330r348b2407],
18	groups	NNS	O	group	prep_between	13	SENT_229	[p14l395t2342r644b2407],
19	compared	VBN	O	compare	_	0	SENT_229	[p14l692t2320r1057b2406],
20	with	IN	O	with	prepc_compared_with	6	SENT_229	[p14l1099t2320r1262b2388],
21	the	DT	O	the	det	22	SENT_229	[p14l1307t2320r1417b2388],
22	differences	NNS	O	difference	pobj	6	SENT_229	[p14l1465t2320r1869b2388],
23	in	IN	O	in	_	0	SENT_229	[p14l1918t2320r1987b2387],
24	the	DT	O	the	det	26	SENT_229	[p14l2030t2320r2142b2388],
25	control	NN	O	control	nn	26	SENT_229	[p14l11t2433r269b2499],
26	phase	NN	O	phase	prep_in	22	SENT_229	[p14l299t2433r528b2518],
27	.	.	O	.	_	0	SENT_229	[p14l299t2433r528b2518],

1	Discussion	NN	O	discussion	_	0	SENT_230	[p14l17t2687r544b2767],

1	The	DT	O	the	det	2	SENT_231	[p14l11t2859r151b2926],
2	results	NNS	O	result	nsubj	6	SENT_231	[p14l173t2859r411b2926],
3	of	IN	O	of	_	0	SENT_231	[p14l436t2859r521b2926],
4	this	DT	O	this	det	5	SENT_231	[p14l530t2859r661b2926],
5	study	NN	O	study	prep_of	2	SENT_231	[p14l688t2859r885b2944],
6	demonstrate	VBP	O	demonstrate	_	0	SENT_231	[p14l907t2859r1354b2926],
7	that	IN	O	that	complm	12	SENT_231	[p14l1377t2859r1516b2926],
8	both	CC	O	both	preconj	9	SENT_231	[p14l1535t2859r1701b2926],
9	clopidogrel	NN	O	clopidogrel	nsubj	12	SENT_231	[p14l1724t2859r2142b2944],
10	and	CC	O	and	_	0	SENT_231	[p14l11t2969r144b3037],
11	clarithromycin	NN	O	clarithromycin	conj_and	9	SENT_231	[p14l172t2969r713b3056],
12	affect	VBP	O	affect	ccomp	6	SENT_231	[p14l742t2969r949b3037],
13	the	DT	O	the	det	15	SENT_231	[p14l974t2969r1085b3037],
14	enantioselective	JJ	O	enantioselective	amod	15	SENT_231	[p14l1116t2969r1706b3037],
15	disposition	NN	O	disposition	dobj	12	SENT_231	[p14l1738t2969r2143b3055],
16	of	IN	O	of	_	0	SENT_231	[p14l11t3082r96b3148],
17	sibutramine	NN	O	sibutramine	prep_of	15	SENT_231	[p14l121t3082r552b3148],
18	and	CC	O	and	_	0	SENT_231	[p14l588t3082r721b3148],
19	its	PRP$	O	its	poss	20	SENT_231	[p14l754t3082r836b3148],
20	metabolites	NNS	O	metabolite	conj_and	17	SENT_231	[p14l871t3082r1316b3162],
21	,	,	O	,	_	0	SENT_231	[p14l871t3082r1316b3162],
22	but	CC	O	but	_	0	SENT_231	[p14l1351t3082r1471b3148],
23	their	PRP$	O	they	poss	24	SENT_231	[p14l1502t3082r1672b3148],
24	effects	NNS	O	effect	nsubj	25	SENT_231	[p14l1705t3082r1944b3148],
25	Vary	VBP	O	vary	conj_but	6	SENT_231	[p14l1979t3103r2143b3167],
26	between	IN	O	between	_	0	SENT_231	[p14l8t3193r317b3260],
27	the	DT	O	the	det	29	SENT_231	[p14l342t3193r453b3260],
28	parent	NN	O	parent	nn	29	SENT_231	[p14l478t3202r711b3278],
29	drug	NN	O	drug	prep_between	25	SENT_231	[p14l736t3193r903b3278],
30	and	CC	O	and	_	0	SENT_231	[p14l931t3193r1063b3260],
31	its	PRP$	O	its	poss	32	SENT_231	[p14l1089t3193r1171b3260],
32	metabolites	NNS	O	metabolite	prep_between	25	SENT_231	[p14l1198t3193r1620b3260],
33	in	IN	O	in	_	0	SENT_231	[p14l1649t3193r1719b3258],
34	addition	NN	O	addition	prep_in	32	SENT_231	[p14l1745t3193r2047b3260],
35	to	TO	O	to	_	0	SENT_231	[p14l2072t3203r2141b3260],
36	the	DT	O	the	det	39	SENT_231	[p14l9t3303r120b3371],
37	enantio	NN	O	enantio	nn	39	SENT_231	[p14l153t3303r966b3390],
38	—	NN	O	—	nn	39	SENT_231	[p14l153t3303r966b3390],
39	conﬁguration	NN	O	conﬁguration	prep_to	25	SENT_231	[p14l153t3303r966b3390],
40	.	.	O	.	_	0	SENT_231	[p14l153t3303r966b3390],

1	Sibutramine	NN	O	sibutramine	nsubjpass	3	SENT_232	[p14l127t3416r571b3482],
2	is	VBZ	O	be	auxpass	3	SENT_232	[p14l608t3416r665b3482],
3	known	VBN	O	know	_	0	SENT_232	[p14l700t3416r954b3482],
4	to	TO	O	to	aux	6	SENT_232	[p14l987t3425r1055b3482],
5	be	VB	O	be	auxpass	6	SENT_232	[p14l1090t3416r1176b3482],
6	metabolized	VBN	O	metabolize	xcomp	3	SENT_232	[p14l1210t3416r1663b3482],
7	primarily	RB	O	primarily	advmod	6	SENT_232	[p14l1695t3416r2038b3501],
8	to	TO	O	to	_	0	SENT_232	[p14l2072t3425r2141b3482],
9	Ml	NN	O	ml	prep_to	6	SENT_232	[p14l10t3529r127b3592],
10	by	IN	O	by	_	0	SENT_232	[p14l164t3527r258b3612],
11	CYPZB6	NN	O	cypzb6	agent	6	SENT_232	[p14l288t3529r641b3608],
12	,	,	O	,	_	0	SENT_232	[p14l288t3529r641b3608],
13	CYP2Cl9	NN	O	cyp2cl9	conj_and	11	SENT_232	[p14l675t3529r1075b3608],
14	,	,	O	,	_	0	SENT_232	[p14l675t3529r1075b3608],
15	and	CC	O	and	_	0	SENT_232	[p14l1109t3527r1241b3594],
16	CYP3A4/5	NN	O	cyp3a4/5	conj_and	11	SENT_232	[p14l1270t3527r1701b3608],
17	,	,	O	,	_	0	SENT_232	[p14l1270t3527r1701b3608],
18	and	CC	O	and	_	0	SENT_232	[p14l1734t3527r1867b3594],
19	further	RB	O	further	advmod	6	SENT_232	[p14l1895t3527r2144b3594],
20	metabolized	VBN	O	metabolize	conj_and	6	SENT_232	[p14l9t3639r461b3707],
21	to	TO	O	to	_	0	SENT_232	[p14l478t3649r547b3707],
22	M2	NN	O	m2	prep_to	20	SENT_232	[p14l568t3641r692b3706],
23	by	IN	O	by	_	0	SENT_232	[p14l712t3639r806b3726],
24	CYPZB6	NN	O	cypzb6	prep_by	20	SENT_232	[p14l826t3641r1157b3707],
25	and	CC	O	and	_	0	SENT_232	[p14l1180t3639r1312b3707],
26	CYP2C19	NN	O	cyp2c19	prep_by	20	SENT_232	[p14l1331t3620r1888b3707],
27	.12	CD	NUMBER	.12	number	28	SENT_232	[p14l1331t3620r1888b3707],
28	’13	CD	NUMBER	’13	num	29	SENT_232	[p14l1331t3620r1888b3707],
29	The	DT	O	the	nsubj	39	SENT_232	[p14l1912t3639r2052b3707],
30	in	FW	O	in	prep	29	SENT_232	[p14l2074t3640r2143b3706],
31	vitro	FW	O	vitro	nn	34	SENT_232	[p15l9t20r180b86],
32	enantio	FW	O	enantio	nn	34	SENT_232	[p15l203t20r470b86],
33	selective	JJ	O	selective	amod	34	SENT_232	[p15l478t20r795b86],
34	metabolism	NN	O	metabolism	pobj	30	SENT_232	[p15l814t20r1246b86],
35	of	IN	O	of	_	0	SENT_232	[p15l1266t20r1351b86],
36	sibutramine	NN	O	sibutramine	prep_of	34	SENT_232	[p15l1361t20r1792b86],
37	in	IN	O	in	_	0	SENT_232	[p15l1813t20r1883b85],
38	HLMs	NNS	O	hlm	prep_in	36	SENT_232	[p15l1902t23r2141b86],
39	demonstrated	VBD	O	demonstrate	ccomp	20	SENT_232	[p15l11t131r509b198],
40	that	IN	O	that	complm	48	SENT_232	[p15l584t131r723b198],
41	the	DT	O	the	det	43	SENT_232	[p15l799t131r909b198],
42	formation	NN	O	formation	nn	43	SENT_232	[p15l990t131r1352b198],
43	rate	NN	O	rate	nsubj	48	SENT_232	[p15l1428t141r1563b198],
44	of	IN	O	of	_	0	SENT_232	[p15l1644t131r1728b198],
45	M1	NN	O	m1	prep_of	43	SENT_232	[p15l1795t133r1912b196],
46	was	VBD	O	be	cop	48	SENT_232	[p15l2000t153r2141b198],
47	consistently	RB	O	consistently	advmod	48	SENT_232	[p15l11t241r452b328],
48	higher	JJR	O	higher	ccomp	39	SENT_232	[p15l508t241r746b328],
49	from	IN	O	from	_	0	SENT_232	[p15l804t241r980b309],
50	S-sibutramine	NN	MISC	s-sibutramine	prep_from	48	SENT_232	[p15l1036t241r1548b309],
51	than	IN	O	than	prep	48	SENT_232	[p15l1606t241r1765b309],
52	from	IN	O	from	pcomp	51	SENT_232	[p15l1825t241r2001b309],
53	Rsibutramine	NN	LOCATION	rsibutramine	pobj	52	SENT_232	[p15l2054t244r2141b308, p15l13t354r465b435],
54	,	,	O	,	_	0	SENT_232	[p15l2054t244r2141b308, p15l13t354r465b435],
55	suggesting	VBG	O	suggest	xcomp	48	SENT_232	[p15l498t354r889b439],
56	that	IN	O	that	complm	63	SENT_232	[p15l916t354r1055b420],
57	the	DT	O	the	det	59	SENT_232	[p15l1079t354r1189b420],
58	plasma	NN	O	plasma	nn	59	SENT_232	[p15l1215t354r1478b439],
59	concentrations	NNS	O	concentration	nsubj	63	SENT_232	[p15l1505t354r2040b420],
60	of	IN	O	of	_	0	SENT_232	[p15l2069t354r2154b420],
61	R-sibutramine	NN	O	r-sibutramine	prep_of	59	SENT_232	[p15l6t465r531b532],
62	are	VBP	O	be	cop	63	SENT_232	[p15l588t487r695b532],
63	higher	JJR	O	higher	ccomp	55	SENT_232	[p15l750t465r988b550],
64	than	IN	O	than	_	0	SENT_232	[p15l1039t465r1199b532],
65	those	DT	O	those	prep_than	63	SENT_232	[p15l1252t465r1445b532],
66	of	IN	O	of	_	0	SENT_232	[p15l1502t465r1587b532],
67	S-sibutramine	NN	O	s-sibutramine	nn	69	SENT_232	[p15l1629t465r2141b532],
68	(	CD	NUMBER	(	num	69	SENT_232	[p15l12t575r278b662],
69	Figure	NNP	O	Figure	prep_of	65	SENT_232	[p15l12t575r278b662],
70	3	CD	NUMBER	3	num	71	SENT_232	[p15l318t576r408b661],
71	)	NN	O	)	dep	69	SENT_232	[p15l318t576r408b661],
72	.	.	O	.	_	0	SENT_232	[p15l318t576r408b661],

1	Consistent	JJ	O	consistent	nsubj	10	SENT_233	[p15l452t575r841b643],
2	with	IN	O	with	_	0	SENT_233	[p15l874t575r1039b643],
3	the	DT	O	the	prep_with	1	SENT_233	[p15l1073t575r1184b643],
4	in	FW	O	in	nn	5	SENT_233	[p15l1222t575r1292b642],
5	vitro	FW	O	vitro	advmod	6	SENT_233	[p15l1326t575r1497b643],
6	results	NNS	O	result	dep	3	SENT_233	[p15l1534t575r1793b657],
7	,	,	O	,	_	0	SENT_233	[p15l1534t575r1793b657],
8	our	PRP$	O	we	poss	9	SENT_233	[p15l1835t597r1957b643],
9	data	NNS	O	datum	appos	3	SENT_233	[p15l1992t575r2143b643],
10	demonstrated	VBD	O	demonstrate	_	0	SENT_233	[p15l11t688r509b754],
11	that	IN	O	that	complm	18	SENT_233	[p15l526t688r665b754],
12	the	DT	O	the	det	14	SENT_233	[p15l683t688r794b754],
13	plasma	NN	O	plasma	nn	14	SENT_233	[p15l813t688r1076b773],
14	levels	NNS	O	level	nsubj	18	SENT_233	[p15l1096t688r1306b754],
15	of	IN	O	of	_	0	SENT_233	[p15l1330t688r1415b754],
16	R-sibutramine	NN	O	r-sibutramine	prep_of	14	SENT_233	[p15l1419t688r1944b754],
17	were	VBD	O	be	cop	18	SENT_233	[p15l1964t709r2141b754],
18	higher	JJR	O	higher	ccomp	10	SENT_233	[p15l9t799r247b884],
19	than	IN	O	than	_	0	SENT_233	[p15l301t799r460b866],
20	those	DT	O	those	prep_than	18	SENT_233	[p15l515t799r709b866],
21	of	IN	O	of	_	0	SENT_233	[p15l768t799r853b866],
22	S-sibutramine	NN	O	s-sibutramine	prep_of	20	SENT_233	[p15l898t799r1431b880],
23	;	:	O	;	_	0	SENT_233	[p15l898t799r1431b880],
24	the	DT	O	the	det	26	SENT_233	[p15l1492t799r1603b866],
25	R/S	NN	O	r/s	nn	26	SENT_233	[p15l1657t799r1792b866],
26	ratio	NN	O	ratio	nsubj	34	SENT_233	[p15l1843t799r2008b866],
27	of	IN	O	of	_	0	SENT_233	[p15l2069t799r2154b866],
28	sibutramine	NN	O	sibutramine	prep_of	26	SENT_233	[p15l13t909r444b976],
29	was	VBD	O	be	cop	34	SENT_233	[p15l472t931r613b976],
30	2.52	CD	NUMBER	2.52	number	31	SENT_233	[p15l643t911r801b976],
31	(	CD	NUMBER	(	nn	34	SENT_233	[p15l834t909r1069b994],
32	Table	NNP	O	Table	nn	33	SENT_233	[p15l834t909r1069b994],
33	l	NN	O	l	dep	31	SENT_233	[p15l1108t910r1191b994],
34	)	NN	O	)	parataxis	10	SENT_233	[p15l1108t910r1191b994],
35	.	.	O	.	_	0	SENT_233	[p15l1108t910r1191b994],

1	The	DT	O	the	det	3	SENT_234	[p15l1225t909r1365b976],
2	R/S	NN	O	r/s	nn	3	SENT_234	[p15l1390t909r1525b976],
3	ratio	NN	O	ratio	nsubjpass	9	SENT_234	[p15l1547t909r1712b976],
4	of	IN	O	of	_	0	SENT_234	[p15l1744t909r1829b976],
5	M1	NN	O	m1	prep_of	3	SENT_234	[p15l1845t911r1962b975],
6	was	VBD	O	be	auxpass	9	SENT_234	[p15l1999t931r2141b976],
7	not	RB	O	not	neg	9	SENT_234	[p15l9t1030r128b1087],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_234	[p15l194t1021r648b1106],
9	differed	VBN	O	differ	_	0	SENT_234	[p15l714t1021r1003b1087],
10	and	CC	O	and	_	0	SENT_234	[p15l1067t1021r1199b1087],
11	the	DT	O	the	det	12	SENT_234	[p15l1262t1021r1372b1087],
12	magnitude	NN	O	magnitude	nsubj	17	SENT_234	[p15l1437t1021r1826b1106],
13	of	IN	O	of	_	0	SENT_234	[p15l1893t1021r1978b1087],
14	the	DT	O	the	det	15	SENT_234	[p15l2030t1021r2141b1087],
15	differences	NNS	O	difference	prep_of	12	SENT_234	[p15l11t1132r416b1199],
16	was	VBD	O	be	cop	17	SENT_234	[p15l451t1154r592b1199],
17	greatest	JJS	O	greatest	conj_and	9	SENT_234	[p15l629t1141r914b1217],
18	in	IN	O	in	_	0	SENT_234	[p15l947t1132r1017b1197],
19	case	NN	O	case	_	0	SENT_234	[p15l1051t1154r1205b1199],
20	of	IN	O	of	_	0	SENT_234	[p15l1242t1132r1326b1199],
21	M2	NN	O	m2	prep_in_case_of	17	SENT_234	[p15l1349t1134r1496b1213],
22	,	,	O	,	_	0	SENT_234	[p15l1349t1134r1496b1213],
23	with	IN	O	with	_	0	SENT_234	[p15l1533t1132r1697b1199],
24	only	RB	O	only	advmod	25	SENT_234	[p15l1731t1132r1894b1217],
25	R-M2	NN	O	r-m2	prep_with	17	SENT_234	[p15l1925t1134r2139b1197],
26	detected	VBN	O	detect	partmod	25	SENT_234	[p15l11t1242r317b1310],
27	in	IN	O	in	_	0	SENT_234	[p15l357t1242r426b1309],
28	our	PRP$	O	we	poss	29	SENT_234	[p15l467t1264r590b1310],
29	system	NN	O	system	prep_in	26	SENT_234	[p15l630t1252r899b1329],
30	.	.	O	.	_	0	SENT_234	[p15l630t1252r899b1329],

1	No	DT	O	no	det	3	SENT_235	[p15l943t1245r1055b1310],
2	chiral	JJ	O	chiral	amod	3	SENT_235	[p15l1098t1242r1303b1310],
3	conversion	NN	O	conversion	nsubjpass	10	SENT_235	[p15l1345t1242r1750b1310],
4	of	IN	O	of	_	0	SENT_235	[p15l1791t1242r1876b1310],
5	sibutramine	NN	O	sibutramine	prep_of	3	SENT_235	[p15l1907t1242r2141b1310, p15l11t1355r232b1421],
6	and	CC	O	and	_	0	SENT_235	[p15l297t1355r429b1421],
7	its	PRP$	O	its	poss	8	SENT_235	[p15l489t1355r570b1421],
8	metabolites	NNS	O	metabolite	prep_of	3	SENT_235	[p15l632t1355r1055b1421],
9	was	VBD	O	be	auxpass	10	SENT_235	[p15l1117t1376r1258b1421],
10	observed	VBN	O	observe	_	0	SENT_235	[p15l1322t1355r1655b1421],
11	when	WRB	O	when	advmod	15	SENT_235	[p15l1713t1355r1915b1421],
12	each	DT	O	each	det	13	SENT_235	[p15l1976t1355r2143b1421],
13	enantiomer	NN	O	enantiomer	nsubjpass	15	SENT_235	[p15l11t1466r426b1533],
14	was	VBD	O	be	auxpass	15	SENT_235	[p15l475t1488r616b1533],
15	incubated	VBN	O	incubate	advcl	10	SENT_235	[p15l671t1466r1030b1533],
16	with	IN	O	with	mark	18	SENT_235	[p15l1080t1466r1244b1533],
17	microsomes	NNS	O	microsome	nsubj	18	SENT_235	[p15l1293t1466r1738b1533],
18	(	VBP	O	(	advcl	15	SENT_235	[p15l1794t1466r1975b1551],
19	data	NNS	O	datum	dobj	18	SENT_235	[p15l1794t1466r1975b1551],
20	not	RB	O	not	neg	21	SENT_235	[p15l2024t1476r2144b1533],
21	shown	VBN	O	show	rcmod	19	SENT_235	[p15l13t1576r301b1662],
22	)	NN	O	)	dobj	21	SENT_235	[p15l13t1576r301b1662],
23	,	,	O	,	_	0	SENT_235	[p15l13t1576r301b1662],
24	suggesting	VBG	O	suggest	partmod	21	SENT_235	[p15l330t1576r722b1663],
25	different	JJ	O	different	amod	27	SENT_235	[p15l746t1576r1060b1644],
26	R/S	NN	O	r/s	nn	27	SENT_235	[p15l1077t1576r1213b1644],
27	ratios	NNS	O	ratio	nsubjpass	30	SENT_235	[p15l1228t1576r1430b1644],
28	were	VBD	O	be	auxpass	30	SENT_235	[p15l1452t1598r1629b1644],
29	not	RB	O	not	neg	30	SENT_235	[p15l1651t1586r1770b1644],
30	attributed	VBN	O	attribute	ccomp	24	SENT_235	[p15l1791t1576r2144b1644],
31	by	IN	O	by	_	0	SENT_235	[p15l8t1689r102b1774],
32	chiral	JJ	O	chiral	amod	33	SENT_235	[p15l136t1689r341b1755],
33	inter-conversion	NN	O	inter-conversion	agent	30	SENT_235	[p15l377t1689r998b1755],
34	.	.	O	.	_	0	SENT_235	[p15l377t1689r998b1755],

1	M1	NN	O	m1	nsubjpass	5	SENT_236	[p15l1037t1691r1154b1754],
2	and	CC	O	and	_	0	SENT_236	[p15l1199t1689r1331b1755],
3	M2	NN	O	m2	nsubjpass	5	SENT_236	[p15l1364t1691r1488b1754],
4	are	VBP	O	be	auxpass	5	SENT_236	[p15l1526t1710r1633b1755],
5	known	VBN	O	know	_	0	SENT_236	[p15l1667t1689r1921b1755],
6	to	TO	O	to	aux	7	SENT_236	[p15l1953t1698r2021b1755],
7	be	VB	O	be	xcomp	5	SENT_236	[p15l2055t1689r2141b1755],

1	556	CD	NUMBER	556	_	0	SENT_237	[p15l97t1849r156b1878],
2	The	DT	O	the	det	3	SENT_237	[p15l1207t1852r1257b1878],
3	journal	NN	O	journal	dep	1	SENT_237	[p15l1265t1852r1368b1886],
4	of	IN	O	of	_	0	SENT_237	[p15l1381t1852r1413b1885],
5	Clinical	JJ	O	clinical	amod	6	SENT_237	[p15l1421t1852r1518b1878],
6	Pharmacology	NN	O	pharmacology	prep_of	3	SENT_237	[p15l1530t1852r1724b1887],
7	/	:	O	/	punct	1	SENT_237	[p15l1736t1852r1747b1878],
8	Vol	NNP	O	Vol	dep	12	SENT_237	[p15l1758t1852r1807b1878],
9	53	CD	NUMBER	53	dep	8	SENT_237	[p15l1823t1851r1856b1878],
10	No	DT	O	no	det	11	SENT_237	[p15l1874t1852r1920b1878],
11	5	CD	NUMBER	5	dep	12	SENT_237	[p15l1935t1852r1950b1878],
12	(	NN	O	(	dep	16	SENT_237	[p15l1966t1851r2025b1886],
13	20	CD	NUMBER	20	num	14	SENT_237	[p15l1966t1851r2025b1886],
14	|	NN	O	|	dep	12	SENT_237	[p15l1966t1851r2025b1886],
15	3	CD	NUMBER	3	num	16	SENT_237	[p15l2035t1851r2061b1887],
16	)	NN	O	)	dep	1	SENT_237	[p15l2035t1851r2061b1887],

1	further	RB	O	further	advmod	2	SENT_238	[p15l10t2023r260b2089],
2	metabolized	VBN	O	metabolize	_	0	SENT_238	[p15l319t2023r772b2089],
3	to	TO	O	to	_	0	SENT_238	[p15l834t2032r903b2089],
4	the	DT	O	the	det	6	SENT_238	[p15l968t2023r1079b2089],
5	hydroxyl	NN	O	hydroxyl	nn	6	SENT_238	[p15l1142t2023r1478b2108],
6	derivatives	NNS	O	derivative	prep_to	2	SENT_238	[p15l1543t2023r1943b2089],
7	and	CC	O	and	_	0	SENT_238	[p15l2010t2023r2143b2089],
8	glucuronide	NN	O	glucuronide	prep_to	2	SENT_238	[p15l9t2135r450b2220],
9	conjugates	VBZ	O	conjugate	dep	2	SENT_238	[p15l531t2117r1156b2220],
10	.7	CD	NUMBER	.7	number	11	SENT_238	[p15l531t2117r1156b2220],
11	’	CD	NUMBER	’	nsubj	2	SENT_238	[p15l531t2117r1156b2220],
12	16	CD	NUMBER	16	number	13	SENT_238	[p15l531t2117r1156b2220],
13	’17	CD	NUMBER	’17	num	14	SENT_238	[p15l531t2117r1156b2220],
14	Differences	NNS	O	difference	nsubj	31	SENT_238	[p15l1237t2135r1664b2202],
15	in	IN	O	in	_	0	SENT_238	[p15l1745t2135r1815b2200],
16	further	JJ	O	further	amod	17	SENT_238	[p15l1894t2135r2143b2202],
17	hydroxylation	NN	O	hydroxylation	prep_in	14	SENT_238	[p15l8t2245r530b2332],
18	and	CC	O	and	_	0	SENT_238	[p15l552t2245r709b2313],
19	/	:	O	/	punct	23	SENT_238	[p15l552t2245r709b2313],
20	or	CC	O	or	dep	23	SENT_238	[p15l711t2267r787b2313],
21	other	JJ	O	other	dep	23	SENT_238	[p15l807t2245r997b2313],
22	unknown	JJ	O	unknown	amod	23	SENT_238	[p15l1014t2245r1362b2313],
23	metabolism	NN	O	metabolism	conj_and	14	SENT_238	[p15l1381t2245r1814b2313],
24	between	IN	O	between	_	0	SENT_238	[p15l1833t2245r2142b2313],
25	enantiomers	NNS	O	enantiomer	prep_between	23	SENT_238	[p15l10t2358r457b2424],
26	of	IN	O	of	_	0	SENT_238	[p15l492t2358r577b2424],
27	M1	NN	O	m1	prep_of	23	SENT_238	[p15l595t2360r713b2423],
28	and	CC	O	and	_	0	SENT_238	[p15l755t2358r887b2424],
29	M2	NN	O	m2	conj_and	14	SENT_238	[p15l916t2360r1041b2423],
30	may	MD	O	may	aux	31	SENT_238	[p15l1073t2379r1233b2443],
31	result	VB	O	result	rcmod	11	SENT_238	[p15l1262t2358r1467b2424],
32	in	IN	O	in	_	0	SENT_238	[p15l1498t2358r1567b2423],
33	similar	JJ	O	similar	amod	35	SENT_238	[p15l1600t2358r1852b2424],
34	plasma	NN	O	plasma	nn	35	SENT_238	[p15l1879t2358r2142b2443],
35	levels	NNS	O	level	prep_in	31	SENT_238	[p15l10t2470r220b2537],
36	of	IN	O	of	_	0	SENT_238	[p15l243t2470r327b2537],
37	R-Ml	NN	O	r-ml	prep_of	35	SENT_238	[p15l331t2472r539b2536],
38	and	CC	O	and	_	0	SENT_238	[p15l570t2470r702b2537],
39	S-Ml	NN	O	s-ml	prep_of	35	SENT_238	[p15l718t2472r914b2537],
40	,	,	O	,	_	0	SENT_238	[p15l929t2526r944b2551],
41	and	CC	O	and	_	0	SENT_238	[p15l968t2470r1100b2537],
42	undetectable	JJ	O	undetectable	amod	43	SENT_238	[p15l1116t2470r1582b2537],
43	concentrations	NNS	O	concentration	prep_in	31	SENT_238	[p15l1604t2470r2140b2537],
44	of	IN	O	of	_	0	SENT_238	[p15l10t2580r95b2648],
45	S-M2	NN	O	s-m2	prep_of	43	SENT_238	[p15l125t2582r328b2648],
46	following	VBG	O	follow	_	0	SENT_238	[p15l375t2580r732b2667],
47	racemic	JJ	O	racemic	amod	49	SENT_238	[p15l774t2580r1063b2648],
48	sibutramine	NN	O	sibutramine	nn	49	SENT_238	[p15l1110t2580r1540b2648],
49	administration	NN	O	administration	prep_following	31	SENT_238	[p15l1587t2580r2138b2662],
50	,	,	O	,	_	0	SENT_238	[p15l1587t2580r2138b2662],
51	despite	IN	O	despite	_	0	SENT_238	[p15l10t2693r267b2778],
52	the	DT	O	the	det	53	SENT_238	[p15l297t2693r407b2759],
53	higher	JJR	O	higher	prep_despite	31	SENT_238	[p15l437t2693r676b2778],
54	in	FW	O	in	nn	55	SENT_238	[p15l703t2693r772b2758],
55	vitro	FW	O	vitro	advmod	57	SENT_238	[p15l800t2693r971b2759],
56	formation	NN	O	formation	nn	57	SENT_238	[p15l1004t2693r1366b2759],
57	rates	NNS	O	rate	rcmod	53	SENT_238	[p15l1392t2702r1564b2759],
58	of	IN	O	of	_	0	SENT_238	[p15l1596t2693r1680b2759],
59	S-Mland	NN	O	s-mland	nn	60	SENT_238	[p15l1697t2693r2039b2760],
60	SM2	NN	O	sm2	prep_of	57	SENT_238	[p15l2065t2694r2140b2759, p15l8t2806r154b2870],
61	.	.	O	.	_	0	SENT_238	[p15l2065t2694r2140b2759, p15l8t2806r154b2870],

1	Previous	JJ	O	previous	amod	2	SENT_239	[p15l121t2914r439b2981],
2	reports	NNS	O	report	nsubj	8	SENT_239	[p15l460t2924r711b2999],
3	on	IN	O	on	_	0	SENT_239	[p15l734t2936r825b2981],
4	obese	JJ	O	obese	amod	5	SENT_239	[p15l846t2914r1051b2981],
5	patients	NNS	O	patient	prep_on	2	SENT_239	[p15l1070t2914r1352b2999],
6	administered	VBN	O	administer	partmod	5	SENT_239	[p15l1376t2914r1846b2981],
7	sibutramine	NN	O	sibutramine	dobj	6	SENT_239	[p15l1869t2914r2140b2981, p15l8t3026r189b3092],
8	demonstrated	VBD	O	demonstrate	_	0	SENT_239	[p15l232t3026r723b3092],
9	that	IN	O	that	complm	20	SENT_239	[p15l760t3026r897b3092],
10	ketoconazole	NN	O	ketoconazole	nn	16	SENT_239	[p15l934t3026r1416b3092],
11	and	CC	O	and	_	0	SENT_239	[p15l1458t3026r1589b3092],
12	erythromycin	NN	O	erythromycin	conj_and	10	SENT_239	[p15l1629t3026r2138b3111],
13	,	,	O	,	_	0	SENT_239	[p15l1629t3026r2138b3111],
14	potent	JJ	O	potent	amod	16	SENT_239	[p15l7t3146r239b3222],
15	CYP3A4	NN	O	cyp3a4	nn	16	SENT_239	[p15l274t3139r607b3204],
16	inhibitors	NNS	O	inhibitor	nsubj	20	SENT_239	[p15l646t3119r1170b3218],
17	,18	CD	NUMBER	,18	num	18	SENT_239	[p15l646t3119r1170b3218],
18	’19	CD	NUMBER	’19	npadvmod	19	SENT_239	[p15l646t3119r1170b3218],
19	moderately	RB	O	moderately	advmod	20	SENT_239	[p15l1206t3137r1618b3222],
20	increased	VBD	O	increase	ccomp	8	SENT_239	[p15l1654t3137r1997b3204],
21	the	DT	O	the	det	24	SENT_239	[p15l2031t3137r2140b3204],
22	steady-state	JJ	O	steady-state	amod	24	SENT_239	[p15l11t3247r436b3334],
23	plasma	NN	O	plasma	nn	24	SENT_239	[p15l499t3247r760b3333],
24	concentrations	NNS	O	concentration	dobj	20	SENT_239	[p15l824t3247r1352b3315],
25	of	IN	O	of	_	0	SENT_239	[p15l1419t3247r1504b3315],
26	sibutramine	NN	O	sibutramine	prep_of	24	SENT_239	[p15l1559t3247r2004b3329],
27	,	,	O	,	_	0	SENT_239	[p15l1559t3247r2004b3329],
28	in	IN	O	in	_	0	SENT_239	[p15l2073t3247r2142b3314],
29	addition	NN	O	addition	prep_in	20	SENT_239	[p15l10t3360r309b3426],
30	to	TO	O	to	_	0	SENT_239	[p15l346t3369r415b3426],
31	its	PRP$	O	its	poss	33	SENT_239	[p15l456t3360r537b3426],
32	active	JJ	O	active	amod	33	SENT_239	[p15l580t3360r794b3426],
33	metabolites	NNS	O	metabolite	prep_to	20	SENT_239	[p15l833t3360r1270b3426],
34	.	.	O	.	_	0	SENT_239	[p15l833t3360r1270b3426],

1	We	PRP	O	we	nsubj	3	SENT_240	[p15l1314t3363r1440b3426],
2	also	RB	O	also	advmod	3	SENT_240	[p15l1482t3360r1624b3426],
3	reported	VBD	O	report	_	0	SENT_240	[p15l1664t3360r1969b3445],
4	that	IN	O	that	complm	15	SENT_240	[p15l2006t3360r2143b3426],
5	clopidogrel	NN	O	clopidogrel	nsubj	15	SENT_240	[p15l10t3471r444b3556],
6	,	,	O	,	_	0	SENT_240	[p15l10t3471r444b3556],
7	a	DT	O	a	det	11	SENT_240	[p15l475t3493r514b3538],
8	strong	JJ	O	strong	amod	11	SENT_240	[p15l543t3480r767b3556],
9	CYP2B6	NN	O	cyp2b6	nn	11	SENT_240	[p15l797t3473r1126b3538],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_240	[p15l1156t3453r1662b3552],
11	,2	NN	O	,2	appos	5	SENT_240	[p15l1156t3453r1662b3552],
12	(	CD	NUMBER	(	num	13	SENT_240	[p15l1156t3453r1662b3552],
13	H4	NN	O	h4	dep	11	SENT_240	[p15l1156t3453r1662b3552],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_240	[p15l1694t3471r2142b3556],
15	inhibited	VBD	O	inhibit	ccomp	3	SENT_240	[p15l10t3583r334b3651],
16	the	DT	O	the	det	17	SENT_240	[p15l352t3583r462b3651],
17	formation	NN	O	formation	dobj	15	SENT_240	[p15l486t3583r843b3651],
18	of	IN	O	of	_	0	SENT_240	[p15l865t3583r950b3651],
19	M1	NN	O	m1	prep_of	17	SENT_240	[p15l960t3585r1077b3650],
20	and	CC	O	and	_	0	SENT_240	[p15l1110t3583r1241b3651],
21	M2	NN	O	m2	prep_of	17	SENT_240	[p15l1260t3585r1385b3650],
22	in	FW	O	in	nn	23	SENT_240	[p15l1410t3584r1479b3650],
23	vitro	FW	O	vitro	advmod	15	SENT_240	[p15l1498t3564r1760b3665],
24	,	,	O	,	_	0	SENT_240	[p15l1498t3564r1760b3665],
25	”	JJ	O	”	dobj	15	SENT_240	[p15l1498t3564r1760b3665],
26	leading	VBG	O	lead	amod	25	SENT_240	[p15l1783t3583r2050b3670],
27	to	TO	O	to	_	0	SENT_240	[p15l2071t3593r2140b3651],
28	an	DT	O	a	det	29	SENT_240	[p15l10t3717r95b3762],
29	increase	NN	O	increase	prep_to	25	SENT_240	[p15l134t3696r427b3762],
30	in	IN	O	in	_	0	SENT_240	[p15l468t3696r538b3761],
31	sibutramine	NN	O	sibutramine	nn	32	SENT_240	[p15l578t3696r1004b3762],
32	exposure	NN	O	exposure	prep_in	29	SENT_240	[p15l1045t3717r1371b3781],
33	in	IN	O	in	_	0	SENT_240	[p15l1412t3696r1482b3761],
34	healthy	JJ	O	healthy	amod	35	SENT_240	[p15l1518t3696r1788b3781],
35	subjects	NNS	O	subject	prep_in	32	SENT_240	[p15l1829t3696r2137b3781],
36	.	.	O	.	_	0	SENT_240	[p15l1829t3696r2137b3781],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_241	[p16l13t20r406b105],
2	increases	NNS	O	increase	nsubjpass	9	SENT_241	[p16l425t20r755b87],
3	in	IN	O	in	_	0	SENT_241	[p16l777t20r847b85],
4	sibutramine	NN	O	sibutramine	nn	7	SENT_241	[p16l870t20r1295b87],
5	and	CC	O	and	_	0	SENT_241	[p16l1317t20r1450b87],
6	M1	NN	O	m1	nn	7	SENT_241	[p16l1468t22r1585b85],
7	exposure	NN	O	exposure	prep_in	2	SENT_241	[p16l1617t42r1944b105],
8	were	VBD	O	be	auxpass	9	SENT_241	[p16l1965t42r2140b87],
9	observed	VBN	O	observe	_	0	SENT_241	[p16l10t130r340b198],
10	with	IN	O	with	_	0	SENT_241	[p16l382t130r545b198],
11	either	CC	O	either	preconj	12	SENT_241	[p16l590t130r796b198],
12	clopidogrel	NN	O	clopidogrel	prep_with	9	SENT_241	[p16l840t130r1253b217],
13	or	CC	O	or	_	0	SENT_241	[p16l1299t152r1376b198],
14	clarithromycin	NN	O	clarithromycin	nn	15	SENT_241	[p16l1418t130r1953b217],
15	pretreatment	NN	O	pretreatment	conj_or	12	SENT_241	[p16l1994t152r2140b216, p16l8t252r370b323],
16	,	,	O	,	_	0	SENT_241	[p16l1994t152r2140b216, p16l8t252r370b323],
17	but	CC	O	but	_	0	SENT_241	[p16l396t243r515b309],
18	the	DT	O	the	det	19	SENT_241	[p16l537t243r648b309],
19	degree	NN	O	degree	nsubj	22	SENT_241	[p16l674t243r913b328],
20	of	IN	O	of	_	0	SENT_241	[p16l940t243r1025b309],
21	interaction	NN	O	interaction	prep_of	19	SENT_241	[p16l1038t243r1426b309],
22	differed	VBD	O	differ	conj_but	9	SENT_241	[p16l1451t243r1736b309],
23	depending	VBG	O	depend	_	0	SENT_241	[p16l1761t243r2141b328],
24	on	IN	O	on	prepc_depending_on	22	SENT_241	[p16l10t376r101b421],
25	the	DT	O	the	det	26	SENT_241	[p16l171t354r281b421],
26	stereo-conﬁguration	NN	O	stereo-conﬁguration	pobj	22	SENT_241	[p16l356t354r1106b439],
27	.	.	O	.	_	0	SENT_241	[p16l356t354r1106b439],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	3	SENT_242	[p16l1184t354r1619b439],
2	signiﬁcantly	RB	O	signiﬁcantly	advmod	3	SENT_242	[p16l1694t354r2142b439],
3	increased	VBD	O	increase	_	0	SENT_242	[p16l10t464r353b531],
4	both	CC	O	both	prep	3	SENT_242	[p16l390t464r555b531],
5	sibutramine	NN	O	sibutramine	dep	4	SENT_242	[p16l598t464r1024b531],
6	(	CD	NUMBER	(	num	7	SENT_242	[p16l1067t465r1282b549],
7	1.82	CD	NUMBER	1.82	dobj	3	SENT_242	[p16l1067t465r1282b549],
8	-	:	O	-	_	0	SENT_242	[p16l1067t465r1282b549],
9	to	TO	O	to	dep	16	SENT_242	[p16l1324t474r1393b531],
10	2.22-fold	JJ	O	2.22-fold	amod	11	SENT_242	[p16l1435t464r1801b549],
11	)	NN	O	)	pobj	9	SENT_242	[p16l1435t464r1801b549],
12	and	CC	O	and	_	0	SENT_242	[p16l1844t464r1976b531],
13	M1	NN	O	m1	nn	14	SENT_242	[p16l2014t466r2132b530],
14	exposure	NN	O	exposure	conj_and	11	SENT_242	[p16l10t597r337b661],
15	(	CD	NUMBER	(	num	16	SENT_242	[p16l382t576r597b661],
16	1.56	CD	NUMBER	1.56	dep	3	SENT_242	[p16l382t576r597b661],
17	-	:	O	-	_	0	SENT_242	[p16l382t576r597b661],
18	to	TO	O	to	_	0	SENT_242	[p16l639t585r708b642],
19	1.86-fold	JJ	O	1.86-fold	amod	20	SENT_242	[p16l760t576r1137b661],
20	)	NN	O	)	prep_to	3	SENT_242	[p16l760t576r1137b661],
21	,	,	O	,	_	0	SENT_242	[p16l760t576r1137b661],
22	but	CC	O	but	_	0	SENT_242	[p16l1180t576r1298b642],
23	the	DT	O	the	det	24	SENT_242	[p16l1337t576r1448b642],
24	magnitude	NN	O	magnitude	nsubj	34	SENT_242	[p16l1488t576r1874b661],
25	of	IN	O	of	_	0	SENT_242	[p16l1917t576r2002b642],
26	the	DT	O	the	det	27	SENT_242	[p16l2031t576r2140b642],
27	differences	NNS	O	difference	prep_of	24	SENT_242	[p16l10t687r409b754],
28	between	IN	O	between	_	0	SENT_242	[p16l444t687r751b754],
29	the	DT	O	the	det	30	SENT_242	[p16l783t687r894b754],
30	S	NN	O	s	prep_between	27	SENT_242	[p16l928t689r1001b754],
31	-	:	O	-	_	0	SENT_242	[p16l928t689r1001b754],
32	and	CC	O	and	_	0	SENT_242	[p16l1039t687r1170b754],
33	R-enantiomer	NN	O	r-enantiomer	conj_and	27	SENT_242	[p16l1200t687r1702b754],
34	was	VBD	O	be	conj_but	3	SENT_242	[p16l1732t709r1873b754],
35	within	IN	O	within	_	0	SENT_242	[p16l1908t687r2143b754],
36	20	CD	PERCENT	20	num	37	SENT_242	[p16l9t799r194b865],
37	%	NN	PERCENT	%	prep_within	34	SENT_242	[p16l9t799r194b865],
38	.	.	O	.	_	0	SENT_242	[p16l9t799r194b865],

1	In	IN	O	in	_	0	SENT_243	[p16l246t800r320b864],
2	contrast	NN	O	contrast	prep_in	6	SENT_243	[p16l367t807r671b879],
3	,	,	O	,	_	0	SENT_243	[p16l367t807r671b879],
4	clarithromycin	NN	O	clarithromycin	nsubj	18	SENT_243	[p16l722t797r1258b884],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_243	[p16l1306t797r1753b884],
6	increased	VBD	O	increase	_	0	SENT_243	[p16l1800t797r2143b865],
7	sibutramine	NN	O	sibutramine	nn	8	SENT_243	[p16l11t910r438b976],
8	exposure	NN	O	exposure	iobj	6	SENT_243	[p16l461t931r787b995],
9	(	CD	NUMBER	(	num	10	SENT_243	[p16l812t910r1027b995],
10	2.01	CD	NUMBER	2.01	dobj	6	SENT_243	[p16l812t910r1027b995],
11	-	:	O	-	_	0	SENT_243	[p16l812t910r1027b995],
12	to	TO	O	to	_	0	SENT_243	[p16l1049t919r1118b976],
13	4.09-fold	JJ	O	4.09-fold	amod	14	SENT_243	[p16l1140t910r1506b995],
14	)	NN	O	)	prep_to	10	SENT_243	[p16l1140t910r1506b995],
15	but	CC	O	but	_	0	SENT_243	[p16l1526t910r1645b976],
16	did	VBD	O	do	aux	18	SENT_243	[p16l1666t910r1782b976],
17	not	RB	O	not	neg	18	SENT_243	[p16l1800t919r1919b976],
18	affect	VB	O	affect	conj_but	6	SENT_243	[p16l1938t910r2143b976],
19	M1	NN	O	m1	nn	21	SENT_243	[p16l8t1023r126b1086],
20	exposure	NN	O	exposure	nn	21	SENT_243	[p16l161t1043r487b1106],
21	(	NN	O	(	dobj	18	SENT_243	[p16l514t1022r576b1106],
22	1	CD	NUMBER	1	num	23	SENT_243	[p16l514t1022r576b1106],
23	.22	CD	NUMBER	.22	dep	18	SENT_243	[p16l593t1023r730b1088],
24	-	:	O	-	_	0	SENT_243	[p16l593t1023r730b1088],
25	to	TO	O	to	dep	23	SENT_243	[p16l753t1031r822b1088],
26	123-fold	JJ	O	123-fold	amod	27	SENT_243	[p16l856t1021r1232b1106],
27	)	NN	O	)	pobj	25	SENT_243	[p16l856t1021r1232b1106],
28	.	.	O	.	_	0	SENT_243	[p16l856t1021r1232b1106],

1	Additionally	RB	O	additionally	advmod	15	SENT_244	[p16l1258t1021r1740b1106],
2	,	,	O	,	_	0	SENT_244	[p16l1258t1021r1740b1106],
3	the	DT	O	the	det	4	SENT_244	[p16l1765t1021r1876b1088],
4	degree	NN	O	degree	nsubj	15	SENT_244	[p16l1901t1021r2140b1106],
5	of	IN	O	of	_	0	SENT_244	[p16l10t1131r95b1199],
6	the	DT	O	the	det	8	SENT_244	[p16l118t1131r229b1199],
7	AUC	NN	O	auc	nn	8	SENT_244	[p16l264t1133r456b1199],
8	increase	NN	O	increase	prep_of	4	SENT_244	[p16l496t1131r790b1199],
9	of	IN	O	of	_	0	SENT_244	[p16l829t1131r914b1199],
10	S-sibutramine	NN	O	s-sibutramine	prep_of	8	SENT_244	[p16l937t1131r1443b1199],
11	by	IN	O	by	_	0	SENT_244	[p16l1477t1131r1571b1218],
12	clarithromycin	NN	O	clarithromycin	prep_by	10	SENT_244	[p16l1607t1131r2142b1218],
13	was	VBD	O	be	cop	15	SENT_244	[p16l8t1265r149b1310],
14	twofold	RB	O	twofold	advmod	15	SENT_244	[p16l184t1244r470b1310],
15	larger	JJR	O	larger	_	0	SENT_244	[p16l506t1244r716b1329],
16	than	IN	O	than	_	0	SENT_244	[p16l749t1244r907b1310],
17	that	DT	O	that	prep_than	15	SENT_244	[p16l940t1244r1078b1310],
18	of	IN	O	of	_	0	SENT_244	[p16l1113t1244r1198b1310],
19	R-sibutramine	NN	O	r-sibutramine	nn	21	SENT_244	[p16l1218t1244r1736b1310],
20	(	CD	NUMBER	(	num	21	SENT_244	[p16l1775t1244r2007b1329],
21	Table	NNP	O	Table	prep_of	17	SENT_244	[p16l1775t1244r2007b1329],
22	1	CD	NUMBER	1	number	23	SENT_244	[p16l2053t1244r2136b1329],
23	)	CD	NUMBER	)	num	21	SENT_244	[p16l2053t1244r2136b1329],
24	.	.	O	.	_	0	SENT_244	[p16l2053t1244r2136b1329],

1	The	DT	O	the	det	3	SENT_245	[p16l9t1355r150b1422],
2	differential	JJ	O	differential	amod	3	SENT_245	[p16l181t1355r580b1422],
3	effects	NNS	O	effect	nsubjpass	10	SENT_245	[p16l612t1355r850b1422],
4	between	IN	O	between	_	0	SENT_245	[p16l879t1355r1186b1422],
5	the	DT	O	the	det	7	SENT_245	[p16l1215t1355r1325b1422],
6	two	CD	NUMBER	two	num	7	SENT_245	[p16l1354t1365r1490b1422],
7	inhibitors	NNS	O	inhibitor	prep_between	3	SENT_245	[p16l1523t1355r1869b1422],
8	can	MD	O	can	aux	10	SENT_245	[p16l1902t1377r2026b1422],
9	be	VB	O	be	auxpass	10	SENT_245	[p16l2054t1355r2141b1422],
10	explained	VBN	O	explain	_	0	SENT_245	[p16l10t1465r365b1551],
11	by	IN	O	by	_	0	SENT_245	[p16l387t1465r481b1552],
12	the	DT	O	the	det	13	SENT_245	[p16l504t1465r615b1533],
13	differences	NNS	O	difference	agent	10	SENT_245	[p16l643t1465r1042b1533],
14	in	IN	O	in	_	0	SENT_245	[p16l1070t1465r1140b1532],
15	the	DT	O	the	det	17	SENT_245	[p16l1163t1465r1274b1533],
16	relative	JJ	O	relative	amod	17	SENT_245	[p16l1299t1465r1569b1533],
17	contribution	NN	O	contribution	prep_in	13	SENT_245	[p16l1597t1465r2042b1533],
18	of	IN	O	of	_	0	SENT_245	[p16l2069t1465r2153b1533],
19	CYP2B6	NN	O	cyp2b6	prep_of	17	SENT_245	[p16l10t1579r340b1644],
20	and	CC	O	and	_	0	SENT_245	[p16l393t1578r524b1644],
21	CYP3A	NN	O	cyp3a	prep_of	17	SENT_245	[p16l574t1579r866b1644],
22	to	TO	O	to	_	0	SENT_245	[p16l913t1587r982b1644],
23	M1	NN	O	m1	nn	26	SENT_245	[p16l1034t1579r1151b1643],
24	and	CC	O	and	_	0	SENT_245	[p16l1212t1578r1344b1644],
25	M2	NN	O	m2	nn	26	SENT_245	[p16l1392t1580r1516b1643],
26	formation	NN	O	formation	prep_to	10	SENT_245	[p16l1571t1578r1945b1644],
27	.	.	O	.	_	0	SENT_245	[p16l1571t1578r1945b1644],

1	Our	PRP$	O	we	poss	3	SENT_246	[p16l2002t1579r2145b1644],
2	previous	JJ	O	previous	amod	3	SENT_246	[p16l7t1689r322b1774],
3	results	NNS	O	result	nsubj	4	SENT_246	[p16l351t1689r587b1756],
4	(	VBP	O	(	_	0	SENT_246	[p16l619t1689r1097b1774],
5	unpublished	JJ	O	unpublished	amod	7	SENT_246	[p16l619t1689r1097b1774],
6	data	NNS	O	datum	nn	7	SENT_246	[p16l1126t1689r1304b1774],
7	)	NN	O	)	nsubj	8	SENT_246	[p16l1126t1689r1304b1774],
8	show	VBP	O	show	ccomp	4	SENT_246	[p16l1337t1689r1528b1756],
9	that	IN	O	that	complm	12	SENT_246	[p16l1556t1689r1693b1756],
10	CYP2B6	NN	O	cyp2b6	nsubjpass	12	SENT_246	[p16l1723t1691r2051b1756],
11	is	VBZ	O	be	auxpass	12	SENT_246	[p16l2083t1689r2140b1756],
12	involved	VBN	O	involve	ccomp	8	SENT_246	[p16l10t1799r330b1866],
13	in	IN	O	in	_	0	SENT_246	[p16l389t1799r459b1865],
14	the	DT	O	the	det	15	SENT_246	[p16l517t1799r626b1866],
15	formation	NN	O	formation	prep_in	12	SENT_246	[p16l689t1799r1046b1866],
16	of	IN	O	of	_	0	SENT_246	[p16l1107t1799r1192b1866],
17	both	CC	O	both	preconj	18	SENT_246	[p16l1237t1799r1402b1866],
18	M1	NN	O	m1	prep_of	15	SENT_246	[p16l1461t1801r1578b1865],
19	and	CC	O	and	_	0	SENT_246	[p16l1649t1799r1780b1866],
20	M2	NN	O	m2	conj_and	18	SENT_246	[p16l1839t1801r1963b1865],
21	but	CC	O	but	_	0	SENT_246	[p16l2024t1799r2144b1866],
22	enantioselectivity	NN	O	enantioselectivity	nsubj	37	SENT_246	[p16l10t1911r650b1996],
23	between	IN	O	between	_	0	SENT_246	[p16l693t1911r999b1977],
24	the	DT	O	the	det	25	SENT_246	[p16l1042t1911r1152b1977],
25	S	NN	O	s	prep_between	22	SENT_246	[p16l1196t1912r1270b1977],
26	-	:	O	-	_	0	SENT_246	[p16l1196t1912r1270b1977],
27	and	CC	O	and	_	0	SENT_246	[p16l1317t1911r1449b1977],
28	R-enantiomers	NNS	O	r-enantiomer	conj_and	25	SENT_246	[p16l1488t1911r2021b1977],
29	of	IN	O	of	_	0	SENT_246	[p16l2068t1911r2153b1977],
30	sibutramine	NN	O	sibutramine	prep_of	28	SENT_246	[p16l12t2022r438b2089],
31	and	CC	O	and	_	0	SENT_246	[p16l458t2022r589b2089],
32	M	NN	O	m	conj_and	30	SENT_246	[p16l605t2025r686b2087],
33	1	CD	NUMBER	1	num	32	SENT_246	[p16l698t2024r723b2087],
34	,	,	O	,	_	0	SENT_246	[p16l737t2078r751b2103],
35	is	VBZ	O	be	cop	37	SENT_246	[p16l774t2022r831b2089],
36	not	RB	O	not	neg	37	SENT_246	[p16l848t2031r967b2089],
37	signiﬁcant	JJ	O	signiﬁcant	conj_but	4	SENT_246	[p16l986t2022r1380b2107],
38	.	.	O	.	_	0	SENT_246	[p16l986t2022r1380b2107],

1	However	RB	O	however	advmod	22	SENT_247	[p16l1403t2025r1757b2103],
2	,	,	O	,	_	0	SENT_247	[p16l1403t2025r1757b2103],
3	CYP3A4	NN	O	cyp3a4	nsubj	22	SENT_247	[p16l1781t2022r2144b2089],
4	/	:	O	/	punct	7	SENT_247	[p16l1781t2022r2144b2089],
5	5	CD	NUMBER	5	nsubjpass	7	SENT_247	[p16l11t2135r48b2200],
6	is	VBZ	O	be	auxpass	7	SENT_247	[p16l77t2132r133b2200],
7	involved	VBN	O	involve	dep	3	SENT_247	[p16l158t2132r478b2200],
8	only	RB	O	only	advmod	7	SENT_247	[p16l500t2132r662b2219],
9	in	IN	O	in	_	0	SENT_247	[p16l684t2132r754b2199],
10	the	DT	O	the	det	11	SENT_247	[p16l774t2132r885b2200],
11	formation	NN	O	formation	prep_in	7	SENT_247	[p16l909t2132r1267b2200],
12	of	IN	O	of	_	0	SENT_247	[p16l1289t2132r1374b2200],
13	M1	NN	O	m1	prep_of	11	SENT_247	[p16l1384t2134r1502b2199],
14	(	CD	NUMBER	(	num	13	SENT_247	[p16l1536t2132r1672b2218],
15	the	DT	O	the	det	16	SENT_247	[p16l1536t2132r1672b2218],
16	contribution	NN	O	contribution	dep	13	SENT_247	[p16l1697t2132r2143b2200],
17	to	TO	O	to	_	0	SENT_247	[p16l8t2254r77b2311],
18	M2	NN	O	m2	nn	19	SENT_247	[p16l102t2247r227b2310],
19	formation	NN	O	formation	prep_to	7	SENT_247	[p16l256t2245r614b2311],
20	is	VBZ	O	be	cop	22	SENT_247	[p16l638t2245r695b2311],
21	trivial	JJ	O	trivial	amod	22	SENT_247	[p16l719t2245r963b2330],
22	)	NN	O	)	_	0	SENT_247	[p16l719t2245r963b2330],
23	while	IN	O	while	mark	29	SENT_247	[p16l988t2245r1190b2311],
24	CYP3A4/5	NN	O	cyp3a4/5	nsubj	29	SENT_247	[p16l1217t2245r1619b2311],
25	was	VBD	O	be	cop	29	SENT_247	[p16l1647t2266r1789b2311],
26	threefold	RB	O	threefold	advmod	29	SENT_247	[p16l1813t2245r2143b2311],
27	more	RBR	O	more	advmod	29	SENT_247	[p16l8t2378r194b2423],
28	catalytically	RB	O	catalytically	advmod	29	SENT_247	[p16l233t2356r675b2441],
29	active	JJ	O	active	advcl	22	SENT_247	[p16l711t2356r924b2423],
30	towards	IN	O	towards	_	0	SENT_247	[p16l961t2356r1249b2423],
31	the	DT	O	the	det	32	SENT_247	[p16l1285t2356r1396b2423],
32	formation	NN	O	formation	prep_towards	29	SENT_247	[p16l1435t2356r1792b2423],
33	of	IN	O	of	_	0	SENT_247	[p16l1829t2356r1914b2423],
34	S-Ml	NN	O	s-ml	prep_of	32	SENT_247	[p16l1937t2358r2131b2423],
35	than	IN	O	than	_	0	SENT_247	[p16l8t2466r166b2533],
36	R-M1	NN	O	r-m1	prep_than	29	SENT_247	[p16l204t2468r438b2533],
37	.	.	O	.	_	0	SENT_247	[p16l204t2468r438b2533],

1	The	DT	O	the	det	2	SENT_248	[p16l487t2466r627b2533],
2	interactions	NNS	O	interaction	nsubj	11	SENT_248	[p16l672t2466r1093b2533],
3	of	IN	O	of	_	0	SENT_248	[p16l1138t2466r1223b2533],
4	sibutramine	NN	O	sibutramine	prep_of	2	SENT_248	[p16l1257t2466r1683b2533],
5	with	IN	O	with	_	0	SENT_248	[p16l1725t2466r1889b2533],
6	clopidogrel	NN	O	clopidogrel	prep_with	4	SENT_248	[p16l1932t2466r2141b2551, p16l10t2578r241b2663],
7	or	CC	O	or	_	0	SENT_248	[p16l282t2599r358b2644],
8	with	IN	O	with	_	0	SENT_248	[p16l394t2578r557b2644],
9	clarithromycin	NN	O	clarithromycin	prep_with	4	SENT_248	[p16l597t2578r1132b2663],
10	are	VBP	O	be	cop	11	SENT_248	[p16l1172t2599r1278b2644],
11	consistent	JJ	O	consistent	_	0	SENT_248	[p16l1320t2578r1683b2644],
12	with	IN	O	with	_	0	SENT_248	[p16l1721t2578r1884b2644],
13	the	DT	O	the	prep_with	11	SENT_248	[p16l1921t2578r2032b2644],
14	in	FW	O	in	nn	16	SENT_248	[p16l2073t2578r2143b2643],
15	vitro	FW	O	vitro	dep	16	SENT_248	[p16l8t2689r178b2756],
16	results	NNS	O	result	advmod	11	SENT_248	[p16l202t2689r457b2756],
17	.	.	O	.	_	0	SENT_248	[p16l202t2689r457b2756],

1	These	DT	O	these	det	2	SENT_249	[p16l487t2689r703b2756],
2	results	NNS	O	result	nsubj	4	SENT_249	[p16l727t2689r963b2756],
3	are	VBP	O	be	cop	4	SENT_249	[p16l990t2711r1096b2756],
4	consistent	JJ	O	consistent	_	0	SENT_249	[p16l1124t2689r1487b2756],
5	with	IN	O	with	_	0	SENT_249	[p16l1509t2689r1672b2756],
6	the	DT	O	the	det	8	SENT_249	[p16l1695t2689r1806b2756],
7	different	JJ	O	different	amod	8	SENT_249	[p16l1833t2689r2143b2756],
8	proﬁles	NNS	O	proﬁles	prep_with	4	SENT_249	[p16l7t2799r280b2885],
9	between	IN	O	between	_	0	SENT_249	[p16l305t2799r612b2867],
10	sibutramine/clopidogrel	NN	O	sibutramine/clopidogrel	prep_between	8	SENT_249	[p16l638t2799r1505b2886],
11	and	CC	O	and	_	0	SENT_249	[p16l1532t2799r1664b2867],
12	sibutramine	NN	O	sibutramine	conj_and	10	SENT_249	[p16l1690t2799r2143b2867],
13	/	:	O	/	punct	15	SENT_249	[p16l1690t2799r2143b2867],
14	clarithromycin	NN	O	clarithromycin	nn	15	SENT_249	[p16l10t2912r544b2997],
15	interactions	NNS	O	interaction	dep	10	SENT_249	[p16l589t2912r1029b2978],
16	.	.	O	.	_	0	SENT_249	[p16l589t2912r1029b2978],

1	The	DT	O	the	det	3	SENT_250	[p16l1079t2912r1218b2978],
2	relative	JJ	O	relative	amod	3	SENT_250	[p16l1262t2912r1533b2978],
3	contribution	NN	O	contribution	nsubj	15	SENT_250	[p16l1579t2912r2025b2978],
4	of	IN	O	of	_	0	SENT_250	[p16l2069t2912r2153b2978],
5	CYP2B6	NN	O	cyp2b6	prep_of	3	SENT_250	[p16l10t3025r340b3090],
6	and	CC	O	and	_	0	SENT_250	[p16l364t3023r495b3090],
7	CYP3A	NN	O	cyp3a	prep_of	3	SENT_250	[p16l517t3025r808b3090],
8	to	TO	O	to	_	0	SENT_250	[p16l826t3033r895b3090],
9	the	DT	O	the	det	10	SENT_250	[p16l917t3023r1027b3090],
10	disposition	NN	O	disposition	prep_to	5	SENT_250	[p16l1050t3023r1451b3108],
11	of	IN	O	of	_	0	SENT_250	[p16l1471t3023r1557b3090],
12	sibutramine	NN	O	sibutramine	prep_of	10	SENT_250	[p16l1568t3023r1994b3090],
13	can	MD	O	can	aux	15	SENT_250	[p16l2017t3045r2142b3090],
14	be	VB	O	be	cop	15	SENT_250	[p16l7t3133r93b3201],
15	further	JJ	O	further	_	0	SENT_250	[p16l125t3133r371b3201],
16	detailed	VBN	O	detail	partmod	15	SENT_250	[p16l400t3133r687b3201],
17	by	IN	O	by	_	0	SENT_250	[p16l713t3133r807b3220],
18	comparing	VBG	O	compare	agent	16	SENT_250	[p16l837t3133r1225b3220],
19	the	DT	O	the	det	21	SENT_250	[p16l1254t3133r1365b3201],
20	metabolic	JJ	O	metabolic	amod	21	SENT_250	[p16l1394t3133r1752b3201],
21	ratio	NN	O	ratio	dobj	18	SENT_250	[p16l1782t3133r1965b3201],
22	.	.	O	.	_	0	SENT_250	[p16l1782t3133r1965b3201],

1	The	DT	O	the	det	4	SENT_251	[p16l2001t3133r2141b3201],
2	M1/sibutramine	NN	O	m1/sibutramine	nn	4	SENT_251	[p16l8t3246r591b3312],
3	AUC	NN	O	auc	nn	4	SENT_251	[p16l649t3247r842b3312],
4	ratios	NNS	O	ratio	nsubj	10	SENT_251	[p16l901t3246r1100b3312],
5	in	IN	O	in	_	0	SENT_251	[p16l1162t3246r1231b3311],
6	R	NN	O	r	prep_in	4	SENT_251	[p16l1284t3249r1371b3311],
7	-	:	O	-	_	0	SENT_251	[p16l1284t3249r1371b3311],
8	and	CC	O	and	_	0	SENT_251	[p16l1432t3246r1563b3312],
9	S-enantiomers	NNS	O	s-enantiomer	prep_in	4	SENT_251	[p16l1619t3246r2140b3312],
10	decreased	VBD	O	decrease	_	0	SENT_251	[p16l10t3357r369b3424],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_251	[p16l408t3357r875b3442],
12	,	,	O	,	_	0	SENT_251	[p16l408t3357r875b3442],
13	by	IN	O	by	_	0	SENT_251	[p16l915t3357r1008b3442],
14	31.8	CD	PERCENT	31.8	number	18	SENT_251	[p16l1047t3359r1281b3424],
15	%	NN	PERCENT	%	dep	18	SENT_251	[p16l1047t3359r1281b3424],
16	and	CC	O	and	_	0	SENT_251	[p16l1321t3357r1453b3424],
17	70.1	CD	PERCENT	70.1	prep_by	10	SENT_251	[p16l1491t3359r1745b3438],
18	%	NN	PERCENT	%	prep_by	10	SENT_251	[p16l1491t3359r1745b3438],
19	,	,	O	,	_	0	SENT_251	[p16l1491t3359r1745b3438],
20	following	VBG	O	follow	_	0	SENT_251	[p16l1789t3357r2141b3442],
21	clarithromycin	NN	O	clarithromycin	prep_following	10	SENT_251	[p16l10t3467r563b3554],
22	,	,	O	,	_	0	SENT_251	[p16l10t3467r563b3554],
23	while	IN	O	while	mark	26	SENT_251	[p16l593t3467r795b3535],
24	the	DT	O	the	det	25	SENT_251	[p16l822t3467r933b3535],
25	values	NNS	O	value	nsubj	26	SENT_251	[p16l959t3467r1191b3535],
26	decreased	VBD	O	decrease	dep	21	SENT_251	[p16l1221t3467r1597b3549],
27	,	,	O	,	_	0	SENT_251	[p16l1221t3467r1597b3549],
28	by	IN	O	by	_	0	SENT_251	[p16l1626t3467r1719b3554],
29	22.9	CD	PERCENT	22.9	number	33	SENT_251	[p16l1746t3469r1982b3535],
30	%	NN	PERCENT	%	dep	33	SENT_251	[p16l1746t3469r1982b3535],
31	and	CC	O	and	_	0	SENT_251	[p16l2011t3467r2143b3535],
32	4.1	CD	PERCENT	4.1	prep_by	26	SENT_251	[p16l8t3581r219b3661],
33	%	NN	PERCENT	%	prep_by	26	SENT_251	[p16l8t3581r219b3661],
34	,	,	O	,	_	0	SENT_251	[p16l8t3581r219b3661],
35	following	VBG	O	follow	_	0	SENT_251	[p16l267t3580r619b3665],
36	clopidogrel	NN	O	clopidogrel	prep_following	26	SENT_251	[p16l665t3580r1098b3665],
37	,	,	O	,	_	0	SENT_251	[p16l665t3580r1098b3665],
38	respectively	RB	O	respectively	advmod	36	SENT_251	[p16l1143t3580r1599b3665],
39	.	.	O	.	_	0	SENT_251	[p16l1143t3580r1599b3665],

1	These	DT	O	these	det	2	SENT_252	[p16l1650t3580r1865b3646],
2	values	NNS	O	value	nsubj	3	SENT_252	[p16l1908t3580r2141b3646],
3	were	VBD	O	be	_	0	SENT_252	[p16l8t3713r183b3758],
4	not	RB	O	not	neg	3	SENT_252	[p16l243t3700r379b3772],
5	,	,	O	,	_	0	SENT_252	[p16l243t3700r379b3772],
6	however	RB	O	however	advmod	3	SENT_252	[p16l442t3691r776b3772],
7	,	,	O	,	_	0	SENT_252	[p16l442t3691r776b3772],
8	statistically	RB	O	statistically	advmod	9	SENT_252	[p16l843t3691r1250b3776],
9	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_252	[p16l1313t3691r1690b3776],
10	(	NN	O	(	nn	11	SENT_252	[p16l1750t3691r1984b3776],
11	Table	NNP	O	Table	nsubj	13	SENT_252	[p16l1750t3691r1984b3776],
12	2	CD	NUMBER	2	num	13	SENT_252	[p16l2044t3691r2138b3776],
13	)	CD	NUMBER	)	xcomp	3	SENT_252	[p16l2044t3691r2138b3776],
14	,	,	O	,	_	0	SENT_252	[p16l2044t3691r2138b3776],

1	supporting	VBG	O	support	_	0	SENT_253	[p17l11t19r399b106],
2	a	DT	O	a	det	4	SENT_253	[p17l424t41r462b87],
3	major	JJ	O	major	amod	4	SENT_253	[p17l482t19r698b106],
4	role	NN	O	role	dobj	1	SENT_253	[p17l716t19r856b87],
5	of	IN	O	of	_	0	SENT_253	[p17l881t19r966b87],
6	CYP3A	NN	O	cyp3a	prep_of	4	SENT_253	[p17l978t21r1268b87],
7	in	IN	O	in	_	0	SENT_253	[p17l1291t19r1360b86],
8	the	DT	O	the	det	9	SENT_253	[p17l1380t19r1491b87],
9	formation	NN	O	formation	prep_in	1	SENT_253	[p17l1515t19r1873b87],
10	of	IN	O	of	_	0	SENT_253	[p17l1896t19r1981b87],
11	M1	NN	O	m1	prep_of	9	SENT_253	[p17l1991t21r2108b86],
12	,	,	O	,	_	0	SENT_253	[p17l2124t75r2139b101],
13	with	IN	O	with	_	0	SENT_253	[p17l8t132r170b198],
14	a	DT	O	a	det	16	SENT_253	[p17l192t153r231b198],
15	high	JJ	O	high	amod	16	SENT_253	[p17l249t132r413b217],
16	afﬁnity	NN	O	afﬁnity	prep_with	1	SENT_253	[p17l435t132r696b217],
17	for	IN	O	for	_	0	SENT_253	[p17l718t132r823b198],
18	the	DT	O	the	det	19	SENT_253	[p17l840t132r951b198],
19	S-enantiomer	NN	O	s-enantiomer	prep_for	16	SENT_253	[p17l971t132r1475b199],
20	.	.	O	.	_	0	SENT_253	[p17l971t132r1475b199],

1	In	IN	O	in	_	0	SENT_254	[p17l1501t135r1577b197],
2	contrast	NN	O	contrast	prep_in	9	SENT_254	[p17l1597t141r1903b213],
3	,	,	O	,	_	0	SENT_254	[p17l1597t141r1903b213],
4	the	DT	O	the	det	7	SENT_254	[p17l1926t132r2036b198],
5	RM2/R-Ml	NN	O	rm2/r-ml	nn	7	SENT_254	[p17l2053t135r2140b197, p17l8t243r365b310],
6	AUC	NN	O	auc	nn	7	SENT_254	[p17l419t245r612b310],
7	ratio	NN	O	ratio	nsubj	9	SENT_254	[p17l658t243r823b310],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_254	[p17l872t243r1320b328],
9	decreased	VBN	O	decrease	_	0	SENT_254	[p17l1366t243r1725b310],
10	by	IN	O	by	_	0	SENT_254	[p17l1766t243r1860b328],
11	34.5	CD	PERCENT	34.5	num	12	SENT_254	[p17l1907t245r2140b310],
12	%	NN	PERCENT	%	prep_by	9	SENT_254	[p17l1907t245r2140b310],
13	following	VBG	O	follow	_	0	SENT_254	[p17l10t353r363b440],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_254	[p17l432t353r845b440],
15	pretreatment	NN	O	pretreatment	prep_following	12	SENT_254	[p17l911t363r1392b439],
16	,	,	O	,	_	0	SENT_254	[p17l911t363r1392b439],
17	while	IN	O	while	mark	20	SENT_254	[p17l1461t353r1663b421],
18	the	DT	O	the	det	19	SENT_254	[p17l1730t353r1841b421],
19	values	NNS	O	value	nsubj	20	SENT_254	[p17l1908t353r2141b421],
20	increased	VBD	O	increase	dep	15	SENT_254	[p17l9t466r353b532],
21	(	CD	PERCENT	(	number	22	SENT_254	[p17l384t466r677b551],
22	22.7	CD	PERCENT	22.7	num	23	SENT_254	[p17l384t466r677b551],
23	%	NN	PERCENT	%	iobj	20	SENT_254	[p17l384t466r677b551],
24	)	CD	NUMBER	)	dobj	20	SENT_254	[p17l384t466r677b551],
25	following	VBG	O	follow	_	0	SENT_254	[p17l710t466r1064b551],
26	clarithromycin	NN	O	clarithromycin	nn	27	SENT_254	[p17l1096t466r1631b551],
27	pretreatment	NN	O	pretreatment	prep_following	20	SENT_254	[p17l1658t475r2136b551],
28	.	.	O	.	_	0	SENT_254	[p17l1658t475r2136b551],

1	These	DT	O	these	det	2	SENT_255	[p17l9t577r225b643],
2	results	NNS	O	result	nsubj	4	SENT_255	[p17l271t577r507b643],
3	collectively	RB	O	collectively	advmod	4	SENT_255	[p17l556t577r978b662],
4	suggest	VBP	O	suggest	_	0	SENT_255	[p17l1027t586r1300b662],
5	that	IN	O	that	complm	9	SENT_255	[p17l1343t577r1480b643],
6	M1	NN	O	m1	nsubjpass	9	SENT_255	[p17l1526t578r1643b642],
7	is	VBZ	O	be	auxpass	9	SENT_255	[p17l1700t577r1757b643],
8	primarily	RB	O	primarily	advmod	9	SENT_255	[p17l1802t577r2142b662],
9	generated	VBN	O	generate	ccomp	4	SENT_255	[p17l9t688r363b773],
10	by	IN	O	by	_	0	SENT_255	[p17l389t688r482b773],
11	CYP3A	NN	O	cyp3a	agent	9	SENT_255	[p17l511t690r820b769],
12	,	,	O	,	_	0	SENT_255	[p17l511t690r820b769],
13	with	IN	O	with	_	0	SENT_255	[p17l851t688r1014b755],
14	CYP2B6	NN	O	cyp2b6	prep_with	9	SENT_255	[p17l1043t690r1371b755],
15	playing	VBG	O	play	partmod	14	SENT_255	[p17l1400t688r1675b773],
16	a	DT	O	a	det	18	SENT_255	[p17l1706t710r1744b755],
17	secondary	JJ	O	secondary	amod	18	SENT_255	[p17l1774t688r2143b773],
18	role	NN	O	role	dobj	15	SENT_255	[p17l8t798r168b880],
19	,	,	O	,	_	0	SENT_255	[p17l8t798r168b880],
20	while	IN	O	while	mark	24	SENT_255	[p17l198t798r399b866],
21	M2	NN	O	m2	nsubjpass	24	SENT_255	[p17l427t800r552b865],
22	appears	VBZ	O	appear	auxpass	24	SENT_255	[p17l583t820r858b884],
23	exclusively	RB	O	exclusively	advmod	24	SENT_255	[p17l889t798r1303b885],
24	mediated	VBN	O	mediate	advcl	9	SENT_255	[p17l1328t798r1665b866],
25	by	IN	O	by	_	0	SENT_255	[p17l1689t798r1782b885],
26	CYP2B6	NN	O	cyp2b6	agent	24	SENT_255	[p17l1810t800r2139b866],
27	in	IN	O	in	_	0	SENT_255	[p17l9t911r79b976],
28	humans	NNS	O	human	prep_in	26	SENT_255	[p17l107t911r411b977],
29	.	.	O	.	_	0	SENT_255	[p17l107t911r411b977],

1	The	DT	O	the	det	2	SENT_256	[p17l122t1022r262b1089],
2	CLim	NN	O	clim	nsubjpass	6	SENT_256	[p17l294t1024r484b1103],
3	of	IN	O	of	_	0	SENT_256	[p17l512t1022r597b1089],
4	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_256	[p17l617t1024r953b1089],
5	is	VBZ	O	be	auxpass	6	SENT_256	[p17l984t1022r1041b1089],
6	reported	VBN	O	report	ccomp	31	SENT_256	[p17l1071t1022r1379b1107],
7	to	TO	O	to	aux	11	SENT_256	[p17l1406t1032r1475b1089],
8	be	VB	O	be	cop	11	SENT_256	[p17l1504t1022r1590b1089],
9	5.6-fold	JJ	O	5.6-fold	amod	10	SENT_256	[p17l1623t1022r1916b1089],
10	times	NNS	O	time	npadvmod	11	SENT_256	[p17l1943t1022r2139b1089],
11	lower	JJR	O	lower	xcomp	6	SENT_256	[p17l9t1132r220b1200],
12	than	IN	O	than	_	0	SENT_256	[p17l277t1132r436b1199],
13	that	DT	O	that	prep_than	11	SENT_256	[p17l495t1132r634b1200],
14	of	IN	O	of	_	0	SENT_256	[p17l694t1132r779b1200],
15	CYP2B6	NN	O	cyp2b6	prep_of	13	SENT_256	[p17l830t1113r1256b1200],
16	.12	CD	NUMBER	.12	num	15	SENT_256	[p17l830t1113r1256b1200],
17	However	RB	O	however	advmod	11	SENT_256	[p17l1318t1135r1677b1213],
18	,	,	O	,	_	0	SENT_256	[p17l1318t1135r1677b1213],
19	a	DT	O	a	det	21	SENT_256	[p17l1742t1154r1781b1200],
20	fourfold	JJ	O	fourfold	amod	21	SENT_256	[p17l1842t1132r2142b1200],
21	increase	NN	O	increase	nsubjpass	31	SENT_256	[p17l9t1244r307b1310],
22	in	IN	O	in	_	0	SENT_256	[p17l355t1244r425b1309],
23	the	DT	O	the	det	24	SENT_256	[p17l470t1244r580b1310],
24	AUC	NN	MISC	auc	prep_in	21	SENT_256	[p17l626t1245r819b1310],
25	of	IN	MISC	of	_	0	SENT_256	[p17l869t1244r954b1310],
26	S-sibutramine	NN	MISC	s-sibutramine	prep_of	24	SENT_256	[p17l987t1244r1499b1310],
27	following	VBG	O	follow	_	0	SENT_256	[p17l1547t1244r1904b1329],
28	clarithromycin	NN	O	clarithromycin	nn	29	SENT_256	[p17l1952t1244r2139b1310, p17l8t1355r388b1440],
29	pretreatment	NN	O	pretreatment	prep_following	26	SENT_256	[p17l434t1364r903b1440],
30	was	VBD	O	be	auxpass	31	SENT_256	[p17l948t1377r1090b1422],
31	estimated	VBN	O	estimate	_	0	SENT_256	[p17l1142t1355r1493b1422],
32	whereas	IN	O	whereas	mark	41	SENT_256	[p17l1539t1355r1840b1422],
33	only	RB	O	only	advmod	36	SENT_256	[p17l1892t1355r2054b1440],
34	a	DT	O	a	det	36	SENT_256	[p17l2104t1377r2143b1422],
35	twofold	JJ	O	twofold	amod	36	SENT_256	[p17l8t1465r297b1533],
36	increase	NN	O	increase	nsubjpass	41	SENT_256	[p17l328t1465r626b1533],
37	following	VBG	O	follow	_	0	SENT_256	[p17l661t1465r1018b1552],
38	clopidogrel	NN	O	clopidogrel	nn	39	SENT_256	[p17l1052t1465r1470b1552],
39	pretreatment	NN	O	pretreatment	prep_following	36	SENT_256	[p17l1501t1475r1968b1551],
40	was	VBD	O	be	auxpass	41	SENT_256	[p17l1998t1487r2140b1533],
41	observed	VBN	O	observe	advcl	31	SENT_256	[p17l10t1578r360b1644],
42	.	.	O	.	_	0	SENT_256	[p17l10t1578r360b1644],

1	Protein	NN	O	protein	nn	2	SENT_257	[p17l408t1578r674b1644],
2	expression	NN	O	expression	nsubj	8	SENT_257	[p17l718t1578r1112b1663],
3	of	IN	O	of	_	0	SENT_257	[p17l1156t1578r1241b1644],
4	CYP3A4/5	NN	O	cyp3a4/5	prep_of	2	SENT_257	[p17l1274t1578r1679b1644],
5	is	VBZ	O	be	cop	8	SENT_257	[p17l1728t1578r1785b1644],
6	approximately	RB	O	approximately	advmod	8	SENT_257	[p17l1831t1578r2140b1663, p17l8t1689r258b1774],
7	9.8-fold	RB	O	9.8-fold	advmod	8	SENT_257	[p17l299t1689r593b1756],
8	greater	JJR	O	greater	_	0	SENT_257	[p17l631t1699r886b1774],
9	than	IN	O	than	mark	31	SENT_257	[p17l921t1689r1080b1756],
10	that	DT	O	that	nsubj	31	SENT_257	[p17l1117t1689r1256b1756],
11	of	IN	O	of	_	0	SENT_257	[p17l1295t1689r1380b1756],
12	CYP2B6	NN	O	cyp2b6	prep_of	10	SENT_257	[p17l1409t1691r1740b1756],
13	in	IN	O	in	_	0	SENT_257	[p17l1782t1689r1852b1754],
14	pooled	JJ	O	pooled	amod	17	SENT_257	[p17l1888t1689r2142b1774],
15	human	JJ	O	human	amod	17	SENT_257	[p17l8t1799r261b1866],
16	liver	NN	O	liver	nn	17	SENT_257	[p17l309t1799r477b1866],
17	microsomes25	NN	O	microsomes25	prep_in	12	SENT_257	[p17l521t1780r1035b1866],
18	and	CC	O	and	_	0	SENT_257	[p17l1087t1799r1219b1866],
19	the	DT	O	the	det	22	SENT_257	[p17l1265t1799r1376b1866],
20	relative	JJ	O	relative	amod	22	SENT_257	[p17l1423t1799r1697b1866],
21	expression	NN	O	expression	nn	22	SENT_257	[p17l1747t1799r2142b1884],
22	level	NN	O	level	conj_and	12	SENT_257	[p17l10t1911r185b1977],
23	of	IN	O	of	_	0	SENT_257	[p17l229t1911r314b1977],
24	CYP3A	NN	O	cyp3a	prep_of	22	SENT_257	[p17l345t1912r638b1977],
25	to	TO	O	to	_	0	SENT_257	[p17l678t1920r746b1977],
26	that	DT	O	that	prep_to	24	SENT_257	[p17l789t1911r927b1977],
27	of	IN	O	of	_	0	SENT_257	[p17l970t1911r1054b1977],
28	CYP2B6	NN	O	cyp2b6	prep_of	26	SENT_257	[p17l1086t1912r1416b1977],
29	is	VBZ	O	be	cop	31	SENT_257	[p17l1462t1911r1518b1977],
30	even	RB	O	even	advmod	31	SENT_257	[p17l1563t1932r1736b1977],
31	greater	JJR	O	greater	advcl	8	SENT_257	[p17l1777t1920r2032b1996],
32	in	IN	O	in	_	0	SENT_257	[p17l2072t1911r2142b1976],
33	human	JJ	O	human	amod	34	SENT_257	[p17l8t2022r261b2089],
34	intestine	NN	O	intestine	prep_in	31	SENT_257	[p17l289t2004r690b2089],
35	.26	CD	NUMBER	.26	num	34	SENT_257	[p17l289t2004r690b2089],
36	Our	PRP$	O	we	poss	37	SENT_257	[p17l721t2024r865b2089],
37	results	NNS	O	result	nsubjpass	41	SENT_257	[p17l888t2022r1127b2089],
38	can	MD	O	can	aux	41	SENT_257	[p17l1157t2044r1283b2089],
39	be	VB	O	be	auxpass	41	SENT_257	[p17l1308t2022r1394b2089],
40	partly	RB	O	partly	advmod	41	SENT_257	[p17l1420t2022r1636b2107],
41	explained	VBN	O	explain	rcmod	34	SENT_257	[p17l1665t2022r2024b2107],
42	by	IN	O	by	_	0	SENT_257	[p17l2048t2022r2142b2107],
43	higher	JJR	O	higher	amod	44	SENT_257	[p17l8t2132r246b2219],
44	expression	NN	O	expression	agent	41	SENT_257	[p17l288t2132r682b2218],
45	of	IN	O	of	_	0	SENT_257	[p17l727t2132r812b2200],
46	CYP3A	NN	O	cyp3a	prep_of	44	SENT_257	[p17l845t2134r1136b2200],
47	in	IN	O	in	_	0	SENT_257	[p17l1181t2132r1250b2199],
48	liver	NN	O	liver	prep_in	34	SENT_257	[p17l1293t2132r1479b2214],
49	,	,	O	,	_	0	SENT_257	[p17l1293t2132r1479b2214],
50	leading	VBG	O	lead	partmod	34	SENT_257	[p17l1527t2132r1796b2219],
51	to	TO	O	to	_	0	SENT_257	[p17l1839t2142r1908b2200],
52	more	JJR	O	more	amod	53	SENT_257	[p17l1952t2154r2140b2200],
53	contribution	NN	O	contribution	prep_to	50	SENT_257	[p17l10t2245r461b2311],
54	of	IN	O	of	_	0	SENT_257	[p17l524t2245r609b2311],
55	CYP3A	NN	O	cyp3a	prep_of	53	SENT_257	[p17l661t2246r953b2311],
56	to	TO	O	to	_	0	SENT_257	[p17l1014t2254r1083b2311],
57	the	DT	O	the	det	58	SENT_257	[p17l1146t2245r1256b2311],
58	formation	NN	O	formation	prep_to	50	SENT_257	[p17l1321t2245r1684b2311],
59	of	IN	O	of	_	0	SENT_257	[p17l1746t2245r1831b2311],
60	M1	NN	O	m1	prep_of	58	SENT_257	[p17l1882t2246r1999b2310],
61	in	IN	O	in	_	0	SENT_257	[p17l2072t2245r2142b2310],
62	human	JJ	O	human	prep_in	34	SENT_257	[p17l8t2357r278b2424],
63	.	.	O	.	_	0	SENT_257	[p17l8t2357r278b2424],

1	In	IN	O	in	_	0	SENT_258	[p17l328t2360r403b2423],
2	addition	NN	O	addition	prep_in	38	SENT_258	[p17l447t2357r768b2438],
3	,	,	O	,	_	0	SENT_258	[p17l447t2357r768b2438],
4	the	DT	O	the	det	5	SENT_258	[p17l815t2357r925b2424],
5	existence	NN	O	existence	nsubj	38	SENT_258	[p17l971t2357r1310b2424],
6	of	IN	O	of	_	0	SENT_258	[p17l1357t2357r1442b2424],
7	other	JJ	O	other	amod	10	SENT_258	[p17l1475t2357r1665b2424],
8	sibutramine	NN	O	sibutramine	nn	10	SENT_258	[p17l1709t2357r2140b2424],
9	metabolic	JJ	O	metabolic	amod	10	SENT_258	[p17l8t2467r369b2535],
10	pathways	NNS	O	pathway	prep_of	5	SENT_258	[p17l402t2467r751b2554],
11	that	WDT	O	that	nsubjpass	14	SENT_258	[p17l785t2467r924b2535],
12	can	MD	O	can	aux	14	SENT_258	[p17l956t2489r1082b2535],
13	be	VB	O	be	auxpass	14	SENT_258	[p17l1112t2467r1198b2535],
14	blocked	VBN	O	block	rcmod	10	SENT_258	[p17l1231t2467r1526b2535],
15	by	IN	O	by	_	0	SENT_258	[p17l1556t2467r1650b2554],
16	clarithromycin	NN	O	clarithromycin	agent	14	SENT_258	[p17l1683t2467r2140b2554, p17l10t2580r139b2661],
17	,	,	O	,	_	0	SENT_258	[p17l1683t2467r2140b2554, p17l10t2580r139b2661],
18	or	CC	O	or	_	0	SENT_258	[p17l199t2601r275b2646],
19	the	DT	O	the	det	21	SENT_258	[p17l326t2580r436b2646],
20	large	JJ	O	large	amod	21	SENT_258	[p17l493t2580r672b2665],
21	contribution	NN	O	contribution	conj_or	10	SENT_258	[p17l729t2580r1180b2646],
22	of	IN	O	of	_	0	SENT_258	[p17l1235t2580r1320b2646],
23	the	DT	O	the	det	24	SENT_258	[p17l1362t2580r1473b2646],
24	intestine	NN	O	intestine	prep_of	21	SENT_258	[p17l1529t2580r1859b2660],
25	,	,	O	,	_	0	SENT_258	[p17l1529t2580r1859b2660],
26	where	WRB	O	where	advmod	30	SENT_258	[p17l1916t2580r2140b2646],
27	CYP3A	NN	O	cyp3a	nsubj	30	SENT_258	[p17l10t2693r303b2758],
28	is	VBZ	O	be	cop	30	SENT_258	[p17l323t2691r379b2758],
29	most	RBS	O	most	advmod	30	SENT_258	[p17l400t2701r580b2758],
30	abundant	JJ	O	abundant	rcmod	24	SENT_258	[p17l600t2691r940b2758],
31	relative	JJ	O	relative	advmod	30	SENT_258	[p17l957t2691r1231b2758],
32	to	TO	O	to	_	0	SENT_258	[p17l1251t2701r1320b2758],
33	other	JJ	O	other	amod	34	SENT_258	[p17l1343t2691r1532b2758],
34	CYPs	NNS	O	cyp	prep_to	31	SENT_258	[p17l1551t2673r1857b2772],
35	,26	CD	NUMBER	,26	tmod	30	SENT_258	[p17l1551t2673r1857b2772],
36	may	MD	O	may	aux	38	SENT_258	[p17l1877t2713r2036b2776],
37	be	VB	O	be	cop	38	SENT_258	[p17l2054t2691r2140b2758],
38	important	JJ	O	important	_	0	SENT_258	[p17l10t2801r368b2886],
39	in	IN	O	in	_	0	SENT_258	[p17l389t2801r459b2867],
40	the	DT	O	the	det	41	SENT_258	[p17l479t2801r589b2868],
41	formation	NN	O	formation	prep_in	38	SENT_258	[p17l615t2801r976b2868],
42	of	IN	O	of	_	0	SENT_258	[p17l998t2801r1083b2868],
43	M1	NN	O	m1	prep_of	41	SENT_258	[p17l1093t2803r1211b2867],
44	from	IN	O	from	_	0	SENT_258	[p17l1245t2801r1421b2868],
45	S-sibutramine	NN	O	s-sibutramine	prep_from	38	SENT_258	[p17l1441t2801r1972b2868],
46	.	.	O	.	_	0	SENT_258	[p17l1441t2801r1972b2868],

1	The	DT	O	the	det	5	SENT_259	[p17l2000t2801r2140b2868],
2	intestinal	JJ	O	intestinal	amod	5	SENT_259	[p17l9t2913r345b2979],
3	CYP3A4	NN	O	cyp3a4	nn	5	SENT_259	[p17l413t2914r749b2979],
4	protein	NN	O	protein	nn	5	SENT_259	[p17l816t2913r1079b2998],
5	levels	NNS	O	level	nsubjpass	7	SENT_259	[p17l1146t2913r1356b2979],
6	are	VBP	O	be	auxpass	7	SENT_259	[p17l1426t2934r1533b2979],
7	known	VBN	O	know	_	0	SENT_259	[p17l1600t2913r1853b2979],
8	to	TO	O	to	aux	12	SENT_259	[p17l1919t2922r1988b2979],
9	be	VB	O	be	cop	12	SENT_259	[p17l2054t2913r2140b2979],
10	approximately	RB	O	approximately	quantmod	11	SENT_259	[p17l10t3024r543b3109],
11	30	CD	PERCENT	30	num	12	SENT_259	[p17l587t3026r752b3091],
12	%	NN	PERCENT	%	xcomp	7	SENT_259	[p17l587t3026r752b3091],
13	of	IN	O	of	_	0	SENT_259	[p17l797t3024r881b3091],
14	hepatic	JJ	O	hepatic	amod	15	SENT_259	[p17l912t3024r1176b3109],
15	CYP3A4	NN	O	cyp3a4	prep_of	12	SENT_259	[p17l1222t3006r1652b3091],
16	.27	CD	NUMBER	.27	num	15	SENT_259	[p17l1222t3006r1652b3091],
17	The	DT	O	the	det	19	SENT_259	[p17l1698t3024r1838b3091],
18	protein	NN	O	protein	nn	19	SENT_259	[p17l1879t3024r2142b3109],
19	content	NN	O	content	nsubjpass	23	SENT_259	[p17l10t3144r281b3201],
20	of	IN	O	of	_	0	SENT_259	[p17l328t3134r414b3201],
21	CYP3A4	NN	O	cyp3a4	prep_of	19	SENT_259	[p17l451t3136r788b3201],
22	was	VBD	O	be	auxpass	23	SENT_259	[p17l836t3156r978b3201],
23	reported	VBN	O	report	rcmod	15	SENT_259	[p17l1026t3134r1334b3219],
24	to	TO	O	to	aux	29	SENT_259	[p17l1379t3144r1448b3201],
25	be	VB	O	be	cop	29	SENT_259	[p17l1496t3134r1582b3201],
26	even	RB	O	even	quantmod	27	SENT_259	[p17l1632t3156r1805b3201],
27	3	CD	NUMBER	3	num	28	SENT_259	[p17l1854t3136r1890b3201],
28	times	NNS	O	time	npadvmod	29	SENT_259	[p17l1943t3134r2139b3201],
29	higher	JJR	O	higher	xcomp	23	SENT_259	[p17l8t3246r246b3331],
30	in	IN	O	in	_	0	SENT_259	[p17l287t3246r357b3311],
31	the	DT	O	the	det	33	SENT_259	[p17l397t3246r508b3312],
32	enterocyte	NN	O	enterocyte	nn	33	SENT_259	[p17l553t3255r934b3331],
33	homogenates	NNS	O	homogenate	prep_in	29	SENT_259	[p17l976t3246r1464b3331],
34	than	IN	O	than	prep	29	SENT_259	[p17l1508t3246r1667b3312],
35	in	IN	O	in	pcomp	34	SENT_259	[p17l1710t3246r1780b3311],
36	the	DT	O	the	det	38	SENT_259	[p17l1820t3246r1931b3312],
37	liver	NN	O	liver	nn	38	SENT_259	[p17l1976t3246r2144b3312],
38	homogenates	NNS	O	homogenate	pobj	35	SENT_259	[p17l8t3340r588b3443],
39	.	.	O	.	_	0	SENT_259	[p17l8t3340r588b3443],

1	”	NN	O	”	_	0	SENT_260	[p17l8t3340r588b3443],

1	Clarithromycin	NNP	O	Clarithromycin	nsubjpass	4	SENT_261	[p17l123t3468r686b3555],
2	is	VBZ	O	be	auxpass	4	SENT_261	[p17l719t3468r775b3536],
3	also	RB	O	also	advmod	4	SENT_261	[p17l811t3468r954b3536],
4	known	VBN	O	know	_	0	SENT_261	[p17l989t3468r1243b3536],
5	as	IN	O	as	_	0	SENT_261	[p17l1276t3490r1348b3536],
6	a	DT	O	a	det	8	SENT_261	[p17l1384t3490r1423b3536],
7	potent	JJ	O	potent	amod	8	SENT_261	[p17l1452t3478r1685b3554],
8	inhibitor	NN	O	inhibitor	prep_as	4	SENT_261	[p17l1718t3468r2036b3536],
9	of	IN	O	of	_	0	SENT_261	[p17l2068t3468r2153b3536],
10	P-glycoprotein	NN	O	p-glycoprotein	prep_of	8	SENT_261	[p17l9t3562r650b3666],
11	.	.	O	.	_	0	SENT_261	[p17l9t3562r650b3666],

1	”	RB	O	”	_	0	SENT_262	[p17l9t3562r650b3666],
2	It	PRP	O	it	nsubjpass	6	SENT_262	[p17l699t3584r753b3647],
3	can	MD	O	can	aux	6	SENT_262	[p17l799t3590r1044b3647],
4	not	RB	O	not	neg	6	SENT_262	[p17l799t3590r1044b3647],
5	be	VB	O	be	auxpass	6	SENT_262	[p17l1088t3581r1174b3647],
6	ruled	VBN	O	rule	ccomp	1	SENT_262	[p17l1220t3581r1410b3647],
7	out	RP	O	out	prt	6	SENT_262	[p17l1456t3590r1573b3647],
8	that	IN	O	that	complm	14	SENT_262	[p17l1618t3581r1756b3647],
9	clarithromycin-mediated	JJ	O	clarithromycin-mediated	amod	10	SENT_262	[p17l1802t3581r2140b3647, p17l8t3692r609b3777],
10	inhibition	NN	O	inhibition	nsubj	14	SENT_262	[p17l655t3692r1014b3759],
11	of	IN	O	of	_	0	SENT_262	[p17l1061t3692r1145b3759],
12	P-glycoprotein	NN	O	p-glycoprotein	prep_of	10	SENT_262	[p17l1180t3692r1730b3777],
13	may	MD	O	may	aux	14	SENT_262	[p17l1774t3714r1933b3777],
14	contribute	VB	O	contribute	ccomp	6	SENT_262	[p17l1980t3714r2140b3759, p18l8t19r245b87],

1	to	TO	O	to	_	0	SENT_263	[p18l300t29r369b87],
2	the	DT	O	the	det	3	SENT_263	[p18l424t19r535b87],
3	increase	NN	O	increase	pobj	1	SENT_263	[p18l591t19r888b87],
4	of	IN	O	of	_	0	SENT_263	[p18l945t19r1031b87],
5	AUC	NN	O	auc	prep_of	3	SENT_263	[p18l1072t21r1265b87],
6	although	IN	O	although	mark	16	SENT_263	[p18l1323t19r1645b106],
7	no	DT	O	no	det	8	SENT_263	[p18l1698t41r1788b87],
8	data	NNS	O	datum	nsubj	16	SENT_263	[p18l1846t19r1997b87],
9	on	IN	O	on	_	0	SENT_263	[p18l2051t41r2142b87],
10	P-glycoprotein-mediated	JJ	O	p-glycoprotein-mediated	amod	11	SENT_263	[p18l9t132r917b217],
11	efﬂux	NN	O	efﬂux	prep_on	8	SENT_263	[p18l942t132r1153b198],
12	of	IN	O	of	_	0	SENT_263	[p18l1179t132r1264b198],
13	sibutramine	NN	O	sibutramine	prep_of	11	SENT_263	[p18l1280t132r1706b198],
14	is	VBZ	O	be	cop	16	SENT_263	[p18l1731t132r1788b198],
15	currently	RB	DATE	currently	advmod	16	SENT_263	[p18l1816t132r2142b217],
16	available	JJ	O	available	pcomp	1	SENT_263	[p18l10t244r354b311],
17	.	.	O	.	_	0	SENT_263	[p18l10t244r354b311],

1	However	RB	O	however	advmod	7	SENT_264	[p18l385t247r740b325],
2	,	,	O	,	_	0	SENT_264	[p18l385t247r740b325],
3	our	PRP$	O	we	nsubj	7	SENT_264	[p18l771t266r894b311],
4	in	FW	O	in	nn	6	SENT_264	[p18l918t244r988b310],
5	vitro	FW	O	vitro	dep	6	SENT_264	[p18l1012t244r1181b311],
6	studies	NNS	O	study	advmod	7	SENT_264	[p18l1213t244r1460b311],
7	demonstrated	VBD	O	demonstrate	_	0	SENT_264	[p18l1490t244r1981b311],
8	that	IN	O	that	complm	10	SENT_264	[p18l2006t244r2143b311],
9	HIMs	NNS	MISC	him	nsubj	10	SENT_264	[p18l9t357r220b421],
10	showed	VBD	O	show	ccomp	7	SENT_264	[p18l244t354r522b421],
11	formation	NN	O	formation	nn	12	SENT_264	[p18l541t354r899b421],
12	rates	NNS	O	rate	nsubj	18	SENT_264	[p18l916t364r1085b421],
13	of	IN	O	of	_	0	SENT_264	[p18l1107t354r1192b421],
14	S-Ml	NN	O	s-ml	prep_of	12	SENT_264	[p18l1198t356r1392b421],
15	and	CC	O	and	_	0	SENT_264	[p18l1422t354r1554b421],
16	R-Ml	NN	O	r-ml	conj_and	14	SENT_264	[p18l1567t356r1774b420],
17	were	VBD	O	be	cop	18	SENT_264	[p18l1802t376r1977b421],
18	2.5	CD	NUMBER	2.5	ccomp	10	SENT_264	[p18l1998t356r2140b421, p18l10t466r142b532],
19	and	CC	O	and	cc	18	SENT_264	[p18l1998t356r2140b421, p18l10t466r142b532],
20	2.3-fold	RB	O	2.3-fold	advmod	18	SENT_264	[p18l189t466r499b546],
21	,	,	O	,	_	0	SENT_264	[p18l189t466r499b546],
22	respectively	RB	O	respectively	advmod	7	SENT_264	[p18l549t466r1008b551],
23	,	,	O	,	_	0	SENT_264	[p18l549t466r1008b551],
24	higher	JJR	O	higher	dep	7	SENT_264	[p18l1059t466r1296b551],
25	than	IN	O	than	_	0	SENT_264	[p18l1339t466r1497b532],
26	those	DT	O	those	prep_than	24	SENT_264	[p18l1543t466r1736b532],
27	in	IN	O	in	_	0	SENT_264	[p18l1785t466r1855b531],
28	HLMs	NNS	O	hlm	prep_in	26	SENT_264	[p18l1902t469r2140b532],
29	(	CD	NUMBER	(	num	30	SENT_264	[p18l11t577r275b662],
30	Figure	NNP	O	Figure	dep	28	SENT_264	[p18l11t577r275b662],
31	3	CD	NUMBER	3	num	30	SENT_264	[p18l310t579r374b658],
32	;	:	O	;	_	0	SENT_264	[p18l310t579r374b658],
33	Table	NNP	O	Table	nn	35	SENT_264	[p18l411t577r616b644],
34	3	CD	NUMBER	3	num	35	SENT_264	[p18l651t577r742b662],
35	)	NN	O	)	dep	28	SENT_264	[p18l651t577r742b662],
36	,	,	O	,	_	0	SENT_264	[p18l651t577r742b662],
37	suggesting	VBG	O	suggest	xcomp	7	SENT_264	[p18l781t577r1169b662],
38	that	IN	O	that	complm	42	SENT_264	[p18l1200t577r1338b644],
39	intestinal	JJ	O	intestinal	amod	41	SENT_264	[p18l1370t577r1700b644],
40	CYP3A4/5	NN	O	cyp3a4/5	nn	41	SENT_264	[p18l1734t577r2137b644],
41	enzymes	NNS	O	enzyme	nsubj	42	SENT_264	[p18l10t709r327b774],
42	contribute	VBP	O	contribute	ccomp	37	SENT_264	[p18l387t687r752b755],
43	signiﬁcantly	RB	O	signiﬁcantly	advmod	42	SENT_264	[p18l813t687r1262b774],
44	to	TO	O	to	_	0	SENT_264	[p18l1316t697r1385b755],
45	the	DT	O	the	det	46	SENT_264	[p18l1443t687r1553b755],
46	disposition	NN	O	disposition	prep_to	42	SENT_264	[p18l1611t687r2012b773],
47	of	IN	O	of	_	0	SENT_264	[p18l2069t687r2153b755],
48	sibutramine	NN	O	sibutramine	prep_of	46	SENT_264	[p18l11t800r456b866],
49	.	.	O	.	_	0	SENT_264	[p18l11t800r456b866],

1	The	DT	O	the	det	5	SENT_265	[p18l498t800r637b866],
2	2.3-fold	RB	O	2.3-fold	advmod	3	SENT_265	[p18l673t800r965b866],
3	higher	JJR	O	higher	amod	5	SENT_265	[p18l998t800r1234b885],
4	formation	NN	O	formation	nn	5	SENT_265	[p18l1268t800r1625b866],
5	rate	NN	O	rate	nsubj	16	SENT_265	[p18l1658t809r1792b866],
6	of	IN	O	of	_	0	SENT_265	[p18l1830t800r1915b866],
7	S-Ml	NN	O	s-ml	prep_of	5	SENT_265	[p18l1937t801r2131b866],
8	compared	VBN	O	compare	_	0	SENT_265	[p18l10t911r370b996],
9	with	IN	O	with	prepc_compared_with	7	SENT_265	[p18l390t911r553b978],
10	that	DT	O	that	pobj	7	SENT_265	[p18l573t911r711b978],
11	of	IN	O	of	_	0	SENT_265	[p18l733t911r818b978],
12	R-Ml	NN	O	r-ml	prep_of	10	SENT_265	[p18l825t913r1032b976],
13	in	IN	O	in	_	0	SENT_265	[p18l1064t911r1134b976],
14	HIMs	NNS	O	him	prep_in	12	SENT_265	[p18l1155t914r1366b978],
15	further	RB	O	further	advmod	16	SENT_265	[p18l1392t911r1639b978],
16	explains	VBZ	O	explain	_	0	SENT_265	[p18l1659t911r1960b996],
17	how	WRB	O	how	advmod	19	SENT_265	[p18l1983t911r2142b978],
18	clarithromycin	NN	O	clarithromycin	nsubj	19	SENT_265	[p18l10t1021r544b1108],
19	caused	VBD	O	cause	ccomp	16	SENT_265	[p18l570t1021r818b1089],
20	a	DT	O	a	det	22	SENT_265	[p18l843t1043r881b1089],
21	4.0-fold	JJ	O	4.0-fold	amod	22	SENT_265	[p18l904t1021r1197b1089],
22	increase	NN	O	increase	dobj	19	SENT_265	[p18l1222t1021r1515b1089],
23	in	IN	O	in	_	0	SENT_265	[p18l1543t1021r1612b1087],
24	S-sibutramine	NN	MISC	s-sibutramine	nn	25	SENT_265	[p18l1635t1021r2140b1089],
25	exposure	NN	O	exposure	prep_in	19	SENT_265	[p18l10t1155r358b1219],
26	,	,	O	,	_	0	SENT_265	[p18l10t1155r358b1219],
27	while	IN	O	while	mark	36	SENT_265	[p18l391t1134r593b1200],
28	only	RB	O	only	advmod	31	SENT_265	[p18l625t1134r787b1219],
29	a	DT	O	a	det	31	SENT_265	[p18l817t1155r856b1200],
30	twofold	JJ	O	twofold	amod	31	SENT_265	[p18l884t1134r1171b1200],
31	increase	NN	O	increase	nsubjpass	36	SENT_265	[p18l1200t1134r1494b1200],
32	in	IN	O	in	_	0	SENT_265	[p18l1527t1134r1597b1199],
33	R-sibutramine	NN	MISC	r-sibutramine	nn	34	SENT_265	[p18l1622t1134r2140b1200],
34	exposure	NN	O	exposure	prep_in	31	SENT_265	[p18l10t1267r337b1330],
35	was	VBD	O	be	auxpass	36	SENT_265	[p18l363t1267r504b1312],
36	observed	VBN	O	observe	advcl	19	SENT_265	[p18l531t1245r861b1312],
37	in	IN	O	in	_	0	SENT_265	[p18l885t1245r955b1310],
38	the	DT	O	the	det	40	SENT_265	[p18l978t1245r1089b1312],
39	clopidogrel	NN	O	clopidogrel	nn	40	SENT_265	[p18l1115t1245r1528b1330],
40	phase	NN	O	phase	prep_in	36	SENT_265	[p18l1552t1245r1779b1330],
41	.	.	O	.	_	0	SENT_265	[p18l1552t1245r1779b1330],

1	Effects	NNS	O	effect	nsubj	16	SENT_266	[p18l121t1355r378b1423],
2	of	IN	O	of	_	0	SENT_266	[p18l432t1355r516b1423],
3	CYPZB6	NN	O	cypzb6	nn	5	SENT_266	[p18l561t1357r895b1437],
4	,	,	O	,	_	0	SENT_266	[p18l561t1357r895b1437],
5	CYPZCI9	NN	O	cypzci9	prep_of	1	SENT_266	[p18l953t1357r1341b1437],
6	,	,	O	,	_	0	SENT_266	[p18l953t1357r1341b1437],
7	and	CC	O	and	_	0	SENT_266	[p18l1396t1355r1528b1423],
8	CYP3A5	NN	O	cyp3a5	nn	9	SENT_266	[p18l1582t1357r1895b1423],
9	polymorphism	NN	O	polymorphism	conj_and	5	SENT_266	[p18l1945t1355r2139b1442, p18l8t1468r384b1553],
10	on	IN	O	on	_	0	SENT_266	[p18l432t1489r523b1534],
11	the	DT	O	the	det	12	SENT_266	[p18l568t1468r679b1534],
12	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_266	[p18l725t1468r1377b1553],
13	of	IN	O	of	_	0	SENT_266	[p18l1428t1468r1513b1534],
14	sibutramine	NN	O	sibutramine	prep_of	12	SENT_266	[p18l1552t1468r1982b1534],
15	are	VBP	O	be	cop	16	SENT_266	[p18l2033t1489r2140b1534],
16	controversial	JJ	O	controversial	_	0	SENT_266	[p18l10t1579r507b1646],
17	.	.	O	.	_	0	SENT_266	[p18l10t1579r507b1646],

1	It	PRP	O	it	nsubjpass	4	SENT_267	[p18l564t1582r618b1645],
2	has	VBZ	O	have	aux	4	SENT_267	[p18l667t1579r788b1646],
3	been	VBN	O	be	auxpass	4	SENT_267	[p18l838t1579r1014b1646],
4	reported	VBN	O	report	_	0	SENT_267	[p18l1063t1579r1371b1664],
5	that	IN	O	that	complm	9	SENT_267	[p18l1420t1579r1559b1646],
6	the	DT	O	the	det	8	SENT_267	[p18l1607t1579r1717b1646],
7	CYP2C19	NN	O	cyp2c19	nn	8	SENT_267	[p18l1774t1581r2141b1646],
8	genotype	NN	O	genotype	nsubj	9	SENT_267	[p18l9t1699r347b1776],
9	played	VBD	O	play	ccomp	4	SENT_267	[p18l397t1689r646b1776],
10	a	DT	O	a	det	12	SENT_267	[p18l698t1711r736b1757],
11	major	JJ	O	major	amod	12	SENT_267	[p18l785t1689r1002b1776],
12	role	NN	O	role	dobj	9	SENT_267	[p18l1049t1689r1190b1757],
13	in	IN	O	in	_	0	SENT_267	[p18l1244t1689r1314b1755],
14	the	DT	O	the	det	16	SENT_267	[p18l1362t1689r1473b1757],
15	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_267	[p18l1524t1689r2140b1775],
16	variability	NN	O	variability	prep_in	9	SENT_267	[p18l8t1802r387b1887],
17	of	IN	O	of	_	0	SENT_267	[p18l418t1802r503b1868],
18	sibutramine	NN	O	sibutramine	prep_of	16	SENT_267	[p18l524t1802r955b1868],
19	in	IN	O	in	_	0	SENT_267	[p18l987t1802r1057b1867],
20	humans	NNS	O	human	prep_in	9	SENT_267	[p18l1085t1802r1393b1883],
21	,	,	O	,	_	0	SENT_267	[p18l1085t1802r1393b1883],
22	while	IN	O	while	mark	29	SENT_267	[p18l1426t1802r1628b1868],
23	CYP2B6	NN	O	cyp2b6	nn	26	SENT_267	[p18l1664t1803r1982b1868],
24	and	CC	O	and	_	0	SENT_267	[p18l2010t1802r2142b1868],
25	CYP3A5	NN	O	cyp3a5	nn	26	SENT_267	[p18l13t1915r326b1980],
26	polymorphisms	NNS	O	polymorphism	nsubj	29	SENT_267	[p18l362t1913r939b1998],
27	did	VBD	O	do	aux	29	SENT_267	[p18l979t1913r1096b1980],
28	not	RB	O	not	neg	29	SENT_267	[p18l1130t1923r1249b1980],
29	affect	VB	O	affect	advcl	9	SENT_267	[p18l1285t1913r1492b1980],
30	the	DT	O	the	det	31	SENT_267	[p18l1526t1913r1637b1980],
31	pharmacokinetics	NNS	O	pharmacokinetic	dobj	29	SENT_267	[p18l1673t1913r2140b1998, p18l8t2025r220b2093],
32	of	IN	O	of	_	0	SENT_267	[p18l254t2025r339b2093],
33	sibutramine	NN	O	sibutramine	prep_of	31	SENT_267	[p18l362t2025r791b2093],
34	or	CC	O	or	_	0	SENT_267	[p18l825t2047r902b2093],
35	its	PRP$	O	its	poss	36	SENT_267	[p18l930t2025r1012b2093],
36	metabolites	NNS	O	metabolite	conj_or	33	SENT_267	[p18l1044t2006r1558b2093],
37	.	.	O	.	_	0	SENT_267	[p18l1044t2006r1558b2093],

1	”	NN	O	”	npadvmod	3	SENT_268	[p18l1044t2006r1558b2093],
2	More	RBR	O	more	dep	1	SENT_268	[p18l1593t2028r1790b2093],
3	recently	RB	DATE	recently	advmod	8	SENT_268	[p18l1821t2025r2137b2112],
4	,	,	O	,	_	0	SENT_268	[p18l1821t2025r2137b2112],
5	Chung	NNP	PERSON	Chung	nsubj	8	SENT_268	[p18l10t2138r256b2223],
6	et	FW	O	et	nn	7	SENT_268	[p18l290t2147r354b2204],
7	al15	FW	O	al15	dep	5	SENT_268	[p18l387t2119r516b2204],
8	reported	VBD	O	report	_	0	SENT_268	[p18l551t2138r859b2223],
9	that	IN	O	that	complm	22	SENT_268	[p18l889t2138r1028b2204],
10	the	DT	O	the	det	13	SENT_268	[p18l1058t2138r1169b2204],
11	primary	JJ	O	primary	amod	13	SENT_268	[p18l1200t2138r1494b2223],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_268	[p18l1524t2138r2140b2223],
13	parameters	NNS	O	parameter	nsubj	22	SENT_268	[p18l7t2259r409b2334],
14	of	IN	O	of	_	0	SENT_268	[p18l439t2249r524b2316],
15	sibutramine	NN	O	sibutramine	prep_of	13	SENT_268	[p18l542t2249r972b2316],
16	and	CC	O	and	_	0	SENT_268	[p18l1001t2249r1133b2316],
17	its	PRP$	O	its	poss	19	SENT_268	[p18l1159t2249r1241b2316],
18	two	CD	NUMBER	two	num	19	SENT_268	[p18l1267t2259r1403b2316],
19	metabolites	NNS	O	metabolite	prep_of	13	SENT_268	[p18l1430t2249r1854b2316],
20	did	VBD	O	do	aux	22	SENT_268	[p18l1883t2249r2000b2316],
21	not	RB	O	not	neg	22	SENT_268	[p18l2024t2259r2143b2316],
22	differ	VB	O	differ	ccomp	8	SENT_268	[p18l10t2359r213b2427],
23	between	IN	O	between	_	0	SENT_268	[p18l256t2359r565b2427],
24	CYP2B6	NN	O	cyp2b6	nn	25	SENT_268	[p18l617t2361r934b2427],
25	genotypes	NNS	O	genotype	prep_between	22	SENT_268	[p18l979t2369r1373b2446],
26	,	,	O	,	_	0	SENT_268	[p18l979t2369r1373b2446],
27	although	IN	O	although	mark	39	SENT_268	[p18l1426t2359r1748b2446],
28	a	DT	O	a	det	35	SENT_268	[p18l1797t2381r1835b2427],
29	signiﬁcantly	RB	O	signiﬁcantly	advmod	30	SENT_268	[p18l1884t2359r2140b2446, p18l10t2472r233b2557],
30	longer	JJR	O	longer	amod	32	SENT_268	[p18l261t2472r497b2557],
31	elimination	NN	O	elimination	nn	32	SENT_268	[p18l523t2472r942b2538],
32	half-life	NN	O	half-life	nn	35	SENT_268	[p18l967t2472r1260b2538],
33	(	NN	O	(	nn	35	SENT_268	[p18l1290t2472r1460b2557],
34	tug	NN	O	tug	nn	35	SENT_268	[p18l1290t2472r1460b2557],
35	)	NN	O	)	nsubjpass	39	SENT_268	[p18l1290t2472r1460b2557],
36	of	IN	O	of	_	0	SENT_268	[p18l1489t2472r1574b2538],
37	M1	NN	O	m1	prep_of	35	SENT_268	[p18l1590t2473r1707b2537],
38	was	VBD	O	be	auxpass	39	SENT_268	[p18l1743t2493r1885b2538],
39	noted	VBN	O	note	advcl	22	SENT_268	[p18l1912t2472r2135b2538],
40	.	.	O	.	_	0	SENT_268	[p18l1912t2472r2135b2538],

1	We	PRP	O	we	nsubj	4	SENT_269	[p18l8t2586r134b2650],
2	did	VBD	O	do	aux	4	SENT_269	[p18l156t2583r273b2650],
3	not	RB	O	not	neg	4	SENT_269	[p18l291t2592r410b2650],
4	observe	VB	O	observe	_	0	SENT_269	[p18l430t2583r714b2650],
5	genotype	NN	O	genotype	nn	6	SENT_269	[p18l736t2593r1074b2668],
6	differences	NNS	O	difference	dobj	4	SENT_269	[p18l1096t2583r1501b2650],
7	of	IN	O	of	_	0	SENT_269	[p18l1524t2583r1609b2650],
8	CYP2C19	NN	O	cyp2c19	prep_of	6	SENT_269	[p18l1621t2585r1989b2650],
9	and	CC	O	and	_	0	SENT_269	[p18l2010t2583r2142b2650],
10	CYP3A5	NN	O	cyp3a5	prep_of	6	SENT_269	[p18l13t2695r326b2760],
11	in	IN	O	in	_	0	SENT_269	[p18l373t2693r443b2759],
12	the	DT	O	the	det	13	SENT_269	[p18l485t2693r597b2760],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	4	SENT_269	[p18l639t2693r1292b2778],
14	of	IN	O	of	_	0	SENT_269	[p18l1340t2693r1425b2760],
15	sibutramine	NN	O	sibutramine	prep_of	13	SENT_269	[p18l1461t2693r1891b2760],
16	or	CC	O	or	_	0	SENT_269	[p18l1938t2715r2015b2760],
17	its	PRP$	O	its	poss	18	SENT_269	[p18l2057t2693r2139b2760],
18	metabolites	NNS	O	metabolite	nsubj	19	SENT_269	[p18l8t2805r432b2871],
19	(	VBP	O	(	conj_or	4	SENT_269	[p18l459t2805r640b2890],
20	data	NNS	O	datum	dobj	19	SENT_269	[p18l459t2805r640b2890],
21	not	RB	O	not	neg	22	SENT_269	[p18l661t2814r780b2871],
22	shown	VBN	O	show	rcmod	20	SENT_269	[p18l805t2805r1091b2890],
23	)	NN	O	)	dobj	22	SENT_269	[p18l805t2805r1091b2890],
24	.	.	O	.	_	0	SENT_269	[p18l805t2805r1091b2890],

1	An	DT	O	a	det	2	SENT_270	[p18l1120t2806r1233b2870],
2	exposure	NN	O	exposure	_	0	SENT_270	[p18l1257t2826r1588b2890],
3	to	TO	O	to	_	0	SENT_270	[p18l1612t2814r1680b2871],
4	sibutramine	NN	O	sibutramine	prep_to	2	SENT_270	[p18l1709t2805r2140b2871],

1	Shinde	NNP	O	Shinde	_	0	SENT_271	[p18l97t2968r187b2994],
2	et	FW	O	et	nn	3	SENT_271	[p18l202t2973r228b2994],
3	al	FW	O	al	dep	1	SENT_271	[p18l241t2968r265b2994],
4	557	CD	NUMBER	557	dep	1	SENT_271	[p18l2003t2965r2063b2994],

1	and	CC	O	and	cc	19	SENT_272	[p18l11t3139r144b3206],
2	its	PRP$	O	its	poss	3	SENT_272	[p18l189t3139r271b3206],
3	metabolites	NNS	O	metabolite	nsubj	19	SENT_272	[p18l318t3139r742b3206],
4	in	IN	O	in	_	0	SENT_272	[p18l791t3139r861b3205],
5	subjects	NNS	O	subject	prep_in	3	SENT_272	[p18l909t3139r1201b3225],
6	with	IN	O	with	_	0	SENT_272	[p18l1248t3139r1412b3206],
7	the	DT	O	the	det	9	SENT_272	[p18l1457t3139r1568b3206],
8	CYP2B6	NN	O	cyp2b6	nn	9	SENT_272	[p18l1620t3139r2151b3206],
9	*	NN	O	*	prep_with	5	SENT_272	[p18l1620t3139r2151b3206],
10	6	CD	NUMBER	6	dep	9	SENT_272	[p18l1620t3139r2151b3206],
11	/	:	O	/	punct	10	SENT_272	[p18l1620t3139r2151b3206],
12	*	CD	NUMBER	*	number	13	SENT_272	[p18l1620t3139r2151b3206],
13	6	CD	NUMBER	6	num	14	SENT_272	[p18l1620t3139r2151b3206],
14	genotype	NN	O	genotype	nsubj	18	SENT_272	[p18l11t3260r349b3337],
15	was	VBD	O	be	cop	18	SENT_272	[p18l393t3273r534b3319],
16	also	RB	O	also	advmod	18	SENT_272	[p18l581t3251r725b3319],
17	not	RB	O	not	neg	18	SENT_272	[p18l769t3261r888b3319],
18	signiﬁcantly	RB	O	signiﬁcantly	dep	10	SENT_272	[p18l933t3251r1388b3337],
19	changed	VBD	O	change	_	0	SENT_272	[p18l1432t3251r1742b3337],
20	compared	VBN	O	compare	_	0	SENT_272	[p18l1785t3251r2149b3337],
21	with	IN	O	with	prepc_compared_with	19	SENT_272	[p18l9t3362r174b3430],
22	those	DT	O	those	pobj	19	SENT_272	[p18l203t3362r397b3430],
23	with	IN	O	with	prep	22	SENT_272	[p18l427t3362r592b3430],
24	the	DT	O	the	dep	25	SENT_272	[p18l621t3362r732b3430],
25	CYP2B6	NN	O	cyp2b6	dep	27	SENT_272	[p18l768t3364r1086b3430],
26	*	CD	NUMBER	*	num	25	SENT_272	[p18l1096t3362r1214b3430],
27	I	PRP	O	I	dep	23	SENT_272	[p18l1096t3362r1214b3430],
28	/	:	O	/	punct	27	SENT_272	[p18l1096t3362r1214b3430],
29	*	CD	NUMBER	*	num	30	SENT_272	[p18l1216t3362r1290b3429],
30	1	CD	NUMBER	1	dep	27	SENT_272	[p18l1216t3362r1290b3429],
31	genotype	NN	O	genotype	dep	30	SENT_272	[p18l1328t3372r1686b3449],
32	.	.	O	.	_	0	SENT_272	[p18l1328t3372r1686b3449],

1	In	IN	O	in	_	0	SENT_273	[p18l124t3478r199b3541],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_273	[p18l282t3475r701b3556],
3	,	,	O	,	_	0	SENT_273	[p18l282t3475r701b3556],
4	racemic	JJ	O	racemic	amod	5	SENT_273	[p18l786t3475r1075b3542],
5	sibutramine	NN	O	sibutramine	nsubj	6	SENT_273	[p18l1162t3475r1594b3542],
6	displays	VBZ	O	display	_	0	SENT_273	[p18l1679t3475r1979b3561],
7	an	DT	O	a	det	10	SENT_273	[p18l2064t3497r2149b3542],
8	enantioselective	JJ	O	enantioselective	amod	10	SENT_273	[p18l11t3587r604b3655],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_273	[p18l623t3587r1242b3673],
10	proﬁle	NN	O	proﬁle	dobj	6	SENT_273	[p18l1261t3587r1502b3673],
11	with	IN	O	with	_	0	SENT_273	[p18l1522t3587r1687b3655],
12	consistently	RB	O	consistently	advmod	13	SENT_273	[p18l1708t3587r2148b3673],
13	high	JJ	O	high	amod	15	SENT_273	[p18l9t3698r175b3785],
14	plasma	NN	O	plasma	nn	15	SENT_273	[p18l207t3698r471b3784],
15	concentrations	NNS	O	concentration	prep_with	6	SENT_273	[p18l507t3698r1044b3766],
16	of	IN	O	of	_	0	SENT_273	[p18l1082t3698r1167b3766],
17	R-enantiomers	NNS	O	r-enantiomer	prep_of	15	SENT_273	[p18l1187t3698r1747b3766],
18	.	.	O	.	_	0	SENT_273	[p18l1187t3698r1747b3766],

1	Additionally	RB	O	additionally	_	0	SENT_274	[p18l1787t3698r2147b3766, p19l11t20r166b106],
2	,	,	O	,	_	0	SENT_274	[p18l1787t3698r2147b3766, p19l11t20r166b106],

1	the	DT	O	the	det	2	SENT_275	[p19l199t20r310b87],
2	disposition	NN	O	disposition	nsubj	7	SENT_275	[p19l342t20r748b106],
3	of	IN	O	of	_	0	SENT_275	[p19l779t20r863b87],
4	S-sibutramine	NN	O	s-sibutramine	prep_of	2	SENT_275	[p19l880t20r1393b87],
5	is	VBZ	O	be	cop	7	SENT_275	[p19l1426t20r1482b87],
6	more	RBR	O	more	advmod	7	SENT_275	[p19l1512t42r1700b87],
7	affected	VBN	O	affect	_	0	SENT_275	[p19l1733t20r2028b87],
8	by	IN	O	by	_	0	SENT_275	[p19l2055t20r2149b106],
9	clarithromycin	NN	O	clarithromycin	prep_by	7	SENT_275	[p19l11t132r555b218],
10	than	IN	O	than	_	0	SENT_275	[p19l577t132r736b199],
11	clopidogrel	NN	O	clopidogrel	prep_than	7	SENT_275	[p19l762t132r1202b218],
12	,	,	O	,	_	0	SENT_275	[p19l762t132r1202b218],
13	while	IN	O	while	mark	17	SENT_275	[p19l1229t132r1432b200],
14	R-sibutramine	NN	MISC	r-sibutramine	nsubjpass	17	SENT_275	[p19l1455t132r1980b200],
15	was	VBD	O	be	auxpass	17	SENT_275	[p19l2005t154r2147b200],
16	equally	RB	O	equally	advmod	17	SENT_275	[p19l11t243r282b330],
17	affected	VBN	O	affect	advcl	7	SENT_275	[p19l355t243r649b311],
18	by	IN	O	by	_	0	SENT_275	[p19l718t243r812b330],
19	clopidogrel	NN	O	clopidogrel	agent	17	SENT_275	[p19l885t243r1304b330],
20	and	CC	O	and	_	0	SENT_275	[p19l1378t243r1510b311],
21	clarithromycin	NN	O	clarithromycin	agent	17	SENT_275	[p19l1582t243r2142b330],
22	.	.	O	.	_	0	SENT_275	[p19l1582t243r2142b330],

1	Considering	VBG	O	consider	dep	15	SENT_276	[p19l12t356r462b442],
2	that	DT	O	that	dobj	7	SENT_276	[p19l515t356r654b423],
3	R-enantiomers	NNS	O	r-enantiomer	nsubj	7	SENT_276	[p19l701t356r1242b423],
4	are	VBP	O	be	cop	7	SENT_276	[p19l1297t378r1404b423],
5	pharmacologically	RB	O	pharmacologically	advmod	7	SENT_276	[p19l1456t356r2148b442],
6	more	RBR	O	more	advmod	7	SENT_276	[p19l9t490r197b536],
7	active	JJ	O	active	pcomp	1	SENT_276	[p19l233t468r449b536],
8	than	IN	O	than	_	0	SENT_276	[p19l483t468r643b536],
9	the	DT	O	the	det	11	SENT_276	[p19l675t468r786b536],
10	corresponding	JJ	O	corresponding	amod	11	SENT_276	[p19l822t468r1351b554],
11	S-enantiomers	NNS	O	s-enantiomer	prep_than	7	SENT_276	[p19l1385t450r2001b550],
12	,	,	O	,	_	0	SENT_276	[p19l1385t450r2001b550],
13	“	NN	O	“	appos	11	SENT_276	[p19l1385t450r2001b550],
14	we	PRP	O	we	nsubj	15	SENT_276	[p19l2041t490r2147b536],
15	suggest	VBP	O	suggest	_	0	SENT_276	[p19l13t589r289b666],
16	that	IN	O	that	complm	22	SENT_276	[p19l339t579r478b647],
17	the	DT	O	the	det	19	SENT_276	[p19l528t579r639b647],
18	clarithromycin	NN	O	clarithromycin	nn	19	SENT_276	[p19l694t579r1237b666],
19	effect	NN	O	effect	nsubjpass	22	SENT_276	[p19l1291t579r1498b647],
20	might	MD	O	might	aux	22	SENT_276	[p19l1548t579r1766b666],
21	be	VB	O	be	auxpass	22	SENT_276	[p19l1815t579r1901b647],
22	overestimated	VBN	O	overestimate	ccomp	15	SENT_276	[p19l1956t601r2147b647, p19l11t692r363b759],
23	in	IN	O	in	_	0	SENT_276	[p19l385t692r455b758],
24	the	DT	O	the	det	25	SENT_276	[p19l476t692r586b759],
25	view	NN	O	view	prep_in	22	SENT_276	[p19l609t692r789b759],
26	of	IN	O	of	_	0	SENT_276	[p19l811t692r896b759],
27	pharrnacodynamics	NNS	O	pharrnacodynamic	prep_of	25	SENT_276	[p19l905t692r1646b778],
28	.	.	O	.	_	0	SENT_276	[p19l905t692r1646b778],

1	In	IN	O	in	_	0	SENT_277	[p19l1675t695r1750b758],
2	this	DT	O	this	det	3	SENT_277	[p19l1770t692r1901b759],
3	study	NN	O	study	prep_in	8	SENT_277	[p19l1928t692r2144b778],
4	,	,	O	,	_	0	SENT_277	[p19l1928t692r2144b778],
5	we	PRP	O	we	nsubj	8	SENT_277	[p19l9t826r115b872],
6	could	MD	O	could	aux	8	SENT_277	[p19l149t804r354b872],
7	not	RB	O	not	neg	8	SENT_277	[p19l382t814r502b872],
8	observe	VB	O	observe	_	0	SENT_277	[p19l533t804r818b872],
9	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_277	[p19l853t804r1237b890],
10	pharrnacokinetic	JJ	O	pharrnacokinetic	amod	11	SENT_277	[p19l1265t804r1883b890],
11	differences	NNS	O	difference	dobj	8	SENT_277	[p19l1917t804r2146b872, p19l11t937r212b983],
12	of	IN	O	of	_	0	SENT_277	[p19l267t915r352b983],
13	sibutramine	NN	O	sibutramine	prep_of	11	SENT_277	[p19l394t915r826b983],
14	among	IN	O	among	_	0	SENT_277	[p19l880t937r1130b1002],
15	volunteers	NNS	O	volunteer	prep_among	8	SENT_277	[p19l1181t915r1565b983],
16	with	IN	O	with	_	0	SENT_277	[p19l1618t915r1782b983],
17	different	JJ	O	different	amod	20	SENT_277	[p19l1834t915r2149b983],
18	CYP2B6	NN	O	cyp2b6	nn	20	SENT_277	[p19l15t1029r350b1110],
19	,	,	O	,	_	0	SENT_277	[p19l15t1029r350b1110],
20	CYP2C19	NN	O	cyp2c19	prep_with	15	SENT_277	[p19l395t1029r782b1109],
21	,	,	O	,	_	0	SENT_277	[p19l395t1029r782b1109],
22	and	CC	O	and	_	0	SENT_277	[p19l824t1028r957b1095],
23	CYP3A5	NN	O	cyp3a5	nn	24	SENT_277	[p19l996t1029r1311b1095],
24	genotypes	NNS	O	genotype	conj_and	20	SENT_277	[p19l1350t1037r1743b1114],
25	.	.	O	.	_	0	SENT_277	[p19l1350t1037r1743b1114],

1	However	RB	O	however	advmod	11	SENT_278	[p19l1786t1031r2144b1109],
2	,	,	O	,	_	0	SENT_278	[p19l1786t1031r2144b1109],
3	the	DT	O	the	det	4	SENT_278	[p19l9t1140r120b1208],
4	exposure	NN	O	exposure	nsubj	11	SENT_278	[p19l145t1162r476b1226],
5	of	IN	O	of	_	0	SENT_278	[p19l501t1140r586b1208],
6	sibutramine	NN	O	sibutramine	prep_of	4	SENT_278	[p19l600t1140r1032b1208],
7	and	CC	O	and	_	0	SENT_278	[p19l1057t1140r1189b1208],
8	its	PRP$	O	its	poss	10	SENT_278	[p19l1211t1140r1293b1208],
9	active	JJ	O	active	amod	10	SENT_278	[p19l1319t1140r1534b1208],
10	metabolites	NNS	O	metabolite	prep_of	4	SENT_278	[p19l1557t1140r1981b1208],
11	was	VBD	O	be	_	0	SENT_278	[p19l2005t1162r2147b1208],
12	tend	VB	O	tend	ccomp	11	SENT_278	[p19l9t1251r169b1319],
13	to	TO	O	to	aux	15	SENT_278	[p19l202t1261r271b1319],
14	be	VB	O	be	cop	15	SENT_278	[p19l305t1251r392b1319],
15	higher	JJR	O	higher	xcomp	12	SENT_278	[p19l427t1251r666b1338],
16	in	IN	O	in	_	0	SENT_278	[p19l700t1251r770b1318],
17	subjects	NNS	O	subject	prep_in	15	SENT_278	[p19l806t1251r1098b1338],
18	with	IN	O	with	_	0	SENT_278	[p19l1134t1251r1298b1319],
19	the	DT	O	the	det	23	SENT_278	[p19l1332t1251r1443b1319],
20	CYP2B6	NN	O	cyp2b6	nn	23	SENT_278	[p19l1484t1253r1802b1319],
21	*	NN	O	*	nn	23	SENT_278	[p19l1811t1251r1896b1319],
22	6	CD	NUMBER	6	num	23	SENT_278	[p19l1811t1251r1896b1319],
23	allele	NN	O	allele	prep_with	17	SENT_278	[p19l1929t1251r2143b1319],
24	.	.	O	.	_	0	SENT_278	[p19l1929t1251r2143b1319],

1	Our	PRP$	O	we	poss	2	SENT_279	[p19l12t1365r155b1431],
2	results	NNS	O	result	nsubj	4	SENT_279	[p19l182t1364r422b1431],
3	further	RB	O	further	advmod	4	SENT_279	[p19l456t1364r706b1431],
4	suggest	VBP	O	suggest	_	0	SENT_279	[p19l738t1373r1013b1450],
5	that	IN	O	that	complm	10	SENT_279	[p19l1042t1364r1181b1431],
6	enantio-selective	JJ	O	enantio-selective	amod	7	SENT_279	[p19l1213t1364r1836b1431],
7	interaction	NN	O	interaction	nsubjpass	10	SENT_279	[p19l1869t1364r2146b1431, p19l9t1476r153b1544],
8	should	MD	O	should	aux	10	SENT_279	[p19l194t1476r439b1544],
9	be	VB	O	be	auxpass	10	SENT_279	[p19l473t1476r559b1544],
10	considered	VBN	O	consider	ccomp	4	SENT_279	[p19l601t1476r1001b1544],
11	in	IN	O	in	_	0	SENT_279	[p19l1039t1476r1109b1542],
12	case	NN	O	case	nn	14	SENT_279	[p19l1147t1498r1302b1544],
13	racemic	JJ	O	racemic	amod	14	SENT_279	[p19l1340t1476r1629b1544],
14	drugs	NNS	O	drug	prep_in	10	SENT_279	[p19l1670t1476r1872b1562],
15	whose	WP$	O	whose	poss	16	SENT_279	[p19l1911t1476r2147b1544],
16	efﬁcacy	NN	O	efﬁcacy	nsubj	20	SENT_279	[p19l11t1587r302b1674],
17	and	CC	O	and	_	0	SENT_279	[p19l326t1587r459b1655],
18	side	JJ	O	side	amod	19	SENT_279	[p19l483t1587r626b1655],
19	effects	NNS	O	effect	conj_and	16	SENT_279	[p19l652t1587r892b1655],
20	differ	VBP	O	differ	rcmod	14	SENT_279	[p19l918t1587r1121b1655],
21	between	IN	O	between	_	0	SENT_279	[p19l1140t1587r1450b1655],
22	enantiomers	NNS	O	enantiomer	prep_between	20	SENT_279	[p19l1475t1587r1922b1655],
23	when	WRB	O	when	advmod	24	SENT_279	[p19l1947t1587r2149b1655],
24	designing	VBG	O	design	advcl	20	SENT_279	[p19l11t1700r370b1786],
25	drug	NN	O	drug	dobj	24	SENT_279	[p19l402t1700r788b1786],
26	—	CD	NUMBER	—	num	27	SENT_279	[p19l402t1700r788b1786],
27	drug	NN	O	drug	dep	24	SENT_279	[p19l402t1700r788b1786],
28	interaction	NN	O	interaction	nn	29	SENT_279	[p19l820t1700r1214b1767],
29	studies	NNS	O	study	dep	27	SENT_279	[p19l1247t1700r1517b1767],
30	.	.	O	.	_	0	SENT_279	[p19l1247t1700r1517b1767],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_280	[p19l9t1908r810b1995],
2	This	DT	O	this	det	3	SENT_280	[p19l10t2019r155b2079],
3	work	NN	O	work	dep	1	SENT_280	[p19l182t2019r355b2079],
4	was	VBD	O	be	auxpass	5	SENT_280	[p19l379t2038r506b2079],
5	supported	VBN	O	support	_	0	SENT_280	[p19l537t2019r864b2096],
6	by	IN	O	by	_	0	SENT_280	[p19l888t2019r973b2096],
7	the	DT	O	the	det	10	SENT_280	[p19l998t2019r1098b2079],
8	National	NNP	ORGANIZATION	National	nn	10	SENT_280	[p19l1123t2019r1411b2079],
9	Research	NNP	ORGANIZATION	Research	nn	10	SENT_280	[p19l1437t2019r1742b2079],
10	Foundation	NNP	ORGANIZATION	Foundation	agent	5	SENT_280	[p19l1768t2019r2149b2079],
11	of	IN	ORGANIZATION	of	_	0	SENT_280	[p19l11t2124r87b2184],
12	Korea	NNP	ORGANIZATION	Korea	prep_of	10	SENT_280	[p19l98t2126r302b2184],
13	(	CD	NUMBER	(	num	12	SENT_280	[p19l324t2124r408b2201],
14	N	NN	O	n	nn	15	SENT_280	[p19l324t2124r408b2201],
15	RF	NN	O	rf	dobj	5	SENT_280	[p19l410t2124r537b2201],
16	)	CD	NUMBER	)	num	17	SENT_280	[p19l410t2124r537b2201],
17	grant	NN	O	grant	dep	18	SENT_280	[p19l561t2133r731b2202],
18	funded	VBN	O	fund	amod	15	SENT_280	[p19l753t2124r984b2184],
19	by	IN	O	by	_	0	SENT_280	[p19l1002t2124r1086b2202],
20	the	DT	O	the	det	24	SENT_280	[p19l1107t2124r1207b2184],
21	Korea	NNP	LOCATION	Korea	nn	24	SENT_280	[p19l1229t2126r1432b2184],
22	govemment	NN	O	govemment	nn	24	SENT_280	[p19l1453t2132r1852b2202],
23	(	CD	NUMBER	(	num	24	SENT_280	[p19l1875t2124r2147b2201],
24	MEST	NN	O	mest	prep_by	18	SENT_280	[p19l1875t2124r2147b2201],
25	)	CD	NUMBER	)	number	26	SENT_280	[p19l1875t2124r2147b2201],
26	(	CD	NUMBER	(	dep	27	SENT_280	[p19l12t2228r154b2306],
27	No.	NN	O	no.	dep	24	SENT_280	[p19l12t2228r154b2306],
28	.	.	O	.	_	0	SENT_280	[p19l12t2228r154b2306],

1	R13-2007-023-00000-0	NN	O	r13-2007-023-00000-0	nn	2	SENT_281	[p19l197t2228r1020b2306],
2	)	NN	O	)	_	0	SENT_281	[p19l197t2228r1020b2306],
3	and	CC	O	and	_	0	SENT_281	[p19l1061t2228r1180b2289],
4	by	IN	O	by	conj_and	2	SENT_281	[p19l1215t2228r1300b2306],
5	a	DT	O	a	det	6	SENT_281	[p19l1339t2248r1374b2289],
6	grant	NN	O	grant	pobj	4	SENT_281	[p19l1412t2237r1582b2306],
7	of	IN	O	of	_	0	SENT_281	[p19l1620t2228r1697b2289],
8	the	DT	O	the	det	10	SENT_281	[p19l1724t2228r1823b2289],
9	National	NNP	ORGANIZATION	National	nn	10	SENT_281	[p19l1860t2228r2148b2289],
10	Project	NNP	ORGANIZATION	Project	prep_of	4	SENT_281	[p19l10t2334r245b2411],
11	for	IN	ORGANIZATION	for	_	0	SENT_281	[p19l266t2334r361b2394],
12	Personalized	NNP	ORGANIZATION	Personalized	nn	14	SENT_281	[p19l380t2334r806b2394],
13	Genomic	JJ	ORGANIZATION	genomic	amod	14	SENT_281	[p19l826t2334r1128b2394],
14	Medicine	NN	ORGANIZATION	medicine	prep_for	10	SENT_281	[p19l1150t2334r1482b2407],
15	,	,	O	,	_	0	SENT_281	[p19l1150t2334r1482b2407],
16	Ministry	NNP	ORGANIZATION	Ministry	appos	2	SENT_281	[p19l1506t2334r1792b2411],
17	for	IN	ORGANIZATION	for	_	0	SENT_281	[p19l1814t2334r1910b2394],
18	Health	NNP	ORGANIZATION	Health	nn	22	SENT_281	[p19l1928t2334r2149b2394],
19	&	CC	ORGANIZATION	&	_	0	SENT_281	[p19l11t2440r72b2499],
20	Welfare	NNP	ORGANIZATION	Welfare	nn	22	SENT_281	[p19l100t2439r383b2513],
21	,	,	O	,	_	0	SENT_281	[p19l100t2439r383b2513],
22	Republic	NNP	O	Republic	prep_for	16	SENT_281	[p19l414t2439r713b2516],
23	of	IN	O	of	_	0	SENT_281	[p19l743t2439r820b2499],
24	Korea	NNP	LOCATION	Korea	prep_of	22	SENT_281	[p19l837t2441r1055b2499],
25	.	.	O	.	_	0	SENT_281	[p19l837t2441r1055b2499],

1	(	NN	O	(	_	0	SENT_282	[p19l1089t2439r1206b2516],
2	Al	NNP	O	Al	dep	1	SENT_282	[p19l1089t2439r1206b2516],
3	1	CD	NUMBER	1	num	5	SENT_282	[p19l1226t2440r1249b2498],
4	1218-PGO2	NN	O	1218-pgo2	nn	5	SENT_282	[p19l1268t2439r1689b2516],
5	)	NN	O	)	dep	2	SENT_282	[p19l1268t2439r1689b2516],
6	.	.	O	.	_	0	SENT_282	[p19l1268t2439r1689b2516],

1	Declaration	NN	O	declaration	_	0	SENT_283	[p19l15t2649r514b2715],
2	of	IN	O	of	_	0	SENT_283	[p19l550t2648r638b2715],
3	Conﬂicting	NNP	O	Conﬂicting	nn	6	SENT_283	[p19l662t2648r1132b2736],
4	Interest	NNP	O	Interest	nn	6	SENT_283	[p19l1168t2649r1502b2715],
5	No	NNP	O	No	nn	6	SENT_283	[p19l7t2770r109b2828],
6	conﬂict	NN	O	conﬂict	prep_of	1	SENT_283	[p19l140t2768r388b2828],
7	of	IN	O	of	_	0	SENT_283	[p19l415t2768r492b2828],
8	interest	NN	O	interest	prep_of	1	SENT_283	[p19l510t2768r768b2828],
9	.	.	O	.	_	0	SENT_283	[p19l510t2768r768b2828],

1	References	NNS	O	reference	nsubj	2	SENT_284	[p19l15t2949r483b3015],
2	l.	VBD	O	l.	_	0	SENT_284	[p19l55t3084r97b3136],
3	Heal	NNP	O	Heal	nn	4	SENT_284	[p19l141t3083r279b3136],
4	DJ	NNP	O	DJ	dobj	2	SENT_284	[p19l304t3085r401b3148],
5	,	,	O	,	_	0	SENT_284	[p19l304t3085r401b3148],
6	Aspley	NNP	LOCATION	Aspley	nn	7	SENT_284	[p19l428t3083r638b3152],
7	S	NNP	LOCATION	S	appos	4	SENT_284	[p19l666t3084r718b3148],
8	,	,	O	,	_	0	SENT_284	[p19l666t3084r718b3148],
9	Prow	NNP	O	Prow	nn	10	SENT_284	[p19l745t3085r901b3136],
10	MR	NN	O	mr	appos	4	SENT_284	[p19l925t3085r1056b3148],
11	,	,	O	,	_	0	SENT_284	[p19l925t3085r1056b3148],
12	Jackson	NNP	PERSON	Jackson	nn	13	SENT_284	[p19l1084t3083r1319b3137],
13	HC	NNP	O	HC	appos	4	SENT_284	[p19l1342t3084r1460b3148],
14	,	,	O	,	_	0	SENT_284	[p19l1342t3084r1460b3148],
15	Martin	NNP	ORGANIZATION	Martin	nn	16	SENT_284	[p19l1487t3083r1688b3136],
16	KF	NNP	ORGANIZATION	KF	appos	4	SENT_284	[p19l1712t3085r1822b3148],
17	,	,	O	,	_	0	SENT_284	[p19l1712t3085r1822b3148],
18	Cheetham	NNP	PERSON	Cheetham	nn	19	SENT_284	[p19l1850t3083r2150b3137],
19	SC	NNP	O	SC	appos	4	SENT_284	[p19l144t3176r245b3229],
20	.	.	O	.	_	0	SENT_284	[p19l144t3176r245b3229],

1	Sibutramine	NNP	O	Sibutramine	_	0	SENT_285	[p19l300t3175r672b3229],
2	:	:	O	:	_	0	SENT_285	[p19l300t3175r672b3229],
3	a	DT	O	a	det	6	SENT_285	[p19l725t3192r756b3229],
4	novel	JJ	O	novel	amod	6	SENT_285	[p19l801t3175r966b3229],
5	anti-obesity	JJ	O	anti-obesity	amod	6	SENT_285	[p19l1013t3175r1360b3244],
6	drug	NN	O	drug	dep	1	SENT_285	[p19l1408t3175r1556b3244],
7	.	.	O	.	_	0	SENT_285	[p19l1408t3175r1556b3244],

1	A	DT	O	a	det	2	SENT_286	[p19l1607t3176r1660b3228],
2	review	NN	O	review	_	0	SENT_286	[p19l1706t3175r1907b3229],
3	of	IN	O	of	_	0	SENT_286	[p19l1954t3175r2022b3229],
4	the	DT	O	the	det	6	SENT_286	[p19l2059t3175r2148b3229],
5	pharmacological	JJ	O	pharmacological	amod	6	SENT_286	[p19l139t3269r633b3338],
6	evidence	NN	O	evidence	prep_of	2	SENT_286	[p19l668t3269r928b3322],
7	to	TO	O	to	aux	8	SENT_286	[p19l961t3276r1016b3322],
8	differentiate	VB	O	differentiate	infmod	2	SENT_286	[p19l1052t3269r1408b3322],
9	it	PRP	O	it	dobj	8	SENT_286	[p19l1443t3269r1482b3322],
10	from	IN	O	from	_	0	SENT_286	[p19l1516t3269r1658b3322],
11	d-amphetamine	NN	O	d-amphetamine	prep_from	8	SENT_286	[p19l1691t3269r2148b3337],
12	and	CC	O	and	_	0	SENT_286	[p19l142t3361r248b3414],
13	d-fenﬂuramine	NN	O	d-fenﬂuramine	prep_from	8	SENT_286	[p19l273t3360r725b3414],
14	.	.	O	.	_	0	SENT_286	[p19l273t3360r725b3414],

1	Int	NN	O	int	nn	2	SENT_287	[p19l751t3363r837b3414],
2	J	NN	O	j	_	0	SENT_287	[p19l855t3363r898b3414],
3	Obes	NNP	O	Obes	nn	6	SENT_287	[p19l918t3361r1066b3414],
4	Relat	NNP	O	Relat	nn	6	SENT_287	[p19l1088t3360r1248b3414],
5	Metab	NNP	O	Metab	nn	6	SENT_287	[p19l1267t3361r1457b3414],
6	Disord	NNP	O	Disord	dep	2	SENT_287	[p19l1480t3361r1699b3414],
7	.	.	O	.	_	0	SENT_287	[p19l1480t3361r1699b3414],

1	l998	NN	O	l998	_	0	SENT_288	[p19l1739t3362r2150b3425],
2	;	:	O	;	_	0	SENT_288	[p19l1739t3362r2150b3425],
3	22	CD	NUMBER	22	dep	1	SENT_288	[p19l1739t3362r2150b3425],
4	:	:	O	:	_	0	SENT_288	[p19l1739t3362r2150b3425],
5	Sl8	NN	O	sl8	nn	7	SENT_288	[p19l1739t3362r2150b3425],
6	—	CD	NUMBER	—	num	7	SENT_288	[p19l1739t3362r2150b3425],
7	S28	NN	O	s28	dep	1	SENT_288	[p19l144t3454r273b3517],
8	;	:	O	;	_	0	SENT_288	[p19l144t3454r273b3517],
9	discussion	NN	O	discussion	nn	10	SENT_288	[p19l301t3453r610b3506],
10	S29	NN	O	s29	dep	7	SENT_288	[p19l636t3454r762b3506],
11	.	.	O	.	_	0	SENT_288	[p19l636t3454r762b3506],

1	2	LS	NUMBER	2	_	0	SENT_289	[p19l48t3547r97b3599],
2	.	.	O	.	_	0	SENT_289	[p19l48t3547r97b3599],

1	Luque	NNP	PERSON	Luque	nn	2	SENT_290	[p19l141t3548r329b3614],
2	CA	NNP	O	CA	_	0	SENT_290	[p19l384t3546r502b3611],
3	,	,	O	,	_	0	SENT_290	[p19l384t3546r502b3611],
4	Rey	NNP	O	Rey	nn	5	SENT_290	[p19l558t3547r676b3614],
5	JA	NNP	O	JA	appos	2	SENT_290	[p19l730t3547r825b3599],
6	.	.	O	.	_	0	SENT_290	[p19l730t3547r825b3599],

1	Sibutramine	NNP	O	Sibutramine	_	0	SENT_291	[p19l886t3545r1258b3599],
2	:	:	O	:	_	0	SENT_291	[p19l886t3545r1258b3599],
3	a	DT	O	a	det	5	SENT_291	[p19l1317t3563r1349b3599],
4	serotonin-norepinephrine	JJ	O	serotonin-norepinephrine	amod	5	SENT_291	[p19l1403t3545r2148b3614],
5	reuptake-inhibitor	NN	O	reuptake-inhibitor	dep	1	SENT_291	[p19l140t3638r675b3707],
6	for	IN	O	for	_	0	SENT_291	[p19l699t3639r784b3692],
7	the	DT	O	the	det	8	SENT_291	[p19l805t3639r894b3692],
8	treatment	NN	O	treatment	prep_for	5	SENT_291	[p19l918t3646r1197b3692],
9	of	IN	O	of	_	0	SENT_291	[p19l1220t3639r1289b3692],
10	obesity	NN	O	obesity	prep_of	8	SENT_291	[p19l1305t3638r1531b3708],
11	.	.	O	.	_	0	SENT_291	[p19l1305t3638r1531b3708],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_292	[p19l1554t3640r1675b3692],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_292	[p19l1698t3639r2141b3692],
3	.	.	O	.	_	0	SENT_292	[p19l1698t3639r2141b3692],

1	1999	CD	DATE	1999	_	0	SENT_293	[p19l149t3731r681b3795],
2	;	:	O	;	_	0	SENT_293	[p19l149t3731r681b3795],
3	33:968	CD	NUMBER	33:968	number	4	SENT_293	[p19l149t3731r681b3795],
4	-978	CD	NUMBER	-978	dep	1	SENT_293	[p19l149t3731r681b3795],
5	.	.	O	.	_	0	SENT_293	[p19l149t3731r681b3795],

1	Lean	VB	O	lean	_	0	SENT_294	[p20l141t24r289b75],
2	ME	NN	O	me	dobj	1	SENT_294	[p20l305t23r430b75],
3	.	.	O	.	_	0	SENT_294	[p20l305t23r430b75],

1	Sibutramine-a	NN	O	sibutramine-a	nn	2	SENT_295	[p20l454t21r869b75],
2	review	NN	O	review	_	0	SENT_295	[p20l885t21r1086b75],
3	of	IN	O	of	_	0	SENT_295	[p20l1103t21r1171b75],
4	clinical	JJ	O	clinical	amod	5	SENT_295	[p20l1180t21r1394b75],
5	efﬁcacy	NN	O	efﬁcacy	prep_of	2	SENT_295	[p20l1413t21r1659b90],
6	.	.	O	.	_	0	SENT_295	[p20l1413t21r1659b90],

1	IntJ	NN	O	intj	_	0	SENT_296	[p20l1677t24r1817b75],
2	Obes	NNP	O	Obes	nn	5	SENT_296	[p20l1829t21r1976b75],
3	Relat	NNP	O	Relat	nn	5	SENT_296	[p20l1991t21r2152b75],
4	Metab	NNP	O	Metab	nn	5	SENT_296	[p20l138t114r328b167],
5	Disord	NNP	O	Disord	dep	1	SENT_296	[p20l350t114r569b167],
6	.	.	O	.	_	0	SENT_296	[p20l350t114r569b167],

1	1997	CD	DATE	1997	num	3	SENT_297	[p20l608t115r836b178],
2	;	:	O	;	_	0	SENT_297	[p20l608t115r836b178],
3	21	CD	NUMBER	21	_	0	SENT_297	[p20l608t115r836b178],
4	:	:	O	:	_	0	SENT_297	[p20l852t115r1152b178],
5	S30-S36	NN	O	s30-s36	dep	3	SENT_297	[p20l852t115r1152b178],
6	;	:	O	;	_	0	SENT_297	[p20l852t115r1152b178],
7	discussion	NN	O	discussion	dep	5	SENT_297	[p20l1180t113r1488b167],
8	37-39	CD	NUMBER	37-39	num	7	SENT_297	[p20l1513t115r1711b167],
9	.	.	O	.	_	0	SENT_297	[p20l1513t115r1711b167],

1	4	LS	NUMBER	4	_	0	SENT_298	[p20l47t207r97b260],
2	.	.	O	.	_	0	SENT_298	[p20l47t207r97b260],

1	Stock	NNP	O	Stock	nn	2	SENT_299	[p20l145t206r310b260],
2	MJ	NNP	O	MJ	_	0	SENT_299	[p20l337t208r445b260],
3	.	.	O	.	_	0	SENT_299	[p20l337t208r445b260],

1	Sibutramine	NNP	O	Sibutramine	_	0	SENT_300	[p20l482t206r854b260],
2	:	:	O	:	_	0	SENT_300	[p20l482t206r854b260],
3	a	DT	O	a	det	4	SENT_300	[p20l890t224r921b260],
4	review	NN	O	review	dep	1	SENT_300	[p20l948t206r1149b260],
5	of	IN	O	of	_	0	SENT_300	[p20l1178t206r1246b260],
6	the	DT	O	the	det	7	SENT_300	[p20l1265t206r1354b260],
7	pharmacology	NN	O	pharmacology	prep_of	4	SENT_300	[p20l1381t206r1807b275],
8	of	IN	O	of	_	0	SENT_300	[p20l1837t206r1905b260],
9	a	DT	O	a	det	12	SENT_300	[p20l1926t224r1957b260],
10	novel	JJ	O	novel	amod	12	SENT_300	[p20l1984t206r2149b260],
11	anti-obesity	JJ	O	anti-obesity	amod	12	SENT_300	[p20l142t299r489b368],
12	agent	NN	O	agent	prep_of	7	SENT_300	[p20l519t307r692b368],
13	.	.	O	.	_	0	SENT_300	[p20l519t307r692b368],

1	Int	NN	O	int	nn	2	SENT_301	[p20l722t301r809b353],
2	J	NN	O	j	_	0	SENT_301	[p20l831t301r875b353],
3	Obes	NNP	O	Obes	nn	6	SENT_301	[p20l899t299r1047b353],
4	Relat	NNP	O	Relat	nn	6	SENT_301	[p20l1074t299r1234b353],
5	Metab	NNP	O	Metab	nn	6	SENT_301	[p20l1257t299r1447b353],
6	Disord	NNP	O	Disord	dep	2	SENT_301	[p20l1475t299r1695b353],
7	.	.	O	.	_	0	SENT_301	[p20l1475t299r1695b353],

1	l997	NN	O	l997	_	0	SENT_302	[p20l1739t300r2150b364],
2	;	:	O	;	_	0	SENT_302	[p20l1739t300r2150b364],
3	2l	NN	O	2l	dep	1	SENT_302	[p20l1739t300r2150b364],
4	:	:	O	:	_	0	SENT_302	[p20l1739t300r2150b364],
5	S25	CD	NUMBER	s25	number	6	SENT_302	[p20l1739t300r2150b364],
6	—	CD	NUMBER	—	num	7	SENT_302	[p20l1739t300r2150b364],
7	S29	NN	O	s29	dep	3	SENT_302	[p20l145t393r254b446],

1	.	.	O	.	_	0	SENT_303	[p20l89t530r97b539],

1	Hind	JJ	O	hind	amod	2	SENT_304	[p20l141t485r290b539],
2	ID	NN	O	id	_	0	SENT_304	[p20l313t487r405b550],
3	,	,	O	,	_	0	SENT_304	[p20l313t487r405b550],
4	Mangham	NNP	ORGANIZATION	Mangham	nn	5	SENT_304	[p20l433t485r734b554],
5	JE	NNP	ORGANIZATION	JE	appos	2	SENT_304	[p20l758t487r846b550],
6	,	,	O	,	_	0	SENT_304	[p20l758t487r846b550],
7	Ghani	NNP	PERSON	Ghani	nn	8	SENT_304	[p20l875t485r1054b539],
8	SP	NN	O	sp	appos	5	SENT_304	[p20l1083t486r1176b550],
9	,	,	O	,	_	0	SENT_304	[p20l1083t486r1176b550],
10	Haddock	NNP	ORGANIZATION	Haddock	nn	11	SENT_304	[p20l1203t485r1473b539],
11	RE	NNP	ORGANIZATION	RE	appos	5	SENT_304	[p20l1495t487r1605b550],
12	,	,	O	,	_	0	SENT_304	[p20l1495t487r1605b550],
13	Garratt	NNP	PERSON	Garratt	nn	14	SENT_304	[p20l1635t486r1841b539],
14	CJ	NNP	O	CJ	appos	5	SENT_304	[p20l1866t486r1957b550],
15	,	,	O	,	_	0	SENT_304	[p20l1866t486r1957b550],
16	Jones	NNP	PERSON	Jones	nn	17	SENT_304	[p20l1985t487r2148b539],
17	RW	NNP	O	RW	appos	5	SENT_304	[p20l141t580r274b632],
18	.	.	O	.	_	0	SENT_304	[p20l141t580r274b632],

1	Sibutramine	NN	O	sibutramine	nn	2	SENT_305	[p20l313t578r669b632],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_305	[p20l700t578r1222b647],
3	in	IN	O	in	_	0	SENT_305	[p20l1255t578r1311b631],
4	young	JJ	O	young	amod	8	SENT_305	[p20l1341t596r1527b647],
5	and	CC	O	and	_	0	SENT_305	[p20l1560t578r1667b632],
6	elderly	JJ	O	elderly	conj_and	4	SENT_305	[p20l1698t578r1901b647],
7	healthy	JJ	O	healthy	amod	8	SENT_305	[p20l1931t578r2149b647],
8	subjects	NNS	O	subject	prep_in	2	SENT_305	[p20l143t671r393b740],
9	.	.	O	.	_	0	SENT_305	[p20l143t671r393b740],

1	Eur	NNP	MISC	Eur	nn	4	SENT_306	[p20l418t673r533b724],
2	J	NNP	O	J	nn	4	SENT_306	[p20l551t673r595b724],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_306	[p20l614t671r735b724],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_306	[p20l757t671r1100b724],
5	.	.	O	.	_	0	SENT_306	[p20l757t671r1100b724],

1	1999	CD	DATE	1999	_	0	SENT_307	[p20l1140t672r1673b736],
2	;	:	O	;	_	0	SENT_307	[p20l1140t672r1673b736],
3	54:847	CD	NUMBER	54:847	number	4	SENT_307	[p20l1140t672r1673b736],
4	-849	CD	NUMBER	-849	dep	1	SENT_307	[p20l1140t672r1673b736],
5	.	.	O	.	_	0	SENT_307	[p20l1140t672r1673b736],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_308	[p20l143t764r298b818],
2	J	NNP	PERSON	J	_	0	SENT_308	[p20l334t766r377b829],
3	,	,	O	,	_	0	SENT_308	[p20l334t766r377b829],
4	Lu	NNP	PERSON	Lu	nn	5	SENT_308	[p20l416t766r498b818],
5	W	NNP	PERSON	W	appos	2	SENT_308	[p20l534t766r619b829],
6	,	,	O	,	_	0	SENT_308	[p20l534t766r619b829],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_308	[p20l657t764r846b833],
8	Q	NNP	O	Q	appos	2	SENT_308	[p20l884t765r951b832],
9	,	,	O	,	_	0	SENT_308	[p20l884t765r951b832],
10	Jiang	NNP	PERSON	Jiang	nn	12	SENT_308	[p20l991t764r1145b833],
11	X.	NNP	O	X.	nn	12	SENT_308	[p20l1182t766r1249b818],
12	Determination	NN	O	determination	appos	2	SENT_308	[p20l1290t764r1716b818],
13	of	IN	O	of	_	0	SENT_308	[p20l1753t764r1821b818],
14	the	DT	O	the	det	16	SENT_308	[p20l1848t764r1937b818],
15	active	JJ	O	active	amod	16	SENT_308	[p20l1975t764r2148b818],
16	metabolite	NN	O	metabolite	prep_of	12	SENT_308	[p20l141t858r450b911],
17	of	IN	O	of	_	0	SENT_308	[p20l488t858r556b911],
18	sibutramine	NN	O	sibutramine	prep_of	16	SENT_308	[p20l584t858r928b911],
19	by	IN	O	by	_	0	SENT_308	[p20l962t858r1038b927],
20	liquid	JJ	O	liquid	amod	25	SENT_308	[p20l1073t858r1245b926],
21	chromatography-electrospray	JJ	O	chromatography-electrospray	amod	25	SENT_308	[p20l1279t858r2149b927],
22	ionization	NN	O	ionization	nn	25	SENT_308	[p20l142t951r436b1004],
23	tandem	JJ	O	tandem	amod	25	SENT_308	[p20l480t951r699b1004],
24	mass	NN	O	mass	nn	25	SENT_308	[p20l741t968r888b1004],
25	spectrometry	NN	O	spectrometry	prep_by	18	SENT_308	[p20l935t958r1332b1020],
26	.	.	O	.	_	0	SENT_308	[p20l935t958r1332b1020],

1	J	NN	O	j	nn	3	SENT_309	[p20l1377t953r1421b1005],
2	Chromatogr	NN	O	chromatogr	nn	3	SENT_309	[p20l1460t951r1826b1020],
3	B	NN	O	b	_	0	SENT_309	[p20l1865t953r1912b1003],
4	Analyz	NNP	O	Analyz	dep	3	SENT_309	[p20l1951t951r2151b1020],
5	‘	CD	NUMBER	‘	num	4	SENT_309	[p20l1951t951r2151b1020],
6	T	NN	O	t	nn	10	SENT_309	[p20l145t1046r189b1096],
7	echnol	NN	O	echnol	nn	10	SENT_309	[p20l184t1044r382b1097],
8	Biomed	NNP	ORGANIZATION	Biomed	nn	10	SENT_309	[p20l400t1044r633b1097],
9	Life	NNP	ORGANIZATION	Life	nn	10	SENT_309	[p20l650t1044r766b1113],
10	Sci	NNP	ORGANIZATION	Sci	dep	4	SENT_309	[p20l789t1045r889b1098],
11	.	.	O	.	_	0	SENT_309	[p20l789t1045r889b1098],

1	2003	CD	DATE	2003	_	0	SENT_310	[p20l922t1045r1499b1109],
2	;	:	O	;	_	0	SENT_310	[p20l922t1045r1499b1109],
3	785:197	CD	NUMBER	785:197	number	4	SENT_310	[p20l922t1045r1499b1109],
4	-203	CD	NUMBER	-203	dep	1	SENT_310	[p20l922t1045r1499b1109],
5	.	.	O	.	_	0	SENT_310	[p20l922t1045r1499b1109],

1	Link	NN	O	link	nn	2	SENT_311	[p20l141t1136r282b1188],
2	M	NN	O	m	_	0	SENT_311	[p20l301t1138r382b1200],
3	,	,	O	,	_	0	SENT_311	[p20l301t1138r382b1200],
4	Hakala	NNP	PERSON	Hakala	nn	5	SENT_311	[p20l407t1136r617b1189],
5	KS	NN	O	k	appos	2	SENT_311	[p20l637t1137r746b1200],
6	,	,	O	,	_	0	SENT_311	[p20l637t1137r746b1200],
7	Wsol	NNP	PERSON	Wsol	nn	8	SENT_311	[p20l770t1136r925b1189],
8	V	NNP	PERSON	V	appos	2	SENT_311	[p20l946t1138r1015b1200],
9	,	,	O	,	_	0	SENT_311	[p20l946t1138r1015b1200],
10	Kostiainen	NNP	PERSON	Kostiainen	nn	11	SENT_311	[p20l1040t1136r1360b1189],
11	R	NNP	PERSON	R	appos	2	SENT_311	[p20l1381t1138r1446b1200],
12	,	,	O	,	_	0	SENT_311	[p20l1381t1138r1446b1200],
13	Ketola	NNP	PERSON	Ketola	nn	14	SENT_311	[p20l1470t1136r1667b1189],
14	RA	NN	O	ra	appos	2	SENT_311	[p20l1688t1137r1804b1189],
15	.	.	O	.	_	0	SENT_311	[p20l1688t1137r1804b1189],

1	Metabolite	NN	O	metabolite	nn	2	SENT_312	[p20l1830t1135r2148b1189],
2	proﬁle	NN	O	proﬁle	_	0	SENT_312	[p20l140t1228r332b1297],
3	of	IN	O	of	_	0	SENT_312	[p20l367t1229r435b1282],
4	sibutramine	NN	O	sibutramine	prep_of	2	SENT_312	[p20l462t1229r807b1282],
5	in	IN	O	in	_	0	SENT_312	[p20l842t1229r898b1281],
6	human	JJ	O	human	amod	7	SENT_312	[p20l930t1228r1134b1282],
7	urine	NN	O	urine	prep_in	4	SENT_312	[p20l1165t1229r1332b1282],
8	:	:	O	:	_	0	SENT_312	[p20l1165t1229r1332b1282],
9	a	DT	O	a	det	13	SENT_312	[p20l1371t1246r1402b1282],
10	liquid	JJ	O	liquid	amod	13	SENT_312	[p20l1435t1229r1607b1297],
11	chromatographyelectrospray	NN	O	chromatographyelectrospray	nn	13	SENT_312	[p20l1640t1229r2147b1298, p20l142t1321r501b1390],
12	ionization	NN	O	ionization	nn	13	SENT_312	[p20l522t1321r816b1375],
13	mass	NN	O	mass	dep	2	SENT_312	[p20l836t1339r982b1375],
14	spectrometric	JJ	O	spectrometric	amod	15	SENT_312	[p20l1006t1321r1402b1390],
15	study	NN	O	study	dep	13	SENT_312	[p20l1427t1321r1599b1390],
16	.	.	O	.	_	0	SENT_312	[p20l1427t1321r1599b1390],

1	J	NNP	O	J	nn	3	SENT_313	[p20l1619t1323r1663b1375],
2	Mass	NNP	O	Mass	nn	3	SENT_313	[p20l1672t1323r1830b1375],
3	Spectrom	NNP	O	Spectrom	_	0	SENT_313	[p20l1850t1322r2141b1390],
4	.	.	O	.	_	0	SENT_313	[p20l1850t1322r2141b1390],

1	2006:4121	CD	NUMBER	2006:4121	_	0	SENT_314	[p20l141t1414r435b1477],
2	171-1	CD	NUMBER	171-1	number	3	SENT_314	[p20l451t1414r621b1467],
3	178	CD	NUMBER	178	num	1	SENT_314	[p20l639t1415r756b1467],
4	.	.	O	.	_	0	SENT_314	[p20l639t1415r756b1467],

1	.	.	O	.	_	0	SENT_315	[p20l85t1552r93b1560],

1	Luscombe	NNP	PERSON	Luscombe	nn	2	SENT_316	[p20l136t1507r444b1561],
2	GP	NNP	O	GP	_	0	SENT_316	[p20l493t1508r601b1572],
3	,	,	O	,	_	0	SENT_316	[p20l493t1508r601b1572],
4	Hopcroft	NNP	PERSON	Hopcroft	nn	5	SENT_316	[p20l650t1507r918b1575],
5	RH	NNP	O	RH	appos	2	SENT_316	[p20l963t1509r1081b1572],
6	,	,	O	,	_	0	SENT_316	[p20l963t1509r1081b1572],
7	Thomas	NNP	PERSON	Thomas	nn	8	SENT_316	[p20l1131t1507r1368b1560],
8	PC	NNP	O	PC	appos	2	SENT_316	[p20l1415t1508r1520b1572],
9	,	,	O	,	_	0	SENT_316	[p20l1415t1508r1520b1572],
10	Buckett	NNP	PERSON	Buckett	nn	11	SENT_316	[p20l1570t1507r1801b1561],
11	WR	NNP	O	WR	appos	2	SENT_316	[p20l1846t1509r1979b1561],
12	.	.	O	.	_	0	SENT_316	[p20l1846t1509r1979b1561],

1	The	DT	O	the	det	2	SENT_317	[p20l2031t1507r2143b1560],
2	contribution	NN	O	contribution	_	0	SENT_317	[p20l138t1599r499b1653],
3	of	IN	O	of	_	0	SENT_317	[p20l532t1599r600b1653],
4	metabolites	NNS	O	metabolite	prep_of	2	SENT_317	[p20l623t1599r962b1653],
5	to	TO	O	to	_	0	SENT_317	[p20l995t1607r1050b1653],
6	the	DT	O	the	det	10	SENT_317	[p20l1084t1599r1173b1653],
7	rapid	JJ	O	rapid	amod	10	SENT_317	[p20l1206t1599r1359b1668],
8	and	CC	O	and	_	0	SENT_317	[p20l1392t1599r1498b1653],
9	potent	JJ	O	potent	amod	10	SENT_317	[p20l1528t1607r1715b1668],
10	downregulation	NN	O	downregulation	prep_to	4	SENT_317	[p20l1748t1599r2143b1668, p20l136t1692r251b1746],
11	of	IN	O	of	_	0	SENT_317	[p20l283t1692r351b1746],
12	rat	NN	O	rat	nn	14	SENT_317	[p20l373t1700r450b1746],
13	cortical	JJ	O	cortical	amod	14	SENT_317	[p20l481t1692r699b1746],
14	beta-adrenoceptors	NNS	O	beta-adrenoceptor	prep_of	10	SENT_317	[p20l730t1692r1291b1761],
15	by	IN	O	by	_	0	SENT_317	[p20l1323t1692r1398b1761],
16	the	DT	O	the	det	20	SENT_317	[p20l1427t1692r1516b1746],
17	putative	JJ	O	putative	amod	20	SENT_317	[p20l1547t1692r1785b1761],
18	antidepressant	JJ	O	antidepressant	amod	20	SENT_317	[p20l1818t1692r2143b1761, p20l139t1793r256b1839],
19	sibutramine	NN	O	sibutramine	nn	20	SENT_317	[p20l309t1785r654b1839],
20	hydrochloride	NN	O	hydrochloride	prep_by	2	SENT_317	[p20l707t1785r1137b1854],
21	.	.	O	.	_	0	SENT_317	[p20l707t1785r1137b1854],

1	Neuropharmacology	NNP	O	Neuropharmacology	_	0	SENT_318	[p20l1191t1785r1820b1854],
2	.	.	O	.	_	0	SENT_318	[p20l1191t1785r1820b1854],

1	l989	NN	O	l989	_	0	SENT_319	[p20l1888t1786r2140b1850],
2	;	:	O	;	_	0	SENT_319	[p20l1888t1786r2140b1850],
3	28	CD	NUMBER	28	num	5	SENT_319	[p20l1888t1786r2140b1850],
4	:	:	O	:	_	0	SENT_319	[p20l1888t1786r2140b1850],
5	129-134	CD	NUMBER	129-134	dep	1	SENT_319	[p20l144t1879r412b1932],
6	.	.	O	.	_	0	SENT_319	[p20l144t1879r412b1932],

1	.	.	O	.	_	0	SENT_320	[p20l85t2016r93b2025],

1	McNee1y	NN	O	mcnee1y	nn	2	SENT_321	[p20l137t1971r412b2040],
2	W	NN	O	w	_	0	SENT_321	[p20l434t1973r519b2037],
3	,	,	O	,	_	0	SENT_321	[p20l434t1973r519b2037],
4	Goa	NNP	O	Goa	nn	5	SENT_321	[p20l546t1973r668b2025],
5	KL	NNP	O	KL	appos	2	SENT_321	[p20l690t1974r802b2025],
6	.	.	O	.	_	0	SENT_321	[p20l690t1974r802b2025],

1	Sibutramine	NNP	O	Sibutramine	_	0	SENT_322	[p20l833t1971r1204b2026],
2	.	.	O	.	_	0	SENT_322	[p20l833t1971r1204b2026],

1	A	DT	O	a	det	2	SENT_323	[p20l1230t1973r1284b2024],
2	review	NN	O	review	_	0	SENT_323	[p20l1306t1971r1508b2025],
3	of	IN	O	of	_	0	SENT_323	[p20l1531t1971r1599b2025],
4	its	PRP$	O	its	poss	5	SENT_323	[p20l1614t1971r1679b2025],
5	contribution	NN	O	contribution	prep_of	2	SENT_323	[p20l1705t1971r2065b2025],
6	to	TO	O	to	_	0	SENT_323	[p20l2087t1979r2142b2025],
7	the	DT	O	the	det	8	SENT_323	[p20l136t2064r225b2118],
8	management	NN	O	management	prep_to	2	SENT_323	[p20l249t2072r628b2133],
9	of	IN	O	of	_	0	SENT_323	[p20l652t2064r720b2118],
10	obesity	NN	O	obesity	prep_of	8	SENT_323	[p20l737t2064r963b2133],
11	.	.	O	.	_	0	SENT_323	[p20l737t2064r963b2133],

1	Drugs	NNS	O	drug	_	0	SENT_324	[p20l988t2066r1187b2133],
2	.	.	O	.	_	0	SENT_324	[p20l988t2066r1187b2133],

1	1998	CD	DATE	1998	_	0	SENT_325	[p20l1226t2065r1698b2129],
2	;	:	O	;	_	0	SENT_325	[p20l1226t2065r1698b2129],
3	56:1093	CD	NUMBER	56:1093	number	4	SENT_325	[p20l1226t2065r1698b2129],
4	-1	CD	NUMBER	-1	dep	1	SENT_325	[p20l1226t2065r1698b2129],
5	124	CD	NUMBER	124	dep	4	SENT_325	[p20l1716t2065r1834b2118],
6	.	.	O	.	_	0	SENT_325	[p20l1716t2065r1834b2118],

1	Bodhankar	NNP	O	Bodhankar	nn	2	SENT_326	[p20l137t2157r465b2211],
2	SL	NNP	O	SL	dep	27	SENT_326	[p20l483t2158r581b2222],
3	,	,	O	,	_	0	SENT_326	[p20l483t2158r581b2222],
4	Thakurdesai	NNP	ORGANIZATION	Thakurdesai	dep	22	SENT_326	[p20l602t2157r966b2211],
5	PA	NN	ORGANIZATION	pa	npadvmod	22	SENT_326	[p20l984t2158r1093b2222],
6	,	,	O	,	_	0	SENT_326	[p20l984t2158r1093b2222],
7	Singhal	NNP	PERSON	Singhal	nn	8	SENT_326	[p20l1117t2157r1339b2226],
8	S	NNP	O	S	appos	5	SENT_326	[p20l1361t2158r1413b2222],
9	,	,	O	,	_	0	SENT_326	[p20l1361t2158r1413b2222],
10	Gaur	NNP	O	Gaur	nn	11	SENT_326	[p20l1435t2158r1583b2211],
11	V.	NNP	O	V.	appos	5	SENT_326	[p20l1597t2159r1664b2211],
12	Anorexic	JJ	O	anorexic	amod	13	SENT_326	[p20l1686t2157r1960b2211],
13	effect	NN	O	effect	dep	11	SENT_326	[p20l1980t2157r2145b2211],
14	of	IN	O	of	_	0	SENT_326	[p20l138t2251r206b2304],
15	(	CD	NUMBER	(	num	16	SENT_326	[p20l228t2251r712b2320],
16	R	NN	O	r	prep_of	13	SENT_326	[p20l228t2251r712b2320],
17	)	SYM	O	)	dep	13	SENT_326	[p20l228t2251r712b2320],
18	-	:	O	-	_	0	SENT_326	[p20l228t2251r712b2320],
19	sibutramine	NN	O	sibutramine	dep	5	SENT_326	[p20l228t2251r712b2320],
20	:	:	O	:	_	0	SENT_326	[p20l228t2251r712b2320],
21	comparison	NN	O	comparison	dep	5	SENT_326	[p20l748t2251r1092b2320],
22	with	IN	O	with	dep	2	SENT_326	[p20l1120t2251r1252b2305],
23	(	CD	NUMBER	(	num	24	SENT_326	[p20l1283t2251r1792b2319],
24	RS	NN	O	r	pobj	22	SENT_326	[p20l1283t2251r1792b2319],
25	)	SYM	O	)	dep	24	SENT_326	[p20l1283t2251r1792b2319],
26	-	:	O	-	_	0	SENT_326	[p20l1283t2251r1792b2319],
27	sibutramine	NN	O	sibutramine	_	0	SENT_326	[p20l1283t2251r1792b2319],
28	[	CD	NUMBER	[	num	27	SENT_326	[p20l1827t2251r2140b2319],
29	corrected	VBN	O	correct	partmod	27	SENT_326	[p20l1827t2251r2140b2319],
30	]	NN	O	]	dobj	29	SENT_326	[p20l1827t2251r2140b2319],
31	and	CC	O	and	_	0	SENT_326	[p20l138t2344r244b2397],
32	(	NN	O	(	nn	33	SENT_326	[p20l281t2344r754b2413],
33	S	NN	O	s	conj_and	30	SENT_326	[p20l281t2344r754b2413],
34	)	SYM	O	)	dep	36	SENT_326	[p20l281t2344r754b2413],
35	-	:	O	-	_	0	SENT_326	[p20l281t2344r754b2413],
36	sibutramine	NN	O	sibutramine	dep	30	SENT_326	[p20l281t2344r754b2413],
37	.	.	O	.	_	0	SENT_326	[p20l281t2344r754b2413],

1	Indian	JJ	MISC	indian	amod	2	SENT_327	[p20l792t2344r985b2397],
2	J	NN	O	j	_	0	SENT_327	[p20l1019t2346r1063b2397],
3	Physiol	NN	O	physiol	nn	4	SENT_327	[p20l1087t2344r1314b2413],
4	Pharmacol	NN	O	pharmacol	dep	2	SENT_327	[p20l1344t2344r1688b2397],
5	.	.	O	.	_	0	SENT_327	[p20l1344t2344r1688b2397],

1	2007	CD	DATE	2007	_	0	SENT_328	[p20l1730t2345r2145b2409, p20l144t2437r262b2490],
2	;	:	O	;	_	0	SENT_328	[p20l1730t2345r2145b2409, p20l144t2437r262b2490],
3	51:175178	CD	NUMBER	51:175178	dep	1	SENT_328	[p20l1730t2345r2145b2409, p20l144t2437r262b2490],
4	.	.	O	.	_	0	SENT_328	[p20l1730t2345r2145b2409, p20l144t2437r262b2490],

1	Glick	NNP	PERSON	Glick	nn	2	SENT_329	[p20l138t2528r301b2582],
2	SD	NN	O	sd	_	0	SENT_329	[p20l330t2530r436b2593],
3	,	,	O	,	_	0	SENT_329	[p20l330t2530r436b2593],
4	Haskew	NNP	ORGANIZATION	Haskew	nn	5	SENT_329	[p20l466t2529r705b2582],
5	RE	NNP	ORGANIZATION	RE	appos	2	SENT_329	[p20l730t2531r840b2593],
6	,	,	O	,	_	0	SENT_329	[p20l730t2531r840b2593],
7	Maisonneuve	NNP	PERSON	Maisonneuve	nn	8	SENT_329	[p20l870t2529r1268b2582],
8	IM	NNP	O	IM	appos	2	SENT_329	[p20l1297t2531r1401b2593],
9	,	,	O	,	_	0	SENT_329	[p20l1297t2531r1401b2593],
10	Carlson	NNP	PERSON	Carlson	nn	11	SENT_329	[p20l1432t2529r1661b2582],
11	JN	NN	O	jn	appos	2	SENT_329	[p20l1687t2531r1784b2593],
12	,	,	O	,	_	0	SENT_329	[p20l1687t2531r1784b2593],
13	Jerussi	NN	PERSON	jerussus	nn	14	SENT_329	[p20l1814t2529r2013b2582],
14	TP	NN	O	tp	appos	2	SENT_329	[p20l2041t2531r2140b2582],
15	.	.	O	.	_	0	SENT_329	[p20l2041t2531r2140b2582],

1	Enantio	NNP	O	Enantio	_	0	SENT_330	[p20l136t2622r364b2675],
2	selective	JJ	O	selective	amod	4	SENT_330	[p20l371t2622r623b2675],
3	behavioral	JJ	O	behavioral	amod	4	SENT_330	[p20l638t2622r950b2675],
4	effects	NNS	O	effect	dep	1	SENT_330	[p20l967t2622r1159b2675],
5	of	IN	O	of	_	0	SENT_330	[p20l1176t2622r1245b2675],
6	sibutramine	NN	O	sibutramine	nn	7	SENT_330	[p20l1254t2622r1598b2675],
7	metabolites	NNS	O	metabolite	prep_of	4	SENT_330	[p20l1613t2622r1968b2675],
8	.	.	O	.	_	0	SENT_330	[p20l1613t2622r1968b2675],

1	EurJ	NN	O	eurj	_	0	SENT_331	[p20l1985t2624r2153b2675],
2	Pharmacol	NN	O	pharmacol	dep	1	SENT_331	[p20l134t2713r476b2766],
3	.	.	O	.	_	0	SENT_331	[p20l134t2713r476b2766],

1	2000	CD	DATE	2000	_	0	SENT_332	[p20l509t2714r1048b2777],
2	;	:	O	;	_	0	SENT_332	[p20l509t2714r1048b2777],
3	397:93	CD	NUMBER	397:93	number	4	SENT_332	[p20l509t2714r1048b2777],
4	-102	CD	NUMBER	-102	dep	1	SENT_332	[p20l509t2714r1048b2777],
5	.	.	O	.	_	0	SENT_332	[p20l509t2714r1048b2777],

1	Bae	NNP	O	Bae	nn	2	SENT_333	[p20l136t2809r250b2860],
2	SK	NNP	O	SK	_	0	SENT_333	[p20l275t2808r381b2872],
3	,	,	O	,	_	0	SENT_333	[p20l275t2808r381b2872],
4	Cao	NNP	O	Cao	nn	5	SENT_333	[p20l406t2808r521b2860],
5	S	NNP	O	S	appos	2	SENT_333	[p20l547t2808r599b2872],
6	,	,	O	,	_	0	SENT_333	[p20l547t2808r599b2872],
7	Seo	NNP	O	Seo	nn	8	SENT_333	[p20l627t2808r732b2860],
8	KA	NN	O	ka	appos	2	SENT_333	[p20l754t2808r875b2872],
9	,	,	O	,	_	0	SENT_333	[p20l754t2808r875b2872],
10	et	FW	O	et	nn	11	SENT_333	[p20l900t2814r952b2860],
11	al.	FW	O	al.	appos	2	SENT_333	[p20l972t2807r1037b2860],
12	.	.	O	.	_	0	SENT_333	[p20l972t2807r1037b2860],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_334	[p20l1064t2807r1428b2876],
2	P450	NN	O	p450	nn	3	SENT_334	[p20l1449t2808r1599b2860],
3	2B6	NN	O	2b6	nsubj	4	SENT_334	[p20l1621t2808r1743b2860],
4	catalyzes	VBZ	O	catalyze	_	0	SENT_334	[p20l1766t2806r2033b2876],
5	the	DT	O	the	det	6	SENT_334	[p20l2055t2807r2143b2860],
6	formation	NN	O	formation	dobj	4	SENT_334	[p20l138t2900r428b2953],
7	of	IN	O	of	_	0	SENT_334	[p20l475t2900r543b2953],
8	pharmacologically	RB	O	pharmacologically	advmod	9	SENT_334	[p20l579t2900r1131b2969],
9	active	JJ	O	active	amod	12	SENT_334	[p20l1179t2900r1352b2953],
10	sibutramine	NN	O	sibutramine	nn	12	SENT_334	[p20l1402t2900r1747b2954],
11	(	NN	O	(	nn	12	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
12	N	NN	O	n	prep_of	6	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
13	(	CD	NUMBER	(	number	14	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
14	3	CD	NUMBER	3	num	16	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
15	)	NN	O	)	nn	16	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
16	N	NN	O	n	dep	12	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
17	,	,	O	,	_	0	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
18	Ndimethylarnine	NN	O	ndimethylarnine	nn	20	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
19	)	NN	O	)	nn	20	SENT_334	[p20l1796t2900r2143b2969, p20l138t2992r602b3061],
20	metabolites	NNS	O	metabolite	appos	6	SENT_334	[p20l650t2992r989b3046],
21	in	IN	O	in	_	0	SENT_334	[p20l1037t2992r1093b3045],
22	human	JJ	O	human	amod	24	SENT_334	[p20l1138t2992r1341b3046],
23	liver	NN	O	liver	nn	24	SENT_334	[p20l1388t2992r1522b3046],
24	microsomes	NNS	O	microsome	prep_in	20	SENT_334	[p20l1566t2992r1937b3046],
25	.	.	O	.	_	0	SENT_334	[p20l1566t2992r1937b3046],

1	Drug	NN	O	drug	_	0	SENT_335	[p20l1985t2995r2146b3061],
2	Metab	NNP	O	Metab	nn	3	SENT_335	[p20l133t3085r324b3139],
3	Dispos	NNP	O	Dispos	dep	1	SENT_335	[p20l346t3088r565b3154],
4	.	.	O	.	_	0	SENT_335	[p20l346t3088r565b3154],

1	2008	CD	DATE	2008	_	0	SENT_336	[p20l596t3087r1212b3151],
2	;	:	O	;	_	0	SENT_336	[p20l596t3087r1212b3151],
3	36	CD	NUMBER	36	num	5	SENT_336	[p20l596t3087r1212b3151],
4	:	:	O	:	_	0	SENT_336	[p20l596t3087r1212b3151],
5	l679-1688	CD	NUMBER	l679-1688	dep	1	SENT_336	[p20l596t3087r1212b3151],
6	.	.	O	.	_	0	SENT_336	[p20l596t3087r1212b3151],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_337	[p20l136t3179r268b3231],
2	KA	NN	PERSON	ka	_	0	SENT_337	[p20l293t3180r416b3244],
3	,	,	O	,	_	0	SENT_337	[p20l293t3180r416b3244],
4	Song	NN	O	song	nn	5	SENT_337	[p20l448t3180r596b3248],
5	WK	NN	DURATION	wk	appos	2	SENT_337	[p20l623t3181r762b3244],
6	,	,	O	,	_	0	SENT_337	[p20l623t3181r762b3244],
7	Park	NNP	O	Park	nn	8	SENT_337	[p20l791t3179r927b3232],
8	JY	NN	O	jy	appos	5	SENT_337	[p20l952t3181r1047b3232],
9	.	.	O	.	_	0	SENT_337	[p20l952t3181r1047b3232],

1	Association	NNP	O	Association	_	0	SENT_338	[p20l1077t3179r1427b3232],
2	of	IN	O	of	_	0	SENT_338	[p20l1454t3179r1522b3232],
3	CYP2B6	NNP	O	CYP2B6	prep_of	1	SENT_338	[p20l1541t3180r1824b3244],
4	,	,	O	,	_	0	SENT_338	[p20l1541t3180r1824b3244],
5	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_338	[p20l1854t3180r2142b3244],
6	,	,	O	,	_	0	SENT_338	[p20l1854t3180r2142b3244],
7	and	CC	O	and	_	0	SENT_338	[p20l138t3271r244b3325],
8	CYP2Cl9	NN	O	cyp2cl9	nn	10	SENT_338	[p20l266t3272r568b3325],
9	genetic	JJ	O	genetic	amod	10	SENT_338	[p20l593t3271r803b3340],
10	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_338	[p20l824t3271r1285b3340],
11	with	IN	O	with	_	0	SENT_338	[p20l1307t3271r1439b3325],
12	sibutramine	NN	O	sibutramine	nn	13	SENT_338	[p20l1462t3271r1806b3325],
13	pharrnacokinetics	NNS	O	pharrnacokinetic	prep_with	1	SENT_338	[p20l1827t3271r2143b3340, p20l136t3364r364b3418],
14	in	IN	O	in	_	0	SENT_338	[p20l426t3364r482b3417],
15	healthy	JJ	O	healthy	amod	17	SENT_338	[p20l541t3364r759b3433],
16	Korean	JJ	MISC	korean	amod	17	SENT_338	[p20l818t3367r1036b3418],
17	subjects	NNS	O	subject	prep_in	1	SENT_338	[p20l1097t3364r1347b3433],
18	.	.	O	.	_	0	SENT_338	[p20l1097t3364r1347b3433],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_339	[p20l1414t3364r1535b3418],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_339	[p20l1594t3364r1929b3418],
3	T	NN	O	t	_	0	SENT_339	[p20l1991t3367r2034b3417],
4	her	PRP$	O	she	dep	3	SENT_339	[p20l2028t3364r2136b3418],
5	.	.	O	.	_	0	SENT_339	[p20l2028t3364r2136b3418],

1	2009	CD	DATE	2009	_	0	SENT_340	[p20l137t3457r677b3520],
2	;	:	O	;	_	0	SENT_340	[p20l137t3457r677b3520],
3	86:511	CD	NUMBER	86:511	number	4	SENT_340	[p20l137t3457r677b3520],
4	-518	CD	NUMBER	-518	dep	1	SENT_340	[p20l137t3457r677b3520],
5	.	.	O	.	_	0	SENT_340	[p20l137t3457r677b3520],

1	Bae	NNP	ORGANIZATION	Bae	nn	2	SENT_341	[p20l137t3551r250b3603],
2	JW	NNP	ORGANIZATION	JW	_	0	SENT_341	[p20l304t3551r418b3614],
3	,	,	O	,	_	0	SENT_341	[p20l304t3551r418b3614],
4	Jang	NNP	PERSON	Jang	nn	5	SENT_341	[p20l474t3551r608b3618],
5	CG	NNP	PERSON	CG	appos	2	SENT_341	[p20l664t3550r780b3614],
6	,	,	O	,	_	0	SENT_341	[p20l664t3550r780b3614],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_341	[p20l836t3551r945b3603],
8	SY	NNP	PERSON	SY	appos	5	SENT_341	[p20l1003t3550r1108b3603],
9	.	.	O	.	_	0	SENT_341	[p20l1003t3550r1108b3603],

1	Effects	NNS	O	effect	_	0	SENT_342	[p20l1165t3549r1370b3603],
2	of	IN	O	of	_	0	SENT_342	[p20l1426t3549r1494b3603],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_342	[p20l1539t3549r1875b3618],
4	on	IN	O	on	_	0	SENT_342	[p20l1930t3567r2002b3603],
5	the	DT	O	the	det	6	SENT_342	[p20l2055t3549r2143b3603],
6	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_342	[p20l135t3642r656b3711],
7	of	IN	O	of	_	0	SENT_342	[p20l685t3642r753b3696],
8	sibutramine	NN	O	sibutramine	prep_of	6	SENT_342	[p20l774t3642r1118b3696],
9	and	CC	O	and	_	0	SENT_342	[p20l1147t3642r1253b3696],
10	its	PRP$	O	its	poss	12	SENT_342	[p20l1280t3642r1345b3696],
11	active	JJ	O	active	amod	12	SENT_342	[p20l1375t3642r1547b3696],
12	metabolites	NNS	O	metabolite	conj_and	8	SENT_342	[p20l1574t3642r1928b3696],
13	.	.	O	.	_	0	SENT_342	[p20l1574t3642r1928b3696],

1	J	NNP	O	J	nn	3	SENT_343	[p20l1956t3645r2000b3696],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_343	[p20l2021t3642r2142b3696],
3	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_343	[p20l134t3734r476b3787],
4	.	.	O	.	_	0	SENT_343	[p20l134t3734r476b3787],

1	201	CD	NUMBER	201	num	2	SENT_344	[p20l509t3735r611b3787],
2	1	CD	NUMBER	1	_	0	SENT_344	[p20l629t3735r1124b3798],
3	;	:	O	;	_	0	SENT_344	[p20l629t3735r1124b3798],
4	5l	CD	NUMBER	5l	dep	2	SENT_344	[p20l629t3735r1124b3798],
5	:1704	CD	DURATION	:1704	num	6	SENT_344	[p20l629t3735r1124b3798],
6	-1711	CD	DURATION	-1711	dep	4	SENT_344	[p20l629t3735r1124b3798],
7	.	.	O	.	_	0	SENT_344	[p20l629t3735r1124b3798],

1	Chung	NNP	PERSON	Chung	_	0	SENT_345	[p21l138t21r335b90],
2	JY	NN	PERSON	jy	dep	1	SENT_345	[p21l384t23r480b86],
3	,	,	O	,	_	0	SENT_345	[p21l384t23r480b86],
4	Lang	NNP	PERSON	Lang	nn	5	SENT_345	[p21l533t23r683b90],
5	SB	NN	O	sb	dep	1	SENT_345	[p21l736t22r838b87],
6	,	,	O	,	_	0	SENT_345	[p21l736t22r838b87],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_345	[p21l890t23r999b75],
8	YJ	NN	O	yj	conj_and	2	SENT_345	[p21l1048t23r1145b86],
9	,	,	O	,	_	0	SENT_345	[p21l1048t23r1145b86],
10	Park	NNP	O	Park	nn	11	SENT_345	[p21l1198t21r1333b75],
11	MS	NN	O	m	conj_and	2	SENT_345	[p21l1380t22r1502b86],
12	,	,	O	,	_	0	SENT_345	[p21l1380t22r1502b86],
13	Park	NNP	O	Park	nn	15	SENT_345	[p21l1554t21r1689b75],
14	K.	NNP	O	K.	nn	15	SENT_345	[p21l1737t23r1804b75],
15	Effect	NN	O	effect	conj_and	2	SENT_345	[p21l1857t21r2036b75],
16	of	IN	O	of	_	0	SENT_345	[p21l2085t21r2153b75],
17	CYP2B6	NN	O	cyp2b6	nn	18	SENT_345	[p21l138t116r404b168],
18	genotype	NN	O	genotype	prep_of	15	SENT_345	[p21l444t122r715b184],
19	on	IN	O	on	_	0	SENT_345	[p21l755t132r828b168],
20	the	DT	O	the	det	21	SENT_345	[p21l865t115r954b168],
21	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	18	SENT_345	[p21l991t115r1513b184],
22	of	IN	O	of	_	0	SENT_345	[p21l1554t115r1622b168],
23	sibutramine	NN	O	sibutramine	prep_of	21	SENT_345	[p21l1654t115r1999b168],
24	and	CC	O	and	_	0	SENT_345	[p21l2039t115r2145b168],
25	active	JJ	O	active	amod	26	SENT_345	[p21l138t208r310b261],
26	metabolites	NNS	O	metabolite	conj_and	2	SENT_345	[p21l347t208r686b261],
27	in	IN	O	in	_	0	SENT_345	[p21l724t208r780b260],
28	healthy	JJ	O	healthy	amod	29	SENT_345	[p21l815t208r1033b277],
29	subjects	NNS	O	subject	prep_in	1	SENT_345	[p21l1071t208r1321b277],
30	.	.	O	.	_	0	SENT_345	[p21l1071t208r1321b277],

1	J	NNP	O	J	nn	3	SENT_346	[p21l1357t210r1402b261],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_346	[p21l1432t208r1553b261],
3	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_346	[p21l1588t208r1931b261],
4	.	.	O	.	_	0	SENT_346	[p21l1588t208r1931b261],

1	2011	CD	DATE	2011	_	0	SENT_347	[p21l1975t209r2141b273],
2	;	:	O	;	_	0	SENT_347	[p21l1975t209r2141b273],
3	5	CD	NUMBER	5	number	4	SENT_347	[p21l139t302r168b354],
4	1	CD	NUMBER	1	dep	1	SENT_347	[p21l182t301r202b353],
5	:53	CD	NUMBER	:53	num	6	SENT_347	[p21l217t301r432b354],
6	—	NN	O	—	dep	4	SENT_347	[p21l217t301r432b354],
7	59	CD	NUMBER	59	dep	4	SENT_347	[p21l217t301r432b354],
8	.	.	O	.	_	0	SENT_347	[p21l217t301r432b354],

1	Noh	NNP	PERSON	Noh	nn	2	SENT_348	[p21l134t393r265b447],
2	K	NNP	PERSON	K	_	0	SENT_348	[p21l288t396r356b459],
3	,	,	O	,	_	0	SENT_348	[p21l288t396r356b459],
4	Bae	NNP	O	Bae	nn	5	SENT_348	[p21l383t396r496b447],
5	K	NNP	O	K	appos	2	SENT_348	[p21l522t396r590b459],
6	,	,	O	,	_	0	SENT_348	[p21l522t396r590b459],
7	Min	NN	DURATION	min	nn	8	SENT_348	[p21l618t394r741b446],
8	B	NN	O	b	appos	2	SENT_348	[p21l764t396r829b459],
9	,	,	O	,	_	0	SENT_348	[p21l764t396r829b459],
10	et	FW	O	et	nn	11	SENT_348	[p21l857t401r908b447],
11	al.	FW	O	al.	appos	2	SENT_348	[p21l934t394r998b447],
12	.	.	O	.	_	0	SENT_348	[p21l934t394r998b447],

1	Enantioselective	JJ	O	enantioselective	amod	2	SENT_349	[p21l1026t394r1513b447],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_349	[p21l1537t393r2058b462],
3	of	IN	O	of	_	0	SENT_349	[p21l2085t394r2153b447],
4	sibutramine	NN	O	sibutramine	prep_of	2	SENT_349	[p21l139t486r484b539],
5	in	IN	O	in	_	0	SENT_349	[p21l509t486r565b538],
6	rat	NN	O	rat	prep_in	2	SENT_349	[p21l588t493r679b539],
7	.	.	O	.	_	0	SENT_349	[p21l588t493r679b539],

1	Arch	NNP	ORGANIZATION	Arch	nn	3	SENT_350	[p21l702t486r848b539],
2	Pharm	NNP	ORGANIZATION	Pharm	nn	3	SENT_350	[p21l871t486r1074b539],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_350	[p21l1096t488r1216b539],
4	.	.	O	.	_	0	SENT_350	[p21l1096t488r1216b539],

1	2010	CD	DATE	2010	_	0	SENT_351	[p21l1247t487r1788b550],
2	;	:	O	;	_	0	SENT_351	[p21l1247t487r1788b550],
3	33:267	CD	NUMBER	33:267	number	4	SENT_351	[p21l1247t487r1788b550],
4	-273	CD	NUMBER	-273	dep	1	SENT_351	[p21l1247t487r1788b550],
5	.	.	O	.	_	0	SENT_351	[p21l1247t487r1788b550],

1	Link	NN	O	link	nn	2	SENT_352	[p21l137t577r277b630],
2	M	NN	O	m	dep	20	SENT_352	[p21l291t579r371b641],
3	,	,	O	,	_	0	SENT_352	[p21l291t579r371b641],
4	Novotna	NNP	PERSON	Novotna	nn	5	SENT_352	[p21l388t579r647b630],
5	R	NNP	PERSON	R	appos	2	SENT_352	[p21l660t579r724b641],
6	,	,	O	,	_	0	SENT_352	[p21l660t579r724b641],
7	Suchanova	NNP	PERSON	Suchanova	nn	8	SENT_352	[p21l746t577r1069b631],
8	B	NNP	PERSON	B	appos	2	SENT_352	[p21l1084t579r1147b641],
9	,	,	O	,	_	0	SENT_352	[p21l1084t579r1147b641],
10	Skalova	NNP	PERSON	Skalova	nn	11	SENT_352	[p21l1169t577r1405b631],
11	L	NNP	PERSON	L	appos	2	SENT_352	[p21l1419t579r1478b642],
12	,	,	O	,	_	0	SENT_352	[p21l1419t579r1478b642],
13	Wsol	NNP	PERSON	Wsol	nn	14	SENT_352	[p21l1496t577r1651b631],
14	V	NNP	PERSON	V	appos	2	SENT_352	[p21l1667t579r1735b642],
15	,	,	O	,	_	0	SENT_352	[p21l1667t579r1735b642],
16	Szotakova	NNP	O	Szotakova	nn	18	SENT_352	[p21l1757t577r2063b631],
17	B.	NNP	O	B.	nn	18	SENT_352	[p21l2077t579r2140b630],
18	The	NNP	O	The	appos	2	SENT_352	[p21l138t670r250b724],
19	stereoselective	JJ	O	stereoselective	amod	20	SENT_352	[p21l303t671r733b724],
20	biotransforrnation	NN	O	biotransforrnation	_	0	SENT_352	[p21l782t671r1313b724],
21	of	IN	O	of	_	0	SENT_352	[p21l1363t671r1431b724],
22	the	DT	O	the	det	25	SENT_352	[p21l1471t671r1561b724],
23	anti-obesity	JJ	O	anti-obesity	amod	25	SENT_352	[p21l1612t671r1959b740],
24	drug	NN	O	drug	nn	25	SENT_352	[p21l2010t671r2143b740],
25	sibutramine	NN	O	sibutramine	prep_of	20	SENT_352	[p21l139t764r484b817],
26	in	IN	O	in	_	0	SENT_352	[p21l513t764r568b816],
27	rat	NN	O	rat	nn	29	SENT_352	[p21l595t771r673b817],
28	liver	NN	O	liver	nn	29	SENT_352	[p21l700t764r834b817],
29	microsomes	NNS	O	microsome	prep_in	25	SENT_352	[p21l859t764r1215b817],
30	and	CC	O	and	_	0	SENT_352	[p21l1245t764r1351b817],
31	in	IN	O	in	_	0	SENT_352	[p21l1378t764r1434b816],
32	primary	JJ	O	primary	amod	33	SENT_352	[p21l1459t764r1694b833],
33	cultures	NNS	O	culture	prep_in	25	SENT_352	[p21l1722t764r1952b817],
34	of	IN	O	of	_	0	SENT_352	[p21l1982t764r2050b817],
35	rat	NN	O	rat	nn	36	SENT_352	[p21l2068t771r2145b817],
36	hepatocytes	NNS	O	hepatocyte	prep_of	33	SENT_352	[p21l136t856r500b925],
37	.	.	O	.	_	0	SENT_352	[p21l136t856r500b925],

1	J	NNP	O	J	nn	3	SENT_353	[p21l524t858r568b910],
2	Pharm	NNP	O	Pharm	nn	3	SENT_353	[p21l580t856r782b910],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_353	[p21l806t856r1148b910],
4	.	.	O	.	_	0	SENT_353	[p21l806t856r1148b910],

1	2005	CD	DATE	2005	_	0	SENT_354	[p21l1181t858r1721b922],
2	;	:	O	;	_	0	SENT_354	[p21l1181t858r1721b922],
3	57:405	CD	NUMBER	57:405	number	4	SENT_354	[p21l1181t858r1721b922],
4	-410	CD	NUMBER	-410	dep	1	SENT_354	[p21l1181t858r1721b922],
5	.	.	O	.	_	0	SENT_354	[p21l1181t858r1721b922],

1	Hinson	NNP	PERSON	Hinson	nn	2	SENT_355	[p21l137t949r351b1002],
2	JL	NNP	O	JL	_	0	SENT_355	[p21l367t951r456b1013],
3	,	,	O	,	_	0	SENT_355	[p21l367t951r456b1013],
4	Leone	NNP	PERSON	Leone	nn	5	SENT_355	[p21l476t951r659b1002],
5	MB	NNP	O	MB	appos	2	SENT_355	[p21l676t951r807b1013],
6	,	,	O	,	_	0	SENT_355	[p21l676t951r807b1013],
7	Leese	NNP	ORGANIZATION	Leese	nn	8	SENT_355	[p21l827t951r997b1002],
8	PT	NN	ORGANIZATION	pt	appos	5	SENT_355	[p21l1015t951r1116b1013],
9	,	,	O	,	_	0	SENT_355	[p21l1015t951r1116b1013],
10	Moult	NNP	O	Moult	nn	12	SENT_355	[p21l1135t948r1317b1002],
11	J	NNP	O	J	nn	12	SENT_355	[p21l1333t951r1360b1002],
12	T	NN	O	t	appos	5	SENT_355	[p21l1362t951r1421b1013],
13	,	,	O	,	_	0	SENT_355	[p21l1362t951r1421b1013],
14	Carter	NNP	PERSON	Carter	nn	15	SENT_355	[p21l1442t950r1625b1002],
15	FJ	NNP	O	FJ	appos	5	SENT_355	[p21l1640t951r1725b1013],
16	,	,	O	,	_	0	SENT_355	[p21l1640t951r1725b1013],
17	Faulkner	NNP	PERSON	Faulkner	nn	18	SENT_355	[p21l1744t949r2008b1002],
18	RD.	NNP	O	RD.	appos	5	SENT_355	[p21l2023t951r2140b1002],
19	.	.	O	.	_	0	SENT_355	[p21l2023t951r2140b1002],

1	Steady-state	JJ	O	steady-state	amod	3	SENT_356	[p21l140t1042r495b1111],
2	interaction	NN	O	interaction	nn	3	SENT_356	[p21l541t1042r856b1095],
3	study	NN	O	study	_	0	SENT_356	[p21l902t1042r1060b1111],
4	of	IN	O	of	_	0	SENT_356	[p21l1105t1042r1173b1095],
5	sibutramine	NN	O	sibutramine	nn	8	SENT_356	[p21l1211t1042r1556b1095],
6	(	CD	NUMBER	(	num	8	SENT_356	[p21l1603t1042r1992b1110],
7	MeridiaTM	NN	O	meridiatm	nn	8	SENT_356	[p21l1603t1042r1992b1110],
8	)	NN	O	)	prep_of	3	SENT_356	[p21l1603t1042r1992b1110],
9	and	CC	O	and	_	0	SENT_356	[p21l2039t1042r2145b1095],
10	erythromycin	NN	O	erythromycin	prep_of	3	SENT_356	[p21l138t1134r535b1203],
11	in	IN	O	in	_	0	SENT_356	[p21l550t1134r606b1187],
12	uncomplicated	JJ	O	uncomplicated	amod	14	SENT_356	[p21l620t1134r1057b1203],
13	obese	JJ	O	obese	amod	14	SENT_356	[p21l1072t1134r1238b1188],
14	subjects	NNS	O	subject	prep_in	3	SENT_356	[p21l1257t1134r1506b1203],
15	.	.	O	.	_	0	SENT_356	[p21l1257t1134r1506b1203],

1	Pharm	NNP	O	Pharm	nn	2	SENT_357	[p21l1522t1134r1724b1188],
2	Res	NNP	O	Res	_	0	SENT_357	[p21l1738t1136r1857b1188],
3	.	.	O	.	_	0	SENT_357	[p21l1738t1136r1857b1188],

1	1996	CD	DATE	1996	num	3	SENT_358	[p21l1888t1135r2046b1200],
2	;	:	O	;	_	0	SENT_358	[p21l1888t1135r2046b1200],
3	13	CD	NUMBER	13	_	0	SENT_358	[p21l2059t1135r2140b1188],
4	:	:	O	:	_	0	SENT_358	[p21l2059t1135r2140b1188],
5	S1	NN	O	s1	dep	3	SENT_358	[p21l140t1228r206b1281],
6	16	CD	NUMBER	16	num	5	SENT_358	[p21l223t1229r303b1281],
7	.	.	O	.	_	0	SENT_358	[p21l223t1229r303b1281],

1	Hinson	NNP	PERSON	Hinson	nn	2	SENT_359	[p21l137t1319r351b1372],
2	JL	NNP	O	JL	_	0	SENT_359	[p21l367t1321r456b1383],
3	,	,	O	,	_	0	SENT_359	[p21l367t1321r456b1383],
4	Leone	NNP	PERSON	Leone	nn	5	SENT_359	[p21l476t1321r659b1372],
5	MB	NNP	O	MB	appos	2	SENT_359	[p21l676t1321r807b1383],
6	,	,	O	,	_	0	SENT_359	[p21l676t1321r807b1383],
7	Leese	NNP	ORGANIZATION	Leese	nn	8	SENT_359	[p21l827t1321r997b1372],
8	PT	NN	ORGANIZATION	pt	appos	5	SENT_359	[p21l1015t1321r1116b1383],
9	,	,	O	,	_	0	SENT_359	[p21l1015t1321r1116b1383],
10	Moult	NNP	O	Moult	nn	12	SENT_359	[p21l1135t1319r1316b1372],
11	J	NNP	O	J	nn	12	SENT_359	[p21l1333t1321r1360b1372],
12	T	NN	O	t	appos	5	SENT_359	[p21l1362t1321r1421b1383],
13	,	,	O	,	_	0	SENT_359	[p21l1362t1321r1421b1383],
14	Carter	NNP	PERSON	Carter	nn	15	SENT_359	[p21l1442t1320r1625b1373],
15	FJ	NNP	O	FJ	appos	5	SENT_359	[p21l1640t1321r1725b1383],
16	,	,	O	,	_	0	SENT_359	[p21l1640t1321r1725b1383],
17	Faulkner	NNP	PERSON	Faulkner	nn	18	SENT_359	[p21l1744t1319r2008b1372],
18	RD.	NNP	O	RD.	appos	5	SENT_359	[p21l2023t1321r2140b1372],
19	.	.	O	.	_	0	SENT_359	[p21l2023t1321r2140b1372],

1	Steady-state	JJ	O	steady-state	amod	3	SENT_360	[p21l140t1412r495b1481],
2	interaction	NN	O	interaction	nn	3	SENT_360	[p21l541t1412r856b1466],
3	study	NN	O	study	_	0	SENT_360	[p21l902t1412r1060b1481],
4	of	IN	O	of	_	0	SENT_360	[p21l1105t1412r1173b1466],
5	sibutramine	NN	O	sibutramine	nn	8	SENT_360	[p21l1211t1412r1556b1466],
6	(	CD	NUMBER	(	num	8	SENT_360	[p21l1603t1412r1992b1481],
7	MeridiaTM	NN	O	meridiatm	nn	8	SENT_360	[p21l1603t1412r1992b1481],
8	)	NN	O	)	prep_of	3	SENT_360	[p21l1603t1412r1992b1481],
9	and	CC	O	and	_	0	SENT_360	[p21l2039t1412r2145b1466],
10	ketoconazole	NN	O	ketoconazole	prep_of	3	SENT_360	[p21l136t1505r525b1559],
11	in	IN	O	in	_	0	SENT_360	[p21l543t1505r600b1558],
12	uncomplicated	JJ	O	uncomplicated	amod	14	SENT_360	[p21l614t1505r1052b1574],
13	obese	JJ	O	obese	amod	14	SENT_360	[p21l1068t1505r1234b1559],
14	subjects	NNS	O	subject	prep_in	3	SENT_360	[p21l1253t1505r1502b1574],
15	.	.	O	.	_	0	SENT_360	[p21l1253t1505r1502b1574],

1	Pharm	NNP	O	Pharm	nn	2	SENT_361	[p21l1519t1505r1722b1559],
2	Res	NNP	O	Res	_	0	SENT_361	[p21l1737t1508r1857b1559],
3	.	.	O	.	_	0	SENT_361	[p21l1737t1508r1857b1559],

1	1996	CD	DATE	1996	num	3	SENT_362	[p21l1888t1507r2140b1571],
2	;	:	O	;	_	0	SENT_362	[p21l1888t1507r2140b1571],
3	l3	CD	NUMBER	l3	_	0	SENT_362	[p21l1888t1507r2140b1571],
4	:	:	O	:	_	0	SENT_362	[p21l1888t1507r2140b1571],
5	S1	NN	O	s1	dep	3	SENT_362	[p21l140t1599r206b1652],
6	16	CD	NUMBER	16	num	5	SENT_362	[p21l223t1599r303b1651],
7	.	.	O	.	_	0	SENT_362	[p21l223t1599r303b1651],

1	Tsuchiya	NNP	PERSON	Tsuchiya	nn	2	SENT_363	[p21l138t1691r409b1760],
2	K	NNP	PERSON	K	_	0	SENT_363	[p21l458t1693r526b1756],
3	,	,	O	,	_	0	SENT_363	[p21l458t1693r526b1756],
4	Gatanaga	NNP	PERSON	Gatanaga	nn	5	SENT_363	[p21l581t1692r860b1760],
5	H	NNP	PERSON	H	appos	2	SENT_363	[p21l908t1693r976b1756],
6	,	,	O	,	_	0	SENT_363	[p21l908t1693r976b1756],
7	Tachikawa	NNP	ORGANIZATION	Tachikawa	nn	8	SENT_363	[p21l1031t1691r1354b1745],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_363	[p21l1402t1693r1472b1756],
9	,	,	O	,	_	0	SENT_363	[p21l1402t1693r1472b1756],
10	et	FW	O	et	nn	11	SENT_363	[p21l1526t1699r1578b1745],
11	al.	FW	O	al.	appos	2	SENT_363	[p21l1629t1691r1693b1745],
12	.	.	O	.	_	0	SENT_363	[p21l1629t1691r1693b1745],

1	Homozygous	JJ	O	homozygous	amod	6	SENT_364	[p21l1748t1693r2142b1760],
2	CYP2B6	NN	O	cyp2b6	nn	6	SENT_364	[p21l138t1785r478b1838],
3	*	NN	O	*	nn	6	SENT_364	[p21l138t1785r478b1838],
4	6	CD	NUMBER	6	num	6	SENT_364	[p21l138t1785r478b1838],
5	(	NN	O	(	nn	6	SENT_364	[p21l528t1785r769b1853],
6	Q172H	NN	O	q172h	nsubj	10	SENT_364	[p21l528t1785r769b1853],
7	and	CC	O	and	_	0	SENT_364	[p21l816t1785r922b1838],
8	K262R	NN	O	k262r	nn	9	SENT_364	[p21l967t1785r1205b1853],
9	)	NN	O	)	nsubj	10	SENT_364	[p21l967t1785r1205b1853],
10	correlates	VBZ	O	correlate	_	0	SENT_364	[p21l1253t1785r1535b1838],
11	with	IN	O	with	_	0	SENT_364	[p21l1582t1785r1713b1838],
12	high	JJ	O	high	amod	15	SENT_364	[p21l1758t1785r1891b1854],
13	plasma	NN	O	plasma	nn	15	SENT_364	[p21l1934t1785r2145b1854],
14	efavirenz	NN	O	efavirenz	nn	15	SENT_364	[p21l138t1878r410b1931],
15	concentrations	NNS	O	concentration	prep_with	10	SENT_364	[p21l446t1878r874b1931],
16	in	IN	O	in	_	0	SENT_364	[p21l912t1878r968b1930],
17	HIV-1	NN	O	hiv-1	nn	18	SENT_364	[p21l1003t1879r1187b1931],
18	patients	NNS	O	patient	prep_in	15	SENT_364	[p21l1228t1878r1458b1947],
19	treated	VBN	O	treat	partmod	18	SENT_364	[p21l1494t1878r1694b1931],
20	with	IN	O	with	_	0	SENT_364	[p21l1728t1878r1860b1931],
21	standard	JJ	O	standard	amod	23	SENT_364	[p21l1897t1878r2145b1932],
22	efavirenz-containing	JJ	O	efavirenz-containing	amod	23	SENT_364	[p21l138t1970r747b2039],
23	regimens	NNS	O	regimen	prep_with	19	SENT_364	[p21l791t1970r1076b2039],
24	.	.	O	.	_	0	SENT_364	[p21l791t1970r1076b2039],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_365	[p21l1121t1970r1380b2024],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_365	[p21l1423t1970r1664b2039],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_365	[p21l1705t1972r1812b2023],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_365	[p21l1861t1971r2136b2024],
5	.	.	O	.	_	0	SENT_365	[p21l1861t1971r2136b2024],

1	2004	CD	DATE	2004	_	0	SENT_366	[p21l137t2064r789b2127],
2	;	:	O	;	_	0	SENT_366	[p21l137t2064r789b2127],
3	319:1322	CD	DURATION	319:1322	number	4	SENT_366	[p21l137t2064r789b2127],
4	-1326	CD	DURATION	-1326	dep	1	SENT_366	[p21l137t2064r789b2127],
5	.	.	O	.	_	0	SENT_366	[p21l137t2064r789b2127],

1	Richter	NNP	PERSON	Richter	nn	2	SENT_367	[p21l137t2155r355b2208],
2	T	NN	PERSON	t	_	0	SENT_367	[p21l400t2157r459b2219],
3	,	,	O	,	_	0	SENT_367	[p21l400t2157r459b2219],
4	Murdter	NNP	PERSON	Murdter	nn	5	SENT_367	[p21l508t2155r752b2208],
5	TE	NNP	PERSON	TE	appos	2	SENT_367	[p21l797t2157r901b2219],
6	,	,	O	,	_	0	SENT_367	[p21l797t2157r901b2219],
7	Heinkele	NNP	O	Heinkele	nn	8	SENT_367	[p21l950t2155r1215b2208],
8	G.	NNP	O	G.	appos	2	SENT_367	[p21l1263t2156r1329b2208],
9	Potent	JJ	O	potent	amod	11	SENT_367	[p21l1380t2157r1570b2208],
10	mechanism-based	JJ	O	mechanism-based	amod	11	SENT_367	[p21l1614t2155r2145b2208],
11	inhibition	NN	O	inhibition	dep	8	SENT_367	[p21l138t2247r425b2301],
12	of	IN	O	of	_	0	SENT_367	[p21l463t2247r532b2301],
13	human	JJ	O	human	amod	14	SENT_367	[p21l561t2247r763b2301],
14	CYP2B6	NN	O	cyp2b6	prep_of	11	SENT_367	[p21l803t2248r1068b2301],
15	by	IN	O	by	_	0	SENT_367	[p21l1107t2247r1182b2316],
16	clopidogrel	NN	O	clopidogrel	prep_by	14	SENT_367	[p21l1222t2247r1556b2316],
17	and	CC	O	and	_	0	SENT_367	[p21l1596t2247r1703b2301],
18	ticlopidine	NN	O	ticlopidine	conj_and	16	SENT_367	[p21l1739t2247r2070b2316],
19	.	.	O	.	_	0	SENT_367	[p21l1739t2247r2070b2316],

1	J	NNP	O	J	nn	4	SENT_368	[p21l2109t2249r2153b2301],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_368	[p21l133t2341r468b2394],
3	Exp	NN	O	exp	nn	4	SENT_368	[p21l487t2343r603b2409],
4	T	NN	O	t	_	0	SENT_368	[p21l632t2343r676b2393],
5	her	PRP$	O	she	dep	4	SENT_368	[p21l669t2341r778b2394],
6	.	.	O	.	_	0	SENT_368	[p21l669t2341r778b2394],

1	2004	CD	DATE	2004	_	0	SENT_369	[p21l809t2342r1387b2406],
2	;	:	O	;	_	0	SENT_369	[p21l809t2342r1387b2406],
3	308:189	CD	NUMBER	308:189	number	4	SENT_369	[p21l809t2342r1387b2406],
4	-197	CD	NUMBER	-197	dep	1	SENT_369	[p21l809t2342r1387b2406],
5	.	.	O	.	_	0	SENT_369	[p21l809t2342r1387b2406],

1	Turpeinen	NN	MISC	turpeinen	nn	2	SENT_370	[p21l138t2434r441b2503],
2	M	NN	O	m	_	0	SENT_370	[p21l462t2436r543b2499],
3	,	,	O	,	_	0	SENT_370	[p21l462t2436r543b2499],
4	Tolonen	NNP	PERSON	Tolonen	nn	5	SENT_370	[p21l569t2434r816b2487],
5	A	NNP	O	A	appos	2	SENT_370	[p21l836t2435r905b2499],
6	,	,	O	,	_	0	SENT_370	[p21l836t2435r905b2499],
7	Uusitalo	NNP	O	Uusitalo	nn	8	SENT_370	[p21l929t2434r1178b2488],
8	J	NNP	O	J	appos	2	SENT_370	[p21l1202t2436r1230b2487],
9	,	,	O	,	_	0	SENT_370	[p21l1234t2479r1245b2499],
10	Jalonen	NNP	PERSON	Jalonen	nn	11	SENT_370	[p21l1271t2434r1497b2487],
11	J	NNP	PERSON	J	appos	2	SENT_370	[p21l1519t2436r1546b2487],
12	,	,	O	,	_	0	SENT_370	[p21l1550t2479r1561b2499],
13	Pelkonen	NNP	PERSON	Pelkonen	nn	14	SENT_370	[p21l1586t2434r1863b2487],
14	o	NN	O	o	appos	2	SENT_370	[p21l1885t2435r1952b2499],
15	,	,	O	,	_	0	SENT_370	[p21l1885t2435r1952b2499],
16	Lame	NNP	O	Lame	nn	18	SENT_370	[p21l1977t2434r2143b2487],
17	K.	NNP	O	K.	nn	18	SENT_370	[p21l137t2528r203b2580],
18	Effect	NN	O	effect	appos	2	SENT_370	[p21l235t2526r414b2580],
19	of	IN	O	of	_	0	SENT_370	[p21l441t2526r509b2580],
20	clopidogrel	NN	O	clopidogrel	prep_of	18	SENT_370	[p21l528t2526r863b2595],
21	and	CC	O	and	_	0	SENT_370	[p21l891t2526r997b2580],
22	ticlopidine	NN	O	ticlopidine	prep_of	18	SENT_370	[p21l1023t2526r1337b2595],
23	on	IN	O	on	_	0	SENT_370	[p21l1367t2544r1439b2580],
24	cytochrome	NN	O	cytochrome	nn	27	SENT_370	[p21l1467t2526r1813b2595],
25	P450	NN	O	p450	nn	27	SENT_370	[p21l1842t2528r1992b2580],
26	2B6	NN	O	2b6	nn	27	SENT_370	[p21l2021t2528r2142b2580],
27	activity	NN	O	activity	prep_on	2	SENT_370	[p21l138t2619r357b2688],
28	as	IN	O	as	advmod	29	SENT_370	[p21l383t2637r441b2673],
29	measured	VBN	O	measure	partmod	2	SENT_370	[p21l467t2619r751b2673],
30	by	IN	O	by	_	0	SENT_370	[p21l773t2619r849b2688],
31	bupropion	NN	O	bupropion	nn	32	SENT_370	[p21l872t2619r1180b2688],
32	hydroxylation	NN	O	hydroxylation	agent	29	SENT_370	[p21l1203t2619r1634b2688],
33	.	.	O	.	_	0	SENT_370	[p21l1203t2619r1634b2688],

1	Clin	NNP	O	Clin	nn	3	SENT_371	[p21l1667t2619r1787b2673],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_371	[p21l1812t2619r2146b2673],
3	Ther	NNP	O	Ther	_	0	SENT_371	[p21l141t2712r287b2765],
4	.	.	O	.	_	0	SENT_371	[p21l141t2712r287b2765],

1	2005	CD	DATE	2005	_	0	SENT_372	[p21l318t2713r859b2776],
2	;	:	O	;	_	0	SENT_372	[p21l318t2713r859b2776],
3	77:553	CD	NUMBER	77:553	number	4	SENT_372	[p21l318t2713r859b2776],
4	-559	CD	NUMBER	-559	dep	1	SENT_372	[p21l318t2713r859b2776],
5	.	.	O	.	_	0	SENT_372	[p21l318t2713r859b2776],

1	Hodgson	NNP	PERSON	Hodgson	nn	2	SENT_373	[p21l137t2804r406b2873],
2	E	NNP	O	E	_	0	SENT_373	[p21l428t2806r488b2870],
3	,	,	O	,	_	0	SENT_373	[p21l428t2806r488b2870],
4	Rose	NNP	O	Rose	nn	5	SENT_373	[p21l514t2806r660b2858],
5	RL	NNP	O	RL	appos	2	SENT_373	[p21l684t2806r792b2858],
6	.	.	O	.	_	0	SENT_373	[p21l684t2806r792b2858],

1	The	DT	O	the	det	2	SENT_374	[p21l820t2804r932b2858],
2	importance	NN	O	importance	_	0	SENT_374	[p21l958t2804r1288b2873],
3	of	IN	O	of	_	0	SENT_374	[p21l1312t2804r1380b2858],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_374	[p21l1396t2804r1742b2873],
5	P450	NN	O	p450	nn	6	SENT_374	[p21l1766t2805r1917b2858],
6	2B6	NN	O	2b6	prep_of	2	SENT_374	[p21l1941t2805r2063b2858],
7	in	IN	O	in	_	0	SENT_374	[p21l2089t2804r2144b2857],
8	the	DT	O	the	det	10	SENT_374	[p21l136t2896r225b2950],
9	human	JJ	O	human	amod	10	SENT_374	[p21l266t2896r469b2950],
10	metabolism	NN	O	metabolism	prep_in	6	SENT_374	[p21l508t2896r853b2950],
11	of	IN	O	of	_	0	SENT_374	[p21l895t2896r963b2950],
12	environmental	JJ	O	environmental	amod	13	SENT_374	[p21l995t2896r1420b2950],
13	chemicals	NNS	O	chemical	prep_of	2	SENT_374	[p21l1462t2896r1770b2950],
14	.	.	O	.	_	0	SENT_374	[p21l1462t2896r1770b2950],

1	Pharmacol	NN	O	pharmacol	nn	2	SENT_375	[p21l1812t2896r2146b2950],
2	T	NN	O	t	_	0	SENT_375	[p21l141t2990r184b3041],
3	her	PRP$	O	she	dep	2	SENT_375	[p21l178t2988r287b3041],
4	.	.	O	.	_	0	SENT_375	[p21l178t2988r287b3041],

1	2007	CD	DATE	2007	_	0	SENT_376	[p21l318t2989r516b3052],
2	;	:	O	;	_	0	SENT_376	[p21l318t2989r516b3052],
3	1	CD	NUMBER	1	number	4	SENT_376	[p21l318t2989r516b3052],
4	13:420	CD	NUMBER	13:420	dep	1	SENT_376	[p21l534t2989r896b3041],
5	-428	CD	NUMBER	-428	dep	4	SENT_376	[p21l534t2989r896b3041],
6	.	.	O	.	_	0	SENT_376	[p21l534t2989r896b3041],

1	Nishiya	FW	MISC	nishiya	_	0	SENT_377	[p21l134t3081r368b3150],
2	Y	NN	O	y	dep	1	SENT_377	[p21l388t3083r456b3146],
3	,	,	O	,	_	0	SENT_377	[p21l388t3083r456b3146],
4	Hagihara	NN	PERSON	hagihara	nn	5	SENT_377	[p21l480t3081r752b3150],
5	K	NN	PERSON	k	appos	2	SENT_377	[p21l772t3083r840b3146],
6	,	,	O	,	_	0	SENT_377	[p21l772t3083r840b3146],
7	Ito	NN	PERSON	ito	nn	8	SENT_377	[p21l865t3083r943b3135],
8	T	NN	O	t	appos	2	SENT_377	[p21l967t3083r1026b3146],
9	,	,	O	,	_	0	SENT_377	[p21l967t3083r1026b3146],
10	et	FW	O	et	nn	11	SENT_377	[p21l1051t3089r1103b3135],
11	al.	FW	O	al.	appos	2	SENT_377	[p21l1125t3081r1190b3135],
12	.	.	O	.	_	0	SENT_377	[p21l1125t3081r1190b3135],

1	Mechanism-based	JJ	O	mechanism-based	amod	2	SENT_378	[p21l1215t3081r1755b3135],
2	inhibition	NN	O	inhibition	_	0	SENT_378	[p21l1776t3081r2063b3135],
3	of	IN	O	of	_	0	SENT_378	[p21l2085t3081r2153b3135],
4	human	JJ	O	human	amod	7	SENT_378	[p21l136t3174r339b3228],
5	cytochrome	NN	O	cytochrome	nn	7	SENT_378	[p21l367t3174r713b3243],
6	P450	NN	O	p450	nn	7	SENT_378	[p21l743t3176r894b3228],
7	2B6	NN	O	2b6	prep_of	2	SENT_378	[p21l923t3176r1045b3228],
8	by	IN	O	by	_	0	SENT_378	[p21l1073t3174r1148b3243],
9	ticlopidine	NN	O	ticlopidine	prep_by	2	SENT_378	[p21l1175t3174r1507b3243],
10	,	,	O	,	_	0	SENT_378	[p21l1175t3174r1507b3243],
11	clopidogrel	NN	O	clopidogrel	prep_by	2	SENT_378	[p21l1539t3174r1890b3243],
12	,	,	O	,	_	0	SENT_378	[p21l1539t3174r1890b3243],
13	and	CC	O	and	_	0	SENT_378	[p21l1922t3174r2028b3228],
14	the	DT	O	the	det	16	SENT_378	[p21l2055t3174r2143b3228],
15	thiolactone	NN	O	thiolactone	nn	16	SENT_378	[p21l136t3267r464b3321],
16	metabolite	NN	O	metabolite	prep_by	2	SENT_378	[p21l538t3267r849b3321],
17	of	IN	O	of	_	0	SENT_378	[p21l925t3267r994b3321],
18	prasugrel	NN	O	prasugrel	prep_of	2	SENT_378	[p21l1058t3267r1348b3336],
19	.	.	O	.	_	0	SENT_378	[p21l1058t3267r1348b3336],

1	Drug	NN	O	drug	_	0	SENT_379	[p21l1424t3269r1585b3336],
2	Metab	NNP	O	Metab	nn	3	SENT_379	[p21l1654t3267r1844b3321],
3	Dispos	NNP	O	Dispos	dep	1	SENT_379	[p21l1917t3269r2136b3336],
4	.	.	O	.	_	0	SENT_379	[p21l1917t3269r2136b3336],

1	2009	CD	DATE	2009	_	0	SENT_380	[p21l137t3360r677b3424],
2	;	:	O	;	_	0	SENT_380	[p21l137t3360r677b3424],
3	37:589	CD	NUMBER	37:589	number	4	SENT_380	[p21l137t3360r677b3424],
4	-593	CD	NUMBER	-593	dep	1	SENT_380	[p21l137t3360r677b3424],
5	.	.	O	.	_	0	SENT_380	[p21l137t3360r677b3424],

1	Kawakami	NNP	PERSON	Kawakami	nn	2	SENT_381	[p21l137t3452r457b3505],
2	H	NNP	PERSON	H	_	0	SENT_381	[p21l483t3454r551b3516],
3	,	,	O	,	_	0	SENT_381	[p21l483t3454r551b3516],
4	Ohtsuki	NNP	PERSON	Ohtsuki	nn	5	SENT_381	[p21l583t3452r815b3505],
5	S	NNP	O	S	appos	2	SENT_381	[p21l845t3453r897b3516],
6	,	,	O	,	_	0	SENT_381	[p21l845t3453r897b3516],
7	Kamiie	NNP	PERSON	Kamiie	nn	8	SENT_381	[p21l927t3452r1142b3505],
8	J	NNP	PERSON	J	appos	2	SENT_381	[p21l1170t3454r1198b3505],
9	,	,	O	,	_	0	SENT_381	[p21l1201t3496r1213b3516],
10	Suzuki	NNP	PERSON	Suzuki	nn	11	SENT_381	[p21l1246t3452r1448b3505],
11	T	NN	O	t	appos	2	SENT_381	[p21l1475t3454r1534b3516],
12	,	,	O	,	_	0	SENT_381	[p21l1475t3454r1534b3516],
13	Abe	NN	ORGANIZATION	abe	nn	14	SENT_381	[p21l1564t3452r1686b3505],
14	T	NN	ORGANIZATION	t	appos	2	SENT_381	[p21l1714t3454r1772b3516],
15	,	,	O	,	_	0	SENT_381	[p21l1714t3454r1772b3516],
16	Terasaki	NNP	PERSON	Terasaki	nn	17	SENT_381	[p21l1803t3452r2055b3505],
17	T.	NNP	PERSON	T.	appos	2	SENT_381	[p21l2083t3454r2140b3505],
18	Simultaneous	JJ	PERSON	simultaneous	amod	20	SENT_381	[p21l140t3545r538b3599],
19	absolute	JJ	O	absolute	amod	20	SENT_381	[p21l593t3545r837b3598],
20	quantiﬁcation	NN	O	quantiﬁcation	dep	17	SENT_381	[p21l892t3545r1298b3614],
21	of	IN	O	of	_	0	SENT_381	[p21l1352t3545r1420b3598],
22	11	CD	NUMBER	11	num	25	SENT_381	[p21l1471t3546r1529b3597],
23	cytochrome	NN	O	cytochrome	nn	25	SENT_381	[p21l1591t3545r1938b3614],
24	P450	NN	O	p450	nn	25	SENT_381	[p21l1992t3546r2142b3598],
25	isoforms	NNS	O	isoform	prep_of	20	SENT_381	[p21l138t3637r393b3691],
26	in	IN	O	in	dep	2	SENT_381	[p21l434t3637r490b3690],
27	human	JJ	O	human	amod	29	SENT_381	[p21l528t3637r731b3691],
28	liver	NN	O	liver	nn	29	SENT_381	[p21l769t3637r904b3691],
29	microsomes	NNS	O	microsome	pobj	26	SENT_381	[p21l940t3637r1296b3691],
30	by	IN	O	by	dep	2	SENT_381	[p21l1335t3637r1410b3706],
31	liquid	JJ	O	liquid	amod	32	SENT_381	[p21l1450t3637r1621b3706],
32	chromatography	NN	O	chromatography	pobj	30	SENT_381	[p21l1660t3637r2144b3706],

1	The	DT	O	the	det	2	SENT_382	[p22l1205t47r1254b74],
2	journal	NN	O	journal	dep	11	SENT_382	[p22l1262t47r1365b82],
3	of	IN	O	of	_	0	SENT_382	[p22l1378t47r1410b81],
4	Clinical	JJ	O	clinical	amod	5	SENT_382	[p22l1418t47r1515b74],
5	Pharmacology	NN	O	pharmacology	prep_of	2	SENT_382	[p22l1527t47r1721b83],
6	/	:	O	/	punct	7	SENT_382	[p22l1733t47r1744b74],
7	Vol	NNP	O	Vol	dep	5	SENT_382	[p22l1755t47r1804b74],
8	53	CD	NUMBER	53	dep	11	SENT_382	[p22l1820t47r1853b74],
9	No	DT	O	no	det	11	SENT_382	[p22l1871t47r1917b74],
10	5	CD	NUMBER	5	num	11	SENT_382	[p22l1932t47r1947b74],
11	(	NN	O	(	dep	15	SENT_382	[p22l1963t47r2022b83],
12	20	CD	NUMBER	20	num	13	SENT_382	[p22l1963t47r2022b83],
13	|	NN	O	|	dep	11	SENT_382	[p22l1963t47r2022b83],
14	3	CD	NUMBER	3	num	15	SENT_382	[p22l2032t47r2058b83],
15	)	NN	O	)	_	0	SENT_382	[p22l2032t47r2058b83],

1	tandem	JJ	O	tandem	amod	3	SENT_383	[p22l151t163r248b187],
2	mass	NN	O	mass	nn	3	SENT_383	[p22l258t171r323b187],
3	spectrometry	NN	O	spectrometry	_	0	SENT_383	[p22l335t167r505b194],
4	with	IN	O	with	prep	3	SENT_383	[p22l516t163r574b187],
5	in	IN	O	in	pcomp	4	SENT_383	[p22l585t163r609b187],
6	silico	NN	O	silico	nn	9	SENT_383	[p22l621t163r690b187],
7	target	NN	O	target	nn	9	SENT_383	[p22l701t167r776b194],
8	peptide	NN	O	peptide	nn	9	SENT_383	[p22l785t163r882b194],
9	selection	NN	O	selection	pobj	5	SENT_383	[p22l894t163r1016b187],
10	.	.	O	.	_	0	SENT_383	[p22l894t163r1016b187],

1	J	NNP	O	J	nn	3	SENT_384	[p22l1026t164r1046b187],
2	Pharm	NNP	O	Pharm	nn	3	SENT_384	[p22l150t204r240b228],
3	Sci	NNP	O	Sci	_	0	SENT_384	[p22l251t205r295b228],
4	.	.	O	.	_	0	SENT_384	[p22l251t205r295b228],

1	201l	NN	O	201l	_	0	SENT_385	[p22l310t205r566b233],
2	;	:	O	;	_	0	SENT_385	[p22l310t205r566b233],
3	l00	NN	O	l00	dep	1	SENT_385	[p22l310t205r566b233],
4	:341	CD	NUMBER	:341	num	3	SENT_385	[p22l310t205r566b233],
5	—	NN	O	—	dep	3	SENT_385	[p22l310t205r566b233],
6	352	CD	NUMBER	352	num	5	SENT_385	[p22l310t205r566b233],
7	.	.	O	.	_	0	SENT_385	[p22l310t205r566b233],

1	Paine	NNP	PERSON	Paine	nn	2	SENT_386	[p22l151t246r223b270],
2	MF	NN	PERSON	mf	_	0	SENT_386	[p22l234t247r289b275],
3	,	,	O	,	_	0	SENT_386	[p22l234t247r289b275],
4	Hart	NNP	PERSON	Hart	nn	5	SENT_386	[p22l301t247r359b270],
5	HJ	NNP	O	HJ	appos	2	SENT_386	[p22l369t247r412b275],
6	,	,	O	,	_	0	SENT_386	[p22l369t247r412b275],
7	Ludington	NNP	PERSON	Ludington	nn	8	SENT_386	[p22l425t246r562b277],
8	SS	NNP	O	SS	appos	5	SENT_386	[p22l574t247r616b276],
9	,	,	O	,	_	0	SENT_386	[p22l574t247r616b276],
10	Haining	NNP	ORGANIZATION	Haining	nn	11	SENT_386	[p22l628t246r734b277],
11	RL	NNP	ORGANIZATION	RL	appos	5	SENT_386	[p22l745t247r794b275],
12	,	,	O	,	_	0	SENT_386	[p22l745t247r794b275],
13	Rettie	NNP	PERSON	Rettie	nn	14	SENT_386	[p22l806t246r883b270],
14	AE	NNP	O	AE	appos	5	SENT_386	[p22l894t247r945b275],
15	,	,	O	,	_	0	SENT_386	[p22l894t247r945b275],
16	Zeldin	NNP	PERSON	Zeldin	nn	17	SENT_386	[p22l957t246r1043b270],
17	DC	NNP	O	DC	appos	5	SENT_386	[p22l151t288r203b312],
18	.	.	O	.	_	0	SENT_386	[p22l151t288r203b312],

1	The	DT	O	the	det	5	SENT_387	[p22l221t288r271b312],
2	human	JJ	O	human	amod	5	SENT_387	[p22l287t288r377b312],
3	intestinal	JJ	O	intestinal	amod	5	SENT_387	[p22l392t288r511b312],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_387	[p22l528t288r681b319],
5	P450	NN	O	p450	_	0	SENT_387	[p22l698t288r765b312],
6	“	CD	NUMBER	“	num	8	SENT_387	[p22l782t288r856b319],
7	pie	NN	O	pie	nn	8	SENT_387	[p22l782t288r856b319],
8	”	NN	O	”	dep	5	SENT_387	[p22l782t288r856b319],
9	.	.	O	.	_	0	SENT_387	[p22l782t288r856b319],

1	Drug	NN	O	drug	_	0	SENT_388	[p22l872t289r944b319],
2	Metab	NNP	PERSON	Metab	nn	3	SENT_388	[p22l957t288r1042b312],
3	Dispo	NNP	PERSON	Dispo	dep	1	SENT_388	[p22l150t330r234b360],
4	.	.	O	.	_	0	SENT_388	[p22l150t330r234b360],

1	2006	CD	DATE	2006	_	0	SENT_389	[p22l248t330r488b358],
2	;	:	O	;	_	0	SENT_389	[p22l248t330r488b358],
3	34:880	CD	NUMBER	34:880	number	4	SENT_389	[p22l248t330r488b358],
4	-886	CD	NUMBER	-886	dep	1	SENT_389	[p22l248t330r488b358],
5	.	.	O	.	_	0	SENT_389	[p22l248t330r488b358],

1	Galetin	NNP	MISC	Galetin	nn	2	SENT_390	[p22l152t371r247b396],
2	A	NNP	MISC	A	_	0	SENT_390	[p22l257t372r288b400],
3	,	,	O	,	_	0	SENT_390	[p22l257t372r288b400],
4	Houston	NNP	LOCATION	Houston	nn	5	SENT_390	[p22l299t372r411b396],
5	JB	NNP	O	JB	appos	2	SENT_390	[p22l421t372r462b396],
6	.	.	O	.	_	0	SENT_390	[p22l421t372r462b396],

1	Intestinal	JJ	O	intestinal	amod	5	SENT_391	[p22l475t371r595b395],
2	and	CC	O	and	_	0	SENT_391	[p22l606t371r654b395],
3	hepatic	JJ	O	hepatic	amod	5	SENT_391	[p22l663t371r757b402],
4	metabolic	JJ	O	metabolic	amod	5	SENT_391	[p22l768t371r897b395],
5	activity	NN	O	activity	_	0	SENT_391	[p22l908t371r1005b402],
6	of	IN	O	of	_	0	SENT_391	[p22l1016t371r1046b395],
7	ﬁve	NN	O	ﬁve	nn	10	SENT_391	[p22l151t413r200b437],
8	cytochrome	NN	O	cytochrome	nn	10	SENT_391	[p22l213t413r366b444],
9	P450	NN	O	p450	nn	10	SENT_391	[p22l379t413r446b437],
10	enzymes	NNS	O	enzyme	prep_of	5	SENT_391	[p22l459t421r581b444],
11	:	:	O	:	_	0	SENT_391	[p22l459t421r581b444],
12	impact	NN	O	impact	dep	5	SENT_391	[p22l595t413r684b444],
13	on	IN	O	on	_	0	SENT_391	[p22l696t421r729b437],
14	prediction	NN	O	prediction	prep_on	12	SENT_391	[p22l740t413r873b444],
15	of	IN	O	of	_	0	SENT_391	[p22l886t413r916b437],
16	ﬁrst-pass	JJ	O	ﬁrst-pass	amod	17	SENT_391	[p22l925t413r1042b444],
17	metabolism	NN	O	metabolism	prep_of	14	SENT_391	[p22l151t455r310b479],
18	.	.	O	.	_	0	SENT_391	[p22l151t455r310b479],

1	J	NNP	O	J	nn	4	SENT_392	[p22l321t456r341b479],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_392	[p22l346t455r495b479],
3	Exp	NN	O	exp	nn	4	SENT_392	[p22l503t456r554b486],
4	T	NN	O	t	_	0	SENT_392	[p22l567t456r586b479],
5	her	PRP$	O	she	dep	4	SENT_392	[p22l584t455r632b479],
6	.	.	O	.	_	0	SENT_392	[p22l584t455r632b479],

1	2006	CD	DATE	2006	_	0	SENT_393	[p22l646t456r735b484],
2	;	:	O	;	_	0	SENT_393	[p22l646t456r735b484],
3	3	CD	NUMBER	3	number	4	SENT_393	[p22l646t456r735b484],
4	18	CD	NUMBER	18	dep	1	SENT_393	[p22l742t456r777b479],
5	:	:	O	:	_	0	SENT_393	[p22l742t456r777b479],
6	l22	CD	NUMBER	l22	dep	4	SENT_393	[p22l784t456r936b479],
7	(	CD	NUMBER	(	num	8	SENT_393	[p22l784t456r936b479],
8	Fl229	NN	O	fl229	dep	6	SENT_393	[p22l784t456r936b479],
9	.	.	O	.	_	0	SENT_393	[p22l784t456r936b479],

1	Richter	NNP	PERSON	Richter	nn	2	SENT_394	[p22l1176t163r1273b187],
2	O	NNP	PERSON	O	_	0	SENT_394	[p22l1283t164r1313b192],
3	,	,	O	,	_	0	SENT_394	[p22l1283t164r1313b192],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_394	[p22l1325t163r1391b187],
5	O	NNP	O	O	appos	2	SENT_394	[p22l1401t164r1431b192],
6	,	,	O	,	_	0	SENT_394	[p22l1401t164r1431b192],
7	From	IN	O	from	_	0	SENT_394	[p22l1443t164r1540b187],
8	MF	NN	O	mf	prep_from	2	SENT_394	[p22l1550t164r1604b192],
9	,	,	O	,	_	0	SENT_394	[p22l1550t164r1604b192],
10	Thon	NNP	PERSON	Thon	nn	11	SENT_394	[p22l1616t163r1686b187],
11	KP	NNP	O	KP	appos	8	SENT_394	[p22l1696t164r1745b192],
12	,	,	O	,	_	0	SENT_394	[p22l1696t164r1745b192],
13	Eichelbaum	NNP	PERSON	Eichelbaum	nn	14	SENT_394	[p22l1756t163r1913b187],
14	M	NNP	O	M	appos	8	SENT_394	[p22l1923t164r1959b192],
15	,	,	O	,	_	0	SENT_394	[p22l1923t164r1959b192],
16	Kivisto	NNP	PERSON	Kivisto	nn	17	SENT_394	[p22l1971t163r2067b187],
17	KT	NNP	O	KT	appos	8	SENT_394	[p22l1176t205r1226b228],
18	.	.	O	.	_	0	SENT_394	[p22l1176t205r1226b228],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_395	[p22l1239t204r1400b235],
2	P403A4	NN	O	p403a4	_	0	SENT_395	[p22l1411t205r1519b228],
3	and	CC	O	and	_	0	SENT_395	[p22l1530t204r1577b228],
4	P-glycoprotein	NN	O	p-glycoprotein	nn	5	SENT_395	[p22l1587t204r1782b235],
5	expression	NN	O	expression	conj_and	2	SENT_395	[p22l1793t204r1933b235],
6	in	IN	O	in	_	0	SENT_395	[p22l1943t204r1968b228],
7	human	JJ	O	human	amod	10	SENT_395	[p22l1978t204r2068b228],
8	small	JJ	O	small	amod	10	SENT_395	[p22l1177t246r1246b270],
9	intestinal	JJ	O	intestinal	amod	10	SENT_395	[p22l1269t246r1388b270],
10	enterocytes	NNS	O	enterocyte	prep_in	2	SENT_395	[p22l1409t250r1558b277],
11	and	CC	O	and	_	0	SENT_395	[p22l1580t246r1627b271],
12	hepatocytes	NNS	O	hepatocyte	conj_and	10	SENT_395	[p22l1648t246r1810b277],
13	:	:	O	:	_	0	SENT_395	[p22l1648t246r1810b277],
14	a	DT	O	a	det	16	SENT_395	[p22l1834t254r1848b270],
15	comprehensive	JJ	O	comprehensive	amod	16	SENT_395	[p22l1869t246r2067b277],
16	analysis	NN	O	analysis	dep	2	SENT_395	[p22l1177t288r1281b319],
17	in	IN	O	in	_	0	SENT_395	[p22l1309t288r1334b312],
18	paired	JJ	O	paired	amod	20	SENT_395	[p22l1359t288r1442b319],
19	tissue	NN	O	tissue	nn	20	SENT_395	[p22l1468t288r1543b312],
20	specimens	NNS	O	specimen	prep_in	16	SENT_395	[p22l1571t288r1713b319],
21	.	.	O	.	_	0	SENT_395	[p22l1571t288r1713b319],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_396	[p22l1743t288r1796b312],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_396	[p22l1823t288r1972b312],
3	T	NN	O	t	_	0	SENT_396	[p22l1999t289r2019b312],
4	her	PRP$	O	she	dep	3	SENT_396	[p22l2016t288r2064b312],
5	.	.	O	.	_	0	SENT_396	[p22l2016t288r2064b312],

1	2004	CD	DATE	2004	_	0	SENT_397	[p22l1176t330r1416b358],
2	;	:	O	;	_	0	SENT_397	[p22l1176t330r1416b358],
3	75:172	CD	NUMBER	75:172	number	4	SENT_397	[p22l1176t330r1416b358],
4	-183	CD	NUMBER	-183	dep	1	SENT_397	[p22l1176t330r1416b358],
5	.	.	O	.	_	0	SENT_397	[p22l1176t330r1416b358],

1	Wakasugi	NNP	PERSON	Wakasugi	nn	2	SENT_398	[p22l1176t371r1308b402],
2	H	NNP	PERSON	H	_	0	SENT_398	[p22l1318t372r1348b400],
3	,	,	O	,	_	0	SENT_398	[p22l1318t372r1348b400],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_398	[p22l1360t372r1430b395],
5	I	NNP	O	I	appos	2	SENT_398	[p22l1442t372r1459b400],
6	,	,	O	,	_	0	SENT_398	[p22l1442t372r1459b400],
7	Ito	NNP	PERSON	Ito	nn	8	SENT_398	[p22l1470t372r1505b395],
8	T	NN	O	t	appos	2	SENT_398	[p22l1517t372r1543b400],
9	,	,	O	,	_	0	SENT_398	[p22l1517t372r1543b400],
10	et	FW	O	et	nn	11	SENT_398	[p22l1555t375r1578b395],
11	al.	FW	O	al.	appos	2	SENT_398	[p22l1589t371r1618b395],
12	.	.	O	.	_	0	SENT_398	[p22l1589t371r1618b395],

1	Effect	NN	O	effect	_	0	SENT_399	[p22l1630t371r1709b395],
2	of	IN	O	of	_	0	SENT_399	[p22l1720t371r1750b395],
3	clarithromycin	NN	O	clarithromycin	prep_of	1	SENT_399	[p22l1757t371r1950b402],
4	on	IN	O	on	_	0	SENT_399	[p22l1960t379r1993b395],
5	renal	JJ	O	renal	amod	6	SENT_399	[p22l2002t371r2067b395],
6	excretion	NN	O	excretion	prep_on	3	SENT_399	[p22l1177t413r1298b437],
7	of	IN	O	of	_	0	SENT_399	[p22l1307t413r1337b437],
8	digoxin	NN	O	digoxin	prep_of	6	SENT_399	[p22l1342t413r1449b444],
9	:	:	O	:	_	0	SENT_399	[p22l1342t413r1449b444],
10	interaction	NN	O	interaction	dep	1	SENT_399	[p22l1460t413r1599b437],
11	with	IN	O	with	_	0	SENT_399	[p22l1608t413r1666b437],
12	P-glycoprotein	NN	O	p-glycoprotein	prep_with	10	SENT_399	[p22l1674t413r1875b444],
13	.	.	O	.	_	0	SENT_399	[p22l1674t413r1875b444],

1	Clin	NNP	O	Clin	nn	3	SENT_400	[p22l1888t413r1941b437],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_400	[p22l1949t413r2067b437, p22l1177t455r1217b479],
3	Ther	NNP	O	Ther	_	0	SENT_400	[p22l1228t455r1293b479],
4	.	.	O	.	_	0	SENT_400	[p22l1228t455r1293b479],

1	l998	NN	O	l998	_	0	SENT_401	[p22l1310t455r1547b484],
2	;	:	O	;	_	0	SENT_401	[p22l1310t455r1547b484],
3	64	CD	NUMBER	64	num	5	SENT_401	[p22l1310t455r1547b484],
4	:	:	O	:	_	0	SENT_401	[p22l1310t455r1547b484],
5	l23	CD	NUMBER	l23	dep	1	SENT_401	[p22l1310t455r1547b484],
6	—	NN	O	—	dep	5	SENT_401	[p22l1310t455r1547b484],
7	128	CD	NUMBER	128	num	6	SENT_401	[p22l1310t455r1547b484],
8	.	.	O	.	_	0	SENT_401	[p22l1310t455r1547b484],

